Evolutionary comparison in the vertebrate lineage of WT1, a Wilms' tumour predisposition gene by Kent, Gillian R.L.
Evolutionary Comparison In The Vertebrate Lineage of WTI, a Wilms' Tumour 
Predisposition Gene 
Gillian R.L. Kent 
Ph.D. 
University of Edinburgh 
and 




This thesis was composed by myself alone 
The work herein is my own unless clearly stated 
In memory of my grandmother 
Lavinia Paterson 
Acknowledgements 
There are many people without whom this project would never have got off the 
ground. Working on so many species would not have been possible without very 
many generous gifts from around the world. Hopefully I have managed to mention all 
of these within the text but there are several people I would particularly like to thank. 
Anne Marie Coriat for the alligator in situ data. 
Trevor Jowett for the zebrafish material and also allowing me to spend a week in a 
contamination-free lab. 
Stephen Wilcox and Jenny Marshall Graves for screening the marsupial library. 
David Housman, Daniel Haber and Alan Buckler for the mouse and human WT1 
cDNA clones. 
P.A. Tsonis for sending me the axolotl WT1 sequence. 
During the last three and a half years at the MRC there have been an immense 
number of kind people who have been very generous with both their time and their 
advice. Among those I probably pestered the most, pinched their solutions, borrowed 
their books etc. are; 
Duncan Davidson, Jonathan Bard, Bob Hill for trying to teach me development. 
Isabel Hanson, Ian Jackson, Wendy Bickmore, Anne Seawright, Andreas Schedi, 
Cathy Abbott for excellent technical advice. 
Lesley McInnes for teaching me the whole-mount technique. 
John Inglis for advice on degenerate PCR and evolution analysis. 
Also without the help of the following I probably would have lost a lot more sleep 
over this thesis. 
Kathy Williamson and Duncan for initiating me into the mysteries of Papayrus 
Andreas, Sarah Danes, James Williams for proofreading. 
Douglas, Norman and Sandy in Photography. 
Justin for always finding one more interesting article. 
Also the whole lab. for putting up with me while I've been writing. 
Finally I've been lucky enough to have some excellent supervisors. 
Andy Leigh-Brown for being my University supervisor. 
Veronica van Heyningen for encouragement, ideas, keeping my English at bay and 
generally trying to mother us all. 
Nick Hastie for always wanting more data! 
4 
Abstract 
The WTI gene was isolated by positional cloning as a candidate gene implicated 
in predisposition to the paediatric kidney cancer Wilms' tumour. Because of its early 
onset and histological resemblance to immature kidneys, Wilms' tumour was thought 
to arise from an aberration in the normal developmental pathway. From the amino 
acid sequence, WTI was predicted to be a transcription factor with an N-terminal 
proline/glutamine rich transregulatory domain and four C-terminal TFIIIA-like zinc 
fingers. Two alternative splices have been found in the transcript, resulting in the 
insertion of l7aa or 3aa (KTS). Functional analysis has shown that WTI is capable of 
sequence specific DNA binding and of regulating transcription. Analysis of WT1 
mRNA in the developing embryo has shown a pattern of expression consistent with an 
important role in nephrogenesis, specifically an involvement in mesenchymal-epithelial 
cell transition. WTI analysis in Wilms' tumours revealed that both functional copies 
are lost in about 10% of sporadic Wilms' tumours. This confirmed the role of WTI as 
a tumour suppressor gene in at least some cases, (following Knudson's two hit 
hypothesis for tumorigenesis). Predisposition to Wilms' tumour can also be 
associated with developmental abnormalities, including genitourinary malformations. 
Expression of WT1 is seen in the earliest stages of gonad development and 
constitutionally heterozygous mutations in WT1 are frequently associated with 
genitourinary abnormalities. The most severe abnormalities, in Denys-Drash 
syndrome, have been linked to heterozygous constitutional WTI missense mutations 
in the zinc fingers. The cloning of the mouse Wtl gene revealed a very high level of 
similarity to the human gene, as well as a very similar pattern of expression during 
development. The major problem with the use of this system as a model is that 
Wilms' tumours have never been observed in mouse, even in the sey()ey)  mouse 
which is hemizygous for Wtl. 
In order to complement the current lines of investigation it was decided to 
attempt to isolate a number of WTI orthologs from a range of vertebrates to produce 
wider sequence comparison and eventually a functional comparison. Evolutionary 
analysis is a particularly appropriate line of investigation for kidney development 
because across all the vertebrates nephrogenesis seems to occur in a similar manner 
and kidney tumours which histologically resemble Wilms' tumours have been found in 
many vertebrates. Also mammalian kidney development passes through three stages. 
In the lower vertebrates only the first two stages occur so that the human foetal 
kidney resembles the adult kidney of the anamniotes. In all the vertebrates the close 
association of the urinary and gonadal systems is maintained, with variations. 
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Therefore the investigation of WTI expression in these different but similar systems 
may point to important roles for WT1. It will also produce more manipulable animal 
models in which the roles of many other developmental genes are now being 
investigated. 
The conservation of sequences homologous to WTI in a range vertebrates was 
first demonstrated by zoo blot hybridisation with human and mouse WT1 probes. 
Partial clones of WT1 orthologs from rat, pig, chick, alligator, Xenopus laevis and 
zebrafish were then isolated by cross-species PCR, using degenerate primers designed 
on the basis of the mouse and human sequences. These were then used as probes to 
isolate larger regions of the gene from cDNA libraries. Clones for marsupial mouse, 
chick, alligator and zebrafish were obtained. Comparison of these has shown that 
there is a high level conservation of the predicted protein sequence due to selection 
pressure. The highest level of conservation is found in the DNA binding zinc fingers, 
which is consistent with that observed in comparisons of other transcription factors. 
Investigation of the conservation of the two alternative splice forms of the gene 
indicated that the KTS alternative splice which is involved in the modulation of DNA 
binding is very probably conserved in zebrafish, but the 17 amino acid alternative 
splice was not observed outside the eutherian mammals and was also adjacent to one 
of the most highly substituted regions of the protein indicating .that this could be 
involved in class specific development. Much of the transregulatory domain was 
highly conserved, the exceptions being two homopolymer motifs indicating that these 
may have arisen due to instability of a trinucleotide repeat and may not be functionally 
important. The mutations so far described in WT1 have all, bar one, been located at 
conserved positions. 
The expression of WT1 in chick, alligator and Xenopus has been investigated by 
Northern blotting and whole mount in situ hybridisation and the expected pattern 
during kidney development seen, consistent with a conserved function. Expression 
was also observed in lateral plate mesoderm and ectodermal derived structures which 
has also been observed in mammals. 
Therefore WTI is a highly conserved gene at both the structural and expression 
level, indicating an evolutionary conserved role in development. This study paves the 
way for a detailed comparison of genitourinary development and Wilms' like tumours 
in the vertebrates. 
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One of the major achievements of molecular genetics so far has been to increase 
the understanding of the basis of human genetic disease. In recent years there has 
been a flood of information pinpointing genes in which lesions can lead to a particular 
disease. In many cases the reason why a genetic lesion is giving rise to a disease is 
easily understood. The classic examples being haemophilias A and B, which result 
from Factor VIII and Factor IX mutations, and the thalassemias which are due to 
mutations of the globin genes. In the vast majority of cases the gene was isolated 
using some information about the gene product - functional cloning. In the last few 
years genes have been isolated by virtue of their physical or genetic linkage to a 
disease locus i.e. by reverse genetics, otherwise known as positional cloning. These 
include the CFTR gene in cystic fibrosis, NFl in neurofibromatosis type 1, FMR in 
Fragile X syndrome and RB] in retinoblastoma. It is then necessary to discover the 
function of the gene product and understand how malfunction can result in the 
particular disease phenotype. 
Cancers and developmental abnormalities are two of the most complex disease 
types, the causes of which are just beginning to be unravelled through molecular 
genetics. Not infrequently these two superficially different classes of disease turn out 
to be intimately related. Cancers arise from a loosening of the strict growth controls 
on cells and development proceeds by the regulation of cell proliferation and 
differentiation. Wilms' tumour is an example of both a kidney developmental 
abnormality and a cancer. 
A predisposition gene for Wilms' tumour, WTI, has been isolated by positional 
cloning on the basis of its genetic linkage to the disease. Since its isolation an 
important role for WTI in kidney and gonad development, as well as in tumorigenesis, 
has been demonstrated. That it is not the sole gene involved in formation of Wilms' 
tumour is also clear. WTI has been shown to have activities consistent with a role as 
a regulatory transcription factor but as yet its interactions in vitro and in vivo are not 
clearly understood. This particularly applies to the part it is playing in a mesenchyme 
to epithelial transition, and how WTI mutants give rise to genitourinary abnormalities. 
Investigations have so far been hampered by the lack of a relevant model system. 
An evolutionary comparison of WD will have many uses. A wider sequence 
comparison of the WT] gene will facilitate the targeting and interpretation of 
structural, functional and mutational analysis. The comparison between the mouse 
and human sequences reveals very little due to the almost complete similarity between 
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the two genes. At the same time the isolation of WTI orthologs will lay the 
foundations for a series of animal models in which WTI can be investigated and 
manipulated. In the case of WTI this is a particularly appropriate line of investigation 
because vertebrate kidney development is based on an initial plan which is then 
modified in the different classes. This seems to have occurred through modifications 
at the later stages of development so that the lower vertebrate kidneys have 
resemblances to foetal mammalian kidneys. By looking at lower vertebrate species it 
may be possible to elucidate the role of WD in early human kidney development. The 
investigation of WTI may also increase the understanding of the evolution of the 
vertebrate kidney. 
1.2 Wilms' Tumour and the identification of a putative predisposition gene-WTI 
1.2.1 Incidence of Wilms' tumour 
Wilms' tumour or nephroblastoma is an embryonic cancer of early childhood 
with 90% of cases presenting in the first 7 years of life, affecting 1 in 10,000 children 
(Young and Miller 1975). The early age of onset and the often undifferentiated 
histopathology of the tumour has suggested that Wilms' tumour can be a result of an 
error in the kidney developmental process, and it is thought to arise from the 
nephrogenic cells of the kidney (Nicholson 1931, Mierau et al, 1987). A 
comprehensive study of the incidence of Wilms' tumours has been produced by the 
US National Wilmst tumour Survey (Beckwith 1983, Breslow et al., 1988, Olson et al 
1993). Although the tumour is observed world-wide, the incidence varies between 
ethnic groups: it is higher in the American Black population than Caucasian (Kramer 
1984) and lower in Asian than European populations (Tadokoro et al, 1992). Most 
cases are sporadic, but 1% of cases are familial with tumour predisposition inherited 
as an autosomal dominant trait with variable penetrance (Matsunga 1981). In 
addition incidence of associated congenital abnormalities in WT patients is greater 
than in the general population. Up to 15% of Wilms' tumour patients have associated 
congenital abnormalities. In particular, 1% have aniridia, 4% have genitourinary 
abnormalities, 1.5% have cardiopulmonary abnormalities and 3% have 
hemihypertrophy (Breslow and Beckwith 1982, Olson et al., 1993). In males who 
have Wilms' tumour and aniridia the frequency of the genitourinary abnormalities rises 
to 40-50% (Shannon et al., 1982, Turleau et al., 1984). The abnormalities can be 
grouped into several syndromes; WAGR, DDS, Penman and BWS (Table 1.1). In the 
case of WAGR patients large cytogenetic deletions have been observed. 
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Table 1.1 Congenital abnormality syndromes associated with Wilms' tumour 
Syndrome Abbreviation Phenotvve Reference 
WAGR WAGR Wilms' tumour, Aniridia, *Genitourinary Abnormalities, Miller et al., 1964 
Mental Retardation  
Denys-Drash DDS Wilms' tumour, Gomerular Nephropathy, Denys et al., 1967  
**Genitourinary Abnormalities Drash et al., 1970 
Beckwith Wiedemann BWS Wilms Tumour, Adrenocortical 	Carcinoma, Beckwith 1969 
Hepatoblastoma, Foetal Gigantism, Exomphalos, Wiedemann 1964 
Macroglossia, Organomegaly, Hemihypertrophy, 
Gonadal Abnormalities  
Perlman Wilms' Tumour, Foetal Gigantism, Bilateral Penman et al., 1973 
Nephromegaly, Nephroblastomatosis, Cryptorchidism  
*Genitourinary Abnormalities 	 Cryptorchidism, Hypospadias, Fused Kidneys, Double Collecting System 
**Genitourinary Abnormalities A spectrum of abnormalities, from the abnormalities above all the way to Pseudohermaphroditism 
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1.2.2 Knudson and Strong two hit model for tumorigenesis. 
Knudson (1971) originally proposed his two hit model of tumorigenesis for 
retinoblastoma (RB), a childhood eye tumour. Using statistical analysis he showed 
that the incidence of unilateral (in one eye), bilateral (in both eyes), familial and 
sporadic cases fitted a minimum of two mutations or 'hits' occurring to initiate 
tumorigenesis. He proposed that for familial cases the first mutation is present in the 
germline and so only one somatic mutation had to occur. In non germline cases both 
mutations had to be somatic and so the later onset than in familial cases was explained 
by the longer time for two mutations to occur. The onset of bilateral cases tended to 
be earlier, in the same range as familial tumours, also indicating the presence of a 
germline predisposition mutation. The tumour is limited to childhood because the 
target cell population are embryonic retinal precursor cells which disappear with time 
after birth. That the mutations resulted in the loss of a tumour suppressor was 
suggested by the association of retinoblastoma with deletions at chromosome 13q14 
as well as loss of heterozygosity for this region in the tumours, the latter being 
consistent with a second hit (which would effectively expose the first hit in a recessive 
gene) (Cavenee et al., 1983). 
That the malignant phenotype can be due to the loss of gene function as 
opposed to dominantly acting oncogenes had been suggested by experiments which 
had demonstrated that a wild type cell could suppress the tumorigenic effect of 
malignant cells on cell fusion (Harris et al., 1969, Stanbridge 1976). The tumour 
suppressor gene involved in retinoblastoma, RB], has been cloned (Friend et al., 
1986, Lee et al., 1987) and so far all cases have been found to be consistent with 
Knudson's model (Goodrich and Lee 1990). 
Comparison of the incidence of Wilms' tumour with retinoblastoma showed 
many similarities, an earlier onset of the presumed germline and bilateral cases, and in 
the few familial cases autosomal dominant inheritance. On the basis of this it was 
proposed that Wilms' tumorigenesis could also arise from two 'hits' (Knudson and 
Strong 1972). The major difference between the two was that although the sporadic 
bilateral (i.e. germline) cases of both were frequent the number of familial cases was 
much lower in WT. These Wi'- familial cases did not segregate with chromosome 
lip to which the sporadic cases had been mapped. This indicated that although there 
were similarities in the molecular basis of the two childhood tumour types, WT maybe 
more complicated, with more than locus involved. 
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1.2.3 Mapping of the WAGR locus to 11p13 
The first information concerning the location of a predisposition gene came 
from the karyotypic analysis of rare cases where Wilms' tumour was associated with 
congenital abnormalities and visible cytogenetic deletions. An interstitial deletion in 
the short arm of chromosome 11 was found in several cases of WAGR syndrome 
(Franke et al., 1977). The localisation was refined in two cases where the only 
deleted region was lipl3 (Franke et al., 1979, Riccardi et al., 1978). This would be 
consistent with the first hit of Knudson theory. That up may also be involved in 
second hit was shown by loss of heterozygosity for this region in tumours compared 
to somatic tissue (Fearon et al., 1984, Orkin et al., 1984, Reeve etal., 1984). Loss of 
heterozygosity on lip was also found to occur in other types of tum ours indicating a 
more general tumour suppressing activity (Koufos et al., 1985). That there was a 
tumour suppressing activity present on chromosome 11 was demonstrated 
experimentally by suppressing tumorigenicity of a putative Wilms' tumour cell line in 
nude mice by introducing chromosome 11 (Weissman et al., 1987). 
1.2.4 Isolation of WTI 
More WAGR cases containing constitutional deletions of lip 13 were used to 
define the WAGR region to between the catalase and follicle stimulating hormone 3 
(FSH) genes (van Heyrnngen etal., 1985, Glaser et al., 1986, Porteous et al., 1987, 
Bickmore et al., 1989). To define the exact extent of the deletions detailed physical 
and genetic maps were built up using newly isolated markers for this region (Porteous 
et al., 1987, Gessler et al., 1989, Compton et al., 1990). Rare cutting enzymes and 
pulsed-field gel electrophoresis were used to identify CpG islands within the region 
(Bickmore et al., 1989) as they are often located at the 5' end of genes (Bird 1986). 
A very detailed physical map of the WAGR region was produced using irradiation 
reduced hybrids in which the only human component was a small part of chromosome 
lip (Rose et al., 1990). 
Lewis et al., (1988) were the first to demonstrate the homozygous deletion of 
an lip 13 marker in a sporadic Wilms' tumour (WiT-3) in a patient with no associated 
abnormalities. The smallest region of overlap (SRO) between the deletions in WiT-3 
was defined, allowing the Wilms' tumour predisposition region to be limited to 345kb 
(Rose et al., 1990). Two single copy probes isolated from chromosome 11 cosmids 
were found to map to this region and were used to isolate a partial cDNA from a pre- 
B cell library that contained an open reading frame (WT33). This was found to 
hybridise to an RNA transcript in mouse and baboon kidney (Call et al., 1990). This 
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Figure 1.1 Schematic representation of the human WTI mRNA transcript 
The exon structure is shown including the two alternative splices (17aa-exon5 and KTS) (Haber et al., 1991, Gessler et al., 1992). The 
major features of the encoded protein, the four zinc fingers, the putative leucine zipper, and the proline/glutamine rich transcription 
regulatory domain including the glycine and proline rich domains within it, are shown. 
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same gene, called WTI, was also isolated by chromosome jumping between CpG 
islands (Gessler et al., 1990). 
1.3 Structure and function of WTI 
The cDNA isolated by Gessler et al., (1990) was 3kb long, corresponding to the 
size of transcript seen in Northern analysis, and contained a 1,725bp open reading 
frame (Figure 1.1). Subsequent analysis of the genomic sequence has shown that the 
transcript is made up of 10 exons, covering 50kb (Haber et al., 1991, Gessler et al., 
1992). 
1.3.1 Zinc fingers 
The sequence of the C-terminal end of the predicted protein was found to 
correspond to four zinc finger motifs of the Cys2 His2 type, first identified in 
Xenopus TFIIIA (Miller et al., 1985). Zinc fingers contain conserved cysteine and 
histidine residues which chelate a zinc ion holding together the tertiary structure of the 
finger (Miller et al., 1985, Pavietich and Pabo 1991, Figure 1.2a). Over 1000 finger 
motifs have been identified in more than two hundred proteins, mostly transcription 
factors e.g. GIl family (Ruppert et al., 1988), and Spi (Kadonaga et al., 1987). 
These motifs have been shown many times to have sequence specific DNA binding 
activities (reviewed in El-B aradi and Pieler 1991) and the orientation of three finger 
regions, Zif 268 (EGR1) (Pavietich and Pabo 1991), GUi (Pavietich and Pabo 1993) 
and tamtrack (Fairall et al., 1993) when bound to DNA has been elucidated by X-ray 
crystallography of DNA-protein co-crystals (Figure 1.2b). The WTI fingers 2-4 most 
closely resemble the three fingers in EGR2 (Krox 20) (Joseph et al., 1988) with an 
identity at the amino acid level of 67% and a similarity of 75% (Figure 1.2c). No 
sequence similarity is seen outside the zinc fingers except for a similar richness in 
certain amino acids. EGR2 belongs to the EGR family which contain virtually 
identical zinc fingers but with only a few regions of homology in the rest of the gene 
(Crosby et al., 1992). They have a conserved function in the early growth response 
to serum stimulation (Sukhatme 1992) and development (Nieto et al., 1991). 
1.3.2 Proline/glutamine rich region 
Upstream of the zinc fingers the WTI coding sequence is particularly rich in 
proline and glutamine residues including a run of fifteen amino acids, thirteen of which 
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Figure 1.2 Secondary and tertiary structure of zinc fingers 
a NMR determined structure for the second zinc finger of SWI5. This shows the 
antiparallel P strands followed by the a helix which are held in the 'finger' 
conformation by the chelation of a zinc 2+ ion by two cysteine and two histidine 
residues and the hydrophobic core (Neuhaus et al., 1990). 
b The orientation of the three zinc fingers of EGRJ in relationship to a DNA binding 
site as determined by the X-ray analysis of the protein-DNA co-crystal (Pavletich and 
Pabo 1991). The finger contacts the DNA in the major groove with the 'tip' of the 
finger closest to DNA, i.e. the C-terminal end of the 3 strand and N-terminal end of 
the a helix. The fingers are also shown to be wrapping around the DNA. 
(Illustrations taken from Travers 1993) 
c Comparison of the amino acid sequence of the zinc fingers of EGR1&2 with fingers 
2-4 of WT1. The conserved zinc chelating residues are shown in bold and the 
structural regions of the fingers indicated, including the regions involved in DNA 
binding. The residues directly involved in base recognition are underlined. 
d Pattern of contacts of the three zinc fingers of EGR1 (Zif 268) with their triplet base 
recognition sequence. The pattern is identical for fingers 1&3 but is different in ZF2 
due to the substitution of an arginine for a threonine residue. 
The positions within the zinc fingers involved in base contacts are circled and the a 
helix is shaded. *Indicates an aspartate residue which interacts with the first arginine 
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are proline. Although there is no actual sequence homology between them, regions 
rich in proline, glutamine or acidic amino acids have been found in an increasing 
number of transcription factors, OTF2 (proline and glutamine rich), Spi (glutamine 
rich), EGR family (proline rich) and CTF/NF1 (proline rich) (Mitchell and Tjian 
1989). Transcription regulatory activity has been localised to this region in CTF/NF1 
(Mermond et al., 1988). The mechanism by which these domains act to alter 
transcription is just beginning to be elucidated. In higher eukaryotes transcription is 
carried out by RNA polymerase H in association with many general transcription 
factors (GTF) e.g. TFIIA-I (Zawel and Reinberg, 1993). Recently interactions 
between these GTFs and regulatory transcription factors have been described e.g. 
between c-rel and TFII'r—the TATA box binding protein (Kerr etal., 1993). 
1.3.3 Alternative splices 
WTI is subject to alternative splicing of the RNA transcript at two positions 
(Figure 1.1). One is an insertion of 3 amino acids, KTS (lysine, threonine, serine) in 
the linker region between zinc fingers 3 and 4 (Haber et al., 1990) and the other 
occurs between the proline/glutamine rich region and the fingers inserting an extra 17 
amino acids (Haber et al., 1991). From characterisation of the genomic structure of 
WTI it is known that the 3 amino acid insertion is achieved through the use of 
alternative splice donor sites in exon 9, and the 51 nucleotides which specify the 17 
amino acid splice are contained within a separate exon, exon 5 (Haber et al., 1991, 
Gessler et al., 1992). The in vivo function of these splices is not known. The 17 
amino acid insertion is at the C4erminal end of a putative leucine zipper (Landshultz 
et al., 1988). Since zippers are dimerisation motifs (Kouzandes et al., 1988) insertion 
at its end might change dimerisation characteristics of the protein. 
The KTS insertion is in a finger linker region, which is a highly conserved 
sequence of amino acids in the TFIIIA type fingers. Insertions and changes in this 
sequence have been shown to change the DNA binding characteristics of TFIIIA 
(Choo and Kiug 1993). The mRNA transcripts containing the KTS insertion have 
been observed to be the most plentiful RNA transcript (Brenner et al., 1992). 
In contrast to many genes a tissue specific pattern of expression of the four 
possible forms of the RNA has not been observed. Instead in the tissues examined a 
constant ratio is present (Haber et al., 1991). On cloning the mouse homolog of WTI 
(Buckler et al., 1991), which is 95% conserved at the amino acid level, both 
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alternative splices were also seen and similar ratios were observed in a wide range of 
tissues (Haber et al., 1991). 
1.3.4 Identification of the WTI protein 
Using WTI specific antibodies, WT1 has been shown to be a 49-54kDa protein, 
this correlates well with the size predicted from the primary sequence of 47-48.9kDa 
(Morris et al., 1991, Telerman et al., 1992). The range in size is thought to arise 
from alternative splicing or to phosphorylation. The latter could not be detected 
when transiently transfected COS-1 cells were 32P labelled although there are 
potential phosphorylation sites (Morris et al., 1991). Subcellular localisation to the 
nucleus consistent with WTI being a transcription factor has been shown by cellular 
fractionation, immunohistochemistry (Morris et al., 1991, Telerman et al., 1992) and 
epitope tagging (Pelletier etal., 1991c). 
1.3.5 Transcription factor activity 
1.3.5.1 DNA binding 
Numerous studies have tried to define in vitro, in various ways, the consensus 
DNA binding sites for the WT1 zinc fingers. The -KTS but not the +KTS isoform 
was found to bind sequences extremely similar to and including the EGR1 consensus 
(GCGGGGGCG) but not to other GC rich sequences, such as those bound by Spi 
and myb (Rauscher et al., 1990). It is not surprising that WTI is capable of binding 
the EGR1 consensus considering the similarity of fingers 2-4 to those of EGR1, 
especially in those regions known to interact with the DNA (Figure 1.2c&d). The 
+KTS isoform has also been shown to bind DNA in a sequence specific manner 
including some of the -KTS binding sites (Bickmore etal., 1992, Wang et al., 1993b). 
As yet no true consensus sequence has been identified for either isoform. 
1.3.5.2 Target promoters 
WTI has been shown in transfection systems to bind and down-regulate 
transcription from genes whose protein products are known to have mitogenic 
properties, EGRJ (Madden et al., 1991), IGF2 (Drummond et al., 1992), PDGFA 
chain (Gashler et al., 1992, Wang etal., 1992) and IGFJR (Werner etal., 1993). 
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These genes could well have a physiological role in kidney development. 
EGR1 is expressed in response to serum stimulation of cells, WTI may antagonise this 
mitogenic response to growth factors by repressing EGR1 expression or repressing 
expression of EGR1 activated genes, as it binds to EGR1-like binding sites. This may 
only occur in certain circumstances because unlike EGRJ, WTI is not expressed in 
response to serum stimulation (Morris et al., 1991). IGF2 (insulin-like growth factor 
2) is a growth factor which is thought to have an important role in development. The 
overexpression of IGF2 mRNA in Wilms' tumours (Reeve et al., 1985, Scott et al., 
1985) makes it a good candidate for regulation by WTI. Down-regulation of IGF2 
gene expression can be seen in the kidney as WT1 is up-regulated (Drummond et at., 
1992, Yun et al., 1993). IGF1R (insulin-like growth factor 1 receptor) is a 
transmembrane tyrosine kinase thought to mediate the effects of IGF1&2. In Wilms' 
tumours there is an inverse relationship between the levels of WTI and IGFJR 
expression which correlate with histological differences (Werner et al., 1993). 
Blockage of IGF1R in nude mice using antibodies can prevent growth of Wilms' 
tumours after inoculation with transformed cells (Gansler et al., 1989). PDGFA 
(platelet derived growth factor A chain) is another growth factor and is a powerful 
chemoattractant and mitogen for cells of mesenchymal origin (Deuel 1987). The 
importance of PDGFA in kidney differentiation has yet to be demonstrated but 
mesenchymal cells play a large role in kidney formation (see below). Therefore if 
functional WTI is lost in Wilms' tumours the loss of repression of these genes and 
therefore their expression may lead to a stimulation of growth as opposed to 
differentiation (Sukhatme 1992). 
1.3.5.3 Mapping of functional domains 
It has been possible, for some transcription factors, to define regions 
responsible for the transacting activity by making deletions in these regions. It has 
been shown that EGR1 contains four regions which are responsible for transactivation 
and one that mediates transrepression (Russo et al., 1993). Binding of WTI to DNA 
is necessary for transrepression and activation. The transrepression activity has been 
mapped to the proline/glutamine rich region as transferring this region to a 
heterologous DNA binding motif (GALA) also transfers the transrepression activity 
(Madden et al., 1993). Finer mapping of this region has failed to produce any 
convincing further localisation of function (Madden et al., 1993, Wang et al., 1993a). 
The deletion of three homopolymer motifs, (Glycine)5 (GGGGG), (Proline)13 
(PAPPPAPPPPPPPPP), (Proline)4 (PPPP) and mutations in the putative leucine 
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zipper reduce but do not ablate transrepression activity suggesting that the effect is 
due to a structural disturbance rather than function residing in this region (Figure 1.1). 
1.3.5.4 Protein-protein interactions and modulation of WTI activity 
From the initial simple model of transcriptional regulation in prokaryotes it has 
become clear that eukaryotic transcriptional regulation occurs through the interaction 
of multiple factors often bound to multiple promoter sequences (Zawel and Reinberg, 
1993). There is some evidence for the modulation of WT1 action by association with 
another tumour suppressor, p53 (Maheswaran et at., 1993). Coimmunoprecipitations 
have shown the presence of p53 and WTI in the same complex. Wild type WTI (-
KTS) could enhance the activation by wild type p53 of one of its targets; MCK 
(muscle creatine kinase) promoter. Also the suppression of transcription using EGR1 
consensus sites by WTI (-KTS) was found only to occur in the presence of wild type 
p53, showing that transcriptional repression mediated by WTI is not an intrinsic 
property, but modulated by the cellular environment. The most often observed effect 
on transcription by WTI is transrepression but this is dependent on the number and 
positioning of binding sites and on cell type. The need for multiple binding sites for 
repression to occur may be due to WTI interacting with itself as has been shown for 
Spi (Su etal., 1991). 
1.3.5.5 Regulation of WTI expression 
As yet very little is known about what controls the expression of WTI. It may 
be that other WT predisposition genes are located upstream of WTI and are involved 
in its regulation. The region 5' to the transcriptional start position has been cloned in 
both mouse and human (Pelletier et al., 1991c, Campbell et at., 1993, Hofmann etal., 
1993). Similarities exist between these regions in that neither possess TATA or 
CCAAT elements but there are numerous putative Spi, EGR1, WT1, PAX8, PAX2, 
AP2, AP4 and GAGA binding sites. The presence of numerous Spi sites is consistent 
with other TATA-less, GC-rich promoters. The binding of Spi to the promoter 
region has been demonstrated in vitro (Hofmann et al., 1993). From the sequence of 
the WTI promoter it was predicted that WT1 may bind it own promoter (Hofmann et 
at., 1993). This has now been shown to be the case in vitro (Campbell et at., 1993). 
All four isoforms of WTI can down-regulate its expression, the isoform which most 
efficiently does this was the +17aa, +KTS isoform (Rupprecht et al., 1994). A basal 
promoter region has also been defmed and similar to other GC-rich TATA-less 
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promoters it is non-cell-specific. It has been proposed that in at least one cell line an 
enhancer of transcription lies 50kb downstream in exon 10 (Frazier et al., 1994). 
1.4 Evidence that WTI is a predisposition gene for Wilms' tumour 
On the basis of the structure of the predicted protein it was proposed that WTJ 
could be acting as a transcription factor involved in the control of kidney development 
and that loss of the gene function would perturb development giving cells the 
opportunity to become neoplastic. In order to demonstrate that WTI is involved in 
the development of Wilms' tumours the presence of intragenic mutations, the ultimate 
test for a candidate gene, in tumour DNA was investigated. In addition the 
expression pattern was investigated to see if it was consistent with a role in kidney 
development. 
1.4.1 Mapping deletions in Wilms' tumours to the WTI locus 
Very few Wilms' tumours have homozygous deletions in WTI detectable by 
Southern blotting (Cowell et al., 1991, Royer-Pakora et al., 1991, Ton et al., 1991a). 
In fact most of the Wilms' tumours examined expressed WT1, indicating that in most 
cases more subtle lesions must be occurring than complete ablation of the gene 
product (Gessler et al., 1990, Huang et al., 1990, Pritchard-Jones et al., 1990). 
Comparison of two tumours WiT- 13 and PER which are both homozygously deleted 
for the WT region defined a region of over 150kb (Gessler et al., 1990, Rose et al., 
1990). As the approximate genomic region covered by a gene is 50kb it was possible 
that WT1 was just very closely linked to the real predisposition gene. A second 
mRNA transcript had already been isolated within the WT region which was also 
expressed in the developing kidney (Bonetta et al., 1990, Huang et al., 1990). The 
WT region was reduced by analysis of another sporadic Wilms' tumour homozygously 
deleted for the WT region (Ton et al., 1991a). The deletions were found not to 
extend 3' of the first few exons of WTI and with the 5' end of the WT region defined 
by the 5' extent of the deletion in PER, the WT region was reduced to 16kb. The 
smallest region of overlap of the homozygous deletions in a sporadic Wilms' tumour 
was found to extend 3' of the WTI gene deleting only the last zinc finger and not 
extending as far as the next CpG island (Cowell et al., 1991). These last two 
deletions do not overlap but both delete part of the WTI gene: this heavily implicates 
WTI as the predisposition gene. 
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1.4.2 Intragemc deletions 
In a sporadic unilateral Wilms' tumour, a small intragenic deletion was found, 
the deletion of 25bp at an exon/intron junction resulted in the deletion of zinc finger 3, 
so altering or abolishing DNA binding activity (Haber et al., 1990, Rauscher et al., 
1990, Wang et al., 1993a). LOH on lip  was detected but the tumour was 
heterozygous for the WTI deletion, and so had one normal copy of the gene, 
suggesting that WTJ mutation was the second hit and the predisposing mutation was 
due to LOH for lip. 
The first reported case where a tumour became homozygous for an intragenic 
deletion in WTI was in a patient with bilateral tumours, with no associated 
abnormalities, who had a constitutional deletion of <11kb within the WTI gene. This 
caused a 97bp deletion in the RNA transcript and truncation of the protein by an in-
frame stop codon. Both tumours were shown to have become homozygous for this 
deletion of WTI but analysis of chromosome 11 markers identified these as separate 
events (Huff et al., 1991). A second phenotypically normal case has been shown to 
have a constitutional deletion of two exons that became homozygous in the tumour 
(Tadokoro et al., 1992) (Table 1.2). 
Analysis of the remaining allele in four unilateral WAGR patients with 
constitutional deletions spanning the WT locus showed that in these cases the 
tumours contained mutations in the WTI gene that would produce a truncated protein 
product (Brown et al., 1992, Baird et al., 1992a, Gessler et al., 1993) (Table 1.3). A 
second independent hit would be expected in these cases as becoming homozygous 
for these large deletions would probably lead to cell lethality. These cases therefore 
show that in most instances Knudson's two hit model does apply for Wilms' tumour 
and WT1. 
So far WT] mutations have been detected in only about 10% of the Wilms' 
tumours analysed, and most have been limited to the zinc fingers (Tables 1.2-1.4). 
These will be expected to change or ablate the DNA binding activity. There have 
been a few reports of changes in the rest of the protein. A point mutation has been 
found in a Wilms' tumour that changes a glycine to aspartic acid in exon 3 (codon 
201) (Park et al., 1993c); this has been shown to change TNT] from a transrepressor 
to transactivator. The removal of exon 2 by alternative splicing has also been shown 
to change the properties of WTI in the same way. This exclusion of exon 2 has been 
found only in cells derived from Wilms' tumours and in the absence of other WT1 
mutations. The resultant protein is found to be unable to repress growth of cells 
unlike wild type WT1, implicating it in tumorigenesis (Haber et al., 1993). Another 
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Table 1.2 WTI mutations in WT with no associated congenital abnormalities 
Summary of characterised WTI mutations in Wilms ' tumour cases where there are no associated congenital abnormalities. The genetic 
events which are thought to be the first and second hits in tumorigenesis are shown. 
Tumour Eix1 Karyotype Mutation in WTI Change in WI] Status of mutation First hit Second hit Reference 
Incidence mutation gpn protein in tumour  
unilateral tumour NID 25bp deletion at Exon skipping heterozygous LOH 11 WT] Haber etal., 1990 
exon 9! intron 9 deletes ZF3 mutation 
boundary  
unilateral tumour N/D missense mutation 366R-C in ZF2 heterozygous ? ? Little et al., 1992a 
inexon8  
unilateral tumour 46XX 4bp insertion in truncation in homozygous WTI LOH lip Park et al., 1993b 
exon 2 exon 2  truncation  
bilateral germline 46XX <11kb deletion from exon 6 deleted, 1) homozygous 1) WT] 1) LOH lip Huff et al., 1991 
intron 5 to 6 truncation in 2) homozygous truncation 2) LOH lip 
exon 7 2) WT] 
truncation  
bilateral germline N/D chain termination 390R-STOP, 1) homozygous 1) WT] 1) LOH lip Little et al., 1992a 
mutation in exon 9 truncation 2) heterozygous truncation 2)? 
in ZF3 2) WI] 
truncation  
unilateral germline 46XY 8kb deletion truncation in homozygous WTI LOH lip Tadokoro et al., 
introns 5-7 ZF2  truncation  1992 
unilateral tumour 46XY lbp insertion in frameshift in homozygous WT] LOH Coppes et al., 
exon 10 ZF4, extension of mutation 1993a 
66aa  
unilateral tumour 46XX lbp deletion in frameshift in homozygous V/Ti LOH Coppes et al., 
exon 10 ZF4, extension of mutation 1993a 
66aa  
unilateral germline 46XX chain termination 362R-STOP homozygous V/Ti LOH Coppes et al., 
mutation in exon 8 truncation truncation 1993a 
in ZF2  
unilateral germline 46XX missense mutation 394R-W homozygous WI] LOH Akasaka et al., 
in exon 9 -  mutation  1993 
unilateral tumour NID chain termination 390R-STOP homozygous V/Ti LOH Varanasi et al., 
mutation in exon 9 truncation truncation 1994 
inZF3  
unilateral tumour N/D deletion & insertion truncation homozygous WI] LOH Varanasi et al., 
in exon 9 in ZF3  truncation  1994 
unilateral tumour N/D chain termination 1) 362R-STOP heterozygous WT] WI] Varanasi et al., 
mutation in exon 8 truncation in ZF2 mutation mutation 1994 
7bp insertion in 2) frameshift and 
exon 3 truncation  
unilateral tumour N/D chain termination 362R-STOP homozygous WI] LOH Varanasi et al., 
mutation in exon 8 truncation truncation 1994 
in ZF2  
unilateral tumour N/D deletion & insertion frameshift and heterozygous ? ? Varanasi et al., 
in exon 8 truncation  1994 
unilateral tumour N/D missense mutation 338S-Y heterozygous ? ? Varanasi et al., 
 in exon 7  1994 
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point mutation in a Wilms' tumour associated with BWS has been reported. This is a 
phenylalanine to serine change in exon 2 (codon 154), as yet it has to be shown if this 
results in a change in the activity of WTI (Park et al., 1993b). 
1.5 Kidney development and WTI 
In order to demonstrate how WTI could be involved in Wilms' tumour 
formation, the expression of WT1 was investigated in the developing human embryo 
and Wilms' tumours (Pritchard-Jones et al., 1990). Subsequently similar patterns of 
developmental expression have been seen in mouse and rat (Buckler et al., 1991, 
Armstrong etal., 1992, Sharma et al., 1992). 
1.5.1 The developing kidney 
The development of the mammalian metanephric kidney has been investigated 
extensively as an example of how development occurs as a result of the interaction 
between the epithelial and mesenchymal components. The metanephric kidney is 
particularly amenable to investigation as it can be cultured and manipulated in vitro. 
It has been shown using transfilter culturing techniques that differentiation is 
dependent on a series of reciprocal inductions between these two components (Saxen 
1970). 
Kidneys arise from the nephrogenic mesenchyme of the intermediate mesoderm 
which lies between the lateral plate mesoderm and the somitic mesoderm and abuts 
onto the coelom (Gilbert 1991). A wave of differentiation extends caudally down the 
mesoderm from the region of the fourth somite forming the filtration units, the 
nephrons (Saxen 1987). Three kidneys are formed successively, the pronephros, 
mesonephros, and metanephros (Figure 1.3). A wave of degeneration follows the 
wave of differentiation removing the first two kidneys during foetal life leaving the 
metanephros as the functional adult kidney. Although the three kidneys are referred 
to as separate entities they are very closely associated and often it is hard to 
distinguish the very transitory pronephros from the beginning of mesonephric 
differentiation (Torrey 1965). 
Kidney development is initiated when the pronephric analage form in the 
intermediate mesoderm, at about the level of the 4th somite, which then differentiate 
into the pronephric tubules. The pronephric duct extends caudally from this region 
until it joins the cloaca. As it extends it induces the differentiation of more pronephric 
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Figure 1.3 Differentiation of the mammalian kidney 
a The first pronephric tubules are seen in human at about day 22 at the level of the 4th 
somite on either side of the midline. The nephric (pronephric) duct extends caudally 
inducing nephron differentiation. 
b The first mesonephric differentiation occurs about day 24 in human. At this time the 
pronephric tubules are already regressing and the nephric (mesonephric) duct has 
reached the cloaca. 
c The metanephros starts to differentiate about the 5th week of gestation, induced by 
the formation of the ureteric bud from the nephric duct near to the cloaca. The 
pronephros has completely regressed and the mesonephros is starting to do so. The 
gonad is differentiating on the medial side of the mesonephros. (Illustrations from 
Gilbert 1991 after Saxen 1987) 
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tubules and then the mesonephric tubules from the nephrogenic mesoderm. In the 
region of the mesonephros it is known as the mesonephric duct (Figure 1.3b). 
The initiation of the metanephros occurs when the ureteric bud branches off the 
mesonephric duct just above the cloaca (Figure 1.3c). This bud induces the 
condensation of the surrounding nephrogenic mesenchyme (Grobstein 1955, Sariola 
et al., 1989, Bard and Woolf, 1992). The bud then divides dichotomously to form 
many branches (Figure 1.4a). As this is happening the mesenchyme proliferates and 
follows one of three pathways either leading to apoptosis (Coles et al., 1993), 
formation of the supporting stroma or differentiation into epithelia of the nephrons. 
Northern blotting and in situ hybridisation of foetal metanephric kidneys shows 
the up-regulation of WTI mRNA as the metanephric blastema is induced to condense 
by the ureteric bud. The induction leads to the formation of characteristic comma 
shaped and then S-shaped bodies as the nephric tubules differentiate (Figure 1.5a). 
The tubules further differentiate into Bowman's capsules, proximal, and distal tubules, 
including loops of Henle. The distal end joins up to the collecting duct system formed 
from the branched ureteric bud. As differentiation proceeds, WT1 expression is 
limited to the developing nephrons becoming localised to the Bowman's capsule, and 
then to the podocytes (Pritchard-Jones et al., 1990). No WT1 expression has been 
seen in the ureteric bud or the collecting system. There is a second wave of 
differentiation of the nephrogenic blastema when the collecting ducts are no longer 
branching but are still competent to induce the metanephric blastema, forming arcades 
of nephrons which empty into the same collecting duct, thus greatly increasing the 
capacity of the kidney. In humans, mice, and rats the level of WTI expression 
declines after the last wave of nephron differentiation and loss of the renal blastema 
has occurred either before birth or neonatally (Pritchard-Jones et al., 1990, Buckler et 
al., 1991, Armstrong et al., 1992, Sharma et al., 1992). WT1 expression is not 
completely down-regulated as WT1 mRNA transcripts can be detected by PCR and 
the WT1 protein is also present in the adult kidney (Mundlos et al., 1993). 
The differentiation of nephrons is thought to occur in a similar way in all three 
kidneys. A similar pattern of expression is seen during nephron differentiation in the 
mesonephros and the metanephros in both man and mouse. Up-regulation of WTI 
occurs during tubule differentiation, declining as regression of the mesonephros takes 
place (Pritchard-Jones et al., 1990, Armstrong et al., 1992). The earliest nephrons in 
the pronephros are different in that there is no Bowman's capsule but filtration is 
through the coelomic epithelia into the coelom. These structures are known as an 
external glomeruli (Figure 1.5b). In these the pattern of WTI expression is not known 
38 
Figure 1.4 Differentiation of the metanephros 
a The ureteric bud within the metanephric mesenchyme divides to form the collecting 
ducts of the mature kidney and induces the differentiation of the mesenchyme into the 
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cortex and the collecting ducts and loops of Henle form the medulla. (Illustration 










because of their very transient nature. 
Vascularisation of the differentiating metanephric kidney is thought to occur 
mainly by invasion of cells from the surrounding capillaries (Saxen 1987) forming the 
glomeruli and the peritubular capillaries. But there is also by some angiogenesis 
within the kidney as demonstrated by capillary formation occurring in culture in the 
absence of the surrounding capillaries. 
1.5.2 The molecular basis of kidney differentiation 
The series of changes which occur within the cells as nephron development 
proceeds is only just becoming elucidated at the molecular level. The inductive 
signals from the nephric duct are thought to be permissive as opposed to instructive 
because other tissues can act as inducers of nephrogenesis demonstrating that the 
mesenchyme is predetermined (Sariola et al., 1989). Following induction by the 
ureteric bud the mesenchymal cells divide and this is followed by a change in surface 
markers. These changes are associated with alterations in the adhesion properties of 
the cells which are very important for the differentiation of the epithelial nephrons 
from mesenchyme. Thirty six hours after induction typically epithelial markers such 
as laminin A chain and V omorulin (L- CAM) are detected. These are involved in the 
formation of a basement membrane and the formation of cell to cell contacts and the 
polarisation of the cells. The mesenchymai marker protein vimentin is lost at this time 
(Ekbiom 1981). 
The control of these events is still unclear. The expression of several 
transcription factors is up-regulated as the cells are starting to differentiate; N-myc (24 
hours after induction) (Mugrauer and Ekbiom 199 1) and then PAX2, PAX8 and WT1 
(36 hours after induction) (Dressler et al., 1990, Plachov et al., 1990). Therefore the 
localisation and timing of expression of these genes points to a role in the control of 
the induction of nephrogenesis; specifically the mesenchymal to epithelial cell type 
transition taking place in the developing nephrons (Pritchard-Jones et al., 1990). The 
importance of one of these genes, PAX2, has been experimentally demonstrated, as 
antisense oligoñucleotides in culture can block the cell type transition (Rothenpieler 
and Dressier 1993) and overexpression produces deformed kidneys in mouse, which 
resemble the condition congenital nephrotic syndrome (Dressler et al., 1993). It is 
thought that the PAX2 gene may be a target for WTJ regulation because in Wilms' 
tumours PAX2 expression similarly to WTI expression is not down regulated as it is in 
normal kidney after tubular differentiation (Dressier and Douglas 1992). A fourth 
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Figure 1.5 Nephron development 
a Mesenchyme is induced to condense by the nephric duct or the ureteric bud. The 
cells become polarised, form a basement membrane and take on the characteristics of 
epithelia. The condensate develops a lumen becoming comma and then S-shaped as 
the renal tubule forms. The end of the nephron nearest the collecting duct fuses to it 
while other end differentiates into the Bowman's capsule. Vascularisation occurs 
forming the glomeruli and the peritubular capillaries. (Illustration from Saxen 1987) 
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Figure 1.5 Nephron development (continued) 
b In most mammalian nephrons the glomerulus is within the Bowman's capsule. 
Occasionally the nephron communicates to the coelom via a nephrostome. In the first 
pronephric tubules and lower vertebrates the glomerulus is in direct contact with the 
coelom (external glomerulus) with the coelomic epithelium equivalent to the 
podocytes of the Bowman's capsule. The nephric tubules also connect to the coelom. 
Therefore the formation of the Bowman's capsule is thought to have occurred by 
invagination of the glomerulus by the nephric tubule (internal glomerulus). 
















gene has also been implicated in this transition, c-met which is the ligand for 
hepatocyte scatter factor (Tsarfaly et al., 1994). 
1.5.3 Wilms' tumours 
Wilms' tumours can be classified on the basis of histology. The most common 
type is triphasic, containing undifferentiated blastema, but also stroma, and elements 
which resemble the tubules and glomeruli. Heterologous tissues such as skeletal 
muscle, cartilage, adipose tissue and bone are also observed and are believed to be 
derived from the stroma. It is thought that after not taking the correct developmental 
pathway these undifferentiated cells can respond to inductive signals to which they are 
subsequently exposed to try to form nephrons or other differentiated tissue types. 
Tumours are also classified according to their association with 'islands' of abnormally 
persistent blastema known as nephrogenic rests. It has been proposed that these arise 
because the system of kidney differentiation depends on a series of inductions and is 
not determined by an inalterable 'blueprint' and is therefore susceptible to error 
(Mierau et al, 1987). if the blastema either does not receive the inductive signal or 
fails to respond correctly to induction it can persist postnatally within the developed 
metanephric kidney. These are divided into either perilobar (PLNR) or intralobar 
(ILNR) types i.e. those found at the margins of the lobes of the metanephros or within 
the lobes (Beckwith et al., 1990) (Figure 1.4b). ILNR associated tumours are often 
triphasic and contain heterologous tissues. PLNR associated tumours have a much 
more homogeneous histology, consisting mostly of blastema and epithelial elements. 
Since the metanephnc blastema differentiates from the centre outwards, the peripheral 
location indicates that PLNR associated tumours have arisen later in nephrogenesis. 
At this time the cells maybe less pluripotent than in the initial wave of nephron 
formation resulting in the persistent blastema having fewer developmental options 
than in ILNR associated tumours. Nephrogenic rests have been reported in <1% of 
infant post-mortem (Bennington and Beckwith 1975). In contrast to the general 
population, rests are present in the kidneys of 40% of unilateral and 100% of bilateral 
Wilms' tumour patients (Bove and McAdams 1976, Beckwith et al., 1990). The high 
incidence of WT and rest association and their similarities have suggested that 
tumours form from rests that have become neoplastic. In the case of ILNRs, these are 
often found at the edge of tumours indicating that the tumour may have arisen from a 
cell within the rest. Further evidence for this comes from two cases where the same 
WTI mutation was found in an associated rest as in the Wilms' tumour (Park et al., 
1993b). There is also a preferential association of rest and tumour type with different 
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associated congenital syndromes (Table 1.1). Both DDS and WAGR associate with 
the intralobar type (Mierau et at., 1987, Heppe et al., 1991) but perilobar types are 
more often to be found in BWS cases. This may indicate that there is genetically 
determined heterogeneity in the developmental abnormalities. 
The expression of WTJ has been investigated in tumours and WTI mRNA 
transcripts were found at high levels, but only in the analogous structures to those 
expressing WT1 in normal development. Tumours with a high blastemal content in 
general express high levels of WTI. In more differentiated tumours WT1 becomes 
localised to the immature tubules and glomeruloid bodies (Pritchard-Jones and 
Fleming, 1991, Miwa et at., 1992a). Stromal rich tumours including stroma derived 
heterologous tissues (e.g. muscle and cartilage) were found to express very low or 
undetectable levels of WTI (Pritchard-Jones and Fleming, 1991, Huang et at., 1990, 
Miwa et al., 1992a, Yeger et at., 1992). The origin of stromal tumours is not as clear 
as for other types. It is not known whether the precursor cells are derived from the 
uninduced or induced metanephric blastema. Pritchard-Jones and Fleming (1991) 
have suggested the second alternative on the basis that in order for a WTI lesion to 
affect cell growth, the cells should have passed though the stage of WTI expression. 
Mesenchymal cells which have not passed though the induced blastemal stage have 
not expressed TNT]. 
In very rare cases tumours histologically identical to nephroblastoma occur 
outside the metanephric kidney and in the adult (Aterman 1989). Extra-renal 
nephroblastoma is mainly found in the retroperitoneal space and in the gonads, or 
their associated ducts. Such tumours were originally thought to be due to displaced 
metanephric tissue, but the tumours could possibly arise from mesonephric kidney 
remnants that have failed to regress or from the gonads themselves as they are very 
closely related to the kidneys (Pritchard-Jones and Hastie 1990). The expression of 
WTI in these tumours has been investigated and it was found that in the endometrial 
derived tumours there is a persistence of high levels of WTI expression similar to 
some Wilms' tumours indicating that WTI may also be involved in their formation 
(Roberts et at., 1993). 
1.6 WTI and intermediate mesoderm development 
The gonads develop in close juxtaposition to the mesonephroi in the 
intermediate mesoderm (Figure 1.3a&1.6a) and in addition it has been shown that for 























Figure 1.6 Secondary sexual determination 
a The indifferent gonad differentiates on the medial side of the mesonephros. The 
Mullerian duct differentiates in both sexes in the intermediate mesoderm parallel with 
the Woiffian (mesonephric) duct and both ducts join the cloaca. 
b In the male the testis produces testosterone and AMH which induces the retention 
and differentiation of the Wolifian duct into the vas deferens and the mesonephric 
tubules into the epididymis and the regression of the Mullerian duct. 
c In females the mesonephric tubules and ducts degenerate and the Mullerian duct 
form the oviducts and the uterus under the influence of oestrogen. (Illustrations from 
Gilbert 1991) 











overlying mesonephros (Byskov 1986, Buehr et al., 1993). The non germ cell 
component of the gonad forms from a thickening of the coelomic epithelium in the 
intermediate mesoderm, differentiating into the interstitial component (including 
Leydig cells) and the epithelial component of the mature gonad involving a 
mesenchymal to epithelial cell type transition. From the first stages of development 
the gonad expresses high levels of WD. On sexual differentiation this becomes 
localised to sex cords, in particular the Sertoli and granulosa cells of the adult gonad 
but not the germ cells (Pelletier et al., 1991c, Armstrong et al., 1992). WTI 
expression is not as down regulated in the adult gonad as in the kidney as it remains 
detectable by northern blotting (Pelletier et al., 1991c). In the testis a smaller 2.5kb 
transcript was noted but not in other tissues (Pelletier et al., 1991c). Since then, the 
presence of a smaller transcript has been observed in other tissues and species 
(Sharma et al., 1992). 
The mesothelium which covers all the internal organs also expresses WTI 
during development and is derived from the coelomic epithelium. The kidney, gonads 
and mesothelium are related by their derivation from the coelomic epithelium, arising 
from the intermediate mesoderm and they all undergo a cell type transition, 
mesenchyme to epithelia, during development. Therefore they are intimately related 
by virtue of position, cell origin, differentiation pathway and the expression of WTJ, 
indicating that many similar developmental decisions are taking place in these cells 
(Pritchard-Jones et al., 1990). The evolutionary origin of the glomerular podocytes is 
directly related to the mesothelium because in the primitive external glomeruli the 
filtration surface is not the podocytes but the coelomic epithelium. The Bowman's 
capsule seems to have been formed by the invagination of the glomeruli by the nephric 
tubules (Figure 1.5b). Interestingly the other organ to be derived from the 
intermediate mesoderm, the adrenal cortex, does not express WT1. 
The genital ducts are also intimately associated with this region. In both sexes a 
second pair of ducts, the Mullerian ducts, forms from a longitudinal groove of the 
coelomic epithelium paralleling the mesonephric duct (Gilbert 1991). At this stage 
these ducts have not been observed to express WTJ. Secondary sex determination 
which decides the fate of the Mullerian and Wolffian ducts (mesonephric ducts) is 
dependent on hormones produced by the developing testes and ovaries. 
The developing testes produce testosterone from the Leydig cells and anti-
Mullerian hormone (AMH) from the Sertoli cells. The former promotes the 
differentiation of the Woiffian ducts and the mesonephroi into the vas deferens and 
epididymis and the latter promotes the degeneration of the Mullerian ducts. (Figure 
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1.6b). Testosterone or its derivatives also affect the development of the external 
genitalia by acting on the urogenital sinus and swellings which then become the penis 
and scrotum (ORahilly 1977). After the initial development of the mesonephros none 
of these structures have been observed to express WTI (Pelletier et al., 1991c). 
In the female in the absence of these two hormones, and in the presence of 
oestrogen produced by the ovaries, the Woiffian ducts and mesonephroi regress and 
the Mullerian ducts differentiate into the internal genitalia (Figure 1.6c). The caudal 
ends of the ducts open into the cloaca and the anterior ends remain open to form the 
ostia, which collects the mature oocytes. In the middle their fusion produces the 
uterus and contributes to the vagina (Jiresek 1977). Of these structures the ostia, the 
myometrium and endometrial stroma of the uterus but not the epithelial component of 
the endometrium have been observed to express WTI in the mouse and rat (Pelletier 
et al., 1991c, Zhou et al., 1993). During normal hormonal cycling in the female the 
expression of WTJ was found to remain constant, but 6 days after fertilisation as the 
myometrial sma differentiated into the decidual cells, up-regulation of expression 
occurred, implicating WTI in differentiation of these cells. 
1.7 WTI expression outside the intermediate mesoderm 
Other cell populations with the same cell type transition have not been observed 
to express WTI by in situ hybridisation e.g. the somites, the endothelial lining of the 
capillaries, the corneal epithelium and the outer lining of the coelom derived from the 
lateral plate mesoderm (Armstrong et al., 1992). By northern blotting heart, lungs, 
and thymus (Buckler et al., 1991) express WTI but by in situ hybridisation this has 
been localised to their mesothelial covering (Armstrong et al., 1992, Park et al., 
1993a). 
At 1 ldpc the central region of the spinal cord in mouse expresses WTI and at 
day 15 this becomes specific to the ventral horn, this is also seen in human and rat. In 
the brain a small part of the medulla oblongata expresses, as does the area postrema in 
rats. Other non mesoderm derived structures, the tongue and the eye, express WTI 
when examined by RT-PCR (Armstrong etal., 1992, Sharma et al., 1992). 
The first WT1 clone was isolated from a preB-cell library (Call et a!,. 1990), SO 
a possible role in haematopoesis has been investigated. WT1 expression has been 
shown to be limited to the splenic capsule and stroma, not the haematopoeitic cells 
(Park et al., 1993a). Expression does occur in some immature leukaemic cells i.e. 
ALL, AML, CML but not in mature types (Call eta!,. 1990, Miwa etal., 1992b). 
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These regions of 14/Ti expression outside the intermediate mesoderm and in 
structures not undergoing the mesenchyme epithelial transition indicate that WTI may 
have additional roles in other cell populations. 
1.8 Involvement of WTI in genitourinary abnormalities 
The association of Wilms' tumour with genitourinary abnormalities is 
particularly interesting because of the intimate association of kidney and genital 
systems and because both of them express high levels of WTI during development. 
1.8.1 Mapping of genitourinary abnormalities to the WTI region 
Mapping of constitutional WAGR deletions demonstrated that the locus 
involved in genitourinary abnormalities was in the same 345kb region that contained 
WTI. At the same time this clearly demonstrated the separate identity of the gene 
causing aniridia. It was proposed that genitourinary abnormalities could be due to a 
pleiotropic effect of WTI as opposed to the deletion of another gene, giving rise to 
this phenotype by haploinsufficiency (van Heyningen et al., 1990). The lack of one 
functional copy of WTI in the developing genitourinary system could perturb 
developmental events such as the production of the hormones from the gonads 
(Pritchard-Jones et al., 1990, Pelletier et al., 1991a) which control the development 
of the external genitalia therefore leading to these malformations (Behringer et al., 
1990). This was further supported by two constitutional intragenic deletions in WTI 
being reported in two patients with Wilms' tumour, hypospadias and cryptorchidisim 
but no aniridia (Pelletier et al., 1991a). As with WT, this cannot be a fully penetrant 
effect because one of these cases was familial but the father from whom the mutation 
was derived was unaffected. Several other cases of constitutional loss of one 
functional copy of WTI not resulting in genitourinary abnormalities have been 
reported (Table 1.2). The frequency of genitourinary malformations in XY WAGR is 
greater than for XX cases (Table 1.3). This could be consistent with the fact that the 
genitalia of females are not as dependent on hormone production from the developing 
gonad as males and so the perturbations caused by loss of one copy of WD do not 
affect female genitalia development to such a great extent. This may be a reason why 
familial WT represents 1% of all cases (c.f. 35-45% for retinoblastoma (Knudson 
1971)) because even where no obvious abnormalities are present fertility may be 
reduced. 
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1.8.2 Denys-Drash Syndrome 
In addition to WAGR syndrome, Wilms' tumour is a component of Denys Drash 
syndrome which has much more severe genitourinary abnormalities in both XX and 
XY cases including ambiguous genitalia, pseudo-hermaphroditism, micropenis, 
cryptorchidism, hypospadias, and streak gonads (Denys et al., 1967, Drash et al., 
1970). The kidneys also are affected and lose their function in childhood due to 
glomerular nephropathy (specifically mesangial sclerosis). Analysis of 10 DDS cases 
revealed constitutional point mutations in zinc fingers 2 and 3 of WTI, in these cases 
the mutations became homozygous in all the Wilms' tumours examined (Pelletier et 
al., 1991b). The majority of DDS patients examined have a specific set of mutations. 
These are mis sense mutations in zinc fingers 2 and 3 (Table 1.4 and references 
therein). These mutations affect the residues chelating the zinc ion or those which had 
been shown to interact with DNA in the co-crystal structure of EGR1 with its 
consensus sequence (Pavletich and Pabo 1991) (Figure 2). Approximately 60% of 
these are at R394 or D369 in ZF3. By analogy with the crystal structure of EGR1, 
the arginine residue probably binds a guanine base and the aspartate residue interacts 
with the arginine to stabilise the interaction with the DNA. Some of these mutations 
have been shown experimentally to destroy DNA binding to the EGR1 consensus 
sequence (Pelletier et al., 1991b). One interesting exception has been reported twice 
(Bruening et al., 1992, Konig et al., 1993) where a mutation in the splice donor site 
of exon 9 prevents the inclusion of the +KTS alternative splice. That this mutation in 
the heterozygous state can give rise to the DDS phenotype indicates that the ratio of 
the different isoforms of WT1 must be of functional importance. 
1.8.3 Dominant-negative hypothesis 
The genitourinary abnormalities produced by these DDS mutations are more 
severe than those in WAGR cases and other constitutional deletion cases (Table 1.1). 
WAGR mutations normally lead to truncation of WTI or one WT1 allele is completely 
deleted (Table 1.3) whereas DDS mutations are mostly missense mutations (Table 
1.4). WAUR genitourinary abnormalities presumably are a result of WT1 
haploinsufficiency, while it is suggested that the DDS phenotype is due to a trans-
dominant or dominant-negative effect (Herskowitz 1987, Su et al., 1993). A 
dominant effect would be due to a new function of the WTI mutant causing the 
phenotype, and a dominant-negative effect where the remaining normal WTI function 
is interfered with by the mutant (Pelletier et al., 1991b, Little et al., 1993). The 
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Table 1.3 WTI mutations in WT with associated congenital abnormalities 
Summary of WTJ mutations reported in Wilms' tumours associated with congenital abnormalities 
(excluding Denys-Drash syndrome) 
Phenotype Tumour Karvotvpe Mutation in V/Ti Change in V/Ti Status of First hit Second hit Reference 
gn protein incidence mutation in 
tumour 
HP, C bilateral 46XY l7bp deletion in truncation in homozygous V/Ti truncation LOU Pelletier et 
exon 4 exon 4 homozygous  at., 1991a 
HP, C unilateral 46XY lbp deletion in truncation in homozygous WTJ truncation LOH Pelletier et 
Familial  exon 6 exon 7  al., 1991a 
HP, C, unilateral 46XY deletion of exons truncation after hemizygous large constitutional WTI Brown et at., 
DK, AN sporadic del(11)p13p14.1 2-3 in mRNA exon 4  deletion truncation 1992 
GU, R, AN unilateral NID lObp insertion in truncation in hemizygous large constitutional WTI Baird et al., 
sporadic del(1 l)pl2pl3 exon 7 exon 7  deletion truncation 1992a 
GU, R, AN unilateral NID chain termination 362R-STOP hemizygous large constitutional V/Ti Baird et al., 
sporadic del(11)p13 mutation in exon8 in ZF2  deletion truncation 1992a 
HP, C, AN unilateral 46XY lbp deletion in truncation in hemizygous large constitutional V/Ti Gessler et 
sporadic del(11)p13p14.1 exon 7 exon 7  deletion truncation at., 1993 
C, AN, R unilateral 46XY missense mutation 201G-D hemizygous large constitutional V/TI Park et at., 
sporadic del(11)p13 in exon 3  deletion mutation 1993c 
AGU, AN, unilateral 46XX l4bp duplication uncharacterised hemizygous large constitutional V/Ti Santos et at., 
R sporadic del(1 1)pl2pl4.3 at exon/intron7 -may be exon deletion mutation 1993 
splice donor site skipping leading 
_ to truncation _ 
46XX ense mutation 154F-S 
_
unilateral 	 V/Ti heterozygous genetic event at Park et at., 
sporadic n exon 2  WT2 mutation 1993b 
AGU, absence of gonads and uterine cavity: AN, aniridia: BWS, Beckwith Wiedemann Syndrome: C, cryptorchidism: DK, duplex kidney: GU, unspecified 
genitourinary abnormalities: HP, hypospadias: R, mental retardation. 
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Table 1.4 WTI mutations associated with Denys-Drash syndrome 
Summary of constitutional WTI mutations found in patients with DDS. 
Phenotype Karvotvpe WI'] mutation in gene Change in Wi'] protein Incidence of Status of mutation Reference 
in tumour  Wilms' tumour 
F, SG 46XY missense mutation in ZF2 366R-H none 
gonadaiblastoma  
- Pelletier et al., 1991b 
AM or F, SG Two, 46XY 
Two, 46XX 
missense mutation in ZF3 394R-W unilateral Homoygous in two 
 cases examined  
Pelletier et al., 1991b 
AM N/D missense mutation in ZF3 394R-W none - Pelletier et al., 1991b 
AM 46XY missense mutation in ZF3 394R-W bilateral 
+JGCT  
homozygous Pelletier et al., 1991b 
F 46XX missense mutation in ZF3 394R-W bilateral N/D Pelletier et al., 1991b 
AM 46XY missense mutation in ZF3 396D-G none - Pelletier et al., 1991b 
F 46XY missense mutation in ZF3 396D-N none - Pelletier et al., 199 lb 
F, SG 46XY splice acceptor site 
mutation in intron 9 
KTS alternative splice 
not inculuded  
none - Bruening et al., 1992 
F 46XY missense mutation in ZF3 394R-P unilateral homozygous Bruening et al., 1992 
AM, SG 46XY missense mutation in ZF3 394R-W unilateral N/D Bruening et al., 1992 
CL 46XX missense mutation in ZF1 330C-Y none - Bruening et al., 1992 
F 46XY missense mutation in ZF3 394R-W none - Little et al., 1993 
Baird etal., 1992b 
F 46XX missense mutation in ZF3 396D-N bilateral both homozygous Little et al., 1993 
F N/D missense mutation in ZF2 360C-G unilateral heterozygous Little et al., 1993 
MP, C, HK 46XY chain termination 
mutation in ZF2 
truncation in bilateral 
exon 8  
both homozygous Little et al., 1993 
HP 46XY missense mutation in ZF2 373H-Q none - Little et al., 1993 
GU 46XY missense mutation in ZF3 394R-W unilateral N/D Baird et al., 1992b 
GU 46XY missense mutation in ZF3 394R-W unilateral homozygous Baird et al., 1992b 
NM 46XY missense mutation in ZF3 396D-N unilateral homozygous Baird et al., 1992b 
AM 46XY missense mutation in ZF3 366R-H unilateral NID Baird et al., 1992b 
AM 46XY insertion lbp in exon 6 truncation bilateral 
exon_6  
homozygous Baird et al., 1992b 
AM 46XY missense mutation in ZF3 394R-W none - Coppes et al., 1992b 
F 46XX missense mutation in ZF3 394R-W bilateral N/D Coppes et al., 1992b 
F, SG 46XY. missense mutation in ZF2 377H-Y none - Coppes et al., 1992b 
F, SG 46XY splice acceptor site mutation 
in intron 9 
KTS alternative splice none 
not included  
- Konig et al., 1993 
F, SG 46XY missense mutation in ZF3 394R-W unilateral NID Sakai et al., 1993 
F 46XX missense mutation in ZF3 394R-W unilateral N/D Sakai et al., 1993 
F 46XX missense mutation in ZF2 355C-Y none - Sakai et al., 1993 
F 46XX missense mutation in ZF3 401H-Y unilateral N/D Baird and Cowell 1993 
HP, C 46XY insertion lbp in exon 9 truncation in none 
ZF3  
- Ogawa et al., 1993b 
AM, HP, C 46XY splice donor site mutation 
exon 6 
Exon skipping deletes 
exon 6 
unilateral 
truncation _in_exon_7  
homozygous Schneider et al., 1993 
F, CL 46XY missense in ZF2 360C-Y none - Clarkson et al., 1993 
HP, C 46XY missense in ZF2 377H-R unilateral N/D Nordenskjold et al., 1994 
HP, C 46XY missense in ZF3 396D-N unilateral homozygous Nordenskjold et al., 1994 
HP, C 46XY missense in ZF3 394R-W none - Nordenskjold et al., 1994 
F, GD 46XX missense in ZF3 396D-N unilateral homozygous Nordenskjold et al., 1994 
AM, ambiguous genitalia: C, cryptorchidism: GD gonadal dysgenesis: GU, unspecified genitourinary malformations: HK, horseshoe kidney: CL, clitromegaly: 
HP, hypospadias: MP: micropenis: NP, female external genitalia: NM, normal male genitalia: SG, streak gonads. 
JGCT, juvenile granulosa cell tumour 
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evidence for the DDS phenotype being caused by a dominant-negative type of 
mutation, as opposed to a purely dominant one, comes from the observation that 
truncation of the WTI zinc fmgers (which leaves the transregulatory and dimerisation 
domains intact) as well as the zinc finger missense mutations can lead to more severe 
genitourinary defects (Baird et al., 1992b, Little et al., 1993, Schneider et al., 1993). 
If WTI functions only as an intact dimer, then such mutations might be expected to 
reduce the functional dimer concentration to 25%. Initially it was thought that DDS 
and WAGR phenotypes were due to different types of WTI mutants. This is not 
exclusively the case as intermediate phenotypes are now being observed e.g. an XX 
WAGR case with an lipl2-13 deletion but with nephropathy which is normally 
characteristic of DDS (Baird et al., 1992b), and other cases lacking the intersex 
disorders but still showing the diagnostically characteristic glomerular nephropathy 
(Habib et al., 1985). The same deletion of lipl3 was inherited as an unbalanced 
translocation in two cousins, the XX case had only aniridia but the XY case had DDS 
like genitourinary abnormalities (Henry et al., 1993b). Therefore it may be that 
WAGR and the DDS represent different parts of a spectrum of genitourinary 
abnormalities dependent on the type of mutation, genetic background and a higher 
susceptibility in XY cases. Like WAGR, DDS may be incompletely penetrant. Two 
phenotypically normal cases where Drash-type WT1 mutations are present 
constitutionally have been observed, a girl with Wilms' tumour (Akasaka et al., 1993) 
and the father of a DDS son (Coppes et al., 1992b). In all the other cases where 
inheritance was looked for parental mutations were not found; phenotypically normal 
carriers of Drash-type mutations are probably very rare. It is now becoming clear that 
different mutations in a single gene can give a range of effects on the developmental 
pathways. This has been found for PAX6 mutations where a range of eye phenotypes 
are obtained (Hanson et al., 1994) and for the ret oncogene (van Heyningen 1994). 
1.9 Involvement in other developmental abnormalities 
Since WT1 is expressed at sites other than the kidney, the possible role of WD 
in tumorigenesis of gonadal tumours and mesotheliomas has been investigated. One 
case has been reported of a cystic peritoneal mesothelioma in which a homozygous 
point mutation was found. It is debatable whether this is a tumour or a developmental 
abnormality and as yet no other mesotheliomas have been detected with mutations in 
WTJ. The mutation found in exon 6 (codon 273) resulted in a serine to glycine 
substitution and has been shown to change the transrepressor activity of WTI into 
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transactivation activity in in vitro systems (Park et al., 1993a). Mutations, such as 
this, that do not delete or change the sequence of the zinc fingers are so far very rare. 
Gonadoblastoma has been observed in a few cases of DDS in which WT1 point 
mutations have been found (Pelletier et al., 1991b, Table 1.4). WTI mutations are 
probably not a major cause of these tumours as no mutations have been seen in 
Frasier's syndrome (nephrotic syndrome and gonadoblastoma) (Poulat et al., 1993), 
ovarian tumours (Bruening et al., 1993), sex cord-stroma tumours (Coppes et al., 
1993b) or other urogenital tumours (Quek et al., 1993). In the ovarian tumours an 
up-regulation of expression was observed, similar to some Wilms' tumours which 
have no detectable WTI mutations (Bruening et al., 1993). 
1.10 The Wtl knockout mouse 
The ultimate demonstration of the importance of a gene in a developmental 
event is the failure of this event to occur when the gene is homozygously deleted. 
Homozygous deletion of the 5' end of the Wtl gene leads to the failure of kidney and 
gonad development and embryonic lethality in mice. Mesonephric differentiation 
occurs, but 2-3 fold fewer tubules form. Formation of the uninduced metanephric 
blastema is also observed but no ureteric bud develops so that induction does not 
happen and the blastema undergoes apoptosis. The initial thickening of the coelomic 
epithelium at the onset of gonad differentiation appears but again development does 
not proceed beyond this point. The embryonic lethality is probably not due to the 
above, but to heart, lung, and diaphragm abnormalities which are also observed, and 
may be ascribed to a failure of the mesothelium which covers these organs to develop 
fully (Kreidberg et al., 1993). This indicates that Wtl is absolutely required for 
murine kidney and gonad development and also suggests that the expression in the 
coelomic epithelium and later in the mesothelium also plays a key role in the normal 
development of heart, lungs, and diaphragm. The heterozygously deleted mice did 
not develop WT (Kreidberg et al., 1993), this indicates that there are some distinct 
differences in the development of mouse and human kidneys. 
1.11 Is WTI the only gene responsible for predisposition to Wilms' tumour? 
1.11.1 Lack of mutations in WTI 
Although it is clear that the homozygous loss of WTI function is the mechanism 
of tumorigenesis in some Wilms' tumours (summarised in Tables 1.2-1.4), it cannot be 
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the only mechanism. Only 1-2% of WT patients have visible cytogenetic deletions in 
lip 13 and only 30% show LOH (Little et al., 1991c). The WTJ gene was found to 
be unaltered in the genome as observed by Southern blotting (Cowell et al., 1991, 
Royer-Pokora et al., 1991), and WTI expression was observed in many Wilms' 
turn ours (Pritchard-Jones et al., 1990). Therefore it was expected that the gene 
would contain small changes resulting in a loss of function of the protein. Many 
Wilms' tumours have now been examined. Analysis of the literature shows that in 
only about 10% is there a loss of the functional gene, corresponding to Knudson's two 
hit model, with many tumours having no changes in WTI in either allele (Baird et al., 
1992a&b). This may be due to mutations outside of the transcribed or coding regions 
which may not have been analysed, affecting WTI transcription or translation, but this 
is unlikely for so many cases. The one group that does seem to follow Knudson's 
model are the DDS cases, except in two cases (Little et al., 1993, K. Williamson 
personal communication) where the constitutional mutation in WTI becomes 
homozygous in the Wilms' tumour (Table 1.4). 
1.11.2 Dominant WTI mutations and trans-splicing affects 
The heterozygous loss of zinc finger 3 in the tumour AR has been further 
investigated to determine if this may have a dominant tumorigenic effect over the 
remaining wild type WTI allele (Haber et al., 1990). The deleted WTI, but not wild-
type 14/T1, can co-operate with adenovirus E1A protein to produce a transformed 
phenotype (Haber et al., 1992). This demonstrates that mutant 14/Ti can act in a 
dominant way, but not that it is responsible for the development of the Wilms' tumour. 
Another mechanism is now becoming apparent with the isolation of some 14/T1 
transcripts lacking exon 2 from Wilms' tumours but not from normal kidney cells. No 
mutations have been detected in the genomic DNA indicating WTI is affected by a 
trans-splicing mechanism (Haber et al., 1993). 
1.11.3 A possible role forimprinting 
It has been observed that the paternal allele is preferentially retained in Wilms' 
tumours, suggesting that tumorigenesis is favoured by the retention of this allele. It 
was proposed that this could be due to imprinting of 14/Ti (Schroeder et al., 1987, 
Williams et al., 1989, Pal et al., 1990). The expression of maternal and paternal alleles 
in kidney and tumour tissue has been shown, disproving this theory (Haber et al., 
1990, Little et al., 1992b). Paternal alleles may be more frequently selected in 
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tumours because they are the ones which contain the mutation and therefore give the 
growth advantage. This is because mutations happen at a higher frequency during 
male meiosis and so will be transmitted through the paternal germline (Charlesworth 
1993). Retention of the paternal allele could also be due the presence of a linked 
imprinted transforming gene which can synergise with WTI to produce a transformed 
phenotype (Wilkins 1988). 
1.11.4 A second Wilms' tumour locus on lip 
From loss of heterozygosity studies a second locus on lip,  up 15.5, has been 
implicated in the predisposition to Wilms' tumour (Mannens et al., 1988, Henry et al., 
1989, Reeve et al., 1989, Wadey et al., 1990). The locus for Beckwith-Wiedemann 
syndrome has now been mapped to lipl5.5 (Waziri et al., 1983, Koufos et al., 
1989). BWS patients are susceptible to several tumours (Table 1.1), although more 
than 50% are Wilms' tumours, indicating that there maybe a second tumour 
predisposing locus, WT2. 
IGF2 has been proposed as a candidate gene for BWS (Little et al., 1991b). 
It is located at 11p15.5 and has been shown to be imprinted in most tissues where it is 
expressed including the foetal kidney, lung, brain, muscle, liver, adult kidney and 
placenta (Kalscheuer et al., 1993, Ohlsson et al., 1993) with only the paternal allele 
being expressed. There is evidence for the overgrowth observed in BWS arising from 
an 'overdose' of IGF2, which is a growth hormone, either owing to deregulation of 
imprinting (Weksberg et al., 1993), or paternal disomy (Henry et al., 1991, Henry et 
al., 1993a). This is consistent with the phenotype observed in mouse as 
overexpression of 1gf2 gives normally proportioned but differently sized mice 
(DeChiara etal., 1991). That an 'overdose' of IGF2 is also involved in Wilms' tumour 
formation is suggested by the observation of deregulation of IGF2 imprinting (Ogawa 
et al., 1993a&c) and LOH (Chao et al., 1993) in Wilms' tumours. There may have to 
be further genetic changes than simple LOH to obtain a phenotype, as lip 
homozygous tissues have also been found to develop with a normal phenotype (Chao 
et al., 1993). 
The loss of heterozygosity at lipl5.S in Wilms' tumours as opposed to 1ip13 
suggests that changes at lip 15.5 (WT2) can co-operate with loss of one copy of WTI 
in tumorigenesis. Recently a heterozygous WTI mutation was detected in a perilobar 
Wilms' tumour from a patient with BWS stigmata (Park et al., 1993b). This suggests 
that the first hit occurred at the W72 locus and the second hit was in WTI. This gives 
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weight to the suggestion that the WTI and W72 loci can co-operate in tumour 
formation. 
1.11.5 Not all Wilms' tumour predisposition loci map to chromosome 11 
Non random allele loss and frequent cytogenetic rearrangements have been 
observed on the long arm of chromosome 16 as well as on lip,  and so 16q has been 
proposed as the location of WT3 (Coppes et al., 1992a, Maw et al., 1992). So far the 
most likely candidate gene is the epithelial protein, vomorulin. 
Familial cases of Wilms' tumour are rare, although there are now cases of 
hereditary 14/Ti mutations (Pelletier et al., 1991a), WAGR cases (Fantes et al., 1992, 
Henry et al., 1993b) and even one DDS mutation (Coppes et al., 1992b). In several 
families predisposition to WT is found not to segregate with lip 13 or lip 15 markers 
(Grundy et al., 1988, Huff et al., 1988, Schwartz et al., 1991) and in one study not 
with chromosome 16 either (Huff et al., 1992). 
1.11.6 Progression of Wilms' tumours 
Secondary mutational events are probably involved in the progression of Wilms' 
tumour once W71 or other Wilms' tumour predisposition loci have been affected. An 
obvious candidate is p53 which is affected in many human tumours and may interact 
with WTI (Maheswaran et al., 1993). p53  has been found to be highly overexpressed 
in Wilms' tumour, particularly in the epithelial elements (Lemoine et al., 1992). In a 
tumour which was without a 14'Ti mutation, a mutation in intron 1 of p53 was found 
(Velasco et al., 1993). p53  mutations have now been specifically linked to the rare 
anaplastic type of Wilms' tumours, which are associated with poor prognosis 
(Bardeesy et al., 1994). Chromosomal abnormalities and allele loss have been found 
in tumours on 1, 4p, 6, 7, 8q, 12, i4q, 16, 17, and 18 (Wang-Wuu et al., 1990, Maw 
et al., 1992). 
1.12 Evolutionary comparison of the vertebrate genitourinary system 
Comparison of the development of the genitourinary systems within the 
vertebrates can be used to explore the relationships between different organs by 
examining the way in which they have evolved. The theme that runs through kidney 
and gonad development is their intimate association with each other and with the 
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coelomic epithelium. This close evolutionary relationship may explain the expression 
of WTJ in all three structures. 
1.12.1 The vertebrate kidney 
The kidney or holonephros is a characteristic feature of vertebrates. 
Holonephros is a term which includes all the nephrogenic tissue (Saxen 1987), and 
also refers to the archetypal vertebrate kidney (Kent 1987). The nephron in its 
various forms is found in all vertebrates, and nephron-like imprints have been found in 
fossils of the ostracoderms, the oldest known vertebrates (Torrey 1965), but not in 
any other sub-phyla of Chordata. The nephrons seem to have developed from 
specialisation of mesodermal ducts, known as coelomoducts, which often lead from 
the coelom. Coelomoducts of mesodermal origin do exist outside of Chordata, but 
do not resemble vertebrate kidneys (Barnes et at., 1993). In all vertebrates the 
differentiation of the intermediate mesoderm occurs as a wave of differentiation 
followed by degradation. The final structures formed depend on the extent of these 
two events (Figure 1.8). 
1.12.2 Amniote kidney development 
The amniotes (mammals, birds and reptiles) all develop three successive 
kidneys, the first two being lost during foetal life or early in adulthood (Figure 
1.7&1.8). The pronephros is not functional, and whether it actually exists in 
mammals has been debated (Torrey 1965). This partly arises from the difficulty in 
defining boundaries between the kidneys, in what is a continuous wave of 
differentiation (Saxen 1987). The origin of the pronephric duct is not well understood 
in mammals. In the chick a distinct duct rudiment differentiates from the lateral plate 
mesoderm before any tubules are seen (P. Lear personal communication), as opposed 
to being derived from the fusion of the first pronephric tubules as has been proposed 
for amphibians (Torrey 1965). The pronephros is less transitory in reptiles although it 
is thought not to be functional (Fox 1977). The mesonephros has been shown to be 
the functional foetal kidney in the reptilian lineages(Romanoff 1960). Its degeneration 
occurs later in the reptilian lineages,so that in some species of snakes it is present until 
after the first moult. This is in contrast to mammals where the mesonephros is 
vestigial and has disappeared well before birth. 
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Figure 1.7 Phylogenetic tree of the vertebrates 
The tree shows the separation of the fish, then amphibian, then reptilian lineages from 
the mammalian lineage. The separation of the bird lineage from the reptilian lineage 
happened after the separation from the mammalian lineage so that birds and some 
reptiles belong to the same dade. (Tree adapted from Powers 1991) 
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Figure 1.8 The relationship between kidney development and evolution 
Vertebrate kidneys are all formed as a result of a wave of differentiation of the 
urogenital ridge of the intermediate mesoderm followed by a wave of degeneration. 
In fish and amphibians this can result in the formation of mesonephroi of different 
extents. In the reptiles, birds and mammals the mesonephros is replaced by the 
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1.12.3 Anamniote kidney development 
In anamniotes (amphibians and fish) the mesonephros is the adult kidney 
(sometimes called the opisthonephros) as no metanephros differentiates (Figure 1.8). 
The pronephros is the functional foetal kidney and in some teleosts it continues to 
function in the adult. Many more of the nephrons, especially the anterior ones, are 
found to have the more ancient external glomeruli (Figure 1.5b). The capacity for 
nephron development may not be limited to embryonic life in lower vertebrates (Fox 
1977). 
1.12.4 The metanephros 
The feature that appears to be the evolutionary novelty that causes the 
metanephros to form is the ureteric bud. The region of nephrogenic tissue that forms 
the metanephros in amniotes, is capable of forming opisthonephric tubules when 
induced by the mesonephric duct in the lamprey, shark and urodele. The 
mesonephros in mammals contains 30-50 nephrons while the metanephric tubules are 
present in their millions. This may be a consequence of the mesonephric function 
becoming of lesser importance, but even in the opisthonephros only a few hundred 
nephrons are present (Kent 1987). The greater capacity of the metanephros could 
have been selected for by a greater requirement for fluid conservation with the 
colonisation of terrestrial habitats. Selection for greater fluid conservation within 
mammals by the metanephros is exemplified by the almost complete water 
conservation achieved by very long loops of Henle in desert species such as the 
kangaroo rat. A greater capacity for excretion may also have been involved in the 
evolution of homeothermy and the associated increase in metabolic rate and 
production of toxic wastes. 
1.12.5 The gonads and genital ducts 
In all vertebrates the gonads develop in very close proximity to the mesonephroi 
and to the coelom. The mechanism by which gonadal sex is determined is very 
variable. In fish and amphibia there is the capacity for sex reversal in adult life. In 
reptiles the mechanism of sex determination can be temperature dependent but can 
also be influenced genetically. In birds and mammals it is determined solely 
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Figure 1.9 The interrelationship between the gonadal and urinary systems 
In the earliest gnathomes the kidney ducts became utilised by the gonads for transport of the sperm to give the basic genitourinary system. 
In the most primitive of fish this organisation has remained. In other groups of vertebrates sperm and urine transport have become separated 
by the production of a second duct, either to carry sperm (fish) or urine (amniotes). (Illustration adapted from Kent 1987) 
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In the most ancient vertebrates, the agnatha, there are no genital ducts and the 
gametes are discharged into the coelom and exit via abdominal genital pores. In the 
most primitive gnathomes the bridge between the testes and kidneys has been made 
and the urinary duct function has been usurped by the gonads. This situation is still 
found in some fish e.g. the sturgeon. In most other systems there has been a 
separation of sperm and urine transport by the formation of a second set of ducts. In 
the fish and urodeles these carry sperm and are formed as outgrowths from the testes 
and in amniotes the urine is transported by the ureter, formed from the ureteric bud 
(Romer and Parsons 1977) (Figure 1.8). In females a second set of ducts is formed in 
all species from the gnathomes onwards. In amphibians and elasmobranchii the 
relationship of the female genitalia to the urinary ducts is closer than in higher 
vertebrates, as the ostia are formed from the pronephric tubules and the Mullerian 
ducts from the longitudinal splitting of the pronephric duct, as opposed to a separate 
origin in the intermediate mesoderm. These ducts become specialised, forming shell 
glands, ovisacs, and uteri. 
1.13 Evolutionary comparison of Wilms'-like tumours 
1.13.1 Mammals 
Although there is a high degree of similarity of the mouse Wtl gene to human 
WTI at both the predicted protein sequence and expression levels, very few 
nephroblastomas have been reported in the mouse (Liebelt et al., 1989). This is 
surprising considering the number of mice in laboratories. This observation is 
supported by the fact that the heterozygous SeyDeY  (small eye) mice, which are 
deleted for the region corresponding to the human WAGR region (Glaser et al., 
1990), have an eye phenotype similar to aniridia (Jordan et al., 1992), but there is no 
evidence of the genitourinary abnormalities or Wilms' tumours. In addition mice 
heterozygous for the Wtl deletion do not develop nephroblastomas (Kreidberg et al., 
1993). This is also the case in retinoblastoma, where the mechanism of tumorigenesis 
differs between mouse and human, as retinoblastornas are not observed in mice 
heterozygous for a non-functional retinoblastoma gene (Jacks et al., 1992). 
Reports of nephroblastomas in other animals tend to be rare and there is often 
the problem of ascertaining whether it is a true nephroblastoma and so comparable 
with Wilms' tumour or is derived from a different type of precursor cell (Hard 1984). 
The rat, has an almost identical Wtl gene to the mouse but has been shown to develop 
nephroblastomas with the characteristic blastemal cells and tubule and glomemlar like 
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structures and certain strains have a higher level of predisposition (Hard and Noble 
1981). Stromal and heterologous elements are also observed in mesenchymal 
tumours. These are not true nephroblastomas but have a histology similar to some 
human Wilms' tumours (Hard 1984). Both these tumours can be induced by exposure 
to nitroso compounds (Jasmin and Riopelle 1970). Wilms' like tumours have also 
been found in a number of eutherian mammals; rabbits, hamsters, pigs, cows, dogs, 
horses, sea-lion, elk, cats, sheep, goats, macaque and red monkey, and in a 
metatherian mammal; the opossum. In some species no age dependency for tumour 
development is observed (dogs), in others it is found at approximately the same time 
as humans (pigs), in others prenatally (cows) (Hard 1984). WTI expression has been 
observed in pigs and shows a similar down regulation in kidney expression in early 
life. In addition contra-lateral nephrectomy induced expression in adult pigs may be 
as a result of compensatory renal growth (Kushner et al., 1992). Nitroso compounds 
have been found to induce tumours in many of these species, the window for exposure 
corresponding to the presence of metanephric blastema (Jurgelski et al., 1976). 
1.13.2 Birds 
In fowl spontaneous nephroblastoma is one of the most common neoplasms, 
occurring mostly in young birds. In the laboratory nephroblastomas can be induced 
by infection with viruses, mainly avian myeloblastosis virus (AMV) (Heine et al., 
1962). Although virus induced tumours and spontaneous ones are histologically 
identical no virus has been shown as yet to be associated with spontaneous ones 
(Heine et al., 1962, Ishiguro et al., 1962). The sites of viral integration have been 
examined and any changes occurring in RNA expression investigated. The gene that 
has been implicated is not WTI but novC (Joliot et al., 1992). In one case a truncated 
transcript was produced as a result of viral integration, in others expression was seen 
to be up-regulated in the resulting nephroblastomas. The predicted protein belongs to 
a cysteine rich secreted family of immediate growth response genes which show 
similarity to insulin-like growth factor 1 binding protein (IGFJBP) (Joliot et al., 
1992). The truncated form of the gene has been shown to transform cells in culture 
but the full length transcript repressed growth. The human homolog NOVH has been 
isolated and maps to 8q24.1 proximal to c-myc. This is a region found to be affected 
in Wilms' tumours with above random frequency (Martinerie et al., 1992). NOVH 
may well have a role in human Wilms' tumour progression but this has yet to be 
demonstrated. 
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The nearest relatives to the ayes are the crocodilians but there are no reports of 
nephroblastoma in the reptilian class. While this may be a true reflection of the 
situation, it is more likely that it is a rare tumour and has not yet been observed (Elkan 
1963). 
1.13.3 Anamniotes 
Nephroblastomas do occur in classes only possessing the pronephros and 
mesonephros. In Xenopus laevis tumours consisting of undifferentiated blastema and 
tubules have been observed (Elkan 1963), and in the fire bellied newt (Cynops 
pyrrhogaster) primitive glomerular differentiation was seen (Zwart et al., 1970). 
Most of the nephroblastomas in fish have been observed in the Salmonidae. In the 
rainbow trout (Salmo gairdneri) tumour induction is possible by exposure of embryos 
to nitroso compounds (Hendricks et al., 1980). Recently there has been a report of 
characteristic Wilms'-type tumours in the Japanese eating eel (Anguilla japonica) 
containing blastemal cells, renal tubules and striated muscle (Masahito et al., 1992). 
1.14 Evolutionary comparison as a method for defining gene function 
1.14.1 Structural analysis 
The rate of change of amino acid sequence can vary by as much as a thousand 
fold; ranging from the fast evolving fibrinopeptides to the virtually static histone H4 
(Nei 1987). Conserved regions between the same gene in different species are 
thought to arise from functional and structural constraints on the gene and gene 
product. Originally it was thought that mutations would become fixed or removed 
from the population owing to their advantageous or disadvantageous phenotype. This 
would be consistent with Darwin's theory of natural selection. Kimura's neutral 
theory of molecular evolution (Kimura 1968, Kimura 1983) was developed in order to 
explain the way in which evolution occurs at the molecular level. This states that 
most mutations are neutral or nearly neutral and these become fixed in the population 
due to factors such as genetic drift and that Darwinian selection will only act on a 
subset of mutations. Some of the best evidence in favour of this is the evolution of 
third bases of codons in protein coding sequences (Kimura 1977). Because of the 
degeneracy of the amino acid code many nucleotide substitutions will be neutral or 
almost so (RNA structure or tRNA abundance can affect this), but these have been 
shown to be some of the most prevalent sites of nucleotide substitution. Even more 
rapidly evolving are regions of DNA with no known function e.g. pseudogenes (Li et 
al., 1981). Therefore it is postulated that, assuming a gene retains a similar function, 
those regions that have been conserved through evolution are important for its 
structure and function. 
The number of known gene sequences is increasing very rapidly, and so the 
opportunities for comparison of orthologs (genes related by speciation) and paralogs 
(genes related by duplication) also increases. In particular the number of transcription 
factors studied has expanded. Comparative sequence analysis has identified several 
important amino acid sequence motifs e.g. the heptad repeat of leucines in the leucine 
zipper (Landshultz et al., 1988), the POU domain (Strum and Herr 1988) and the 
REL homology domain (Kerr et al., 1993). Also comparison of newly isolated genes 
containing known motifs may give clues to the characteristics and function of the gene 
product. In this way many genes are now being grouped into families and 
superfamilies e.g. API family (containing the fos and jun transcription factors) 
(reviewed by Lamb and McKnight 1991) and the immunoglobulin superfamily. In 
addition many related sequences are being isolated on the basis of the conserved 
motifs e.g. zinc fingers and tyrosine kinases. 
In the absence of obvious similarities with known genes inter-species 
comparison can yield important information. In the case of the tumour suppressor 
gene p53, the cloning of a range of orthologs allowed comparison with the human and 
mouse genes revealing a distinctive pattern of conserved and non-conserved regions 
(Soussi et al., 1990). Subsequent analysis of mutant p53 in tumours has shown 
clustering of nucleotide mutations resulting in amino acid changes in the evolutionarily 
conserved regions (Levine 1992). 
With the isolation of more orthologs and paralogs for comparative analysis the 
study of chromosome evolution is becoming more feasible. The chromosomes of 
vertebrates are surprisingly variable, considering how well the actual genes 
themselves have been conserved. The way in which some of these changes have 
occurred can be recognised by defining homologous syntenic regions conserved 
between species. In vertebrate evolution several tetraploidisations have been known 
to occur and these have been followed by reorganisation to regain diploidy. The way 
in which this occurred may tell us about chromosome structure and behaviour (Lundin 
1993). 
1.14.2 Functional analysis 
The genes present in organisms can to some extent be grouped by their function 
into classes such as metabolic, cell cycle control, and developmental specification. 
The conservation of a gene and its maintenance through evolution will depend on its 
function. In the case of the metabolic enzymes which fulfil very basic and necessary 
functions, many are conserved in both prokaryotes and eukaryotes. Glutamate 
synthetase is one such gene which duplicated 3,500 Myra (Kumada et al., 1993) and 
GSI or GSII is found in every kingdom. The regulation of the eukaiyotic cell cycle is 
another highly conserved function, the human homolog of yeast Schizosaccharomyces 
pombe cdc2 has been found to be capable of complementing Schizosaccharomyces 
pombe lacking functional cdc2 (Lee and Nurse 1987). Within the vertebrates cell 
regulatory and tumorigenesis mechanisms can be conserved, as was recently 
demonstrated in that zebrauish c-myc was capable of co-operating with mammalian H-
ras to transform mammalian cells (Schreiber-Agus et al., 1993). 
The regulation of development has evolved with the advent of Metazoa. In 
recent years much has been learnt about the genetic control of development of the 
fruit fly Drosophila. One of the major findings is that many of the Drosophila 
developmental genes have homologs in the vertebrates which also have roles in 
development. This is the case for Notch (Bierkamp and Campos-Ortega 1993), the 
Wnt family (Sidow 1992), the hedgehog family (Ingham 1994), and the HOM-C and 
Hox gene clusters (Holland 1990). Most of the genes seem to be involved in position 
specification in the embryo as opposed to specifying specific structures. The 
resemblances between phyla in Hox gene expression has lead to the proposal of the 
'zootype' stage where the animal body plan is being set up and can be recognised by 
characteristic gene expression patterns (Slack et al., 1993). In many cases this 
coincides with the phylotypic stage which was based on morphological similarities. 
WTI is a gene that does not seem to be involved in pattern specification but 
rather in subsequent differentiation of a predetermined region. The evolution of the 
vertebrate genitourinary system, which is effectively the modification of a basic plan, 
is quite well understood. The similarities in nephrogenesis and nephroblastoma 
throughout the vertebrates would imply that the investigation of the anamniote kidney 
could be applied to the understanding of the development of the amniote kidney and 
Wilms' tumour. 
1.14.3 Animal models 
The mouse is currently the favourite animal model for understanding human 
development. This has become a much more powerful system since the advent of 
transgenic techniques. For developmental genes, the disadvantage of viviparity, 
making embryonic stages not particularly accessible has yet to be overcome. In the 
study of Wilms' tumour, the mouse has the added disadvantage of a very low level of 
incidence of this tumour. The more user friendly free-living embryos of anamniotes 
have been exploited. In particular much infomiation has been derived from Xenopus 
laevis on control of early development, and now new contributions to knowledge are 
coming from zebrafish (Brachydanio rerio) systems which are genetically more 
manipulable (reviewed in Strahle and Ingham 1992) especially with the advent of 
transgenic fish. All of these different systems have advantages and disadvantages, 
their combined use can allow different questions to be asked and the answers to be 
compared. The most recent example of this are the studies of chick, mouse and 
zebrafish hedgehog paralogs (Echelard et al., 1993, Krauss et al., 1993, Riddle et al., 
1993). 
1.15 Conclusion and aims of the project 
Since its isolation in 1990 much has been learnt about WTI but it is far from 
being fully understood. The specific DNA binding activity and nuclear localisation of 
WTI is consistent with a role as a transcription factor, but true binding sites for both 
+KTS and -KTS isoforms remain to be defined. The most often observed effect on 
transcription by WTI was transrepression but this is dependent on the number and 
positioning of binding sites and on cell type. The need for multiple binding sites for 
repression to occur may be due to WT1 interacting with itself and it maybe this 
interaction with which mutant WTI interferes. The cell type specificity and the 
interaction with p53 indicates that transrepression is not an intrinsic property of WTI 
but depends on the proteins with which it interacts. Therefore in different cell types 
in vivo and as cells differentiate the action of WT1 may change from activator to 
repressor of genes or vice versa. Most of the analyses have been performed by 
transient transfection assays which result in very high non-physiological expression 
levels and it has been shown that the results obtained for WTI were very sensitive to 
the systems used so that its in vivo actions may be very different from those observed 
in vitro. 
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The histological and mutational observations described above suggest that loss 
of normal WTJ function would affect normal differentiation, specifically disturbing the 
mesenchymal-epithelial transition of nephrogenesis. Disturbances of this type are 
thought to cause the nephrogenic rests, which would then be open to neoplastic 
transformation. From in vitro studies of WTJ function, loss of regulation of growth 
factor expression and loss of WTI autoregulation are candidate mechanisms at the 
protein level. If the cells cannot pass though the WTJ expressing stage, i.e. the 
induced blastema and differentiating nephrons, this would explain the persistent 
expression of the gene as seen in some tumours. In other cases the cells fail to form 
nephrons and take other developmental pathways where WTI is not expressed. 
It seems that some cases of Wilms' tumour probably do involve the loss of both 
functional copies of WT1, but it is also clear that there is at least a second 
predisposing locus at 1 'p15.5  which can either act alone or in concert with WTI 
malfunction leading to tumorigenesis. Also there is some evidence for WTI acting in 
a dominant manner; as an oncogene. It is not yet possible to correlate tumour type, 
WTJ expression and presence and type of WT1 mutations. The only correlation that 
has been found so far is between BWS (and therefore WT2) and perilobar rest 
associated tumours, and between WAGR and DDS (and therefore WTI) and 
intralobar rest associated tumours. 
In order to add to the understanding of how WTI is acting in development and 
tumorigenesis it was proposed to isolate WTI from as many relevant developmental 
systems as possible. First, this would produce a structural comparison which can be a 
powerful tool in the dissection of protein function. Second, the comparison of WTI 
expression patterns would demonstrate if WTI has a conserved function in 
genitourinary development and therefore whether the study of WTI in different classes 
of vertebrates would be relevant to the study of the function of WTI in humans. 
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Chapter 2 
Materials and Methods 
M. 
2.1 Bacterial manipulation 
2.1.1 Genotypes 
2.1.1.1 Cell strains 
JM101 supE, thi-1, A(lac-proAB), [F traD36, proAB, laclZAM15] (Yanish-Perron 
et al., 1985). 
XL1-Blue recAl, endAl, gyrA96, thi-1, hsdRl7, supE44, relAl, lac, [F proAB, 
laclqZAIvI] 5, Tnl O(tetT)]  (Stratagene). 
Y1090 A(lac)U169, A(lon)?, araD139, strA, supF, mcrA, trpC22..TnlO (t etr), 
(pMC9,.tetrampr) (Young and Davis 1983a). 
SURE e14-(mcrA), A(mcrCB-hsdSMR-mrr)171, sbcC, recB, recJ, umuC::Tn5 
(kanr), UVrC, supE44, lac, gyrA96, relAl, thi-1, endAl [F'proAB, lacIqZAM15, 
TWO (tetr)]  (Stratagene). 
2.1.1.2 Bacteriophage 
?ZAP AsbhI2d° chiA131 (T amp Co1E1 ori lacZ T3 promoter-polycloning site-
T7promoter I) srl?3 0 c1ts857 srIA4° nin5o srI?50 SamlOO. 
ZAPII as for AZAP but no Sam 100 mutation (Short et al., 1988). 
Agtll 2dac5 Ashndllt&2-3 srI?30 c1ts857 srIA4° nin5 srIX5 0 Sam 100 (Young and 
Davis 1983b). 
2.1.2 Elecfro-transformation of E.coli 
2.1.2.1 Preparation of electro-competent cells 
Bacterial cells were streaked out onto arL-agar 1 plate from a 200C  glycerol 
stock. lOmi of L-broth were inoculated with a single colony and grown overnight in a 
shaking incubator at 370C. This was used to inoculate 1 litre of L-broth. Cells were 
grown until they were in log phase, this was estimated for XL1-Blues or JM1O1s to 
be at an OD600  of approximately 0.8. 
Cells were harvested by chilling the culture on ice as rapidly as possible and 
leaving on ice for 30 minutes. This was spun at 7,000rpm for 15 minutes and the cell 
pellet resuspended in 1 litre cold sterile dH20. This was centrifuged three times more 
and the cells concentrated down by resuspension in 500m1 dH20, 20m1 10% glycerol 
'Recipes for media and solutions are at the end of the methods section. 
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and 2-3m! 10% glycerol respectively to give an approximate final cell density of 
3x10'°cells/m!. Aliquots were frozen in liquid N2 and stored at -70 0C. 
2.1.2.2 Electro-transformation 
Salt was removed from the DNA to be electroporated by dialysis for 15 minutes 
on a 0.025jim type VM Millipore filter floating on dH20. Competent cells were 
thawed, and 40tl added to a cold 0.4 cm electroporation cu-vette containing 1-5il 
ligation mixture or ing plasmid DNA and this was allowed to stand on ice for 1 
minute. The cells were pulsed on a BRL Gene PulserTM set at 25pF, 2.5kV and 
200. imi of cold L-broth was added immediately afterwards and the cells were 
allowed to recover at 37 0C for 1 hour with shaking before 100-150j.tl was plated on 
agar containing the appropriate selection. 
2.1.3 Selection of cells harbouring recombinant plasmids 
All the vectors used in this study carry ampicilhin resistance. Therefore cells 
harbouring plasmids were selected for after transformation by the presence of 
100pg/m1 ampicillin in the agar. The pBluescript vectors used contain a partial lacZ 
gene and the host cells used contain an F episome harbouring the rest of the gene. 
LacZ expression can be induced by addition of 40j.tgIml IPTG 
(isopropyithiogalactose) to the medium, the two parts of the gene are then capable of 
metabolising X-gal (5-bromo-4-chloro-3-indolyl-galactose) which is also added to the 
medium at 40pgIml. The product formed is a blue precipitate. if an insert is present 
in the vector the lacZ gene is disrupted and the colonies are white. White colonies 
were streaked out onto a fresh agar plate. 
2.1.4 Bacterial colony lifts 
After streaking out, colonies were allowed to grow overnight, the plates were 
then chilled for at least two hours at 4 0C. Gridded nitrocellulose circles (Schleicher 
& Schuell) were gently placed over the plates and left until the whole circle had 
absorbed moisture, approximately two minutes. The filters were treated by placing 
them DNA side up on to Whatmann 3MM paper soaked with denaturing solution for 
5 minutes, and then on to paper soaked in neutralising solution for 5 minutes. These 
were washed briefly (< 1 minute) in 2xSSC. (The cell debris and agar were removed 
in the 2xSSC wash by rubbing with gloved fingers.) Excess moisture was then 
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removed with blotting paper. DNA was fixed to the nitrocellulose by baking for 2 
hours at 800C under vacuum. The agar plates were placed at 370C  overnight to 
allow the colonies to recover. 
2.1.5 Small scale preparation of plasmid DNA 
2.1.5.1 Method 1 
A bacterial culture was prepared by the inoculation of 1- 1.5m1 of L-Broth or 
Terrific Broth containing selection with cells picked from a single colony. This was 
incubated overnight at 37 0C in a shaker. The cells were spun down in a microfuge 
for 1 minute and as much growth medium as possible removed. The pellet was 
resuspended in lOOj.il GTE solution, then 200j.il of 1%SDS, 0.2mM NaOH were 
added and the tube inverted several times to mix the solution. This was incubated on 
ice for 5 minutes, then 150pl 3M5MKAc solution was added, mixed by inversion, and 
replaced on ice for 5 minutes. The suspension was spun for 5 minutes and the 
supernatant retained. To this 1 volume of EtOH was added, vortexed and the DNA 
precipitate spun down for 5 minutes in a microfuge. The pellet was washed in imi 
70% EtOH and freeze dried. This was resuspended in 20tl TE buffer or sterile 
dH20. This method produced high quality DNA which was suitable for DNA 
sequencing (Jones and Schofield 1990). 
2.1.5.2 Method 2 
The above procedure was used for most of the experiments but in the final year 
the MagicTM Miniprep purification system was produced by Promega. The main 
advantage was the increased yield, purity, and speed of the system. 
Cells were harvested from 1-3m1 of overnight culture as above. The cell pellet 
was resuspended in 200 p1 of cell resuspension solution and inverted until the solution 
cleared. To this was added 200p1 cell lysis solution, the solutions were mixed by 
inverting the tube and then 200 p1 2.55M KAc was added and mixed as before. This 
was spun in a microfuge for 5 minutes and the supernatant retained. lml of warmed 
(250C) resin (containing 7M guanidine HCl) was added to the supernatant. This was 
pipetted into a 2m1 syringe barrel attached to a MagicTM Column. The solution was 
pushed though the column and the column washed with 2m1 column wash solution. 
The column was dried by spinning for 20s and leaving at 50-60 0C for 5 minutes. 
50j.tl of dH20 at 65-700C was applied to the column and the DNA was eluted into an 
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eppendorf by spinning for 20s. Elution was found to be more successful if the dH20 
was allowed to stand on the column for 5-10 minutes before spinning. 
2.1.6 Large scale preparation of plasmid DNA 
500m1 of Terrific broth containing the appropriate selection were inoculated 
with bacteria from a single colony. This was incubated overnight at 37 0C with 
shaking. The cells were harvested by centrifugation at 6,000rpm for 5 minutes and 
the cell pellets drained on ice to remove as much of the growth medium as possible. 
The cells were resuspended in 18m1 of GTE and then 2m1 of freshly prepared 
lysozyme solution (lOmg/ml in 10mM Tris-HC1 pH8.0) was added. To lyse the cells 
40m1 1% SDS, 0.2M NaOH was added and mixed by inversion of the centrifuge 
bottle. After 10 minutes on ice 30m1 3M5MKOAc was added, mixed thoroughly, and 
replaced on ice for 10 minutes. This was centrifuged at 10,000rpm for 30 minutes 
and the supernatant filtered through muslin. To this 0.6 volume isopropanol was 
added and incubated at RT for 10 minutes. The DNA precipitate was then spun down 
at 8,000rpm for 10 minutes at RT. The pellet was drained, washed with 70% EtOH 
and freeze dried. The pellet was resuspended in 6m1 TE buffer, care being taken to 
avoid shearing of the high molecular weight chromosomal DNA. The volume of the 
DNA solution was measured and lg/ml CsCl was added and the volume re measured 
(the solution was warmed to 30 0C to facilitate dissolution of the salt). To this 0.08 
volume lOmgIml ethidium bromide solution was added. This solution was put into 
Beckman QuickSealR Bell Top centrifuge tubes and sealed. Balanced tubes were 
spun at 100,000rpm in a Beckman TL-100 ultracentrifuge for at least 4 hours. Of the 
two bands visible in the CsCl gradient the lower plasmid band was removed by 
piercing the tube with a needle and drawing out the band into a syringe while avoiding 
the upper chromosomal band. 
The ethidium bromide was removed by butan-1-ol extraction until the solution 
was colourless. The volume of DNA solution was kept constant by adding H20. To 
the plasmid DNA, 3 volumes dH20 and 2 volumes EtOH were added and 
precipitation of the DNA allowed to occur over 30 minutes at -70 0C. The DNA 
precipitate was spun down at 12,000rpm for 10 minutes, washed with 70% EtOH and 
freeze dried. The DNA was resuspended in lmlTE buffer and the concentration 
estimated by measuring OD260um  in a spectrophotometer. This assumes that an 
OD260um of 1 is equivalent to SOng/ml DNA. The ratio of the optical densities at 
260nm and 280nm was used to assess the purity of the DNA, as at 280nm any protein 
73 
contamination is detected. For an acceptably pure DNA solution a ratio of 
approximately 2 was expected. 
2.1.7 Glycerol stocks of bacteria 
Stocks of bacterial cells were produced by setting up an overnight culture as for 
a small scale plasmid preparation. The cells were grown overnight and then chilled 
and a 1:1 ratio of 50% filter sterilised glycerol to culture added. Stocks were then 
stored at 700C.  When bacteria were required a sterile inoculation loop was dipped 
into the briefly defrosted stock and used to streak an agar plate containing selection, if 
appropriate. The plate was incubated at 370C  overnight and then stored at 40C. 
2.1.8 Isolation of clones from bacteriophage libraries 
2.1.8.1. Preparation of host cells for bacteriophage 
25 ml of L-Broth containing 0.2% maltose (filter sterilised) and 10mM MgSO4 
was inoculated with a single colony of bacterial host cells from a fresh agar plate. 
These were grown overnight with shaking at 300C.  The cells were harvested by 
centrifuging at 4,000rpm for 10 minutes. The cell pellet was resuspended in 10mM 
MgSO4 to give an OD600 of 0.5 for screening or amplification, or 1.0 for in vivo 
excision. Cells were made fresh whenever possible but it was found that infection was 
not impaired for cells stored at 4 0C for up to 2 weeks. 
2.1.8.2 Titering of libraries 
Serial dilutions of the lambda phage libraries were made in SM buffer. These 
were added to 200p1 of host cells and incubated at 37 0C for 15 minutes to allow 
infection to occur. 3m1 of CY top agarose at 43 0C was added, mixed quickly, and 
poured onto prewarmed, predried 9cm plates containing CY select agar. The top 
agar was allowed to harden for 10 minutes at RT and then incubated at 37 0C 
overnight. The number of plaques produced were then counted and the number of 
plaque forming units (pfu) calculated for the undiluted library. 
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2.1.8.3 Screening libraries 
24cm x 24cm plates (Nunc) were sterilised by wiping with ethanol and then 
exposing to ultraviolet light for a minimum of ihour. These were poured with 150m1 
CY select agar and allowed to dry. 0.8ml cells were inoculated with an estimated 
1x105 phage and incubated at 37 0C for 15 minutes. This was then plated as above 
using 30m1 of CY top agarose and incubated overnight. Typically four plates were 
used so approximately 4x105 phage were screened per experiment. 
The plates were chilled at 40C for at least 2 hours before lifts were taken. Lifts 
were taken by lowering a 20cm x 20cm Hybond N+ filter (Amersham) onto each plate 
and leaving for two minutes. The position of the filter on the plate was marked by 
pricking with a needle attached to a syringe containing ink through the filter into the 
agar to make an asymmetric pattern. The filter was removed with care in order not to 
disturb the top agar. Duplicate lifts were made, the second filter was left on the agar 
twice as long as for the first lift. The filters were then processed by immersion, phage 
side up in; 
denaturing solution for 2 minutes 
neutralising solution for 5 minutes 
washing solution for < 1 minute (0.2M Tris-HC1 pH 7.5, 2xSSC) 
After removal from the last solution excess moisture was removed on blotting paper. 
Any top agar attached to the filters was removed by rubbing with gloved fingers at the 
denaturation and washing stages. The DNA was fixed to the filters by laying them 
DNA side up on blotting paper soaked in 0.4M NaOH and then washing them in 
SxSSC. The filters were then hybridised in PVC sandwich boxes to an appropriate 
probe. Positive signals were considered to be those that were present on both 
duplicates. The filters were lined up with the plates using the needle holes and the 
positions of positives on the plates identified. These were removed by coring the agar 
with an inverted yellow tip and put into lml SM buffer. These were left overnight at 
40C or at least 2 hours at RT to allow the phage to diffuse into the buffer. The 
number of pfu was calculated by estimating 1x10 6 phage per plaque. Serial dilutions 
were prepared to give 450 and 50 plaques per 9cm plate. These were plated as for 
titering and screened as before except gridded nitrocellulose circles (Schleicher & 
Schuell) were used. This meant that excess top agar was removed in the 2xSSC wash 
and DNA was fixed to the nitrocellulose by baking for 2 hours at 80 0C under 
vacuum. Screening was repeated a third time so that an isolated and therefore pure 
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plaque could be cored. This plaque was put into 0.5m1 SM buffer containing a drop 
of CHC13, and the phage allowed to diffuse out as before. 
2.1.8.4 Amplification of phage by the plate lysate method 
The isolated phage was amplified by infecting 0.3m1 of host cells with 
approximately 50,000 phage and plating in 3m1 CY top agarose onto 9cm CY agar 
plates as above. These were grown for 8 hours so that the plaques were 1-2mm 
across. The agar was overlaid with 4-5m1 SM buffer and the phage allowed to diffuse 
into the buffer overnight at 40C. The SM buffer was collected and spun at 8,000rpm 
for 10 minutes to remove cell debris. To the supernatant 0.3% CHC13 was added and 
in addition 7% DMSO was added to imi for a -70 0C stock. 
?ZAP and XZAPII were plated out on SURE or XL1-Blue cells as above, and 
Xgtl 1 on Y1090 cells as above except 50pg/ml ampicilhin was included in the 
medium. The quality of the agar was found to be variable, and L-agar was sometimes 
substituted for CY(select) agar. 
2.1.8.5 In vivo excision of XZAP phagemid 
XZAP phage have been designed so that a phaid (plasmid) can be excised 
from the phage and recirularised in vivo. This is due to the inclusion at separate 
positions in the phage of the sites of initiation and termination of the +strand origin of 
replication of the fl bacteriophage which are adjacent to each other in the f  phage. 
Fl (helper) phage are co-infected with AZAP, at the site of initiation the phage DNA 
is nicked and the +strand replicated as far as the terminator sequence and then the 
new strand is circularised. This is then packaged and secreted. When this is infected 
into new host cells the second strand is synthesised. The plasmid thus obtained is 
pBluescriptSK-. 
ipi amplified phage isolate and lpi R408 helper phage (>lxlO 6pfu/ml Russel et 
al., 1986) were added to 200pl host cells and 200pi SM buffer. The mixture was 
incubated for 15 minutes at 37 0C and then 5m1 Terrific broth was added and this 
shaken at 37 0C for 3 hours. The cells were killed by incubation at 70 0C for 15 
minutes, then the cell debris were spun down at 6,000rpm for 5 minutes. 10.il or lOp! 
of a lOOx dilution of the phaid stock was added to 0.2m1 host cells and incubated 
at 370C for 15 minutes. 1-100pi was then spread on to L-agar plates containing 
100pg/ml ampicillin and grown overnight at 37 0C. PhaEids  were then analysed. 
,I1 
To avoid contamination with the fl phage, DNA was prepared by small scale 
plasmid preparation from colonies and transformed into electro-competent cells. 
2.1.8.6 Purification of?gtll DNA using LambdaSorbTM  (Promega) 
Phage DNA is purified using antibodies to the phage particles which are added 
to the crude plate lysate. This initial purification eliminates purification steps needed 
at a later stage in other protocols. 
1/100th volume of phage adsorbent was added to the plate lysate and incubated 
on ice for 30 minutes and then spun at 7,500rpm for 10 minutes. The pellet was 
resuspended in SM buffer (1/10th the original lysate volume), spun in a microfuge for 
1.5 minutes and resuspended in 10mM Tris-HC1 pH 7.8, 10mM EDTA (1/20th 
original lysate volume). This was heated for 15 minutes at 70 0C. The EDTA 
chelates Mg2+ ions which are necessary for the integrity of the phage coat, so the 
phage DNA is released. The phage solution was then spun for 2 minutes down to 
remove the absorbent and two phenol/chloroform extractions and one chloroform 
extraction were performed to remove the phage proteins. The DNA was ethanol 
precipitated with 0.5 volume 5M NH4Ac and two volumes EtOH and incubation at - 
200C for 30 minutes. The DNA was washed with 70% EtOH and resuspended in 20-
50j.il TE buffer. 
2.2 DNA/RNA manipulations 
2.2.1 DNA preparation from tissue 
The tissue (approximately 1cm 2) was chopped as finely as possible and homogenised. 
To this lOml 10mM Tris-HC1 pH7.8, 150mM NaCl, 10mM EDTA and then 50jig 
RNase was added. This was incubated at 37 0C for 30-60 minutes. 10%11 20% SDS 
and 5-10mg proteinase K was added and incubated overnight at 37 0C. This was 
purified by a phenol, a phenol: chloroform, and a chloroform extraction (chloroform 
contained 1 volume octan-2-ol for every 24 volumes chloroform). The DNA was 
precipitated by adding 0.5 volume 7.5M NH4Ac and 2 volumes of EtOH. The DNA 
was spooled out onto a sealed Pasteur pipette and air dried and resuspended in 8m1 
TE. The DNA concentration was measured as for plasmid DNA. 
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2.2.2 RNA preparation from tissue or cell lines 
Tissue was dissected as quickly as possible in sterile conditions in PBS 
(phosphate buffered saline). Cell pellets from cell lines were produced by 
irypsinisation of the cell cultures (to release attached cells if necessary) and spinning 
down the resulting cell suspension and then washing the pellet. 
The sample was added to 0.6m1 6M Urea, 3M LiC1 in an eppendorf tube 
(approx. 5x106 cells) and homogenised on ice using a syringe and progressively 
smaller gauges of needle as far as 25. The homogenate was sonicated using an 
amplitude of 2211. for 3x20s on ice and then incubated overnight at 4 0C. The 
precipitated RNA was spun down for 15 minutes in a microfuge at 4 0C. The pellet 
was resuspended in 0.5m1 LiClIUrea and incubated 2-3hours at 4 0C and spun as 
before. The pellet was resuspended in 0.4m1 10mM Tris-HC1 pH8.0, 0.5% SDS, 
20mg proteinase K added and incubated at 37 0C for 30 minutes. The protein was 
removed by a phenol, a chloroform (containing 1/25 octan-2-ol) and then two ether 
extractions. The RNA was precipitated with 2 volumes EtOH and 1/10th volume 3M 
NaAc pH 5.2. After overnight incubation at -20 0C the RNA was spun down and 
resuspended in DEPC dH20. The OD260 um was measured and the concentration 
was then calculated assuming OD260um  of 1 is equivalent to an RNA concentration 
of 401g/ml. The OD280um was also measured to assess the purity of the sample. A 
ratio of 0D260/0D280um of approximately 2 is expected for a acceptably pure 
sample. 
All solutions to come into contact with the RNA were either treated by adding 
1/1000 volume DEPC (diethylpyrocarbonate), leaving for at least 2 hours and then 
autoclaving, or were made up using DEPC treated dH20 (Tris and urea containing 
solutions). 
2.2.3 Agarose gel electrophoresis 
2.2.3.1 DNA electrophoresis 
DNA fragments were resolved on agarose gels, the agarose concentration being 
optimised for maximum resolution at the expected sizes of fragments. For 
concentrations 0.7-1.2g/l agarose was used but for higher concentrations a mixture of 
agarose and NuSieve GTG low melting point agarose. 
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For analytical gels the running buffer used was 1xTBE. Routine analysis was 
performed using a BRL Horizon 58TM minigel system at 100V, or 60V for low 
melting point agarose. 
For preparative gels and genomic gels, the running buffer was 1xTAE. 
Preparative gels also used the BRL Horizon 58 1 minigel system and genomic 
gels on maxi (in house made) gel tanks. Preparative gels were run at 60V and 
genomic gels at 35V overnight. 
6x glycerol loading buffer was added to samples before loading. DNA standards were 
loaded either, ADNA/HindllI fragments, X174/HaeIII fragments, or 1kb DNA 
ladder (Promega). The DNA was visualised by adding one drop of ethidium bromide 
to agarose solution before the gel was cast. The DNA-ethidium complex then 
fluoresced under UV light. 
2.2.3.2 RNA electrophoresis 
Total RNA was resolved by electrophoresis in 1% agarose gels containing 2.2M 
formaldehyde. Either midi or maxi gel tanks were used. Before loading the RNA was 
mixed in a 1:1 ratio with formaldehyde sample buffer (1 volume lOxgel running 
buffer, 2 volumes formamide, 1.2 volumes formaldehyde) and heated to 650C  for 5-
10 minutes and the chilled on ice to denature any secondary structure. To this 1 
volume of formamide loading dye was added and ijil 10% ethidium bromide. 0.24-
9.5kb RNA markers (Gibco BRL) were treated in the same way and loaded as size 
standards. Gels were run in lxgel running buffer initially for 10 minutes at 100V and 
then overnight at 45V. 
2.2.4 Vacuum transfer of DNA and RNA 
Vacuum transfer of DNA and RNA on to nylon filters was performed using the 
LKB vacuum blotting apparatus. The apparatus was set up according to the 
manufacture's instruction. A plastic mask was placed over the porous support with a 
window cut out approx. 5mm smaller than the gel. The filter was Cut slightly smaller 
than this window and carefully placed within it. The gel was placed over the filter so 
that no gaps between the gel and mask are present and no air bubbles were trapped 
between the filter and gel. The top frame was screwed down and vacuum pump 
started and the tightness of the gel-mask seal checked. 
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DNA was depurinated by the addition of 0.25M HC1 to just cover the surface of 
the gel. After 4 minutes this was replaced with denaturing solution. After a further 3 
minutes the denaturing solution was removed and replaced with alkaline transfer 
buffer. RNA was transferred using 1OxSSC. Depending on the size of the gel, 
transfer took from 35-60 minutes. That the transfer was successful was verified by 
restaining the gel with ethidium bromide and inspecting the filter under UV light. The 
filters used were Hybond N or N+ (Amersham). In the case of the positively charged 
nylon the DNA was already fixed to the filter by alkali, otherwise the RNA or DNA 
was fixed using a Stratalinker (Stratagene) which gives a fixed UV exposure. 
2.2.5 Hybridisation 
Filters onto which DNA or RNA had been fixed were wet with 2xSSC. Filters, 
separated by a nylon mesh, were rolled up and uncurled in Hybaid hybridisation 
bottles containing 2xSSC, leaving as few air bubbles as possible. The. DNA was on 
the side not contacting the glass. 2xSSC was replaced with Church and Gilbert's 
buffer, prewarmed to the hybridisation temperature. Bottles were put into a Hybaid 
rotisserie oven and filters were prehybridised for at least 1 hour. The probe was 
incubated at 1000C for 10 minutes and immediately added to the bottles. 
Approximately 5x105 counts/ml hybridisation mix were used when hybridising to 
cloned DNA or PCR products, and lx 106  counts/ml hybridisation mix for genomic 
DNA Library primary screen filters were hybridised in sandwich boxes in Perspex 
containers. These were treated in the same way as the bottles except that they were 
incubated in a shaking oven. After overnight hybridisation the solution was removed 
and the filters washed with the appropriate concentrations of SSC solution containing 
0. 1%SDS. Following washing, filters were briefly dried on blotting paper, then 
wrapped in Saran wrap. 
Hybridisation conditions were determined by whether high or low stringency 
was required, depending on the level of identity of the probe to the target DNA. High 
stringency hybridisation and washes were at 68 0C, with 0.5xSSC and 0.1xSSC 
washes. Reduced stringency was variable, in general hybridisation and washing took 
place at 58 0C with washes of 3xSSC and 1xSSC, unless indicated in the text. 
2Counts are in dpm (degenerations per minute) and were calculated using the formula: 
Counts in dpm = .tCi 32P added to labelling reaction x % incorporation of label x 2.2x io 
2.2.6 Purification of DNA 
Purification of DNA away from modification enzymes (and unused primers and 
nucleotides in the case of PCR) was performed either by phenol:chloroform extraction 
or GENECLEAN® II (Bio 101). 
2.2.6.1 Phenol: chloroform extraction 
The reaction was made up to at least lOOpi by addition of dH20. To this an 
equal volume of water saturated phenol was added. The phases were mixed 
thoroughly by vortexing and then separated by spinning in a microfuge for 1 minute. 
The top phase was then removed, avoiding any protein at the interface, and retained. 
This was repeated and then again with a chloroform: octan- 2-ol (24:1) mixture. The 
DNA was then ethanol precipitated. 
2.2.6.2 GENECLEAN® II (Bio 101) 
To the reaction mixture 3 volumes 6M Nal were added and then 5p1 glassmilk 
(suspension of silica matrix in H20). If more than 5j.ig of DNA was being purified an 
extra 1tl glassmilk per 0.5pg extra DNA was added. This was left on ice for 5-10 
minutes. The glassmilk was spun down for 5s in a microfuge and the Nal solution 
removed, this was repeated to remove any traces of NaT. The glassmilk was 
resuspended in 200p1 NEW wash, pelleted by a lOs spin and the supernatant 
removed. This was repeated twice but for the final wash 400.il NEW wash was used. 
Any traces of ethanol from the NEW wash were removed by briefly (1 minute) freeze 
drying. To elute the DNA the pellet was resuspended in 25p1 of H20 at 550C and 
incubated at 550C for 5 minutes. The glassmilk was spun down for 1 minute and the 
supernatant removed to another eppendorf. This was repeated and the two elutes 
combined. This was spun briefly (30s) before use to make sure that any glassmilk 
accidentally carried over was pelleted. 
2.2.6.3 Purification of a specific DNA fragment 
If a specific fragment was desired a preparative agarose gel was run and the 
desired band excised with a scalpel. The bands were purified away from the agarose 
by either GENECLEAN® or Spin-X. 
2.2.6.3.1. GENECLEAN®  II (Bio 101) 
The gel slice was melted at 55 0C in 3 volumes Nal and purified as above. 
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2.2.6.3.2. Spin-X 
The agarose slice was placed in the insert of a Spin-X tube (Costar). On 
spinning in a microfuge the DNA moved though the 0.22 gm cellulose acetate filter at 
the bottom of the insert leaving the agarose behind. The tube was spun twice for 15 
minutes, the agarose was redispersed and about 50jtl TE buffer added between spins. 
The DNA in the elute was precipitated by adding 1/10th volume 3M NaAc pH5.2 and 
2 volumes EtOH. This was incubated at -20 0C for at least 30 minutes, the precipitate 
was spun down, dried, and resuspended in 20jil. 
2.2.6.4 "Double GENECLEAN®" protocol for cloning PCR products 
This is a strategy for cloning PCR products which involves firstly 
GENECLEANing directly or after purification on an agarose gel, then modification of 
the PCR ends and a second GENECLEAN. The whole PCR reaction was 
GENECLEANed using 25ji1 glassmilk and eluting in 20jil dH20. The second 
GENECLEAN used lOj.tl glassmilk and eluted in 25p1 dH20. 
2.2.7 Quantification of DNA fragments 
The amount of a DNA fragment isolated was quantified by running an analytical 
agarose gel with 1-2pi of the DNA solution. In parallel, a range of known amounts of 
size markers were run at approximately the same concentration as the expected DNA 
concentration. The amount of DNA in the sample was estimated by comparison with 
the brightness of a size marker band of approximately the same size. 
2.2.8 Enzyme modification of DNA and RNA 
2.2.8.1 Restriction digest of plasmid DNA 
Typically ijig of DNA was digested per lOj.tl reaction volume with 1 unit of 
restriction enzyme (Boehringer Mannheim), in the restriction buffer recommended by 
the manufacturer and at the appropriate temperature. For most enzymes the 
appropriate temperature was 37 0C. If the plasmid DNA had been prepared by the 
small scale plasmid preparation method 4mM spermidine was included in the reaction 
and 3jig RNase A (DNase free). The cutting of DNA was analysed using agarose gel 
electrophoresis. 
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For analytical digestion approximately 0.5-1jig DNA was digested for about 1 
hour. 
For preparative digestion approximately 10-20j.ig DNA was digested overnight. 
After digestion the enzyme was heat inactivated if appropriate. 
2.2.8.2 Restriction digests of genomic DNA 
Digests were set up containing 1Oj.tg mammalian DNA or the genomic 
equivalent as the size of the genome varied for the classes used. 
lOj.ig mammalian DNA or the genomic equivalent, 
5mM spermidine, 
lx restriction enzyme buffer, 
3U restriction enzyme per ijig DNA, 
dH20 to 50il. 
To ensure even digestion of the DNA, the reactions were set up minus the enzyme 
and left at 40C for 1-2 hours occasionally stirring with a yellow pipette tip. The 
enzyme was then added, mixed thoroughly and the reactions left for another hour at 
40C and then at 37 0C overnight. To check that the digestion was complete 0.5 jig 
was run on a minigel before loading the rest of the sample on a maxi gel. 
2.2.8.3 Production of radiolabelled DNA probes 
2.2.8.3.1 Random primed labelling 
The Boehringer Mannheim Random primed DNA labelling kit was used, 
utilising a technique developed by Feinberg and Vogelstein (1983). DNA fragments 
to be labelled were produced by restriction digest and purified using agarose gel 
electrophoresis and Spin-X. 
25-30ng DNA in 9ji1 dH20 was boiled for 5 minutes and immediately chilled on 
ice. To this ijil 0.5mM dATP, dGTP, dTTP, 3jil 10xreaction buffer (containing 
10%d hexanucleotide mixture), 5p1 [a- 32 lJCTP (3000CiJmmol, Amersham) and 2U 
Kienow enzyme was added. This was incubated overnight at RT or for 1 hour at 
370C. Incorporation of the label was assessed by precipitation of 0.5ji1 reaction mix 
on a GF/B Whatmann filter with approximately 3x15m1 5% TCA, where 
incorporation of 30% or more had occurred the labelled DNA was used as a probe. 
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Unincorporated nucleotides were removed by purification on a nick translation 
column (Pharmacia) containing Sephadex® G-50. The DNA eluted in 400j.ii TE 
buffer and the unincorporated nucleotides were retained on the column. 
2.2.8.3.2 Specific primed labelling 
This was used for labelling of the genomic zebrafish probe used for screening 
cDNA libraries. Random priming was not used due to the small size of the probe, 
instead the PCR primer C229 which was at the 5' end of the probe was used to prime 
the extension using Taq polymerase. 
25ng DNA was denatured by boiling for 5 minutes in 6.8tl cJH20 and then 
each o 
chilled on ice. To this 3.2i1 lOxTaq polymerase buffer (Promega), Lt1,.p.5mIv1 dATP, 
dGTP, dTTP, ipi 0.lmg/ml primer, 5.il [(X- 32 dCTP, ipi Taq polymerase (ABI) 
was added. This was then subjected to three rounds of; 72 0C 25 minutes, 940C 2 
minutes, 550C 1 minute, and a final extension of 72 0C 30 minutes, using a Hybaid 
Omnigene thermal cycler. The incorporation of radiolabel was checked and the probe 
purified as for random primed probes. 
2.2.8.4 Preparation of riboprobes 
This was performed using the Boehringer Mannheim DIG RNA labelling kit, 
utilising the T7 and T3 promoter sites at either side of the cloning site. 
The transcription reaction was set up by adding, 
1.ig of linearised DNA purified by phenol:chloroform extraction, 
4j.il lOx transcription buffer, 
4p1 10mM dATP, dCTP, dGTP, 6.5mM dUTP, 3.4mM DIG-UTP, 
1.t1 1M DTT, 
2pJ RNase inhibitor, 
2p1 Ti or T3 RNA polymerase, 
redistilled dH20 to give total volume of 40p1. 
This was incubated for 1 hour at 37 0C whereupon a second dose of enzyme was 
added and the incubation repeated. To remove the DNA template, 2p1 (20U) DNaseI 
and ipi 1Og/tl tRNA was added and incubated at 37 0C for 15 minutes. The 
reaction was stopped with 4p1 0.2mM EDTA pH8.0 and the RNA precipitated by 
adding 5t1 4M LiC1 and 150pi EtOH. This was left overnight at -20 0C, then spun at 
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40C for 30 minutes. The RNA pellet was washed three times with 70% EtOH at - 
200C and freeze dried. The RNA was resuspended in 20pJ DEPC dH20 and lj.tl 
RNase inhibitor added. 
The amount of riboprobe produced was assessed by comparison with the 
labelled RNA supplied with the kit, using the Boehringer Mannheim DIG Nucleic 
Acid Detection kit. Serial dilutions of the probe and standard were dot blotted onto 
Hybond N and fixed by UV exposure. The filters were then washed in buffer 1 for 1 
minute at RT on a shaker, then in buffer 2 for 30 minutes. This was followed by 
another brief wash in buffer 1 and then filters were soaked in buffer 1 containing 
115000 dilution of the anti-DIG-alkaline phosphatase conjugate for 30 minutes. The 
unbound antibody was removed by washing twice for 15 minutes in buffer 1, then 
equilibrated in buffer 3 for 2 minutes. This was replaced with buffer 3 containing 
4.541 NBT solution and 3.541 BCIP (X-phosphate) and incubated in the dark until the 
dots became visible (about 20 minutes). The reaction was stopped by washing in 
buffer 4. In general a yield between 0.1-1 p1/jig of RNA was obtained The probe was 
denatured prior to use in 20j.tl DEPC dH20 at 80°C for 5 minutes and cooled on ice. 
2.2.8.5 cDNA synthesis 
This was performed using the Boehringer Mannheim cDNA synthesis kit (Gubler and 
Hoffman 1983). The first DNA strand was synthesised by adding, 
2il buffer I, 
0.5tl (12.5U) RNase inhibitor, 
ipi 40mM dNTVs, 
ipi lOng/mi random hexamers, 
1 jil (20U) AMY-Reverse Transcriptase, 
2pg of total RNA, 
redistilled dH20 to a total volume 1%t1. 
Incubation was at 420C for 1 hour. 
The second strand was synthesised by adding, 
20pi buffer II, 
0.5p1 RNaseH, 
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2.5j.il (12.5U) E.coli DNA polymerase I, 
7jfl redistilled dH20, 
and incubating at 16 0C for 1 hour, RT for 1 hour and 650C for 10 minutes. 
2.2.8.6 Modification of ragged ends of PCR products 
For blunt ended cloning the non template directed extra base added by the Taq 
polymerase to the 3' end of the PCR product was chewed back. The reaction was set 
up as follows: 
One half of a GENECLEANed PCR reaction, 
lOpi lOx E.coli DNA polymerase I buffer, 
1i1 100mM rATP, 
lOU T4 polynucleotide kinase, 
lOU E.coli DNA polymerase I (BRL), 
total volume of 100g l. 
This was incubated for 1 hour at 37 0C and the reaction stopped by the addition of 1.tl 
0.5M EDTA pH8.0. 
2.2.8.7 Ligation of DNA fragments into vectors 
Initially the pBluescript vector, pSKII+ (Stratagene) was used. This is a 
derivative of pUC19. It has a high copy number in E.coli. and contains a multiple 
cloning site (MCS) with unique restriction sites and the T7 and T3 promoters. It also 
has a partial lacZ gene and so blue /white selection to detect the presence of an insert 
can be used. 
2.2.8.7.1 Cohesive end ligation 
The DNA fragment and the vector were digested with the appropriate enzymes 
and gel purified. The vector and the insert were mixed at a molar ratio of about 3:1 
(about lOOng DNA) in a volume of 7t.tl  and warmed for 5 minutes at 450C and then 
chilled on ice. 1.tl of lOx ligation buffer, ipi  rATP, 1il (1U) T4 ligase were added 
and incubated overnight at 16 0C. 
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2.2.8.7.2 Blunt ended ligation of PCR products 
pSKII+ was cut with EcoRV in the MCS to produce blunt ends. The PCR 
product was purified using the "Double GENECLEAN®" protocol, ragged ends were 
chewed back to produce blunt ends. 40ng of vector and insert were added to ipi of 
lOx ligation buffer, 1j.tl rATP, 1tl (1U) T4 ligase and incubated at least overnight at 
16°C. 
2.2.8.7.3 Turbo cloning of PCR products 
This is a very fast and non size selective method for cloning (Boyd 1993), and is 
explained in Chapter 4. pBS:lox is a manipulated version of pBluescribe (pBS) 
(Stratagene). A recognition site (lox site) for the Cre enzyme has been introduced at 
the Pvull site 5' to the MCS. 
The ends of the GENECLEANed PCR products were made flush (section 
2.2.8.6) and the modifying enzymes were inactivated by treatment at 750C for 5 
minutes, and the DNA was desalted by dialysis on a Millipore filter (section 2-1.2.2). 
The ligation mixture was set up; 
7pi (lOng) PCR product, 
1tl (lOOng) Smal cut and dephosphorylated pBS:lox (gift A.C. Boyd), 
1.6xl lOx buffer, 
6jil 40%(wlv) PEG 6000, 
0.4iil(O.4U) T4 ligase. 
This was incubated at 200C for 15 minutes, the ligase was then inactivated by 10 
minutes at 650C. 64p1 M restriction enzyme buffer (Boehringer Mannheim) and 0.5il 
Cre enzyme (NEN) was added. This was incubated at 30 0C for 30 minutes. The 
enzyme was heat inactivated as above. 
2.3 Sequencing DNA 
The method used is based on the original method of Sanger et al., (1977) which 
involved extension of a primer with a polymerase. The DNA produced is labelled by 
incorporation of [a- 35S]dATP and reactions terminated by the incorporation of 
dideoxynucleotides. The Sequenase®  II kit produced by USB was used which 
includes an engineered version of the T7 polymerase, Sequenase®  enzyme. This 
increases the processivity of the enzyme and therefore increases the readability of 
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sequence obtained. The primers used were pBluescript primers or those originally 
designed for PCR. 
2.3.1 Double stranded sequencing of plasmid DNA 
1-5pg of plasmid DNA in 16j.il dH20 was denatured by adding 4j.tl 1M NaOH, 
1mM EDTA and incubating at 650C for 5 minutes before chilling on ice. The DNA 
was precipitated by adding 2p1 2M NH4Ac pH4.5, 60j.il cold EtOH and leaving on 
dry ice for 10 minutes. The DNA was pelleted at 4 0C for 10 minutes and washed in 1 
volume 80% EtOH, then dried. 
The annealing mix was made up; 
241 SxSequenase®  buffer, 
ipl (100 j.Ig/ml) sequencing primer, 
7p1 DNA pellet resuspended in dHO 
This was heated to 650C  for 2 minutes and then at 37 0C for 15 minutes. 
The template mix was assembled; 
ljiJ 0.1mM DTT, 
2j.tl 115 dilution dGTP labelling mix, 
0.5pi [(x-35S]dATP (<1000CiJmmol, NEN), 
lj.il 1/8th dilution of Sequenase®  in enzyme dilution buffer. 
The template mix was added to the annealing mix, incubated at RT for 4 minutes and 
3.4tl was added to 2.5p1 of each termination mix (prewarmed at 37 0C). This was 
incubated for 4 minutes at 37 0C, the extension was stopped with 4tl formamide 
loading buffer. About 3p1 of each termination reaction was loaded per lane of a 
sequencing gel. 
2.3.2 Direct sequencing of PCR products 
This is an adaption of the Sequenase®  method for plasmid DNA sequencing, 
and involves the use of DMSO to retain the PCR template in a denatured state 
(Winship 1989). 
The annealing mix was made up; 
I 
approximately 300ng of gel purified PCR fragment in 6tl dH20, 
ipi 0.5p.M primer, 
2t1 5xSequenase®  buffer, 
ljtl DMSO. 
This was denatured at 1000C for 3 minutes and snap frozen on dry iceIEtOH. 
The labelling mix was assembled; 
ljilO.1MDTT, 
2j.tl 1/15th dilution dGTP labelling mix, 
0.5pJ [a-35SJdATP, 
1.5p1 Sequenase®. 
This was added to the annealing mix as it was thawing. This reaction mix was 
incubated at RT for 45s and then 3tl added to 2p1 of each termination mix 
(containing 10% DMSO and prewarmed to 37 0C). These were incubated at 37 0C for 
5 minutes and the reactions stopped by adding 4j.il  formamide dye. 4j.tl of each 
termination reaction was loaded per lane of a sequencing gel. 
2.3.3 Polyacrylamide gel electrophoresis (PAGE) of sequencing reactions 
Prior to using, the glass sequencing plates were washed with soap, dried and 
one plate coated in dichiorodimethylsilane, to prevent the gel adhering to this plate. 
The plates were taped together along the sides separated by 0.4cm spacers and 
gripped together by bulldog clips. The Sequagel system (National Diagnostics) was 
used for making up acrylamide. Just prior to use the appropriate amounts of 
concentrate, dilution buffer and running buffer were mixed to give the desired 
acrylamide concentration. To this was added 1/10 volume 10% ammonium 
persuiphate and 5Opi TEMED (N,N,N'N'-tetramethylethylenediamine), this was 
quickly poured between the plates while the mixture remained liquid. 0.5-0.8% 
acrylamide was used depending on the resolution required (Sambrock et al., 1989). 
Gels were run in 1xTBE using a limiting factor of 30W, the current and voltage 
being approximately 24mA and 1250V. Gels were typically run between 1.5-5 hours, 
using bromophenol blue and xylene cyanol dye fronts to estimate the positions of the 
fragments. A metal plate, clipped to the front of the plates, acted as a heat distributor 
to avoid 'smiling' of the gel. After the run was completed the gel plates were 
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separated and the gel fixed in 10% acetic acid, 10% methanol for 15-30 minutes. The 
gel was then transferred onto 3MM Whatman paper, covered with Saren wrap and 
dried under vacuum for 1 hour. 
2.4 Detection of radioactive signal 
2.4.1 Autoradiography 
This was the most frequently used method for detecting radioactive signal. 
Filters hybridised to [(X-32p]  labelled probes were exposed to Kodak XAR-5 film at - 
700C with an intensifier screen. In the first instance exposure was overnight except 
for PCR fragments which were exposed for 1-2 hours. Spots of Glow Juice (IBI) at 
the edge of the filters were used to line up the filters with the film. 
The DNA sequence ladders' were visualised by exposure to Kodak XAR-5 film 
at RT, in the first instance overnight or longer if the signal was faint. 
2.4.2 Phosphorlmager analysis 
This was used towards the end of the project, particularly for genomic DNA 
and Northern blots. The filter or sequencing gel was placed in a Phosphorlmager 
cassette, and depending on the signal, left for an appropriate amount of time at RT. 
(1-2 hours for sequencing gels or overnight for blots). The Phosphorlmage screen 
was then analysed by the Phosphorlmager using a laser and an image produced and 
analysed using the ImageQuantTM  software (Molecular Dynamics). 
2.5 Incubation and analysis of embryos 
2.5.1 Rearing of Xenopus embryos 
Xenopus eggs were obtained from Professor P.M. Gaze, Department of 
Zoology, University of Edinburgh. The embryos were kept in clean Xenopus rearing 
solution and fed on Nettle Powder (Philip Harris Scientific) and Complan (Boots). In 
order to stop the embryos swimming so that they could be staged (Niewkoop and 
Faber 1967), the tadpoles were anaesthetised by placing them in a very dilute solution 
of MS222. Prior to dissection the tadpoles were placed in a more concentrated 
solution. 
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2.5.2 Whole mount in situ hybridisation 
This protocol is an adaptation by Lesley McInnis of that described by Wilkinson 
(1992). 
2.5.2.1 Incubation and dissection of embryos 
Hen eggs were supplied by the AFRC unit at Roslin, East Lothian. These were 
incubated at 370C  and turned every 24 hours for the first 3 days. Embryos were 
dissected at RT in sterile PBS. As many extra-embryonic membranes as possible were 
removed to avoid trapping of the probe/antibody. They were then placed on ice in 
PBS pH7.2 in Sterilin conical tubes. Embryos were staged according to the tables of 
normal development (Hamburger and Hamilton 1951). 
2.5.2.2 Preparation of embryos 
The embryos were treated as follows (all washes were for 10 minutes in 5- lOml); 
Washed embryos twice in ice cold PBS. 
Fixed embryos for at least 2 hours in freshly made 4% paraformaldehyde (PFA) 
in PBS at 40C. 
Washed, twice in PBT (PBS+0.1%Tween 20). 
Dehydrated on ice through 25%, 50%, 75% and 100% (twice) methanol in PBS. 
The embryos were stored at 200C  until required. 
Rehydration on ice through the same percentages as above. 
Washed three times in PBT. 
Bleached with 6%H202 in PBT for 1 hour. 
Washed three times in PBT. 
Digested with lOj.tg/ml proteinase K in PBT for 15 minutes. 
Washed in 2mg/mi glycine in PBT. 
Washed twice in PBT. 
Refixed in fresh 0.2% gluteraldehyde/4%PFA in PBT for 20 minutes. 
Washed twice in PBT. 
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2.5.2.3 Hybridisation 
Hybridisation of the riboprobe was performed as follows (in a volume of imi); 
Washed in 50% hybridisation buffer:50% PBT at RT. 
Washed in hybridisation buffer at RT. 
Prehybridisation in hybridisation buffer containing lOOj.tg/ml tRNA and 
100pg/m1 denatured salmon sperm DNA at 700C  for 1 hour. 
Replaced solution with the same containing 500ng denatured riboprobe. 
Tubes humidified by placing a 0.5m1 eppendorf tube containing hybridisation 
buffer into the neck of the tube. 
Hybridisation overnight at 70 0C. 
Washed twice in hybridisation buffer at 700C  for 10 minutes. 
Washed twice for 5 minutes, and three times for 30 minutes at 65°C in post 
hybridisation wash. 
Allowed embryos to cool to RT. 
Washed in 1xTBST three times. 
2.5.2.4 Antibody conjugate binding and staining 
Diluted anti-DIG alkaline phosphatase conjugate 1 in 500 in1xTBST,l% heat 
inactivated sheep serum (Scottish Laboratories Products) and added 6mgIml heat 
inactivated embryo powder from the appropriate species. 
Preadsorbed antibody 1 hour at 4 0C. 
Blocked embryos with 1xTBST, 10% heat inactivated sheep serum for 1 hour at 
RT. 
Replaced blocking solution the same solution containing 1 in 2000 dilution of 
preadsorbed antibody. Allowed antibody to bind overnight at 4 0C. 
Washed 3 times for 5 minutes and 3-5 times 30-60 minutes in1xTBST. 
Equilibrated embryos in fresh alkaline phosphitase buffer by washing 3 times for 
10 minutes 
Replaced solution with alkaline phosphatase buffer containing 4.5j.tl NBT and 
3.5tl BCIP in glass vials. 
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Allowed stain to develop in the dark and examined at regular intervals until a 
stain appeared. 
Stopped reaction by rinsing in PBT containing 0.2M EDTA 
Refixed the embryos in 4%PFA. 
2.5.2.5 Photography of embryos 
Stained embryos were photographed using a Wild Heerbrugg Photomakroskop 
M400 and a Wild Leitz WPS Photoautomat using 64 ASA colour film (Fuji). 
2.6 Polymerase chain reaction (PCR) 
2.6.1 Synthesis and purification of oligonucleotides 
PCR primers were synthesised by either D. Chambers or A. Gallacher on an 
Applied Biosystems 381 A synthesiser. 350ji1 ammonium hydroxide stock of 
oligonucleotides was precipitated with 35jil 3M NaAc pH5.5 and 770p1 EtOH. This 
was incubated at -20 0C for 30 minutes and the precipitate spun down in a microfuge 
at 40C for 15 minutes. The pellet was washed twice in 80% EtOH and then freeze 
dried. The pellet was resuspended in 200p1 TE and the concentration estimated from 
the OD260. An 013260 of 1 was estimated to be equivalent to 25 jig/mi single 
stranded oligonucleotide. 
2.6.2 Reaction conditions 
The standard PCR mix contained; 
lx Taq polymerase reaction buffer (Promega or nbl (Northumbria biolabs)), 
200 jiM each dNTP, 
5jig/ml each PCR primer, 
2.5U Taq polymerase (Promega or nbl), 
sterile dH20. 
The reactions were set up in 0.5m1 eppendorf tubes generally using either 25 or 50 jil 
reaction mix, and covered with 3-4 drops mineral oil. Amplification was performed 
by an initial 3 minute denaturation (94 0C), and then 30 cycles; 50 0C 2 minutes 720C 
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1 minute 940C 1 minute, followed by a final extension of 500C 1 minute and 72 0C 10 
minutes. 
If hot start PCR was used the reaction mix, minus the enzyme, was heated to 
940C for 3 minutes and the temperature was then held at 72 0C while the Taq 
polymerase was added. The annealing temperature was subject to variation 
depending on the primers involved and whether they were 100% identical to the 
template or not. The extension time was increased to 2 minutes or more when long 
products (>1kb) were expected. For exon 1 PCR 10% glycerol was included to 
minimise amplification of spurious bands, these probably occurred due to the high (3€ 
content of the region and of the primers. Initially reactions were performed using 
Perkin Elmer Cetus DNA thermal cyclers and later Hybaid Omnigene thermal cyclers. 
2.6.3 PCR template 
Several different templates were used in the course of this project. 
PCR analysis of bacterial colonies was performed by picking the colony and 
vortexing in imI dH20. The cell suspension was boiled for 1 minute and chilled on 
ice. 1tl was then used as a template. 
For PCR directly from bacteriophage, 5tl phage suspension in SM buffer were 
placed in the balance dH20 for the PCR reaction and boiled for 5 minutes, the rest of 
the PCR mix was then added. 
If cDNA was used 1/10th- 1/5 of the PCR reaction volume was added, 
equivalent to 25-50ng RNA per 50p1 PCR reaction. 
For PCR from genomic DNA, 0.3pg genomic DNA was added per 100pl 
reaction 
2.7 Solutions 
Bacteria and bacteriophage media 
L-Broth 	 lOg tryptone (Difco), 
per litre, pH7.2 	 5g yeast extract (Difco), 
lOg NaCl, 
2.46g MgSO4 
L-agar 	 contains L-both plus 15g agar/litre. 
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CY (select) agar lOg casamino acids (Difco), 
per litre, pH7.2 5g yeast extract, 
3g NaCl, 
lOg agar. 
CY top agarose contains 6.5g/l agarose in place of agar. 
Terrific Broth 12g tryptone, 
per 800m1. 24g yeast extract, 
4m1 glycerol. 
KPO4 buffer 	 170mM KH2PO4, 
720mM K2HPO4 
1/10 volume added to Terrific broth. 
SM buffer 	 100mM NaCl, 
10mM MgSO4, 
50mM Tris-HC1 pH7.5, 
0.01% Gelatin. 
All reagents were sterilised by autoclaving before use. 
Ampidillin stock solution 	lOOmg/ml in dH20 (filter sterilised). 
IPTG stock solution 	20mg/ml in dH20 (filter sterilised). 
X-Galactose 	 20mg/ml in dimethylformamide. 
DNA manipulation and purification 










GTE 	 50mM Glucose, 




10mM Tris-HC1 pH7.6, 





Cell Lysis Solution 
Column Wash Solution 
50mM Tris-HC1 pH7.5, 
10mM EDTA, 




10mM Tris-HC1 pH7.5, 
2.5mM EDTA, 
50% EtOH. 
Electrophoresis and hybridisation 
1xTAE 	 40mM Tris-Acetate, 
1mM EDTA pH8.0. 
1xTBE 	 90mM Tris-Borate, 
2mM EDTA pH8.0. 
lOx RNA gel running 	0.4M MOPS (morpholinopropansulphonic acid), 
buffer 	 100mM NaAc, 
10mM EDTA pH8.0. 
6x glycerol loading buffer 
Formamide loading buffer 
Alkali transfer buffer 
Church and Gilbert's 
solution 
Enzyme buffers 
lOx E.coli DNA 
polymerase I buffer 
0.25% bromophenol blue, 
0.25% xylene cyanol FF, 
30% glycerol in dH20. 
95% formamide, 
20mM EDTA, 
0.05% bromophenol blue, 
0.05% xylene cyanol. 
0.25 NaOH, 
1.5M NaCl. 
0.5M Na Phosphate pH7.2, 
7%SDS. 
0.5M Tris-HC1 pH7.5, 
0. 1M M902, 
10mM DTF, 
500pg/ml BSA (Fraction V), 
200pM dNTPs. 
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lOx T4 Ligation buffer 
lOx Turbo cloning buffer 
lOx Taq polymerase 
buffer (Promega) 
200mM Tris-HC1 pH7.6, 
50mM M902, 
50mM DTT, 
500p.g/ml BSA (Fraction V). 




1.5mM M902 , 
50mM KC1, 
10mM Tris-HC1 pH 90, 
1% Triton X-100. 
Alkaline phosphatase colour reaction 
Buffer 1 	 0.1M Tris-HC1 pH 7.5, 
0.15 M NaCl. 
Buffer 2 	 buffer 1 containing 1% blocking reagent. 
Buffer 3 	 0.1M Tris-HC1 pH9.5, 
0.1M NaCl, 
50mM M902. 
Buffer 4 	 10mM Tris-HC1 pH8.0, 
1mM EDTA. 
NBT solution 	 75mg/ml nitroblue tetrazolium in dimethylformamide. 
BCIP or X-phosphate 	50mg/mi toluidinium 5-bromo-4-chloro-3-indolyl-phosphate 
solution 	 in dimethylformamide. 
Whole mount in situ hybridisation 
Hybridisation buffer 	50% deionised formamide, 
pH to 5 with 1M citric 5xSSC, 
acid. 	 50j.tg/ml Heparin, 
0.1% Tween-20. 






1xTBST 	 140mM NaCl, 
3mM KC1, 
25mM Tris pH7.5, 
0.1% Tween-20. 
Alkaline phosphatase 	100mM Tris-HC1 pH9.5, 
buffer 	 100mM NaCl, 
50mM MgC12, 
0.1% Tween-20. 
Heat inactivated embryo 	ground, acetone dehydrated, homogenised embryonic tissue, 
powder 	 heated at 700C for 30 minutes in 1xTBST 
Xenopus rearing 	60mM NaCl, 






2.8 Computer analysis of DNA sequences 
The University of Wisconsin's Genetics Computer Group have produced an 
extensive and expanding set of programs for DNA sequence analysis and manipulation 
(GCG 1991). Routine functions were performed using these programs. In addition 
sequence comparison of the WTI orthologs was performed using the gap program. 
The pepplot program was used to draw the protein structure prediction plots, motifs 
and helicalwheel programs were used to investigate protein structure motifs. The 
Blast program was used to search the EMBL, GenBank and SwissProt sequence 
databases using sequences isolated in this study (Altschul et al., 1990, Karlin and 
Altshul 1990). Clustal V was used for phylogenetic analysis and multiple alignment of 
the WTI sequences (Higgins and Sharpe 1988, Higgins et al., 1992), and is described 
in Chapter 5. Signal Scan was used to locate the presence of any possible 
transcription binding sites (Prestridge 1991). All the above programs were used via 
the Human Genome Mapping computing facility. 
The Coils program (Lupas et al., 1991) and three updates were used to analyse 
the potential of WT1 to form coiled coils. A UNIX version (Yauso Ina 1993) of Li's 
1993 program, lwllS, (Li et al., 1985, Li 1993) was used for the calculation of KS 
and KA  to investigate the rate of evolution of WTI. 
V. 
Chapter 3 
Identification of sequences cross hybridising to WTI in the vertebrates 
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3.1 Introduction 
Initially, to determine whether sequences homologous to the WTI gene were 
present in species other than mouse and human, hybridisation of a WT1 probe to a 
range of vertebrate DNA's was carried out at low stringency. This technique known 
as zoo blot hybridisation is often used in gene mapping to determine whether a single 
copy probe is conserved across species and therefore may correspond to exonic gene 
sequence (Monaco et al., 1986). It has been used to demonstrate, for known genes, 
the conservation of homologous sequences in the genomes of different species, in 
some cases as far as Drosophila e.g. PAX6 (Ton et al., 1991b). 
Comparison of nucleotide sequences of mouse and human WTI showed 81% 
overall identity of the entire cDNA and this increased in the protein coding region to 
91%, and was even higher in the zinc finger region at 95% (Buckler et al., 1991). 
This indicated that the WTI gene is highly conserved between mouse and human and 
therefore probably highly conserved within the rest of the mammalian lineage at least. 
3.2 Detection of sequences cross hybridising to WTI in mammals 
In order to determine the presence of WTI in other mammalian species apart 
from human and mouse, genomic DNA was obtained from human (Homo sapiens), 
mouse (Mus domesticus), rat (Wistar), guinea pig (Cava porcellus), pig (Sos scrofa), 
sheep (Ovis aries), and cow (Bos tarsus) (gifts R. Hill and A. Archibald). A mouse 
Wtl cDNA clone pK/S2 (gift Buckler et al.) containing all but the first 779bp of exon 
1 was used to probe the EcoRI restricted DNA's at reduced stringency. The 
hybridisation temperature that was used was determined using the formula of 1-1.5 0C 
reduction in melting temperature (Tm) per percentage mismatch of the probe with the 
target DNA (Sambrook et al., 1989). Washing was carried out in stages and 
autoradiography performed before the stringency was increased. 
Bands were observed in the pig, sheep and cow samples after washing at 58 0C 
in 2xSSC. For human, mouse, rat and guinea pig, bands were seen after washing at 
670C in 0.5xSSC (Figure 3.1). 
The strongest band detected in mouse was 8kb and this corresponded with the 
band seen in C5711116 mice (Buckler et al., 1991) under high stringency conditions. In 
human genomic DNA a WTI cDNA probe detects 8 EcoRl fragments (13.6, 10.4, 
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Detection of sequences that hybridise to WTI in a range of mammalian 
genomes. 
a Ethidium bromide stained agarose gel of EcoRI digested genomic DNA. 
b Autoradiographs after hybridisation at reduced stringency (580C) with mouse Wtl 
cDNA (pKJS2). 
Washing conditions at which specific bands were observed are indicated. 




experiment the 3.7 and 3.1 kb bands were faint and the 6.1kb band was not detected 
but all the rest were seen (Figure 3. lb). Therefore it was thought that the conditions 
used were detecting WTI sequences and so it could be presumed that sequence 
homologous to WTI were present in rat, guinea pig, pig, sheep and cow genomes 
(Figure 3.1). 
3.3 Detection of sequences cross hybridising to WTI in non mammalian 
vertebrates 
A major problem with low stringency hybridisation with a probe containing a 
motif is that hybridisation may be occurring to paralogous or related genes also 
containing this motif, and therefore giving spurious signals. In the case of TFIIIA -like 
zinc fingers it has been estimated that there are 300-700 finger containing genes in the 
vertebrate genome (Crossley and Little 1989). In order to avoid cross finger 
hybridisation a 454bp NcoI resction digest fragment of WT33 was subcloned 
(H454). This contained of part of exon 1 and exons 2-4 but not the zinc finger 
encoding region. WT33 was one of the first human WTJ cDNA clones to be isolated, 
containing all but the 5' 630 bp (Call et al., 1990). 
Human, mouse, rat, pig, chick (Gal/us domesticus), frog (Xenopus laevis) aid 
trout (Salmo) genomic DNA was digested either with BamHI or EcoRI. The amount 
of DNA used for the digestion was calculated so that the equivalent number of 
haploid genomes was used for each species (Table 3). Hybridisation was performed 
at 550C with the human probe H454 and washing carried out until bands were 
observed (2xSSC). These conditions had previously been shown to detect cross 
species hybridisation for SRY-like sequences in vertebrate genomes (Tiersch et al., 
1991). Bands were observed in human, mouse, chick, frog and trout with the Bamfil 
digest (Figure 3.2) and frog with EcoRI digest (data not shown). 
3.4 Conclusions 
Zoo blotting of vertebrate genomic DNA has demonstrated the presence of 
sequences capable of cross hybridisation to WTJ probes in four of the five vertebrate 
classes (mammal, bird, amphibian, and fish). These may not be WTI orthologs but 
closely related sequences, however it was shown that mostly WTI specific bands were 
being detected in species where the sizes of WT1 specific bands were known (Figure 
3.1). Secondly the possibility of hybridisation to other zinc finger genes was reduced 
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by the use of a probe not containing the zinc finger encoding region. The sequence of 
the part of WTI sequence used was not similar to any known sequence on searching 
of the EMBL and GenBank databases. Therefore these results showed that it was 
likely that WTI -like genes were present in all vertebrate genomes and gave 
encouragement to attempt the cloning of WTJ from various species. 
Table 3 Size of vertebrate genomes. 
Organism Nucleotide pairs x102 
per haploid genome 
Homo sapiens 3.4 
Musmusculus 3.36 
Rattus norvegicus 2.9 
Gallus gallus 1.2 
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Detection of sequences that hybridise to WTI in a range of vertebrate genomes. 
a Ethidium bromide stained gel of BamHT digested genomic DNA 
b Autoradiograph after hybridisation at reduced stringency (550C) with a subclone of 

















Isolation of WTI orthologs 
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4.1 Isolation by cross species PCR 
4.1.1 Introduction 
Since it had been shown, by reduced stringency hybridisation, that there were 
sequences within non mammalian vertebrate genomes which hybridised to a WT1 
probe, the' cloning of sequences homologous to WTI within the vertebrates was 
attempted. The traditional method for the isolation of sequences homologous to a 
known gene, such as orthologs and paralogs, has been by reducing the stringency of 
hybridisation when screening libraries. This can be a very time consuming process 
and often many unrelated sequences are isolated. 
In the last few years a major change in methodology has come about with the 
invention of the Polymerase Chain Reaction (PCR). PCR was developed in 1984 by 
the Cetus Corporation and is a method of amplification of specific DNA sequences in 
a cell-free system. PCR abrogates the need for the initial cloning of the DNA prior to 
amplification (Saiki et al., 1985, Mullis and Faloona 1987). It is based on two 
oligonucleotide primers flanking the region of interest on opposite strands of the 
DNA, and cycles of annealing the primers to the template, extension of the primers by 
a DNA polymerase, and denaturation of the product. The presence of two primers 
instead of one results in an almost exponential, rather than linear, amplification of the 
target region (Mullis and Faloona 1987). The speed and sensitivity of PCR has been 
enhanced by microchip controlled heating blocks, and isolation of a heat stable DNA 
polymerase (Taq polymerase) from The rmus aquaticus. The simplicity of this 
technique lends itself to manipulation and therefore a wide range of uses (reviewed by 
Arnheim and Erlich 1992). 
Although PCR was originally developed for situations where the template 
sequence was known and so complementary primers could be designed (e.g. for the 
analysis of mutations (Saiki et al., 1985)), it quickly became clear that by lowering the 
stringency of the reaction a degree of mismatch between the primer and template 
could be tolerated. This has been exploited to amplify related genes, genes from 
different species and phyla (Orlandi et al., 1989, Sarker and Sommer 1989, Pang et 
al., 1990, Sarker et al., 1990, Sommer et al., 1992), or where only the amino acid 
sequence of the protein is known (Lee et al., 1988). Once part of the target gene has 
been isolated this can be used as an homologous probe for library screening (Lee et 
al., 1988). 
For the isolation of WTI orthologs cross species PCR was particularly 
applicable for several reasons. The speed of the technique makes it the best 
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Table 4.1 Sources of RNA from which the isolation of WTI orthologs was attempted 
Species Taxon Stage/Age Tissue Source 
Mouse (BALB/c) Mammal Adult Testis  
Rat (Wistar) Mammal Adult Testis  
Pig Mammal Juvenile Testis Testis - A. Archibald, 
(Sos scrofa)  AFRC Roslin, Midlothian 
Chick Bird 8-14 day Embryo Mesonephros I 
(Gallus domesticus) Metanephros and 
Gonad combined  
Alligator Reptile Stage 20 Embryo Gonad RNA - AM. Coriat, 
(Alligator University of Manchester 
mississippiensis)  
Frog Amphibian Stage 45 Tadpole Whole tadpole Eggs - P.M. Gaze, 
(Xenopus laevis) - 	 - University of Edinburgh 
Frog Amphibian Stage 53 Tadpole Mesonephros it 	it 	 it 
(Xenopus laevis)  
Zebrafish Fish Larva Whole larva RNA - P. Ingham, 
(Brachydanio rerio) Teleost ICRF, Oxford 
Reverse transcribed RNA - T. Jowett, 
University of Newcastle 
Ascidian Tunicate Tadpole Whole tadpole RNA - M. Levine, 
(Herdinania momus) Queensland Institute of Medical 
Research, Australia 
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way of isolating multiple sequences and therefore for producing sequence 
comparisons. The zinc finger motif is one of the most highly conserved regions within 
WTI when human and mouse are compared and therefore is most likely to hybridise 
cross species. As mentioned in chapter 3, the numbers of this motif are high in the 
vertebrate genome (Crossley and Little 1991). Therefore if reduced stringency 
screening with the motif was used, non WTI orthologs especially the EGR family (the 
most similar fingers to WTI) could be isolated. The use of two primers in PCR allows 
for the selection of zinc fingers at one site and WTI specificity in the other primer. 
4.1.2 Experimental design 
The main aim of the design was to favour the amplification of WTI-like genes 
over any other genes in PCR i.e. to fmd the balance between specificity and 
degeneracy. If non specific amplification occurs, in addition to obscuring the desired 
product, it can inhibit its amplification by sequestering substrates. 
4.1.2.1 Template 
Three PCR strategies were considered. PCR from genomic DNA amplifying 
across introns (interexonic); amplifying each exon separately (intraexonic); and RT-
PCR using RNA from a tissue likely to be expressing WTI. RNA was chosen as the 
starting material rather than genomic DNA. This was because the genomic structure 
of only the zinc finger region was known (Haber et al., 1991). For both interexonic 
and intraexonic PCR a knowledge of the genomic structure is needed. 
Total RNA was prepared wherever possible from tissue found to express WTI 
in mammals (Table 4.1). The gonads were frequently chosen as these are easily 
recognised and WTI expression had been demonstrated to be at a higher level than in 
the kidney of the post natal mouse. The species chosen represent every gnathostome 
class and one non-vertebrate chordate. Mammalian species were included mainly to 
act as a test system to show that cross species PCR of WTI was possible. Other 
species were chosen as the most studied example of their class and are therefore 
widely obtainable and the most useful for subsequent studies. 
4.1.2.2 Primer design 
Probably the most important feature of cross species PCR is the design of the 
oligonucleotide primers. It has been found that for successful priming mismatches are 
not tolerated in the three 3' bases for a 20bp primer (Sommer and Tautz 1989, Sarker 
et al., 1990), although some priming can sometimes be obtained in longer primers 
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Figure 4.1 Predicted amino acid sequence of human WTI showing the exon 
structure and the positions of degenerate PCR primers used in this study 
Exon 1 
1 	MGSDVRDLNA LLPAVPSLGG GGGCALPVSG AAQWAPVLDF APPGASAYGS 
B312-> 
51 LGGPAPPPAP PPPPPPPPHS FIKQEPSWGG AEPHEEQCLS AFTVHFSGQF 
101 TGTAGACRYG PFGPPPPSQA SSGQARMFPN APYLPSCLES QPAIRNQGYS 
Exon 2 	 Exon 3 
151 TVTFDGTPSY GHTPSHHAAQ FPNHSFKHED PMGQQGSLGE QQYSVPPPVY 
Exon 4 
B300-9 	B297- 
201 GCHTPTDSCT GSQALLLRTP YSSDNLYQMT SQLECMTWNQ MNLGATLKGV 
Exon 5 	 Exon 6 	 C227-* 
251 AAGSSSSVKW TEGQSNHSTG YESDNHTTPI LCGAQYRIHT HGVFRGIQDV 
Exon 7 	 B620-* 	 C229- 
301 RRVPGVAPTL VRSASETSEK RPFMCAYPGC NKRYFKLSHL QMHSRKHTGE 
Exon 8 	 Exon 9 
351 KPYQCDFKDC ERRFSRSDQL KRHQRRHTGV KPFQCKTCQR KFSRSDHLKT 
Exon 10 
-C228 	-B298 
401 HTRTI-iTGKTS EKPFSCRWPS CQKKFARSDE LVRHHNNHQR NMTKLQLAL* 
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with a mismatch in the third base from the 3' end. Mismatches between primer and 
template in any position will affect the melting temperature of the primer template 
hybrid. In the 5' region mismatches are tolerated as shown by the inclusion of 
restriction enzyme recognition sites (Scharf et al., 1986). 
For WTI, primers were designed by comparison of the two known sequences, 
mouse (Buckler et al., 1991) and human (Call et al., 1990, Gessler et al., 1990) using 
both the nucleotide and predicted amino acid sequences. Figure 4.1 shows the 
positions of the chosen primers relative to human WTI. To minimise the number of 
mismatches regions of greatest conservation were used and sequences selected 
containing amino acids with the least number of codon degeneracies. The 
downstream primer was made complementary to a region within the zinc fingers in the 
linker region between ZF3 and 4 just downstream of the KTS alternative splice. This 
linker is a highly conserved motif between the TFIIIA-like zinc fingers (Choo and 
Klug 1993). It was hoped that the proximity to a splice site might lead to greater 
conservation at the nucleotide level. The positioning of the upstream primers was not 
as obvious. Therefore two primers were made complementary to parts of the putative 
leucine zipper, which is methionine rich (methionine is encoded by only one codon). 
Further upstream the sequence is GC and proline rich. The former is known to inhibit 
PCR of WTJ (W. Bickmore personal communication); the latter increases the possible 
degeneracy of the coding sequence and therefore increases the likelihood of 
mismatches and failure of amplification. One primer was made complementary to the 
sequence thought least likely to be degenerate in this region. When variation in 
nucleotide sequence could be predicted from codon degeneracy, or there were 
changes between human and mouse sequences, mixed bases or inosine were 
incorporated (Lee et al., 1988, Sommer and Tautz 1989). Inosine is capable of 
complementing all four bases. Codon preference can sometimes be useful in defming 
whether codons are likely or not to appear in a species. For those vertebrate species 
used there only seems to be slight differences in codon preference. No codons were 
exclusively favoured or unused (Wada et al., 1991). This is different to the situation 
in some organisms such as E.coli or yeast where some codons are used exclusively 
and some not at all, arising from differences in proportions of tRNA molecules for 
the different codons (Ikemura 1985). In humans the GC content of the genome is 
known to influence codon choice. The primers were designed to amplify all of the 
species selected rather than targeting one. At the same time primer degeneracy was 
kept to a minimum as the number of sequences to which primers can anneal increases 
very rapidly with increasing degeneracy. To produce specific amplification the right 
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Table 4.2 Sequence of degenerate primers for cross species PCR 
Primer 
Number 





T 	 G 
5 CGCICCCCCACTCITTCATCAAACA 3 
Human 	 CGCCGCCGCCTCACTCCTTCATCAAACA 
1111111 	II 	11111111111111111 
Mouse 	 CGCCGCCACCCCACTCCTTCATCAAACA 




5 AGCIGACAATTTATACCAAATG 3' 
Human 	 AGCAGTGACAATTTATACCAAATG 
_______ 11111 	11111111111_I__11111 
Mouse 	 AGCAGTGACAATTTATACCAAATG 




5' TGTCGACATGACCTGGAATCAGATG 3 
Human 	 CTTGAATGCATGACCTGGAATCAGATG 
11111111111 	1111111IIliii 
Mouse 	 CTTGAATGCATGACCTGGAATCAGATG 




5' TGCAACIICAGCTGAAGGGTTTTTC 3 
Human 	 GGCCACCGACAGCTGAAGGGTTTTTC 
_______ 1111 	11111__11111111 
Mouse 	 TGCCACCGACAGCTGAAGGGTTTTTC 
aasequence 	P 	W 	R 	C 	S 	F 	P 	K 	E 
Underlined sequences indicate changes made to produce restriction enzyme recognition sites 
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balance between selectivity and degeneracy must be found. To facilitate cloning Sail 
restriction enzyme recognition sites were designed three bases in from the 5' end of 
the upstream primers and a HindIII site in the downstream primer. Table 4.2 shows 
the primers and the sequence from which they were designed. 
4.1.2.3 Reaction conditions 
An estimate of the melting temperature (Tm) of a primer template hybrid can be 
calculated on the basis of the primer sequence (Sambrook et al., 1989). This can be 
used as a guideline to define the annealing temperature of the PCR. With degenerate 
primers only an average value can be obtained as more than one the primer sequence 
is present. The Tm is affected by mismatches; the magnitude of the effect can depend 
on the position of the mismatch within the primer. Therefore conditions at which 
primers produced specific amplification of 14'Ti were obtained empirically. The 
stringency of the reaction could be altered by changing either the annealing 
temperature or the magnesium concentration, both of which influence the binding of 
primer to the template. 
4.1.3 Testing PCR primers 
All three upstream primers (13312, B300, B297) were tested in combination 
with the downstream primer (13298) using either a mouse Wti cDNA clone (pK/52) 
and/or total RNA reverse transcribed by the first strand synthesis method (RT-PCR) 
(using the protocol described in Innis et aL, 1990). A range of conditions were tried 
the most successful, producing specific amplification of Wtl, were 940C 1 minute, 
490C 2 minutes, 720C 1 minute for 30 cycles and a final extension of 20 minutes at 
720C (in a magnesium concentration of 1.5mM). 'Hot start' PCR where the enzyme is 
not added until after the first denaturation step was also used. This is in order to 
avoid non specific extension by the enzyme that can occur at room temperature 
(Arnheim and Erlich 1992). That Wti was represented within the PCR products was 
verified by Southern blotting and hybridisation to the mouse Wtl cDNA clone (Figure 
4.2). 
4.1.4 Isolation of rat, pig and alligator WTI orthologs 
4.1.4.1 Cross species PCR 
Using the conditions which were found to amplify mouse Wtl, RT-PCR was 
performed on rat, pig, chick, alligator and Xenopus RNA. Unfortunately no specific 
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amplification products were detected. RT-PCR was thought not to be as efficient as 
conventional PCR from double stranded DNA (I. Jackson personal communication). 
Therefore cDNA was produced from total RNA using a Boehringer Mannheim cDNA 
synthesis kit. After 30 cycles of PCR, bands on an agarose gel of the predicted size 
could be detected with the combination of primers B297-B298 with rat, pig and 
alligator cDNA templates and with B312-B298 in rat (Figure 4.3a shows a typical 
amplification with strong specific bands being produced). The possibility of that these 
PCR products were homologous to WTI was confirmed initially by Southern blotting 
and reduced stringency hybridisation with the probe Wtl. That non specific 
amplification was also occurring was evident from the appearance of other non 
hybridising bands. No specific amplification was detectable using chick or Xenopus 
cDNA as a template either by ethidium bromide staining or by hybridisation to Wtl. 
The same negative result was obtained with all combinations of primers, using a range 
of temperatures, primer and template concentrations. 
4.1.4.2 Cloning PCR products 
For all successful amplifications, specific WTI products were purified away 
from non-specific products, primers, nucleotides and Taq polymerase by excision of 
the band from an agarose gel followed by purification away from the agarose using 
GENECLEAN (Bio 101). If the amount of isolated DNA was insufficient for 
subsequent manipulations a second round of PCR was performed using the purified 
fragment. Products were digested with Sail and HindIII restriction enzymes to cut 
within the sites included in the ends of the I'CR primers and then ligated into the 
appropriately digested and dephosphorylated pBluescript SKII+ vector. On 
transformation of JM101 or XL1-Blue cells no clones were obtained. The exact 
reason for this failure is not known, but it could be due to the enzymes not cutting 
these sites near the end of DNA primers. However both Hind][II and Sall sites have 
been used successfully in this context before (Lee et al., 1988 and personal 
experience). The second possibility became clear when these products were 
eventually cloned by another method. It was found that very few of the primers were 
full length, in particular the 5' end, which includes the restriction site, was often lost. 
If this was also the case in the uncloned product it would mean that many fewer 
product molecules would be substrates for the restriction enzymes. Therefore fewer 
molecules with compatible sticky ends would be generated, reducing cloning 
efficiency. 
Blunt ended cloning following the 'double GENECLEAN' protocol (Bio 101) 
was subsequently used. The ends of PCR products were chewed back and kinased using 
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Figure 4.3 Isolation of WTI orthologs 
a Ethidium bromide stained agarose gel of PCR products amplified from cDNA from 
mouse, rat, chick, alligator and Xenopus. * indicates the presence of the 
expected size band on the gel. No amplification with these primers was obtained with 
Xenopus cDNA, and with chick cDNA only a smear of non-specific amplification was 
obtained. 
b Reduced stringency hybridisation with Wtl (KS/2) to white colonies after 
transformation with rat PCR products ligated into pBluescript SKII+. Filters were 
hybridised and washed at 610C  and washed to 0.5xSSC (2hr exposure). 
c PCR products resolved on an agarose gel. PCR analysis of the bacterial colonies 
giving a positive signal after hybridisation to WtJ. The forward and reverse M13 
vector primers were used to amplify across the cloning site. The expected sizes of the 
products, depending on the PCR product cloned, are indicated by arrows. Most of 
the colonies were found to contain inserts of the expected size. 
Lane PCR Template Primers 
1 Rat cDNA B31 2/8298 
2 Mouse cDNA B297/B298 
3 Chick cDNA B2971B298 
4 Xenopus mesonephnc cDNA B312/B298 
5 Alligator cDNA B297/B298 
6 Xenopus tadpole cDNA 13297113298 
7 WT33 (positive Control) B297/13298 
8 No DNA (negative) Control B297/B298 









Figure 4.4 Blunt ended cloning strategy used for cloning PCR products 
The ragged ends of the purified PCR products were chewed back and the 5' ends 
kinased before ligation into EcoRV cut pBluescriptSKll+. After transformation white 
colonies were selected and screened for WTI inserts by low stringency hybridisation. 
The inserts from positive colonies were analysed by PCR across the cloning site. 
PCR Product 
chew back and kinase 
5' 
I 	 40 
Primer 	 Primer 
+ 
5' 	 EcoRv Digested pBluescript SKII+ 	
3 
:: 
Blunt End ligation 
Eco RV 
Transform into XLI Blues 
Antibiotic and blue/white selection 
Screen white colonies by low stringency hybridisation 
11, 
Analyse hybridising colonies by minipreps and restriction digest or 
PCR using vector primers 
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DNA polymerase I and polynucleotide kinase prior to ligation with EcoRV digested 
pBluescript SKII+ (Figure 4.4). Chewing back the DNA ends was performed because Taq 
polymerase, in common with several other polymerases can add a non template 
directed nucleotide (normally dATP) to the 3' OH of blunt ended double stranded 
DNA (Clarke 1988). This would interfere with blunt ended ligation. After 
transformation, recombinants were identified using the blue/white system which relies 
on the (x complementation of -galactosidase function. Recombinants were screened 
for WTI-like inserts by reduced stringency hybridisation to Wtl (Figure 4.3b). 
Plasmid DNA from positive clones was prepared by small scale plasmid preparations. 
The presence of an insert was then confirmed by restriction digest, or PCR across the 
cloning site using vector primers (Figure 4.3c). Inserts of the expected size were then 
sequenced. 
All the clones sequenced from the three species (rat, pig, and alligator), 
contained inserts which encoded predicted open reading frames. These closely 
resembled but differed from the two known primary amino acid sequences of WTI 
and also differed from each other. 1  Table 4.3 shows the homology at the nucleotide 
and amino acid levels. These were named RWT1, (rat WTI), PWTJ (pig WTI) and 
AWT1 (alligator WTI). This high level of similarity at the nucleotide and amino acid 
level provided strong evidence that orthologs of WTI had been isolated. More than 
one clone was sequenced for each species as Taq polymerase has a higher rate of 
misincorporation as it lacks 3'5' exonuclease (proof-reading) activity. The error rate is 
currently estimated to be 8.5x10 6 but is known to vary with the conditions 
(Fuchareon et al., 1989). Therefore for a 200bp fragment an estimated 3% of cloned 
products will contain errors. This error rate was consistent with the very low level of 
variation between clones e.g. in alligator only one point of variation in three 500bp 
clones was found. On publication the sequence of the entire coding region of WTI 
from a rat cDNA (Sharma et at., 1992) corresponded to that obtained here. 
Sequencing several clones also revealed variation (Figure 4.5) owing to the presence 
of the two alternative splices which have already been observed in mouse and human 
(Haber et al., 1991). 
1 The sequences of all the clones and a nucleotide comparison are contained in Appendix A. 
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Table 4.3 Similarity of the PCR clones isolated to human and mouse WTI at the 
nucleotide and amino acid level. 









Human Mouse  Human Mouse 
Rat 91.5 95.2 335 99.1 99.1 
Pig 95.1 91.9 165 98.7 97.0 
Alligator 81.0 81.5 156 96.1 95.5 
Chick 82.5 80.3 154 96.7 96.7 
Xenopus 84.2 83.8 82 100 100 





82.2 72 97.3 97.3 
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T 	T 	G 
5 CTGCGGAGCCCAATACAGAATICA 3 
Human 	 CTGCGGAGCCCAATACAGAATACA 
____ III 	II 	11111 	11111111111 
Mouse 	 CTGTGGTGCCCAGTACAGAATACA 
111111 	11111 	IIIIIIIIIII 
Alligator 	CTGTGGAGCCCAATACAGAATACA 




5 GAG_CTGAGAAACGICCITTCATGTG 3 
Human 	 GAGACCAGTGAGAAACGCCCCTTCATGTG 
Mouse 	 GAAACCAGTGAGAAACGTCCTTTCATGTG 
_______ II 	1111111111111111111111 
Alligator 	GAGACAAATGAAAAACGTCCCTTCATGTG 
aasequence E 	T 	S 	E 	K 	R 	P 	F 	M 	C 
C229 Exon7/ZF1 
(1384-1406bp) 
T A 	T 
5 AAGCTCTCCCACTTACAGATGCA 3 
Human 	 AAGCTGTCCCACTTACAGATGCA 
_______ I__II 	__ 11111__11111111111 
Mouse 	 AAGCTGTCCCACTTACAGATGCA 
111111111 	11111111111 
Alligator 	AAGTTATCCCATTTACAGATGCA 
aasequence K 	L 	S 	H 	L 	Q 	M 	H 
C228 Exon 9 / ZF3 
(1579-1599bp) 
A 
(antisense) 	5 ACCTGTATGAGTCCTIGTGTG 3' 
Human ACCTGTATGAGTCCTGGTGTG 
IIIIIIIIIIIIIIIIIIIII 
Mouse 	 ACCTGTATGAGTCCTGGTGTG 
IIIIIIIIIIIIIIIIIIIII 
Alligator 	ACCTGTATGAGTCCTGGTGTG 
aasequence G 	T 	H 	T 	R 	T 	H 
Underlined sequences indicate changes made to produce restriction enzyme recognition sites. 


















N/A = region not covered by clone 
N/D = not observed but not large 
sample examined 
* Probes used for library screens 
+ Not to scale 
Figure 4.5 Schematic representation of the human WTI cDNA and the WTI clones isolated by degenerate PCR. 
The primers with which successful amplifications were obtained are shown as well as the alternative splice forms observed. The clones 
which were subsequently used as probes are also indicated (*). 
I 	I 
lOObp 
5' 	Exons 1 	 2 	3 4(5) 6 	7 	8 9 	 10 	 3' 
822 
1123 1 103 178 	151 190 114 11 1399 
1 2 	3 	4 	* 
ATG 
	
B300 	 ZINC FINGERS 
-4 
1st generation primers 	13312 	 -+ 	 4- 
B297 B298 






PCR Primers Species 
5' 3' 
B312 B298 Rat 
B297 B298 
B297 B298 Pig 
B300 C228* Chick 
C227 C228 
C229 C228 
B297 B298* Alligator 
B620 B298t Xenopus 
C229 C228 
B620 C228 Zebrafish 
C229 C228* 
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4.1.5 Redesign of PCR primers 
The extra sequence information provided by these different species, in particular 
the first non mammalian WTI to be isolated, AWTJ, enabled several more primers to 
be designed from conserved regions. Upstream primers C227, B620 and C229 were 
synthesised, the latter two were complementary to ZF1. A second downstream 
primer C228 with the 3' end within one of the invariant zinc chelating histidines in ZF3 
was also made (Table 4.4, Figure 4.1). These primers were tested on alligator eDNA 
and found to give specific amplification of AWT1 (data not shown). 
4.1.6 Isolation of chick, Xenopus and axolotl WT1 orthologs 
Amplification using chick cDNA from 8-14 day embryos was successful with all 
the combinations of new primers and the combination B300-C228. That B300-B298 
combination failed to work but B300-C228 gave a strong specific signal suggests that 
there was a mismatch between the chick sequence and B298. Amplification with 
Xenopus cDNA was successful with only the primer combinations 13620-13298 and 
C229-C228. Two sources of total RNA were used; either whole stage 45 tadpoles or 
mesonephros from stage 53 tadpoles (Nieuwkoop and Faber 1967). Only RNA from 
the mesonephros produced specific amplification, suggesting that in the whole tadpole 
RNA the concentration of template was too low. Figure 4.6 shows WTI specific 
amplification from chick and Xenopus cDNA. These PCR products were cloned and 
sequenced as above. Again sequences resembling but not identical to previously 
cloned WTI genes were obtained (Table 4.3, Appendix A). These were named CWT1 
and XWT1 for chick and Xenopus respectively. In both cases only the shortest 
transcript was isolated (Figure 4.5) even though the l7aa region was covered in chick 
and the KTS region in Xenopus. 
These primers, along with XWT1, were supplied to P.A. Tsonis at the University 
of Dayton, Ohio who subsequently amplified and cloned 216bp of WTI from the 
axolotl (Ambystoma mexicanum) , AXWT1 (Table 4.3). 
4.1.7 Isolation of the zebrafish WT1 ortholog 
4.1.7.1 Degenerate PCR 
The presence of WT1 in the zebrafish, and the ascidian (a non-vertebrate 
chordate) was investigated by PCR from whole larva or tadpole cDNA. In both cases 
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Figure 4.6 Isolation of chick and Xenopus WTI orthologs 
Resolution of PCR products on an agarose gel. PCR used the primers designed on 
the basis of the clones already obtained. Strong bands and a low level of non-specific 
amplification were observed. 
Lane 	PCR Template 
1 Chick cDNA 
2 Chick cDNA 
3 Xenopus mesonephric cDNA 
4 Xenopus rnesonephric cDNA 
5 Chick cDNA (RePCR) 
6 	Alligator cDNA 

















M 1 2 2 i 
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amplification was obtained, but on cloning these products either non WTI -like 
products or contaminants were found. 
To avoid contamination problems, PCR on zebrafish was repeated at the source 
of zebrafish material in Newcastle. A range of conditions and primer combinations 
which had been known to produce WTI specific amplification were used with either 
whole embryo RNA (reverse transcribed by first strand synthesis of RACE reaction) 
or genomic DNA (both a gift from T. Jowett). Genomic DNA was used in case PCR 
from whole embryo RNA was not successful. The primers used were known to cross 
introns in the human genomic structure therefore PCR products would probably not 
be the same size as any contaminants, but this meant the size of the WTI specific 
products could not be predicted. 
Very little amplification with the RNA derived template was seen even with 
nested PCR (Mullis and Faloona 1987). In contrast a wide range of bands were 
observed with genomic DNA (Figure 4.7a). To identify which of these bands might 
be WTI orthologs, Southern blotting and reduced stringency hybridisation to AWT1 
was performed. By comparison of the ethidium stained agarose gel and the 
autoradiograph two genomic bands were identified that hybridised to AWT1 far more 
strongly than any others (Figure 4.7b). These corresponded to amplifications with 
primers B620-C228 and C229-C228. These primers were ones that had given 
amplification with Xenopus WTI (the most diverged WTI gene so far isolated). Both 
bands were very faint, this could well have been due to the large size, approximately 
2.8kb, of the products. PCR is known to favour the amplification of smaller products 
as extension as far as the other primer is more likely to occur for shorter regions. The 
similar size of the two products was consistent with the human exon structure, in 
which B620 and C229 would be in the same exon separated by 60bp (Figure 4.9a). 
4.1.7.2 Turbo cloning 
The B620-C228 band was purified away from non-specific products as before 
(section 4.1.4.2). This was used as template in heminested PCR (Li et al., 1990) with 
primers C229-C228 to produce sufficient material for cloning. It was found for 
successful rePCR of such a long product the fragment could not be directly visualised 
with ethidium bromide and LW light, as nicking of the DNA inhibited the second PCR 
resulting in a smear, or a ladder of smaller bands. 
Most conventional cloning techniques can be size selective because the ends of 
smaller fragments have a greater chance of being ligated to the ends of the same 
vector DNA molecule. To avoid this turbo cloning was used (Boyd 1993) (Figure 
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Figure 4.7 Isolation of zebrafish WTI 
a Agarose gel electrophoresis of zebrafish PCR products. RT-PCR and PCR from 
genomic DNA were tried using two annealing temperatures and a range of different 
primer combinations. Multiple bands were obtained with genomic DNA but none 
with RT-PCR after 30 rounds of amplification. 
b Identification of WTI specific bands. 
Autoradiograph of PCR products after hybridisation with AWTJ at low stringency. 
Digestions of WTJ clones were also run on the gel for comparison of the level of 
hybridisation to the probe (1 .5hr exposure). 
—* identifies two bands showing strong hybridisation to AWTJ, but were only just 



























Figure 4.8 Turbo cloning of PCR products 
The ragged ends of the PCR products were chewed back and the 5' ends kinased. 
These were ligated to Smal digested pBS:lox in conditions of macromolecular 
crowding. To the ligation products Cre enzyme was added which catalysed 
recombination of the lox sites leading to circularisation of molecules where the lox 
sites were in the same orientation. After transformation, white colonies were 
screened for WTI inserts by low stringency hybridisation to AWTJ and positive 
colonies were further analysed by restriction digest of the plasmid DNA. 
PCR Product 
Sma I cut, dephosphorylated 4, chew back and kinase 	 pBS:lox lox site 3  
pBS:lox 
blunt end ligation 
in conditions of rnacromolecular crowding 	4, 
\. 
Crc mediated recombination between lox sites. 
Only those with lox sites in the same orientation +Cre 
circularise 
lox PCR product 
Screen colonies by hybridisation 
Analysis of inserts by miniprep and 
restriction enzyme digestion 
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4.8). This involves blunt ended ligation in conditions of macromolecular crowding 
into pBS:lox, where the ends of the insert can rapidly independently ligate to vector 
molecules. Circularisation is achieved afterwards by utilisation of the Cre:lox 
recombination system of P1 bacteriophage. Cre enzyme is added and recognises lox 
sites in the vector, and those with lox sites in the same orientation are circularised. 
After electroporation into XL1-Blue cells recombinants were screened for inserts with 
the blue/white selection system and for WT1 specific inserts by hybridisation to AWT1 
at low stringency. About 10% of white colonies were found to contain inserts that 
hybridised to the probe. These were analysed by purification of the plasmid by 'Magic 
Minipreps' (Promega) and restriction digest. 50% of these had the same restriction 
pattern and the inserts were the expected size. Sequencing of the inserts using vector 
primers showed the presence of the PCR primers (C228/C229) at either end of the 
insert, confirming these as full length products. 
From comparison with the human genomic structure it was expected that the 
clones would contain sequences homologous to the three exons 7, 8 and 9 encoding 
Z171-3. Sequencing of the genomic clones revealed three regions of homology 
corresponding to these exons. These, as expected, were separated by unconserved 
sequences when compared with the human genomic sequence (Gessler et al., 1992). 
The AT richness and repetitive nature of the sequences suggested that they were 
indeed introns. The regions of homology were found to extend just outside the exons 
to include the splice donor and acceptor sequences. From this it was predicted that 
the zebrafish WTI cDNA had a similar exon structure to human, although the actual 
sizes of the introns were completely diverged (Figure 4.9). The 60bp between 
primers B620 and C229 was amplified by heminested PCR using B620 and a ZF2 
primer designed from the sequence of the cloned region. The product was sequenced 
directly (Winship et al., 1989) and found to correspond to the part of ZF1 expected. 
4.2 Isolation by library screening 
4.2.1 Introduction 
PCR is a fast and relatively easy method for obtaining conserved regions of a 
gene. From the sequence data obtained above it was clear that WTI has not evolved 
quickly within the vertebrates, especially within the zinc fingers (Table 4.3). This is 
consistent with mutation analysis of WTI, where almost all mutations found in WTI 
affect the zinc fingers. To isolate more of the coding sequence, to determine the 
extent and pattern of conservation within the proposed transregulatory domain, 
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Figure 4.9 
Comparison of human and zebrafish WTI genomic structures in the zinc finger 
region 
a Human genomic structure showing positions of primers producing WTI specific 
amplification in zebrafish. 
Exon 7 	 Exon 8 	Exon9 
ZF1 ZF2 ZF3 
	
Human 	 r—, 	r--7M 
Krs 
-*--* 	 2kb 	 óOObp 	<-- 
B620 C228 
C229 
- PCR primers 
b Genomic structure of zebrafish WTI 
ZF1 52 	 53 
Zebrafish r—i ri  
8Obp 	 2.5kb 
PBS:Iox 	 ZWT1 
PCR clone 
Sail 	Rsal 
Comparison with the human intron/exon structure shows conservation of the 
organisation of the exons but not the intron sizes in the PCR clone ZWT1. The 
SalIfRsäI fragment used to probe the cDNA libraries is shown. 
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several strategies could be used. Library screening was chosen in preference to PCR 
based techniques such as 5' RACE (Rapid amplification of cDNA ends) because of the 
difficulty experienced amplifying this GC rich region in humans and the possibility of 
contamination. The major disadvantage to cross species isolation by library screening 
had been removed by the isolation of homologous probes. 
4.2.2 Library screens 
cDNA libraries in bacteriophage vectors were obtained either from the 
embryonic stages most likely to be expressing WTI mRNA or from adult testis (Table 
4.5). These libraries were titred on the relevant host cells, and approximately 4x10 5 
clones screened following the recommended method supplied by Stratagene for 
AZAPII. Cloned PCR products were used to probe the library of the same species 
under high stringency conditions. Clones giving positive signals were purified with 
further rounds of screening. On isolation the phage were amplified and either 
converted into phagemids by in vivo excision (?ZAP type vectors) or the inserts were 
subcloned into pBluescript SKII+ at the EcoRI site (2gt1 1 type vectors). The isolates 
were then sequenced. The library from the striped-faced dunnart (Sminthopsis 
,nacroura), a marsupial that resembles a mouse, was initially screened by S. Wilcox at 
La Trobe University, Australia with the human WT1 probe (WT33) at reduced 
stringency. Five positives from this primary screen were then analysed for WTI by 
PCR directly from the bacteriophage and a single clone isolated by hybridisation at 
reduced stringency to AWT1. 
4.2.3 WTI eDNA clones isolated 
The results of the library screens are summarised in Table 4.5 and Figure 4.10. 
The percentage similarities to mouse and human WTI are shown in Table 4.6, 
calculated using the gap program of GCG'. 
A unique clone was isolated from the chick (C2.1), the alligator (ALl), and the 
marsupial mouse (Sc41). The three partial cDNA clones between them cover the 
entire coding region, the entire 3' non coding region and probably most of the 5' non 
coding region, with large amounts of overlap between them. The alligator and chick 
clones were found to contain the regions isolated by PCR and their sequence was 
found to be identical to the consensus sequences obtained from multiple PCR clones. 
1 A11 sequences are contained in Appendix A 
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Table 4.5 Summary of libraries screened for WTI and the clones isolated 
Species Taxon Vector for Source of Clone 	Isolated Source 
Library cDNA Name / Size Region covered 
construction  
Alligator Reptile ?. ZAP II Embryonic ALl /1.3kb Exon 2 to 3' Paul Sharpe 
(Alligator (Stratagene - Stage 20 untranslated region University of Manchester 
mississippiensis)  custom made)  
Chick Bird Agt11 Embryonic C2.1 /1.6kb 5' untranslated region Nick Platt 
(Gallus domesticus) -Stage 20 to exon 9 University of Oxford 
Frog Amphibian XgtlO Neuralation None Doug Melton 
(Xenopus laevis) - Stage 17 Harvard University, USA 
?gt1 1 Embryonic None Igor Dawid 
- Stage 22-24  NIH, USA 
Marsupial Mouse Marsupial X ZAP Testis Sc41 / 2kb Exon 3 to poly A tail Stephen Wilcox, Jenny 
(Sminthopsis Marshall Graves 
macroura) La Trobe University, 
Australia. 
Zebrafish Fish X ZAP II Adult Zia / 3.5kb Genomic David Grunwald 
(Brachydanio rerio) Intron 6 to 9 University of Utah, USA 
X ZAP II Post None 
somitogenesis  
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Figure 4.10 Diagram of WTI clones isolated by library screening, in relation to the human WTI gene. 
The presence of alternatively spliced sequences within the clones is indicated. 
lOObp 
5 	Exons 1 	 2 	3 4 (5) 6 	7 	8 9(. ) 	10 	 3 
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Table 4.6 Similarity of clones isolated from libraries to human and mouse 071 
at the nucleotide and amino acid level. 
Figures were calculated using the Gap program from GCG. 
Species Nucleotide No. Amino Amino Acid 
% Identity Acids % Similarity 
Compared  
Human Mouse  Human Mouse 
Marsupial Mouse 84.8 84.8 240 96.7 95.0 
Chick 83.4 82.5 390 93.8 92.3 
Alligator 84.0 84.0 289 95.8 95.8 




Although approximately 1x10 6 clones were screened from both Xenopus cDNA 
libraries and rescreened at reduced stringency with the non finger region of the 
alligator clone (Nco 1/Sail restriction digest fragment of ALl covering exons 2-6, 
Figure 4.10) no positives were found. 
4.2.4 Analysis of zinc finger 4 in chick 
On sequencing the 3' end of C2.1 it became apparent that the 3' lOObp following 
ZF3 did not correspond to ZF4 as would have been expected. The sequence encoded 
a termination codon four residues downstream from the end of ZF3 (Figure 4.11 a). 
The sequence did not correspond to any sequences in the GenBank or EMBL 
databases and so was not part of the bacteriophage vector accidentally included 
during subcloning. 
This and the previous inability to amplify chick WTJ with a ZF4 primer B298 
(Section 4.1.6) led to doubts about the conservation of ZF4 in the chick. To test this 
another ZF4 primer (D502) was designed using the closely related alligator sequence 
(Figure 4.11a). PCR with a chick cDNA template showed specific amplification of 
the expected size band (Figure 4.1 lb). The PCR product was directly sequenced and 
was found to encode the 'missing' zinc finger. That this product was derived from 
chick and no other contaminating species was verified by comparing the sequence of 
ZF3 from the PCR product. The sequences of the chick PCR clones, C2.1 and the 
PCR product were found to be identical. On the sequencing gel it was found that 
once the boundary from ZF4 to ZF3 was crossed two sequences became 
superimposed on each other (Figure 4.1lci). This was found to be due to the 
presence of a 9bp insertion encoding the KTS alternative splice in some transcripts 
(Figure 4.1 lcii & iii). 
The origin of the non ZF4 sequence is not clear but that it commences exactly at 
the position of a splice site points to it being due to an aberrant splicing event. The 
possibility that it is due to the intron at this position not being excised was considered. 
In human the first 9bp of this intron encode the KTS alternative splice. It has been 
shown that this sequence is also present in chick WT1 transcripts but no such 
sequence was present in C2.1. This suggests that the unknown sequence is not this 
intron. Clone C2.1 could have been produced from contaminating genomic DNA, or 
from a pseudogene from which ZF4 had been lost. The presence of a pseudogene in 
the chick genome was investigated. Figure 4. lid shows a zoo blot of EcoRI genomic 
digests probed at high stringency with CWT1. Only one band was detected, 
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Figure 4.11 Isolation of ZF4 from chick 
a Nucleotide and amino acid comparison of C2.1 and human WTJ ZF3&4 showing a high level of similarity in ZF3 but not in the region 
expected to be ZF4. 
b PCR amplification of chick ZF4 
The three 3' primers were used to try to amplify WTI from chick cDNA in combination with 5' primer C227 (located in exon 6). 
In accordance with earlier results amplification was seen with C228 (ZF3) but not B298 (ZF4), in addition amplification of a band the same 
size as the alligator was seen with the new ZF4 primer D502. This suggested that the unidentified sequence in C2.1 was a cloning or 
splicing artefact and that ZF4 is conserved in chick. 
(D502 5' CATG1TGTGATGACGAACTAA(C/T)TC(A/G)TC 3') 
ci Direct sequencing of the chick cDNA PCR product with D502 
A single sequence is seen until the ZF3/4 boundary is crossed, and then the amount of cross banding increases. This was found to be due to 
two sequences superimposed on each other. 
ii&iii Dissection of the two sequences showed that they were both identical to C2.1 in the ZF3 region and that they correspond to the + and 
- KTS forms of the mRNA, owing to the insertion of the 9bp at the exon 9/10 boundary. The splice site between ZF3&4 was also seen to be 
the position where the homology between C2.1 and CWT1 ended indicating the probability that the mRNA transcript from which C2.1 was 
made was aberrently spliced. 
<- indicates the positions of the splice sites. * indicates the position of a mismatch between the chick sequence and primer B298 which 
probably inhibited amplification with this primer. 
d Phosphorlmager analysis of a zoo blot probed at high stringency with CWTJ (PCR clone). Only a single band was detected indicating that 
WT1 is single copy in the chick genome and that C2.1 could not have been derived from a pseudogene. 
(B, bovine, C, chick, A, alligator) 
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demonstrating the WTI gene to be single copy in the chick genome. 
4.2.5 Isolation of a zebrafish 971 genomic clone (Zia) 
To screen the zebrafish libraries a SalIIRsaI fragment from a zebrafish genomic 
PCR clone was used that contained part of ZF1, ZF2 and the 80bp intron between 
them (Figure 4.9b). This excluded the long 2.5kb intron between ZF2 and ZF3. Two 
cDNA libraries were screened, a posomitogenesis one and an adult one. One 
positive was obtained; from the adult library. On sequencing the isolated clone (Zia) 
it was found to contain interruptions between the zinc finger encoding sequences 
identical to the predicted introns in the genomic PCR clones ZWT1. This could either 
be because introns had not been removed due to partial splicing of the pre-mRNA 
transcript or that the clone was generated from contaminating genomic DNA in the 
RNA preparation. The presence of four introns within the clone favoured the latter 
possibility (Figure 4.12a). The clone extends 5' and 3' of the PCR clone containing 
the whole of exons 7, 8 and 9 and therefore includes the region of intron 9 which 
encodes the KTS alternative splice in humans. In zebrafish the two alternative splice 
donor sites are very highly conserved suggesting it is very likely that both + and -KTS 
isoforms are expressed in fish (Figure 4.12b). Therefore genomic organisation of 
WTI with each zinc finger in a separate exon has been conserved through vertebrate 
evolution. In contrast the sizes of the introns are completely different; introns 7 and 8 
being 2kb and 600bp respectively in human (Haber et al., 1991) whereas in zebrafish 
they are 80bp and 2.5kb (Figure 4.9). 
4.3 Discussion 
PCR and library screening was an effective method for isolating a number of 
different WTI orthologs. Less sequence was isolated than was desired especially in 
the transregulatory domain. This was firstly due to PCR in this region not being 
successful, either because the sequence variation was too great for the primers used, 
or the GC content was too high. Secondly 5' incomplete clones were obtained from 
the library screens. This could be a result of the reverse transcription step not 
producing full length DNA; reverse transcriptase can be inhibited due to the presence 
GC rich regions and RNA secondary structure. The first clones isolated for mouse 
and human also lacked part of the 5' region. 
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Figure 4.12 Genomic structure of zebrafish WTI 
a Comparison of region covered by the PCR and library clones. Zia contains 460bp and 200bp of the introns flanking exon 7 (ZF1) and 
exon 9 (ZF3) an includes the region encoding the KTS alternative splice in human. 
ZF1 ZF2 	 ZF3 
- - 	.. 	- ------------------------=1 - 2OQb 
SObp 	 2.5kb 	
KIS 
ZWT1 PCR clone 
Zia Library clone 
b Comparison of the sequence of Zia with the human genomic sequence showing the conservation of the region containing the KTS 
alternative splice, indicating that there is a high probability that the inclusion of this alternative splice is conserved across 400Myr. 
SPLICE SITE CONSENSUS 	 A/CAGGTAAGT 
A/CAGGTAAGT 
ZEBRAF I SH GTTTTCACGTTCAGACCACCTTAAGACCCACACGCGGACACATACAGGTAAAACAAGTOCOTAAACCTTTTCATTTTTTTCATGATTCOCTCCTCTCTT 
HUMAN 	GTTCTCCCGGTCCGACCACCTGAAGACCCACACCAGGACTCATACAGGTAAAACAAGTGCGTAAACTTTTCTTCACATTTATTTTTCATTATTTTTTTA 
EXON9/ZF3 	 KTS 	 INTRON 
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Much time was wasted because of PCR contamination. Cross species PCR is 
more prone to contamination than homologous PCR for several reasons. 
Primers are designed from known and therefore amplified or cloned 
sequences. These are likely be more similar to the primers than the desired template 
and so in the first few rounds of amplification these will be preferentially amplified. 
This means that even if the template is initially in excess of the contaminant the final 
product may contain enough contaminant to obscure the real product or take over the 
reaction. 
If only one species is involved the presence of a contaminant can be assayed 
for by high stringency hybridisation with the suspected contaminant, but where many 
species are involved it may not be known which is the contaminant. 
The precautions advised to avoid contamination were followed (Clackson et al., 
1991). It was found that consistent contamination free PCR was only possible by 
using a separate room for setting up the reactions. 
The reason for failure to isolate cDNA sequences from zebrafish and ascidian 
(tunicate) by PCR may be because of a restriction of high levels of WD mRNA to 
certain structures. In whole embryo preparations WTI message might be at too low a 
concentration for cross species PCR. This seems to have been the case for Xenopus 
as amplification was successful only with RNA isolated from the mesonephros 
(Section 4.1.6). There are no vertebrate-like kidneys present in the ascidian from 
which RNA could be isolated. The gonads may be a possible source of material but 
these gonadal structures may have a completely different origin to vertebrate gonads. 
That no larger Xenopus clone was obtained from cDNA library screens was 
disappointing. This was maybe because WTI was not expressed in the early stages 
from which the libraries were made. In the mouse the first Wt] expression is observed 
at about 9 days, just before the onset of mesonephric differentiation (Armstrong et 
al., 1992). In Xenopus the first evidence of pronephros differentiation is seen at stage 
23 with the slight thickening of the mesoderm corresponding to the pronephric duct 
rudiment (Nieuwkoop and Faber 1967, Lynch and Fraser 1990). It was not possible 
to locate libraries later than stage 24. This is probably owing to the major interest in 
Xenopus concentrating in the earliest stages of development. The zebrafish 
posomitogenesis library was thought likely to contain WTI clones, although none 
were detected. It may be that the intron within the probe reduced the affinity of the 
probe for a cDNA to a too large extent. The isolation of the genomic clones has 
allowed the comparison of WT1 to be extended to genomic structure. 
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In Xenopus there are probably two copies of WT1 in the genome, arising from a 
tetraploidisation event which occurred about 30 Myra (Tymowska and Fischberg 
1973). In the three Xenopus PCR clones which were sequenced three differences 
were found in one clone relative to the others. It is not known if these arose from 
PCR errors or if the two forms were isolated. The number of differences was higher 
than for the three alligator clones sequenced, where one change was noted in clones 
twice the length of XWTJ. If these clones do represent the two copies of WT1 they 
are very highly conserved. This could be because substitutions within WTJ zinc 
fingers are thought to have dominant negative properties, which has lead to selection 
for conservation. 
The sequence information derived here will enable further species to be cloned 
more easily and also lead to suggestions about the structure and evolution of WTI, 
which are discussed in the next chapter. 
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Chapter 5 
Structural and evolutionary comparison of WT1 orthologs 
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5.1 Introduction 
The sequence information from the WT1 orthologs obtained can be used to 
analyse the conservation of structural features of the WTI protein. Conservation can 
then be used to make inferences about the structural and functional importance of 
these regions. This can be especially useful when combined with functional studies of 
the gene. The sequences can also be used to investigate the evolutionary changes that 
have occurred, such as the rate of change of both the nucleotide and the encoded 
amino acid sequence. 
In the following discussion it was found that the most convenient way in which 
to define the regions referred to was to use the exon structure of the gene. 
Knowledge of the exon structure is based entirely on the information from the human 
and zebrauish, as no information has been as yet been obtained for other species. In 
addition all positions in the amino acid and nucleotide sequence refer to numbering of 
the human +17aa, +KTS isoform. 
5.2 Structural analysis 
5.2.1 Sequence motifs 
5.2.1.1 Structure prediction 
The nucleotide sequences of WT1 orthologs were translated to produce the 
predicted amino acid sequence of the protein (Figure 5.1). Most of the amino acid 
changes fall into the category of frequently accepted, conservative mutations which 
are due to single base pair mutations when compared against those in Dayhoffs matrix 
(Dayhoff et al., 1972). Therefore since multiple changes have not occurred, 
mutations which result in an accepted change must occur infrequently. The sequences 
were analysed using the motifs program from GCG, but no other sequence motifs 
were found in addition to the zinc fingers. The hydrophobicity profiles (Kyte and 
Doolittle 1982) and secondary structure predictions (Chou and Fasman 1978) of each 
ortholog were compared and no great changes were observed in the different species 
(Appendix B). An increase in hydrophilicity was seen in the zinc finger region 
consistent with it interacting with DNA. Protein structure prediction from the 
primary amino acid sequence alone is still in its infancy. Only a low level of accuracy 
is obtained with the Chou and Fasman prediction (Creighton 1984) and so a newer 
and more reliable program was tried. This was Predict Protein (Sander and Schneider 
1991) which relies on sequence comparison to predict a structure. The only region 
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Figure 5.1 Comparison of the predicted amino acid sequences of the WTI 
orthologs 
The human exon structure is shown as are the positions of residues discussed in the 
text (bold). The alternative splices and known sequence motifs are highlighted. 
142 
EXON1 
Human 	 MGSDVRDLNALLPAVPSL GGGGGCALPVSGAAQWAPVLDFAPPGASAYGSL 
Mouse S. .G ......G ...... R ................... 
Rat S ......... G ...... R ................... 
Chick 	 S.. - 	P.NSN. .M. . .S .......... - ..... 
P"iIIIII 0 11 1 0 
Human 	 GGPAPPPAPPPPPPPPPHS FIKQEPSWGGAEPHEEQCLSAFTVHFSGQFTGT 
Mouse .......................................... L ......... 
Rat .......................................... L ......... 




..... T ............ 
..... S ............ 






Q .......... S..P ... D ................. 
A ........ S ......... TA. .T. . 
EXON4 	 EXON5 
SCTGSQALLLRTpYSSDNSQLECMTwMNLgAKGvAAcSSSSvK 
................ M. 
........ H ......... 
.......................................... M ......... 
N ........................... 
T ............. N ......... R ............ S.... 
N ...................... S.... 
puthve IeucMie zipper 
EXON6 273 	 EXON7 
WTEGOSNHSTGIEBDNHTIPIL - - CGAQYRIHTHGVFRGIQDVRRVPGVAPT 
G ...... T.A .................................. 
GI. . . .E. . .A ........................... S ..... 
G ..... E ...............................S ..... 
.T .... N ...................................... 
.T .... NE. .SA.M.YS ............................ 
.A .... NE.. .A.M.YS ............................ 
17as 	 IT.A 



































































for which a comparison was obtained was the zinc fingers for which we already have 
structural information. 
5.2.1.2 Post-translational modification 
To investigate whether WTI protein may be post-translationally modified, 
searches were made for recognition sequences for N-linked glycosylation (Doolittle 
1986) and phosphorylation (Kemp and Pearson 1990) sites. No putative 
glycosylation sites were found in any species, but putative phosphorylation sites were 
found. Recognition sites found included casein kinase I and H, proline dependent 
kinase and cAMP dependent kinase. Caution must be observed when drawing 
conclusions from the presence of recognition sites as it is known that not all sites are 
recognised and there can be synergy between different sites. Although these sites are 
present, no phosphorylation of WT1 has been observed (Morris et al., 1991). The 
conservation of these sites was found to be variable with some being present in all 
species and some in only one. 
5.2.1.3 Exon structure 
To investigate if the exon structure of WTI is conserved in all vertebrates will 
require the isolation of genomic sequences. Comparison of the sequences at the 
known human splice sites in the cDNAs isolated can only give limited information 
because the most invariant splice site sequences occur in the introns. The first and last 
two bases of an exon tend to be GT and AG. This is the case in some of the human 
WTJ splice sites, but most are at least purine rich. Table 5.1 shows that most of these 
sites are conserved. Substitutions which have occurred increase the similarity to the 
consensus sequence, indicating that the exon structure may well have been conserved, 
as seen for exons 7-9 in the zebrafish. 
5.2.25' Non coding region 
Multiple transcription start points have been reported in the WTI promoters 
from mouse and human, approximately 500-400bp upstream of the predicted initiation 
codon (Pelletier et al., 1991c, Hofmann et al., 1993). Within the 5' non coding region 
there is still over 80% nucleotide sequence identity between mouse and human (Table 
5.2). Alignment with the chick reveals a lower level of conservation but several 
regions with a higher than background level of identity. These may correspond to 
protein binding sites (Figure 5.2). Wi'] has been shown to bind this region in mouse 
(Rupprecht et al., 1994) but since the true DNA consensus sequence for WTI is 
unknown comparison cannot reveal whether binding is conserved in chick. The C+G 
144 
Table 5.1 Conservation of splice sites in WTI 
The sequence of the exons at the splice donor and acceptor sites in human WT1 is compared with the 
consensus sequence and the sequence in the W71 orthologs. 
EX—OR Soecies Splice accentor seouence Splice donor seouence 
GTA/GAGT A/CAG 




2 Human GTTACAGC GCTCGCTGG 
Mouse -A 
Rat -A 
Chick G-- CA--T--A- 
__________ Alligator CT--C--A- 
3 Human GTGAGCAG CTACAGCAG 
Mouse C 
Rat C 
Marsupial mouse A--- 
Chick -G--C --- 
Alligator -A--C--- A--- 
4 Human TGACAATT CTTAAAGGG 
Mouse 
Rat ---G ----- 
Marsupial mouse C AC-G 
Chick GC-G ----- 
Alligator A-------- 
5 Human AGTTGCTG GCAGAGCAA 
Mouse -A-G---- 
Rat -A-G ---- 
Pig 
6 Human CCACAGCA GGCATTCAG 
Mouse ---- G-T- 
Rat ----G--- 
Marsupial mouse C- - -A--A--A  
Chick ---T-CG A--A 
Alligator ---TGCA --A--A--A 
7 Human GATGTGCG AGCACACTG 
Mouse 
Rat 







8 Human GTGAGAAA GACATACAG 
Mouse ----C---- 
Rat ----C---- 
Marsupial mouse - - - - C - - - - 
Chick ----A--- ----C---- 










Xenopus _ __ jjiIj 
Zebrafish  














content of this region is high (over 70%) in all species; this drops along the sequence 
falling to 50% in exon 4. The percentage of CpG dinucleotides is normally under-
represented in the vertebrate genome due to deamination of methylated cytosine(Bird 
1986). In exon 1, CpG dinucleotides have been retained in all species. This would 
indicate the conservation of the mammalian CpG island in chick and probably 
transcriptional control of this region. 
5.2.3 The predicted initiation codon is conserved 
The clone C2.1 (chick cDNA clone - Figure 4.10) extended 370bp 5' to the 
predicted mammalian methionine initiation codon. Although it has not been 
demonstrated in vivo that this is the initiation codon the protein observed on Western 
blots is of the predicted size (Morris et al., 1991, Telerman et al., 1992). Table 5.2 
compares the nucleotide identity between species in the coding and non coding 
regions of exon 1 and shows that the identity between all species increases 
immediately downstream of the putative initiation codon consistent with this being the 
initiation codon. The Kozak sequence is the optimum sequence required for initiation 
of translation in eukaryotes (Kozak 1987). It has been found that this is not the most 
frequent sequence at translation start sites and A/GNC most commonly precedes the 
initiation codon (Cavener and Ray 1991). This is not the case in all the WTI 
orthologs, but this sequence is found two bases further upstream, probably making it a 
favourable site of translation initiation (Table 5.3). Any upstream methionine 
initiation codons that are present in human, mouse and chick transcripts are followed 
by downstream termination codons indicating no N-terminal extended version of WTI 
can be produced. 
5.2.4 Transregulatory domain 
5.2.4.1 Homopolymer domains 
The transactivating/repressing activity of WTI has been located to the N-
terminal 324 amino acids (exons 1-7) using domain swap experiments (Madden et al. 
1991). In the amino acid comparison the two most striking inter-species changes in 
this domain are those affecting two homopolymer sequences (Proline)13 (54-68aa) 
and (Glycine)5 (19-23aa) (Figure 5.1). The lack of conservation of these regions is 
especially noticeable in the context of rest of the transregulatory domain where only a 
few scattered amino acid changes are seen (Figure 5.1). 
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Figure 5.2 
Multiple sequence alignment of the non coding region of exon 1 using CLUSTAL V 
Sequence footprinted by both -/+KTS isoforms are indicated (overlined) as well as 
regions of greater than average similarity between the three species (highlighted). 
WT1 binding________________________ 
HUMAN 	AGTG- -AATCGAGCGGCCGAGCCTCC-TGGCTCCTCCTCTTCCCCGCGCCGCCGGCCCCT 
MOUSE TGTGTGAATGGAGCGGCCGAGCATCC -TGGCTCCTCCTCCTTCCC -TGCTGCCGGCCCCT 
CHICK 	CG-GCACG-AGGGCGCTGAGGCGGCTGTGGGTCCACCCCCTCCCTAT--------CCCCC 
* * 	* *** 	** * *** *** ** * * ** 	 **** 
HUMAN 	CTTATTTGAGCTTTGGGAAGCTGAGGGCAGCCAGGCAGCTGGGGTAAGGAGTTCAAGGCA 
MOUSE CTTATTTGAGCTTTGGGAAGCTGGGGGCAGCCAGGCAGCTGGGGTAAGGAGTTCAAGGCA 
CHICK 	C --------- CCCCGGCACGC ----- GCGGACAGACA ---------------- CACGGC- 
* 	* 	** * ** 	** * *** ** 	 ** *** 
HUMAN 	GCGCCCACACCCGGGGGCTCTCCGCAACCCGACCGCCTGTCCGCTCCCCCACTTCC - - - - 
MOUSE GCGCCCACACCCGGGG -CTCTCCGCAACCCGACCGCCTGCCTGCCTCCCCCTTTCCTTTT 
CHICK 	-CGCACACAC ---- GGACACGCGGCCA--CGGACACGCGCGCACC --------------- 
*** ***** 	** * * * ** * ** * * * 	* 
WT1 binding__________________ 
HUMAN 	- -CGCCCTCCCTCCCACCTACTCATTCACCCACCCACCCACCCAGAGCCGGGACGGCAGC 
MOUSE TTCCCCGCCCCTCCCTCCCACCCACTCATTCACCCACCCACCCAGAGAGAGGACGGCAGC 
CHICK 	---- CCACCCTGCGCTGCGAGCGG ------- GCACAGC--CCCGGAG -------- GCGAT 
** ** * * * * 	 * ** * *** *** 	** 
HUMAN 	CCAGGCGCCCGGGCCCCGCCGTCTCCTCGCCGCGATCCTGGACTTCCTCTTGCTGCAGGA 
MOUSE CCAGGAACCCGGGCCC -GCCGCCTCCTCGCCGCGATCCTGGACTTCCTCCTGTCGCAGGA 
CHICK 	CCTGGAGAACAA-CC------TTTCCCTGT-GCGCTGCTCGCCGCTCCCGCGG-GCTGGA 
** ** 	* 	** 	*** * *** * ** * * 	* * * ** *** 
HUMAN 	CCCGGCTTCCACGTGTGTCCCGGAGCCGGCGTCTCAGCACACGCTCCGCTCCGGGCCTGG 
MOUSE GCCGGCTTCCACGTGTGTCCCGGAGCCGCGTCTCAGCACACGCTCCGCCGGGAGCCCGG 
CHICK 	CCCGGGGAGC ---TGCGTCGCGGAGCAAACCTCTC--CAAGGGCTGAGCTCTCCGGCTGG 
**** 	* 	** *** ****** 	* **** ** 	*** ** 	* * ** 
HUMAN 	GTGCCTACAGCAGCCAGAGCAGCAGGGAGTCCGGGACCCGGGCGGCATCTGGGCCAAGTT 
MOUSE GTGCGTCCAGCAGCCGGAGCAACCTGGGGACCGAGGCCCCCGGAGCGCCTGGGCCAAGT- 
CHICK 	-TGCCT --- GCAGCCGGAGCGTCCGG- ---CTGGCGGC--AGAGGCAGGTGTCCTGGAAT 
*** * 	****** **** * * 	* * 	* 	* ** 	** * 
HUMAN 	AGCCGCCGCCGAGGCCAGCGCTGAACGTCTCCAGGGCCGGAGGAGCCGCGGGGCGTCCGG 
MOUSE --------------CCAGCGCCGAGAATCCGCAGGATCGCAGGAGCGGAGAACCGTCCGC 
CHICK 	AAGTGCGGCCTGGGGGGAGACTGGCTGCCC ---- GGCGGCAGG--CAGAAG ---GTCTG- 
* * 	* 	* 	* *** * * 	*** * 
HUMAN 	GTCTGAGCCTCAGCAA 
MOUSE ATCCGAGCCGCACCTC 




Percentage nucleotide identity between WT1 orthologs in the non coding and 




human 81.4 45 
mouse 47 
mouse rat chick 
human 87.9 89.7 81.3 
mouse 96.1 81.5 
rat 79.0 
Calculations performed using the gap program from the GCG 
Table 5.3 








The initiation codon is highlighted and the Cavener and Ray (199 1) sequence is underlined 
Table 5.4 Percentage amino acid composition of the transregulatory domain 
Species Ecsn % Proline % Glutamine % Serine 
Human 1 20.5 9.6* 95 
2-3 13.8 9.2 13.3 
4 0.0 11.5 3.8 
Chick 1 14.7 10.9* 13.4 
2-3 13.8 10.8 10.6 
4 0.0 11.5 7.2 
Alligator 2-3 13.8 9.2 13.0 




5.6 4.3 7.0 
* Calculation using only the second half of exon 1 
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(Proline) 13  In human exon 1 there is a region of 15 amino acids, 13 of which are 
proline (the other two being alanine). In mouse and rat this is one proline shorter, but 
in contrast it is completely absent in the clone C2. 1. PCR with primers flanking this 
region gave a product 54bp smaller from chick genomic DNA and cDNA than from 
mouse genomic DNA (Figure 5.3a). Direct sequencing of the products confirmed 
that this was due to the absence of (Prolin) 13  in chick. The presence of this motif was 
investigated in other mammals besides the primate and rodent orders by PCR. The 
PCR products in two artiodactyls (pig and cow) were the same size as that in the 
mouse (Figure 5.3b) and by direct sequencing the proline stretch was found to be 
present (data not shown). 
(Glvcine)5 This stretch of five glycines (rat and human), or six (mouse), is also 
located in exon 1. In C2.1 the predicted amino acid sequence of this region is 
completely diverged due to point mutations at non-degenerate sites (Figure 5.1). 
Direct sequencing of this region from the PCR products above, showed in pig and 
cow that the glycine region was conserved in these species (data not shown). 
(Proline),j A third homopolymer sequence was is also present PPPP (Proline)4 (114-
1 17aa) in exon 1. In the chick this was not 100% conserved, being APPP. 
5.2.4.2 The amino acid composition is similar to other transregulatory domains 
The proportion of proline in exon 1 is reduced to 15% in chick (mostly due to 
the deletion of (Proline)13) as compared with 20% in humans, but this is still higher 
than the average value for vertebrates of 6.1% (Doolittle 1986) (Table 5.4). This is of 
importance because the high levels of proline and glutamine are thought to be 
characteristic of some transactivation domains, although the reason for this is not 
known (Mitchell and Tjian 1989). Although these levels are conserved in WTJ and 
are more than double the average (Table 5.4) they are lower than the 
proline/glutamine rich regions of other transcription factors. The transactivation 
domains of CTF and human and Xenopus Spi contain 20-30% proline and 25% 
glutamine respectively (Mitchell and Tjian 1989). WT1 is more similar to another 
transcription factor, Krox 20 (EGR2), where the tranactivation domain contain 12% 
proline and 13% serine. Krox 20 also contains a conserved proline stretch, in this 
case it is seven residues long (Sukhatme et al., 1988, Oxtoby and Jowett 1993). The 
proline and glutamine rich regions of WTI overlap but they are not are not identical. 
The proline rich region extends from exon 1 to 3 (amino acids 1-223), but the 
glutamine rich region covers the C-terminal half of exon 1 to exon 4 (amino acids 73-
248). This may point to a modular arrangement of functions. 
149 
Figure 5.3 
Investigation into the conservation of homopolymer domains in exon 1 
a Schematic comparison of the human, mouse and rat WTI amino acid sequence in 
exon 1 with the sequence derived from the chick clone C2. 1. The two homopolymer 
domains (Glycine) and (Proline) 13  were found not to be conserved in C2. 1. 
b Verification that the loss of the homopolymer domains is not a cloning artefact. 
PCR across the two domains with primers D742 and B621 showed that the band 
obtained with chick genomic and cDNA templates is the same size as from C2. 1. 
These three bands are all approximately 50bp smaller than that amplified  from mouse 
genomic DNA. 
(13621 5' GGC1TGCAGGTAGGGCGC(A/G)I1TIGG(A/G)AACA 3') 
(D742 5' AGATGGGGTCCGACGTCCGGGACC 3') 
c Investigation of exon 1 in other mammals. PCR using pig and cow genomic DNA 





C2.1 - 	 4- 
D742 B621 
-, PCR primers 
D Sequence not conserved 
o Region not conserved 
 
Lane PCR Template 	 bp 
	
1 	Mouse genomic DNA 10 
2 Chick genomic DNA 
3 Chick cDNA 
4 	C2.1 
5 	No DNA (negative) control 	3i 
344 
11 	 3 
C) 	
bp 
Lane PCR Template 
1 	Mouse genomic DN 
2 Pig genomic DNA 
3 Cow genomic DNA 





There are two instances where a somatic mutation in a Wilms' tumour occurs in 
the transregulatory domain. These are a phenylalanine to serine change at codon 154 
and a glycine to aspartic acid change at codon 201 (Park et al., 1993b&c, Table 1.3). 
Both are non conservative changes with an aliphatic residue being converted to a 
more hydrophilic residue. These changes may affect protein interactions, disrupt the 
hydrophobic core, or the folding of the protein. The G to D mutation changes the in 
vitro transrepression activity to transactivation. In both cases these two residues were 
found to be conserved; suggesting an important role in all species so far examined 
(Figure 5.1). The effect of the exclusion of exon 2 by alternative splicing in Wilms' 
tumour cell lines is to covert WTI into traIctivator. Unlike wild type WTI, exon 2-
less transcripts cannot repress the transformed phenotype of a Wilms' tumour cell line 
(Haber et al., 1993). This therefore implicates exon 2 in both transcription repression 
and tumorigenesis, consistent with a high level of evolutionary conservation. 
5.2.5 The conservation of putative leucine zipper in exon 4 
The proposed leucine zipper motif, defined by the presence of leucines every 
seven residues, and the absence of helix breaking prolines, is encoded by exon 4. It 
may extend as far as the first proline in exon 6. Leucine zippers are a subset of helices 
that are amphipathic. The hydrophobicity of one face of the helix favours the 
interaction with another such helix on the hydrophobic side, forming a structure called 
a coiled coil. Figure 5.4a shows chick exon 4 and exon 6 as far as the first proline, 
drawn in a cx helical format (helicalwheel program-GCG). This demonstrates that 
there is a grouping of hydrophobic residues on one side of the helix, and the amino 
acid substitutions observed are located outside this. It is also known that the polar 
residues are important stabilising the contact between the helices (Conway and Parry 
1990). This may explain the high level of conservation of the non-hydrophobic 
residues. 
Although many sequences with a heptad repeat of leucines have been proposed 
to form coiled coil interactions it is doubtful that they all do (Lupas et al., 1991). It is 
now possible to estimate statistically the likelihood of a coiled coil being formed by 
comparison with the positions of amino acids with proven coiled coil forming domains 
using the Coils program (Lupas et al., 1991, and updated 1993, A Lupas, personal 
communication). The predicted likelihood of a coiled coil forming in this region of 
the WT1 protein is very low. This program is known not to detect buried helices or 
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Figure 5.4 Helical representation of the putative leucine zipper 
Sequence of chick and human WTI covering the putative leucine zipper region, exons 
4-6 (221-279aa, human numbering). This was drawn in (x helical format, using the 
helical wheel programme of GCG. Hydrophobic residues are boxed 
a In the -17aa isoform (chick WT1) there is a grouping of hydrophobic residues and a 
lack of hydrophiEk residues on one side of the helix. This is conserved in all species 
examined. 
Cross species substitutions are indicated for all orthologs except pig. Most variability 
is located in the outer ring of the wheel which corresponds to exon 6 sequence (* = 
exon 6 onwards). 
b When the l7aa alternative splice is included in mammals the localisation of 
hydrophobic residues is changed. (Cross species substitutions shown for the 
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those in bundles of more than three in antiparallel orientation. However if these types 
of helices were present in WT1 their availability for the proposed protein-protein 
interaction function is probably limited. 
5.2.6 Exon 5 - The 17aa alternative splice is not conserved in the archosaur 
lineage 
Exon 5 is an alternatively spliced exon in human, mouse (Haber et al., 1991) 
and rat (Sharma et al., 1992) and the sequence is conserved in those species. In this 
study its presence has only been observed in the clones obtained from the mammalian 
species rat and pig (Figure 4.5). This demonstrates that although the PCR method by 
which the WTI orthologs were isolated did not exclude +17aa isoforms none were 
obtained from chick or alligator. To investigate whether this alternative splice occurs 
in the alligator and chick, PCR with primers flanking this region was performed with 
rat, chick and alligator cDNA template. A band was seen corresponding to the +17aa 
isoform only in the rat, but in all species the smaller isoform was detected (Figure 
5.5). It may be that a low and therefore undetected level of the +17aa isoform is 
produced. Even this explanation points to a different role to mammals as at least 60% 
of transcripts in mouse and human are +17aa (Haber et al., 1991). 
5.2.7 Divergence and conservation of exon 6 
Exon 6 is the first exon within which a clear difference between conserved and 
unconserved regions is apparent (Figure 5.6). The C-terminal end of exon 6 is 
perfectly conserved whereas there are many substitutions in the N-terminal end of the 
exon. The adjacent N-terminal region of exon 7 is also subject to variation, although 
these are only conservative changes. This may point to an important role for the C-
terminal region of exon 6, although it contains no known motifs. 
The first point mutation outside the zinc fingers in WTJ was observed in a 
benign mesothelioma (Park et al., 1993a). The tumour-specific homozygous A to G 
(1 195nt) transition resulted in a serine to glycine (273aa) substitution which is 
considered to be a conservative change (Dayhoff et al., 1972). This particular 
mutation was shown to have the capacity, in vitro, to change the transrepression 
activity of WT1 to transactivation. This is surprising considering that in all species 
except the eutherian mammals, this position is found to be an asparagine. An 
asparagine to serine change is considered a non conservative substitution. This 
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Figure 5.5 
Investigation into the conservation of the 17 amino acid alternative splice-exon 5 
a Schematic representation of the + and - l7aa isoforms of WTI found in mammals 
showing the position of the PCR primers used. 
b Amplification across exons 4-9 in chick, alligator and rat cDNA. Two bands 51bp 
apart corresponding to +1- l7aa isoforms are observed in rat. But in chick and 
alligator no larger band is detected. 
(13797 5' AGCTTGAATGCATGACATGGAA 3') 
(D798 5' TGGGTGTGTATT'CTGTATAGGG 3') 
Exons 456 7 8 
I I 	I I I+l7aa 
I 	I I 	I 	I —17aa 
- 4- 
D797 	D798 
PCR primers -* 
 
Lane 	PCR template 
1 Chick cDNA 
2 	Alligator cDNA 
3 Rat cDNA 
4 	No primers (negative) control 
5 No DNA (negative) control 







substitution may have become fixed because other substitutions in this region 
compensate for, or neutralise, this change, or there is a functional difference between 
the species. 
The region has also been implicated in type II RNA editing in rat and human 
(Sharma et al., 1994). A T to C (1220nt) transition was found in the some mRNA 
transcripts, resulting in a leucine to proline (281aa) substitution, that was not encoded 
by the genomic DNA. Leucine was found to be conserved at this position in all 
species so far examined, including the rat. To try to assess the likelihood that editing 
at this position is conserved in other species the conservation of the nucleotide 
sequence was examined (Figure 5.6). RNA editing in mammals has been most closely 
studied in apolipoprotein B (Chan 1993). Dissection of the sequences required for 
editing has shown that an 1 lbp sequence, 5bp downstream from the edited position, is 
required and is not species-specific (Backus and Smith 1991). A species-specific 
sequence has been inferred further downstream. Downstream of the edited site in 
WTI there are certain conserved similarities to the apolipoprotein B non species-
specific editing box. In alligator and chick immediately downstream from the affected 
nucleotide there is a 6 nucleotide insertion. This insertion results in a tyrosine, serine 
insertion in the gene product (Figure 5.6). Therefore the editing box in chick and 
alligator is in a different location relative to the putative edited nucleotide and so it is 
unlikely that the same nucleotide is edited in the reptilian lineage. The effect of a 
leucine to proline substitution in alligator and chick may be different to mammals 
because of presence of the YS insertion in the gene product. In the chick the 
apolipoprotein form produced by editing has not been detected; so editing of 
apolipoprotein B is thought not to be conserved in chick (Tarugi et al., 1990). 
5.2.8 The zinc finger region is the most highly conserved region of WTI 
The region encoding the first three zinc fingers was the region for which the 
greatest number of sequences was obtained and therefore has the greatest depth to the 
comparison. In exons 7-10, which encode the zinc fingers of WTJ, only 14 changes 
were observed in the 130 amino acid residues compared. Of these, seven were 
observed in the part of exon 7 which precedes ZF1, and these were conservative 
changes (Dayhoff et al., 1972) or a deletion/insertion (Figure 5.1). Five of the seven 
substitutions found within the fingers were located either in the predicted 3 loop 
between the two zinc chelating cysteines or in the a helix between the two zinc 
chelating histidines (Figure 5.7). Another residue substituted in ZF2 of the zebrafish 
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MUTATED 	 EDITED 	NON SPECIES SPECIFIC 
NUCLEOTIDE 	G 	 C 	 EDITING BOX 
SEQUENCE 1' 1' <-Sbp->TGATCANTATA 
Human 	GAGAGCGATAACCACACAACGCCCATCCT ...... CTGCGGAGCCCAATACAGAATACA 
Mouse T--G--------GG-C-----------------T--T-----G 
Rat TG-----------C-----------------T--T-----G 
Pig CGGC -------------------- TT ----- G 
Marsupial Mouse --A-AT ----------- GTG ----------- GT ----------- T 
Chick 	 AATG ------- GTGTGGTATACAGTG----------------- 
Alligator -AATG -------- TGTGGTATACAGT-------------------- 
PREDICTED 	MUTATED EDITED 
AMINO ACID G 	P 
SEQUENCE 	 T I 
Human 	HSTGYESDNHTTPIL- CGAQYRIHTHGVFRGIQDVRRV 
Mouse .GI. . . .E. . .A. . . -- ...................... 
Rat .G ............. ........................ 
Pig .G ...... T.A ............................ 
Marsupial Mouse T. . . . N ........ ........................ 
Chick 	 .T .... NE. .SA.M.YS ...................... 
Alligator .A .... NE. . .A.M.YS ...................... 
Figure 5.6 Mutation, editing and conservation of exon 6 
The changes in the exon 6 sequence due to mutation and editing in mammals are compared with substitutions in other species. The serine 
residue mutated in a benign cystic mesothelioma, causing a loss of transrepressor activity and gain of transactivator activity is not 
conserved outside of the eutherian mammals. The edited nucleotide in human and rat causes a leucine to proline change at a position 
conserved in all species. The nucleotide sequence does show some similarity to the 3' non species specific editing box in apolipoprotein 
but in alligator and chick this site is no longer 5bp downstream due to the insertion of 6bp directly 3' to the edited nucleotide. 
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V/Ti is immediately after the second invariant cysteine in the f3 sheet. In the X-ray co-
crystal structure of EGR1 (Zif 268) all these residues are away from the DNA binding 
end of the finger (Figure 1.2b) and therefore probably have a limited role in binding to 
DNA (Pabo and Pavletich 1991). EGR1 mutations at these sites had no effect on 
DNA binding (Wilson et at., 1992). 
The one substitution found in Xenopus was in the linker region between ZF2 
and 3. It is conservative substitution of one hydrophobic amino acid for another 
(va]ine for isoleucine). In a study of mutations which would change the function of 
the zinc finger proteins EGRJ and TFIIIA, changes at this position were found to have 
no effect (Wilson et at., 1992, Choo and Kiug 1993). This is in contrast to the 
neighbouring lysine residue where mutation inhibits DNA binding activity (Wilson et 
at., 1992). All the substitutions found are therefore located in sites already thought to 
have lesser importance in the function of the zinc fingers. This is in contrast to the 
positions at which pathogenic mutations have been found, which are all conserved 
residues. 
One other change in the fingers apart from those mutations found in DDS and 
Wilms' tumours was found in one of the first WTI transcripts to be isolated, WT33 
(Call et al., 1990). This is a serine to phenylalanine change (365aa) in ZF2 in the C-
terminal end of the 13  sheet (Figure 5.7); this is the part of the finger involved in DNA 
binding and the substitution has been shown to affect binding to some DNA target 
sequences (Bickmore et al., 1992). It is not known whether this is a pathogenic 
mutation or a polymorphism, but as it has only been observed once it is unlikely to be 
a polymorphism. The library from which it was isolated was from a pre-B cell 
leukaemia cell line and so this change may be a pathogenic mutation involved in 
tumour progression (Bickmore et al., 1992). This is also suggested because this 
position has been shown to be a conserved in WT1 and in other homologous finger 
proteins. 
The contribution made by ZF1 to the binding of WTI to its target DNA 
sequence is not known but a constitutional mutation of one of the zinc chelating 
cysteines results in DDS (Bruening et al., 1992). The complete conservation through 
400Myr, since the divergence of the fish lineage, supports an important function for 
ZF1. Although no missense mutations in ZF4 have been reported, this finger is 
conserved to the same degree as the other three fingers, indicating a functional role. 
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Figure 5.7 Schematic representation of the four zinc fingers of WTI. 
The region cloned and sequenced in each species is shown and any substitutions relative to the human sequence are indicated. The positions 
of the missense DDS mutations are also indicated as are the important residues in DNA binding; inferred from EGR1 and Spi fingers (Pabo 
and Pavletich 1991, Kriwacki et al., 1992). The substitutions found in the different species can be seen not to coincide with any mutated or 
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5.2.9 The KTS alternative splice has been conserved through vertebrate 
evolution 
The role of the KTS alternative splice is not well understood. Previously the 
presence of +KTS isoform had been reported in mammalian species (human, mouse 
and rat). Transcripts containing the KTS isoform have been isolated from the non 
mammalian species, marsupial mouse, chick and alligator, and in the latter two both + 
and -KTS transcripts have been observed (Figure 4.5, Figure 4.11). In the zebrafish 
genomic clone, Zia, the 9bp which encode the KTS are present at the 3' end of ZF3 
and, in contrast to the lack of conservation in rest of the introns, both alternative 
splice donor sites are perfectly conserved between human and zebrafish. The 
conservation extends well past the minimal consensus sequence, making it very likely 
that +/-KTS isoforms are produced (Figure 4.12). 
5.2.10 The C-Terminal region is not changed in mouse 
C-terminal to the second conserved hisfldine of ZF4 there are only 11 amino 
acids before the stop codon in mammals, marsupials and alligator. In the published 
mouse and rat sequences (Buckler et al., 1991, Sharma et al., 1992) there is a two 
amino acid difference to the human sequence, QL becoming HV (448-9aa). This is 
not seen in either alligator or marsupial sequences and is attributable to an inversion 
from GC to CG (1715-1716nt) in human to mouse. To investigate if this a real 
sequence difference a mouse cDNA clone KS/2 (gift Buckler et al.) was sequenced 
and found to resemble the human (Figure 5.8). This has also been independently 
confirmed by Melissa Little (personal communication). This would explain why 
monoclonal antibodies raised against this region of the human sequence also bind the 
mouse WT1 protein (V. van Heyningen personal communication). It is highly likely 
that the original sequencing error has been perpetuated in the sequence analysis of the 
rat. All calculations included in this study therefore have been based on the C-
terminal end of mouse and rat Wi resembling human, marsupial and alligator. 
5.2.113' Non coding region 
Clones which extended past the stop codon were obtained for marsupial mouse 
and alligator. In the 3' untranslated region the level of identity between the clones 
became much lower, and an increase in the AT richness and repetitive character of the 



























nt seq. aa seq. 
-> differences in the published mouse sequence 
Figure 5.8 Sequence of the mouse Wtl cDNA clone, KS/2. 
The sequencing gel of the mouse clone KS/2 shown above differs from the published 
mouse sequence (Buckler et al., 1991) by the inversion of a GC to a CG and 
therefore a two amino acid difference QL to HV. The mouse sequence therefore does 
not differ from the human in the C-terminal region as previously supposed. 
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Table 5.5 
Percentage similarities between coding and non coding regions of exon 10 
Coding 
mouse rat marsupial 
mouse  
alligator 
human 95.0 92.6 88.5 83.6 
mouse  95.9 86.9 81.3 





mouse rat marsupial 
mouse  
alligator 
human 72.0 73 •4* 455* 45.2* 
mouse  91.4* 48.2* 43.6* 




Calculations performed using the Gap program from GCG. 
Figures calculated using of the corrected mouse and rat sequences (see text for 
details) 
* indicates incomplete sequences compared 
163 
entire 3' non coding was isolated as polyA tail was observed at the 3' end of the clone. 
The marsupial mouse untranslated region was approximately 1.3kb long (only 400bp 
were sequenced) which is the same as the length of this sequence in mouse and 
human. In the 3' untranslated region of the marsupial mouse the similarity to the 
human, mouse and rat regions was found to be as low as the alligator (Table 4.5). At 
the 3' end of the marsupial sequence a higher degree of similarity to the eutherian 
mammals was seen including a AUUAAA sequence approximately 15bp away from 
the beginning of the polyA tail (in bold in Appendix A). This is a weaker 
polyadenylation signal than the canonical AAUAAA (Proudfoot 1994) but its position 
and conservation in marsupial, human and mouse suggests it is the polyadenylation 
signal recognised. In humans and mouse a polyadenylation signal (AAUAAA) is 
located approximately 900bp from the 3' end of the mRNA. In alligator this sequence 
was repeated twice (890-899bp in ALl), only 20bp downstream from the stop codon, 
suggesting that in certain circumstances shorter transcripts could be produced if these 
sequences were recognised. 
5.3 Evolutionary analysis of WTI 
The main objectives of the comparison of WD orthologs was to gain 
information at the structural and functional level, rather than to address the issues of 
rate of evolution and vertebrate phylogeny. Analysis of changes in the nucleotide 
sequence of WT1 with time was performed mainly to investigate the reason for the 
high level of conservation of the protein sequence. At the same time it was tested if 
the data from these sequences were consistent with present notions of evolution and 
vertebrate phylogeny. 
5.3.1 Rate of sequence evolution of WTI 
5.3.1.1 Introduction 
The structural analysis of WD has shown that the predicted amino acid 
sequence has diverged very little in particular in the zinc finger domain. At the 
nucleotide level comparison of the of the coding versus the non coding regions 
(introns, 5' and 3' non coding regions, (Tables 5.2&5.5)) shows that the rate of change 
of the non coding region must be very much higher than the coding region. It is now 
known that the rate of change of coding sequences is dependent on both the actual 
rate of mutation and the amount of purifying selection exerted on the gene. For 
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protein coding sequences most of the purifying selection will operate at the level of 
the protein produced. Mutations which affect the nucleotide sequence without 
changing the encoded protein (synonymous sites) are effectively 'silent' and can be 
fixed in a population by such means as genetic drift. However these substitutions can 
have an effect at the level of GC content, codon preference, neighbouring base 
mutational effects, and RNA secondary structure (Eyre-Walker 1991). Therefore to 
quantify the evolution of a nucleotide sequence it is better to compare the 'silent' and 
non 'silent' sites separately rather than comparing the sequences simply on a 
percentage basis. A percentage comparison does not compensate for multiple, 
backwards and convergent substitutions. These can be corrected for, to some extent, 
by equations such as the Jukes and Cantor formula (Jukes and Cantor 1969). 
Several programs for comparing the rate of mutation at synonymous and 
nonsynonyrnous sites have been produced. The method published by Li et al., 1985 
and updated in 1993 (Li 1993) was used to calculate the rate of synonymous 
substitutions per synonymous site (KS)  and the rate of nonsynonymous substitutions 
per nonsynonymous site (KA) for WTI. The rate of nonsynonymous substitutions can 
be compared to the rate of synonymous substitutions by the formula KA/KS.  If there 
is selection acting on the protein sequence the value for KA  will be much lower than 
the value for KS. 
The program classifies each site in the two sequences compared into 1) non-
degenerate, 2) two-fold degenerate or 3) four-fold degenerate, depending on whether 
nucleotide substitutions at a site will change the amino acid sequence 1) always (non-
degenerate), 2) one out of three times (two-fold) or 3) never (four-fold degenerate). 
The values obtained are then averaged between the two sequences. The sequences 
are then compared and the changes classified according to the above scheme. At two-
fold sites transitions are taken as degenerate changes and transversions as non-
degenerate. In the case of multiple substitutions in a codon the pathway within which 
the least number of non-degenerate changes would have occurred is given the higher 
weighting. 
5.3.1.2 Analysis of WTI 
The sequence information obtained for the WD orthologs did not cover 
identical regions. It was suspected that analysing different regions for different 
species may well produce a bias in the figures, in particular for those clones where 
only the highly conserved zinc fingers had been obtained. Therefore exons 7-9 were 
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Table 5.6 Figures obtained for KS  and  KA  using Li's program 





H M R P MM C AL X AX 
Human 22 24 10 55 58 60 114 62 
(6) (6) (3) (13) (13) (12) (34) (18) 
Mouse 0.5 5 22 58 88 60 105 79 
(0.5)  (2) (6) (12) (19) (12) (30) (23) 
Rat 0.5 0.0 26 62 87 67 97 82 
(0.5) (0.0)  (7) (13) (19) (14) (25) (24) 
Pig 0.0 0.5 0.5 62 84 80 111 92 
(0.0) (0.5) (0.5)  (14) (19) (19) (32) (44) 
Marsupial 1.3 1.7 1.6 1.3 85 79 112 70 
Mouse (0.8) (0.9) (0.9) (0.7)  (19) (16) (34) (19) 
Chick 1.7 2.1 2.0 1.7 0.4 25 79 57 
(0.9) (0.9) (0.9) (0.8) (0.4) (6) (20) (14) 
Alligator 1.7 2.1 2.0 1.6 0.4 0.0 99 47 
(0.9) (0.9) (0.9) (0.8) (0.4) (0.0)  (25) (13) 
Xenopus 0.9 0.8 0.8 0.8 0.8 0.8 0.8 75 
(0.7) (0.7) (0.7) (0.8) (0.7) (0.7) (0.7)  (19) 
Axolotl 0.9 0.8 0.8 0.8 0.8 0.8 0.8 1.7 
(0.9) (0.8) (0.8) (0.8) (0.8) (0.8) (0.8) (1.1)  





H M R MM C A 
H 35.3 34.2 72.6 95.4 100.4 
(5.7) (5.4) (11.3) (14.1) (15.8) 
M 1.8 10.7 81.6 93.3 89.2 
(0.6)  (2.7) (11.7) (13.3) (12.2) 
R 1.7 0.8 86.2 94.7 95.1 
(0.6) (0.4) (12.3) (13.6) (13.1) 
MM 1.6 3.0 2.4 84.0 89.6 
(0.6) (0.8) (0.8)  (12.9) (14.1) 
C 3.3 3.6 3.9 1.2 32.4 
(0.8) (0.9) (0.9) (0.6)  (5.3) 
A 2.5 2.7 3.1 1.3 1.0 
(0.7) (0.7) (0.8) (0.5) (0.5)  
Estimation of the rate of change of WTI 
Calculations were performed for two regions of WTI using the program (Li 1993) for 
estimating the number of synonymous changes per synonymous site (KS)  and the 
number of nonsynonymous changes per nonsynonymous site (KA).  (Standard errors 
are in parenthesis) 
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Table 5.7 Comparison of KS  and  KA  values for WTI with other genes 
a Comparison of Kç and KA between mouse and rat 
Gene Ks 
Chaperonin 0.077 0.0007 
c43 Crystallin 0.182 0.0000 
Nucleolin 0.110 0.0281 
GADPDH 0.167 0.0104 
Average 0.144 0.0148 
WTI (exons 7-9) 0.050 0.0000 
WTI (exons 3-10) 0.107 0.0080 
Data taken from Li 1993 





Histone 4 0.000 






WTI (exons 7-9) 0.045 
WTI (exons 3-10) 0.051 
Data taken from Li et al., 1985*  and Li 1993 
*Figures calculated using old method which underestimates KS  and overestimates KA 
to some extent. 
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compared for all the orthologs isolated (Table 5.6a) and exons 3-10 compared in the 
mammalian and reptilian lineages (Table 5.6b). 
In general the increase in evolutionary distance correlated well with an increase 
in the values of KA  and  KS.  The only major inconsistency was that the value for KS 
in Xenopus was much higher than for axolotl, although both are amphibians and 
therefore similar values would have been expected. This could be owing to the small 
amount of sequence available and the large standard errors. The KA  values for 
Xenopus and axolotl were lower than for the reptiles although it is believed that 
amphibians diverged from common ancestors 60Myr earlier (Benton 1990). This is 
probably because the N-terminal sequence of exon 7 could not be included for 
Xenopus and axolotl. 
For exons 7-9 KA approaches zero as would be expected. The standard error 
therefore was very high (Table 5.6a). For exons 3-10 KA  was higher than for exons 
7-9, consistent with a larger number of amino acid substitutions. In both regions the 
value for KS  was found to be much higher than the value for KA,  thus  KA/KS  is very 
low, which is consistent with purifying selection acting at the level of the protein 
sequence. The data obtained for WD were compared with other proteins, the KA, 
KS and KAIKS values were in the same range as those calculated for other proteins 
(Table 5.7). 
To investigate the relationship of KS  with time, the values for KS  within each 
dade were averaged and these values plotted against the estimated divergence times 
of the groups (Benton 1990). The relationship was found to show a linear trend 
(Figure 5.9). The rate of synonymous substitutions per site per year was found to be 
similar for both regions examined at 1-1.25x10 9 using the formula rate = K5/2T 
(T=divergence time) (Li and Graur 1991). This is lower than values obtained 
previously (1.7-11.8x10 9) (Li et al., 1985) but the updated method (Li 1993) is 
known to give a lower, more realistic, value for KS.  It was noticed from these graphs 
that the values obtained for comparisons with the chick and alligator sequences lay 
below the line (Figure 5.9). The KS  and  KA  values were subjected to a relative rate 
test (Li and Graur 1991) and this suggested that the rate of evolution of WT1 may be 
slower in the reptilian lineage. This could possibly be an artefact owing to a small 
data set. To discover the real reason behind the differences in the apparent rates a 










Figure 5.9 Graphs plotting KS  against divergence time 
The KS  values (number of synonymous changes per synonymous site) for each species was calculated (Table 5.6) and these were averaged 
within each group; mammals (eutheria), marsupials, archosaur lineage (birds and some reptiles) and amphibians. The KS  values were then 
plotted against the divergence times for amphibians from tetrapods, archosaurs from the mammalian lineage, ayes from crocodilians, eutheria 
from metatheria, mammalian radiation and mouse from rat. 
No definitive conclusions can be drawn from this data as the errors are high, but points including data from the chick and alligator tended to 
lie below the line, maybe indicating a non constant rate of evolution of the nucleotide sequence of WTI. 
a Exons 7-9 	 b Exons 3-10 
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5.3.2 Phylogenetic analysis 
In order to calculate the divergence between sequences, from which to derive a 
phylogenetic relationship, multiple alignment of the nucleotide sequence of exons 7-9 
was performed using the Clustal V program. The sequences are initially aligned using 
a fast comparison of the sequences, by producing k-tuple scores for the sequences, 
plotting these on a dot matrix and finding the diagonals with the most matches. Using 
the similarity scores a dendrogram was produced using the UPGMA (unweighted pair 
group method with arithmetic mean) method. The sequences were then aligned 
starting with the most closely related sequences. This alignment can be used to 
produce an unrooted phylogenetic tree using the neighbour joining method of Saitou 
and Nei 1987 (Figure 5.10). This is a distance method, as opposed to a parsimony 
method, where the percentage divergence is calculated from the alignment and then 
used to produce the tree. The tree was bootstrapped 500 times (i.e. samples of 
sequence were taken and from them a tree calculated, the number of times the same 
internal branches are found gives the degree of confidence in the tree). The weakest 
parts of the tree were found to correspond to the non mammalian branches. The 
major inconsistency with palaeontological relationships (Figure 1.7) -was also found in 
this region. The reptiles are shown to form a dade with amphibians rather than with 
mammals (the amniotes). In addition, the axolotl sequence was found to diverge from 
the reptiles after Xenopus, whereas they would be expected to group together. The 
figures for the percentage divergence from which the tree was drawn, were plotted 
against time. A linear increase in divergence with time was seen (Figure 5.11). It was 
found that the values for the reptilian lineage were again relatively lower than 
expected, perhaps explaining why the amphibians and reptiles grouped together in the 
tree. 
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Figure 5.10 Unrooted phytogenetic tree for exons 7-9 of WTI. 
This was produced by the neighbour joining method using a CLUSTALV. alignment. Branch lengths are drawn approximately to scale and 






















Figure 5.11 Graph of divergence of WTI against divergence time 
Graph plotting percentage divergence, calculated using CLUSTAL V. against divergence 
time. An approximately linear  increase in divergence with time was found. Outlying 
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Chapter 6 
Investigation of the Expression of WTI 
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6.1 Introduction 
The cloning of WTI orthologs in the different classes of vertebrate will allow 
the investigation of the similarities and differences of WTI gene expression among 
them. Knowledge of normal expression patterns is an initial requirement before 
manipulation of a system can be attempted. Northern blotting and in situ 
hybridisation techniques were therefore used to investigate the size and expression 
pattern of WTJ mRNA in several of the species from which WT1 had been isolated so 
these could then be compared with that of mammals. The most extensive study was 
performed in chick and alligator embryos. The development of the genitourinary 
system in the reptilian lineage is of interest because of its intermediate nature between 
that of the mammals and lower vertebrates. In alligators the metanephros does form 
but contains relatively few nephrons while a functional mesonephros persists into post 
hatching stages (Forbes 1940). In reptiles, but not birds, the mechanism of sex 
determination is of interest because it is temperature dependent as opposed to being 
genetically determined (Ferguson and Joanen 1982). This mechanism is under 
investigation in alligators as it is a solely temperature dependent mechanism. In other 
reptiles there is also a genetic element. The cloning and determination of the function 
of genes involved in the early developing gonad will help elucidate this. 
6.2 Northern analysis of WTI mRNA 
Total RNA was prepared from the genitourinary systems of pig, chick, alligator, 
and Xenopus. In order to determine the size of WTJ mRNA transcripts in these 
species this RNA was probed with WTI. RNA was resolved on a denaturing agarose 
gel, and then transferred by vacublotting onto Hybond N (Amersham). The filters 
were then hybridised at high stringency with the appropriate homologous probe 
(Figures 6.1&6.2). Details of RNA samples and probes used are contained in Table 
4.1 and Figure 4.5. 
The major transcript detected in chick, alligator, and pig was approximately 
3kb, the same size as that observed in human, mouse, and rat (Call et at., 1990, 
Buckler et at., 1991, Sharma et al., 1992). An additional 2kb transcript was detected 
in chick RNA obtained from the complete developing genitourinary system of 11 day 
embryos, but not from RNA isolated from the mesonephros alone (Figure 6.1). 
Total RNA from both whole Xenopus iaevis tadpoles (stages 45-46) and 
mesonephros (stage 55) was probed with XWTJ. Consistent with a higher level of 
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Figure 6.1 Detection of WTI mRNA in pig, chick and alligator 
Lane Source of RNA 
Species Organ 
1 Pig Juvenile Testis 
2 Chick lid genitourinary system 
3 Chick 13d mesonephros 
4 Alligator St. 20 male gonad (33 0C) 





Autoradiograph of a northern blot after high stringency hybridisation with the 
homologous PCR clones to total RNA from pig, chick and alligator. 3kb bands are 
present in all tracks demonstrating the conservation of the length of the mRNA 
transcript in mammals, birds and reptiles. A 2kb hand is also detected in the sample 
from the 11 day chick genitourinary system. 
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Figure 6.2 Detection of Xenopus WTI mRNA 
Lane 	Source of RNA 
1 St. 55 mesonephros 
2 	St. 45 tadpole 
3 St. 45 tadpole 
4 	St. 46 tadpole 
5 St. 46 tadpole 
1 	2 345 
18S 
Phosphorlmager analysis of a northern blot of total RNA from whole tadpole (St. 45-
46) and mesonephros (St. 55) after high stringency hybridisation to XWT] (PCR 
clone). XWTI is only detected in the sample from mesonephros and the transcript size 
is 5kb. 
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WT1 expression in the mesonephros than elsewhere a 5kb transcript was detected only 
in mesonephric RNA (Figure 6.2). 
6.3 In situ hybridisation 
Recently, the technique of whole-mount in situ hybridisation has been 
developed which allows the expression pattern of a gene to be analysed in the whole 
embryo as opposed to having to reconstruct this from sections. The embryos can then 
be sectioned to identify more closely the sites of the expression. In situ hybridisations 
on sections can be used to obtain better histological detail than in whole-mounts. 
Whole-mounts also enable unexpected sites of expression to be identified which may 
not have been included in sections. 
Antisense digoxigenin-dUTP labelled riboprobes were prepared from chick and 
alligator PCR clones CWTLAand AWTJ (probes described in Figure 4.5) by in vitro 
transcription, using the Boebringer Mannheim kit. Chick and alligator embryos were 
collected at various timepoints after incubation at the appropriate temperature. 
Albino Xenopus laevis embryos between stages 14-39 were generously donated by 
Richard Harland. Embryos were dissected away from the surrounding membranes, 
fixed, and hybridised with the appropriate riboprobe (as described in Materials and 
Methods). The signal was visualised by binding an alkaline phosphatase conjugated 
anfidigoxigenin antibody to the annealed probe. When NBT (nitroblue tetrazolium 
salt) and BCIP (5-bromo-4-chloro-3-indolyl phosphate) were added, they were 
catabolised by the alkaline phosphatase to give a insoluble blue precipitate at sites of 
mRNA expression. To detect any non-specific signal produced due to trapping of the 
probe (in particular in the intraembryonic spaces), a sense riboprobe or vector-only 
riboprobe was hybridised in parallel to the antisense riboprobe. 
6.3.1 Comparison of the developmental stages of amniotes 
A guide to the equivalent stages of human, mouse, chick and alligator 
development based on somite number and limb development and other developmental 
features such as branchial arches, is provided in Table 6. Exact whole embryo 
comparison between species let alone across classes is impossible as different 
structures are found to develop at different stages and at different rates. This 
changing of developmental timing and rates (heterochrony) is probably one of the 
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Table 6 Development of the chick showing comparisons with human, mouse and alligator. 
Comparisons based on somite number, limb development or branchial arch or other recorded features 
Derived from Hamburger & Hamilton (1951), Romanoff (1960), Thelier (1972), Ferguson (1985), Wanek (1989), Kaufman (1992) and 
Moore and Persaud (1993). 
Chick Chick somite Alligator Mouse Human Chick developmental events 
number stage/age equivalent equivalent equivalent 
general features somites/limbs 
Isomites  
St. 1  Prestreak (no primitive streak) 
St. 2/6-7h  Initial streak 
St. 3  15d Intermediate streak (primitive streak extending) 
St. 4  16d Definitive streak (primitive at maximun length) 
St. 5  St. 11/7.5d Head process appears 
St. 6/23-24h  Head fold forms 
St. 7 1 somite  St. 12/8d  Nephrogenic cord forms, mesonephros potentiality determined 
St. 8 4 somites  18d Neuralation 
St. 9 8 somites St. 1318.5d Pimordia of the pronephric tubules first appear as paired thickenings in the 
intermediate mesoderm in the region of somites 5-8 
St. 10 10 somites Eggs laid Pronephric buds grow in a dorsolateral direction 
Posterior neuropore closes, tail bud stage 
St. 11 13 somites St. 1/1 St. 14/9d Pronephric duct has lumen 
Closure of anterior neuropore 
St. 12-13 16-19 somites  
St. 14/50-53h 21 somites St. 2/2 St. 15/9.5d 24d Degeneration of pronephros as far as somite 11 
St. 15 24 somites St. 3/3 25-26d 11 pairs of pronephric tubules 5-16 somite region 
limb primordia-prospective limb areas flat not yet determined 
St. 16 26-28 somites  27-29d Wing lifted off blastoderm, leg primordium is condensation of mesoderm 
St. 17 29-32 somites St. 4-6/4 St. 16/10d Pronephric glomeruli first appear after the pronephros has begun to 
degenerate. The mesonephros starts to differentiate, condensing blastema 
from somites 13/14-20 
limb buds apparent 
St. 18/3d 30-36 somites St. 7-8/4 St. 15 Anterior, non functional, mesonephric tubules have fused with the 
mesonephric duct 
Limb buds enlarged 
St. 19 37-40 somites St. 9/5 St. 17/10.5d 32d Differentiation of principle mesonephric region (somites 20-30) occurring 
St. 16  First sign of genital ridge development 
St. 20 40-43 somites  St. 18/11d 32-33d Tip of tail still unsegmented, faint eye pigment 
St. 21 43-44 somites St. 10 St. 19/11.5d 37d  
St. 17  
St. 22  Somites extend to tip of tail 
St. 23/4d St. 11 St. 18-19 5w Pronephros degeneration is complete 
Ureteric bud appears shortly after the nephric duct opens into the cloaca 
First sign of Mullerian duct 
St. 26/5d St. 12-13 St. 20 41d Mesonephros begins to function - evidence hydronephrosis in cut ducts and 
movement of dyes against gradient 
Ureteric bud turns anteriorly, metanephros is separated from the 
mesonephros by a region corrsponding to 2 somites developing no tubules 
Primary sex cords in indifferent gonad 
6d  St. 14  4w Appearence of genital tubercale 
6.5d  St.21-22/31-40d St. 21/13d 7w Testis differentiation begins 
7d  St. 22-23/36-45d St. 22/13.5d lOw Ovarian differentiation begins 
8-9d 14d Beginning of disintegration of mesonephros, loss of lumen in tubules 
Metanephric tubules present but as yet undifferentiated 
Male and right female Mullerian ducts stop developing and degeneration 
starts 
lOd  St. 24/45-50d St.25116.5d  Vascularisation of the mesonephros 
1 Id 11w Maximum function of mesonephros, metanephros starts to function 
Left female Mullerian duct reaches cloaca 
Rete cords of testis associate with the mesonephros 
12d 11-13w First loops of Henle appear in metanephros 
Male mullerian ducts completely regressed 
lSd  Major functioning transferred to metanephros 
15-21d  Loss of 77% mesonephric weight 
21d approx St. 28/65d 19d birth 9 months Mesnephros stops functioning 
hatching  hatching  birth  
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major mechanisms of evolution. One of the most obvious changes in the species 
investigated here is the difference in relative timing of somite and limb bud 
development. The onset of development of the limb buds in the chick and alligator 
occurs when a higher number of somites have developed than in mammals. Also the 
hind limb bud develops first in alligator, as opposed to the forelimb bud in mammals. 
These two characteristics are used for staging mammalian, chick and alligator 
embryos and so discrepancies can arise depending on which features of the embryos 
are compared. 
If the developmental events in the genitourinary system are compared against 
other developmental events, mammalian pronephros differentiation and degeneration 
occurs at about the same time as in the chick, but mesonephros differentiation and 
degeneration occurs earlier. Mammalian mesonephros function has never been 
demonstrated, i.e. it is vestigial. This is in contrast to the chick and alligator where 
the mesonephros does function and develops as a much larger organ than that 
observed in mammals (Romanoff 1960). 
6.3.2 WTI expression in chick embryos 
Chick embryos were harvested between stages 15-20 (53 hrs-3.5 days) 
(Hamburger and Hamilton 1951) approximately equivalent to 9.5-11 day mouse 
(Table 6). These stages corresponded to the development of the mesonephros from 
the urogenital ridge and therefore with expression of V/Ti observed in mammals 
(Armstrong et al., 1992). The analysis of WTI expression in chick embryos was 
prevented in the anterior region due to trapping of the probe. It was decided that the 
signal present in the anterior region but not the posterior region was non-specific 
because signal was also obtained with a vector only probe in the anterior but not the 
posterior region (Figure 6.3c). In early stages WTI expression was observed in the 
urogenital ridge region of the intermediate mesoderm, extending caudally from the 
level of the heart, and in later stages expression in the developing paired mesonephroi 
was seen. Figure 6.3a shows a stage 16 embryo probed with antisense WTI RNA. 
The paired regions of expression extend caudally from the heart along the ventral 
surface. At this stage no tubules were visible in this region and the mesonephric duct 
which induces their differentiation has just reached the posterior end of the embryo 
(Figure 6.3b), indicating that this may correspond to the early stage of nephron 
differentiation following induction by the mesonephric duct. By stage 19 tightly 
packed tubules are visible in mesonephros (data not shown). In the stage 20 embryo 
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Figure 6.3 Expression of WTI in the developing chick 
a Whole-mount in situ hybridisation of St. 16 chick embryo with an digoxigenin 
labelled antisense WTI RNA probe. Staining of paired ridges in the posterior end of 
the embryo corresponding to the differentiating intermediate mesoderm (urogenital 
ridge) is visible. The curve of the embryo hides the fact that the expression extends as 
far anterior as the heart. The most posterior end of the embryo was lost during 
dissection as it had not been completely delineated from the blastoderm (15x 
magnification). 
b Drawing of a St. 15 chick embryo (Balinsky 1981) showing the position of the 
intermediate mesoderm and mesonephros corresponds exactly with the region of 
14/Ti expression seen above. 
c Whole-mount in situ hybridisation, with a vector only probe, of a St. 16 chick. 
Staining is only seen in the anterior region, due to trapping of the probe in 
intraembryonic cavities (lOx magnification). 
d A St. 20 embryo lying on its back to show the expression of WTI in the developing 
right mesonephros. The 14/Ti signal does not appear to be uniform along the 
mesonephros and this may correspond to localisation of high expression levels in the 
developing nephrons. One of the forelimbs is also visible and no WTI expression was 
detectable (12x magnification). 
(h heart, im intermediate mesoderm, fl forelimb bud, in mesonephros, n developing 
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the signal is discontinuous along the ventral edge of the mesonephros, consistent with 
the localisation of WTI to the differentiating nephrons, perhaps to the glomeruli which 
develop after the tubules are seen (Figure 6.3d). 
6.3.3 WTI expression in alligator embryos 
The collection of alligator eggs from Louisiana, USA, their incubation and in 
situ hybridisation was performed by AM Coriat at the University of Manchester as 
part of a collaborative study on early gonad development in alligators. Alligator 
embryos at stages 3-14 (3-17days) (Ferguson 1987) were investigated. These are 
equivalent to chick stages 15-29 (2-6days) (Hamburger and Hamilton 1951). Earlier 
embryos were not obtained because some development has occurred before 
oviposition and eggs cannot be immediately collected from nests. 
No expression was detectable in alligator at stages 3 and 5 (Figure 6.4 a&b). 
The onset of WTI expression in the alligator occurs at stage 6 (Figure 6.4), equivalent 
to about stage 17 in chick (Table 6.1). The expression is localised to the anterior end 
of the intermediate mesoderm at the level of the heart (Figure 6.4c) and the roof of 
the rhomboencephalon (hind brain) (Figure 6c&d). In a number of embryos, signal 
was observed in the forebrain but this was probably due to trapping of the probe as a 
similar signal was observed in a stage 6 embryo probed with the sense control (Figure 
6.41). In stages 9-11, the expression of WTI extends down the intermediate 
mesoderm corresponding with the wave of differentiation of the urogenital ridge 
induced by the mesonephric duct (Figure 6.5). Two components of the developing 
circulatory system seem to express WTI . At the level of the developing forelimb bud, 
a paired region of expression ventral to the mesonephros is observed, this is thought 
to correspond to the viteffine veins which overlie the mesonephros and above this 
there is signal in the developing heart. At stages 10 and 11 the signal extends the 
length of the intermediate mesoderm and is also found in the fore and hind limb buds 
(Figure 6.5c-e). As the hand plate forms in stages 13-14 the limb bud expression 
becomes localised to the presumptive wrist and armpit regions and a region adjacent 
to this on the body wall (Figure 6.6). On either side of these embryos from the neck 
region downwards signal is also visible, this is thought to correspond to the lateral 
plate mesoderm, which is differentiating into the body wall. Sections of the 
mesonephros of stage 21 embryos show the tubules passing through the comma and 
S-shaped stages of differentiation (Figure 6.7). In situ hybridisation demonstrates 
localisation of WTI expression to the tubules. 
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Figure 6.4 Whole-mount in situ hybridisation of alligator embryos - onset of 
WT1 expression 
a&b St. 3 and 5 embryos probed with antisense WTI riboprobe, no expression of WTI 
is detectable. 
c St. 6 embryo hybridised with antisense probe. The onset of WTI transcription is 
detected in anterior end of intermediate mesoderm beginning at the level of the heart 
St. 6 showing that staining is also apparent in the roof of the rhomboencephalon, 
the hind brain. 
St. 7 embryo showing persistence of the hind brain expression 
St. 6 embryo probed with sense probe. Only non WTI specific signal was found in 
the fore brain 
(fb fore brain, hb hind brain, h heart, im intermediate mesoderm) 
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Figure 6.5 WTI expression in stage 9-11 alligator embryos 
a &b St. 9 embryos, left and right sides respectively, showing the extension caudally 
of WTJ expression in the differentiating urogenital ridge as far as the cloaca. 
Expression in the heart and vitelline veins is apparent as is expression in the roof of 
the hind brain. Also at this stage the otocyst is stained, this is probably due to the 
trapping of the probe as well as in the forebrain. 
c St. 10 embryo, expression of WTI is detected in the limb buds as well as the 
intermediate mesoderm. 
d&e St. 11 embryos either lightly or heavily stained. Expression is maintained in the 
intermediate mesoderm, limb buds, heart and vitelline veins. 
(fl forelimb bud, hi hind limb bud, h heart, hb hind brain, im intermediate mesoderm, o 






Figure 6.6 WTI in stage 13-14 alligator embryos 
a-c. Stages 13-14. The abdominal body wall has formed so the mesonephros is no 
longer visible. WTI expression in the limbs has become to limited specific regions in 
the forelimbs. 
The body wall is also expressing WTI, from the neck region down. The expression 
seen in the heart is probably due to a high level of expression in the mesothelium. 
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6.3.4 Xenopus whole-mount hybridisation 
In the Xenopus embryos probed with an antisense XWT1 riboprobe (transcribed 
from PCR clone XWTJ) no convincing signal was detected, compared with the sense 
control. This could be because the probe that was used was too short. It was only 
277bp long and the minimum recommended length is 500bp. The isolation of a larger 
region of XWTJ had been attempted by library screening but no clones were obtained. 
Alternatively the stages used may have been too early. This probably not the case as 
in the oldest embryos used (stage 39) pronephric tubules were apparent and the 
nephric duct had extended along the length of the embryo (Lynch and Fraser 1990) 
and so the induction of the urogenital ridge would be expected to be underway and 
therefore WTI should be expressed. The dissection of WT1 expression in Xenopus 
will have to await the isolation of a longer probe. 
6.4 Comparison of WTI expression 
In contrast to the detailed information about the chick genitourinary system, 
information on the timing of the onset of alligator nephrogenic differentiation is 
limited. The earliest reports observe the presence of what is thought to be the nephric 
duct rudiment in stage 1 embryos. In stage 3 embryos 5-6 nephric tubules are present 
at the level of the heart and this is therefore thought to be the onset of pronephric 
development (Reese 1908). This corresponds with the timing of pronephric 
development observed in chick. By stage 5, tubule formation has extended as far 
as the liver (Reese 1908). The metanephric anlagen has been observed at >40 somites 
(St. 12) (Forbes 1940) and many metanephric tubules are present by stage 20 (Reese 
1908). 
In the chick, expression was seen all along the urogenital ridge at stage 16. This 
is just before the first mesonephric differentiation is observed (stage 17), but after the 
mesonephric duct has reached the cloaca (stage 15) and therefore at the stage of 
induction of the mesonephric blastema (Romanoff 1960). The expreon in chick just 
precedes the first observation of WD expression in the anterior end of the urogenital 
ridge in the alligator. The stage 6 alligator in which this was seen was approximately 
equivalent to a stage 17 chick, and so WTI expression in the alligator is detectable 
around the times when pronephric and mesonephric differentiation is occurring in the 
chick, but with a slightly later onset than seen in the chick. Expression was detected 
in the region where the first tubules are observed in the alligator (somites 4-10), but 
after their differentiation has been reported. It maybe that in the pronephros, where 
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the nephrons have external glomeruli WTI is regulated in a slightly different manner, 
or that WTI levels were below the detection threshold. In both species WTI 
expression extends the length of the urogenital ridge from the level of the heart 
(similarly to mouse) as far as the cloaca. In both species evidence of localisation to 
the developing nephrons has been found. These results agree with the timing and 
localisation of WTI expression in the mouse mesonephros (Armstrong et al., 1992). 
Several other sites of WTJ expression were observed in alligator embryos. The 
possible neural expression is of interest. The expression of WTI in the roof of the 
developing hind brain has not been detected in any species apart from the alligator. 
Expression in the newborn rat (Sharma et al., 1992), and in 15 day mouse brain and in 
neural tissue of the spinal cord of the developing human, mouse and rat (Pritchard-
Jones et al., 1990, Armstrong et al., 1992, Sharma et al., 1992) has been reported 
indicating that VvTI can be expressed in tissues which are ectodermally derived in 
addition to those of mesodermal origin. 
Expression is also present in the lateral plate mesoderm which will give rise to 
the connective tissue, blood vessels and musculature of the body wall. A transient 
localisation of signal in the developing striated musculature of the body wall has been 
observed in day 13 mice (Armstrong et al., 1992). This is a particularly interesting 
property considering that ectopic striated muscle is histologically observed in Wilms' 
tumours whereas only smooth muscle is present in normal kidneys (Mierau et al., 
1987). The alligators in which this signal was observed were of a similar 
developmental stage to the mice indicating a possible conserved role for WTI in the 
developing body wall. The alligator expression in the limb buds and the vitelline veins 
represent new sites of WTI expression. The observed heart expression may be 
analogous to the mouse and human pattern where WTJ is expressed in the overlying 





The evolutionary history of WT1 in the vertebrate classes has been illuminated by the 
findings presented above. 
• WTI orthologs have been isolated by a combination of PCR and library screening 
from representatives of all the vertebrate classes. 
• A high degree of conservation, attributable to purifying selection, has been 
observed between the predicted protein sequences. 
• Conservation is particularly stringent in the zinc fingers which are almost identical 
in all vertebrates. 
• The human genomic structure which is one exon for each zinc finger domain has 
been conserved in zebrafish, including the presence in this species too of the 
alternative splice donor sequence that is responsible for the KTS insertion between 
ZF3 and ZF4. 
• However two homopolymer domains in the transregulatory domain, the 17 amino 
acid alternative splice, and the N-terminal region of exon 6 are not highly 
conserved. 
All residues shown to be mutated in Wilms' tumours, both somatic and 
constitutional, are conserved. 
The WTI expression pattern has been shown to be conserved in the developing 
genitourinary ridge, in particular the developing nephric tubules. 
Expression of WTI outside of the intermediate mesoderm derived tissues has been 
found in the alligator as well as in mammals. 
This study has made a significant start to the comparative analysis of WTI structure 
and function in the vertebrates. 
7.1 The evolution of transcription factors in vertebrates 
Comparison of the predicted amino acid sequences has revealed very few 
substitutions in the WTI orthologs, particularly in the zinc fingers. The conservation 
of other transcription factors for which a number of orthologs have been isolated was 
compared with WTI. Table 7.1 shows the percentage conservation for a selection of 
transcription factors within the vertebrate lineage. The figures were either taken from 
the quoted paper or calculated using the gap program of GCG from sequences in the 
GenBank database. The figures are similar to those obtained for WTI (Table 4.3 & 
4.6), and with all of these there is a striking increase in homology within the 
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conservation 
% Conserved 
Amino Acids in 
 this Region  
Reference 
p53 Human-Mouse 85.5% Regions 4&5 
96% Soussi et at., 1990 
 100%  
Human-Chick 69%  92% 
Human -Xenopus 51%  100% 
Mouse-Xenopus 57%  100% 
Chick-Xenopus 69% 
Krox-20 Human-Mouse 90% Zinc fingers 100% 
Oxtoby and Jowett 1993 





Basic Helix ioophelix 
Basic Helix loop helix 
98% 
94% 
Whitfield et al., 1993 
Schreiber-Agus et al., 1993 
100%  
Human-Zebrafish 61% Basic Helix loop helix 81% 
Mouse-Zebrafish 63% Basic Helix loop helix 83% 
Xenopus-Zebrafish 65% Basic Helix loop helix 83% 
Trout-Zebrafish 77% Basic Helix loop helix 98% 
max Human-Mouse 98% Basic Helix loop helix 100% 
Human-Zebrafish 86% Basic Helix loop helix 
SRY Human-Marmoset 61% HMG box 95% 
Whitfield et al., 1993 
Schult-Merker et al., 1992 
>94%  
94%  








DNA binding region 84.5% 
Xenopus-Zebrafish 76% DNA binding region 
Snail Mouse-Xenopus  Zinc fingers2-5 86% Hammerschmidt and 
Nusslein-Volhard 1993 
71%  
Mouse-Zebrafish  Zinc fingers2-5 83% 
Xenopus-Zebrafish  Zinc fingers2-5 88% 
Zebrafish-Drosophila  Zinc fingers2-5 
Pax 6 Human-Mouse <99%  _________________ 
Ton et at., 1992 
Human-Quail 98.6% paired domain 100% Martin et at., 1992 
100%  Human-Quail  homeodomain 
Human-Zebrafish 96% paired domain 100% Krauss et at., 1991 
100%  
Human-Zebrafish  homeodomain 100% 
Quail-Zebrauish 96% paired domain 98.2% 
 Quail-Zebrafish  homeodomain 
presumed DNA binding domains as compared to the rest of the protein. For both 
tumour suppressor genes (WTI and p53) the pathogenic mutations found have been 
almost all located in these conserved regions (Soussi et al., 1990). This confirms the 
supposition that positions which have been found to be mutated in pathological states 
in humans are conserved in evolution. A high level of conservation has been observed 
for many transcription factors. Changes in the regulatory genes in development could 
be under a high level of selection because changes in these may affect more than one 
pathway so it may be a rare event that changes one of these proteins so that there is 
no deleterious effect on any of the pathways. 
7.2 Rate of evolution of WTI 
The comparison of the rate of change at synonymous and nonsynonymous sites 
demonstrated that the former was far greater than the latter, indicating that the slow 
rate of change of the protein sequence resulted not from an intrinsically slow rate of 
nucleotide mutation but was due to selection. By comparing the amount of sequence 
divergence with divergence time a linear trend was seen. The major anomaly seen 
was that the rate of change in the reptilian lineage seems to be lower than expected. It 
is difficult to make definite conclusions about rates in different lineages because of the 
considerable uncertainty about the true divergence times. Differences in the rate of 
evolution have been seen in a number of taxa, and it has been observed before that the 
rate of sequence change in the ayes is lower than in some other lineages (Britten 
1986). Attempts have been made to account for these differences in the framework of 
the theory of a molecular clock (Wilson et al., 1987). The idea that local clocks exist 
as opposed to a single global clock, seems to have gained greater acceptance. There 
is probably a range of variables involved in the rate of sequence change, including 
generation time effect (Kohne 1970), DNA repair (Britten 1986), or metabolic rate 
(Martin and Palumbi 1993). 
7.3 The transregulatory domain 
The mechanism by which sequence specific transcription factors, such as WT1, 
act to activate or repress expression from their target genes is just beginning to be 
elucidated. There seems to be a common theme for the diverse regulators, in that 
they affect transcription from a wide variety of promoters and they can function 
synergistically and co-operatively with other factors. The stage at which these factors 
are now thought to act is at the initiation of transcription, by modulating the 
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formation of the complex between the RNA Polymerase II complex and its associated 
general transcription factors, which is now known to be a highly ordered multi-step 
process (Zawel and Reinberg 1993). Although the DNA binding regions in these 
transcription factors show a limited number of recognisable motifs e.g. zinc fingers, 
homeodomains, and bZip motifs, the only similarities between putative transregulatory 
domains is a richness in certain sorts of amino acids; the acidic domains or proline or 
glutamine rich (Mitchell and Tjian 1989). Experiments to define the functionally 
important regions within these domains have been tried. In several transcription 
factors different regions have been found to be acting independently to activate or 
repress transcription (Russo et al., 1993, Chi and Carey 1993). In most experiments 
the effect of WTI has been to repress transcription from reporter genes and it seems 
that disturbing the structure of the transregulatory region of WTI always disturbs the 
repression effect of the protein (Madden et al., 1991, Drummond et al., 1992, 
Gashler et al., 1992, Wang et al., 1992, Werner et al., 1993, Wang et al., 1993a). It 
had been hoped that the pattern of conservation of this region of WT1 would provide 
insight into the architecture of this region. No strikingly modular pattern of 
conserved and non-conserved residues was observed for WT1 which would point to 
functional and non-functional regions. In some ways the high level of conservation of 
this region was surprising considering only a very small percentage of mutations occur 
in this region. When comparing mutated regions with evolutionarily conserved ones, 
evolutionary conservation probably provides a better picture of functional regions, as 
mutations will only be observed if the phenotypic change is large enough to be noticed 
but is not lethal. In addition only a subset of genitourinary abnormalities, mostly 
Wilms' tumours, have been analysed for WTI mutations. As yet only somatic 
mutations have been observed in the transregulatory domain and it may be that a 
constitutional change in this region of WTI may produce a different phenotype to 
constitutional zinc finger mutations. 
The major difference observed was in the two homopolymer domains of 
polyproline (Proline)13 and polyglycine (Glycine)5. The conserved, higher than 
average levels, of proline, glutamine, and serine are consistent with a non random 
distribution of amino acids found in transcription factor transactivation domains. Also 
using the Chou and Fasman program for prediction plots of a helix, 0 sheet and 
turns and the Kyte and Doolittle program for estimation of hydrophobicity no great 
changes between the different species was shown (Appendix B). The high level of 
conservation of the WTI orthologs points to the functional importance of this region 
suggesting that WTI is not merely acting as a structural antagonist of EGR1 
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(effectively blocking EGR1 binding to its target promoters), and repressing growth in 
that manner. 
7.3.1 Evolution of homopolymer domains 
The mechanism by which the difference in these domains arose can be 
speculated on. (Proline)13 is not present in the chick WTI ortholog and the region 
encoding (Glycine)5 has not been conserved. It is not known whether or not the 
(Proline)i3 region has been inserted or deleted in WTI, since the mammalian/reptilian 
divergence. To answer this question will require the isolation of this region from 
more diverged species. Insertions or deletions can arise from slippage of the DNA 
polymerase during replication resulting either in replication of a region already 
replicated or skipping of a region. Slippage is known to happen in the regions of 
DNA containing contiguous short repeats due to the increased chance in mispairing 
between these repeats (Li and Graur 1991, Richards and Sutherland 1994). It could 
be speculated that the two regions (Glycine)5 and (Proline) 13  in W71 have been 
produced by insertion or expansion of a trinucleotide repeat of CCN and GGN which 
encode proline and glycine respectively. (Glycine)5 may have been produced prior to 
mammalian/reptilian divergence but was only conserved in the mammalian lineage. 
Both of these homopolymer motifs are conserved in three mammalian orders, primate, 
rodent and artiodactyls (Figure 5.3), although the number of residues is not 
completely stable, indicating that some replication slippage is occurring. 
There is growing interest in these homopolymer motifs and their origin. This 
has been aroused by a new sort of pathogenic mutation, the expansion of trinucleotide 
repeats, called dynamic mutations (Richards and Sutherland 1992). The first 
incidence was discovered in the FMR gene. It was found that an increase in the 
number of CCG repeats in the gene was associated with Fragile X syndrome. Carriers 
are found to have a greater than normal number of repeats, and in affected individuals 
this is even further increased. The number of disease genes where this has been found 
to occur is expanding, e.g. X-Linked spinal and bulbar muscular atrophy (La Spada et 
al., 1991), myotonic dystrophy (Brook et al., 1992, Fu et al., 1992, Mahadevan et al., 
1992), FRAXE site (Knight et al., 1993) and Huntington's Chorea (The Huntington's 
Disease Collaborative Group 1993). The position within the gene is not the same for 
all diseases; expanded repeats are found in coding or non coding regions, suggesting 
that the expansions can interfere with gene expression or function in a variety of ways. 
Only two trinucleotides have been found to be expanded in this way, CCG and CAG; 
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EGR2 Proline Joseph et al., 1988 
Androgen receptor Glutamine Tilley et al., 1989 
Yeast ADR6 Asparagine, Threonine O'Hara et al., 1989 
Human calcineurin A Proline Guerini and Klee 1989 
Glucocorticiod 
Receptor  
Glutamine Evans 1989 
EBNA2 Proline Horvath and Schwbach 1993 
Mouse Sry Glutamine Gubbay et al., 1990 
GALl] Glutamine Suzuki et al. 1988 
MCM1 Glutamine Passmore et al. 1988 
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it is not known whether this is because these trinucleotides are more susceptible to 
expansion or whether it is due to the protein products produced. The mechanism by 
which these expansions occur has been elucidated in one gene: spinocerebella ataxia 
type 1. In this gene the normal repeat has a single base change interrupting it; if this is 
mutated back to perfect repeat it becomes unstable (Chung et al., 1993). Instability 
of di, tn, and tetranucleotide repeats has now been seen in some cancers arising from 
mutations in the DNA repair mechanism (Richards and Sutherland 1994). 
On searching databases many other genes have homopolymer domains which 
may also be attributable to the insertion or expansion of a trinucleotide repeat during 
evolution but in a much more minor way than that seen in disease (Table 7.2). As yet 
no expansions in WT1 have been found but it may be speculated that if the region 
encoding the polyproline region became unstable, expansion could be a mechanism of 
gene inactivation. 
7.3.2 Function of homopolymers 
Homopolymer domains are thought to play a role in transcription regulation, 
since proline and glutamine homopolymers are mostly found in transcription factors. 
Fusion of these to GALA DNA binding domains show that they can change the level 
of transcription from a reporter gene in vitro (Gerber et al., 1994). The deletion of 
(Proline) 13  and (Glycine)5 homopolymer domains from the human WT1 in vitro 
caused only a small reduction in the repression of transcription from reporter genes 
(Madden et al., 1993, Wang et al., 1993a). Although (Proline) 13  is interrupted at 
two positions by alanine residues, these are related to proline by only a single change 
in the nucleotide sequence i.e. CCN to GCN. This may be due to a selection for a 
functional domain as proline homopolymer domains have their maximum effect in 
vitro at 10 residues long (Gerber et al., 1994). 
From the Chou and Fasman structure prediction plots no structure is predicted 
for (Proline)13 and (Proline)4 (Appendix B). Studies on polyproline in solution have 
found that two structures, type I and type II helices can be formed, dependent on 
whether the a carbon is in the cis or trans conformation (Mandelkern 1967). 
Therefore in WTI these sequences may be forming this rigid rod type of structure if 
exposed to the solvent on the surface of the protein. The observation that WTI 
protein can exist with or without (in the chick) the (Proline)13 sequence but without 
any other large sequence changes suggests that there is a certain degree of structural 
flexibility in this region. This would suggest a surface location, as seen for this type of 
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helix in other globular proteins (Adzhubei and Sternberg 1993). Therefore in 
mammals it may be involved in the type of protein-protein interactions seen with other 
proline rich sequences e.g. SH3 target binding sites, which have been shown to have a 
proline type II helix (Yu et al., 1994). The function of (Glycine)5 is unknown. 
Glycine having no side chain is the residue with the greatest propensity for rotation 
and therefore this region may be expected to be flexible, which is consistent with the 
prediction of a high level of probability of a 0 loop in this region (Appendix B). 
Why these regions have been conserved in mammals but not in birds may only 
be revealed by a comparison of the in vivo interactions made by the transregulatory 
domain with other proteins. It could be that there are other changes in the proteins 
with which it associates which compensate for the WTJ differences. Another 
possibility is that the insertion or deletion event which produced the difference in 
(Proline) 13  is not as deleterious as substitutions occurring in this region so the region 
can be wholly conserved or not at all. 
7.3.3 Conservation of the putative leucine zipper 
At the C-terminal end of the transregulatory domain there is a putative leucine 
zipper. This has been proposed to be the means by which WTI protein molecules 
could dimerise. It is of particular interest because it is thought that the DDS 
phenotype arises as a result of a dominant-negative mutation, with the mutant WT1 
possibly interacting with wild type WTI through this domain. The conservation and 
lack of helix breaking prolines in all species would support the existence of leucine 
zipper. In conflict with this, structure prediction algorithms do not predict the 
presence of a coiled coil (leucine zipper) in this region. Therefore it may be that 
interaction of WT1 protein molecules, leading to a dominant-negative phenotype, 
occurs in a different manner. 
7.4 A region of WTI with species-specific function? 
The most variable region between the orthologs is located in exon 6, 
immediately adjacent to a perfectly conserved region. Comparison of the chick and 
alligator orthologs reveals throughout the protein that the same positions are often 
substituted when compared with mammalian WTI. N-terminal to exon 6, the amino 
acids found at these substituted positions are often different in chick and alligator, 
which points to flexibility of the sequence in this region. In the highly substituted 
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region of exon 6 substituted amino acids are almost identical in chick and alligator. 
This suggests that some selection may be acting on this region which is different in the 
two lineages i.e. the sequence difference did not arise from sequence drift due to lack 
of function but a change in functional properties. This region is adjacent to the l7aa 
alternative splice (exon 5) which has not been detected in chick or alligator. This 
region is thought to have a function in the human for several reasons. A mutation in 
this region was found in a benign mesothelioma and is associated with a change in 
transrepression activity (Park et al., 1993a). In the same Wilms' tumour cell line that 
excluded exon 2 from transcripts, exon 5 was also not included, suggesting a role for 
exon 5 in tumorigenesis (Haber et al., 1993). Also the inclusion of exon 5, converts 
the +KTS isoform of WD from a weak repressor into a strong repressor of WD 
transcription in vitro (Rupprecht et at., 1994). 
Species differences in regulatory genes are very important in development as 
they may be the source of species-specific features. The genitourinary system in 
which WTI is expressed has many specialisations within the vertebrates; the most 
obvious of these being the development of the metanephros. In addition there are 
differences between classes in the organisation of the genital and urinary ducts. In 
particular the female genital ducts become highly specialised for viviparity and 
oviparity. Therefore the changes in exons 5 and 6 may give rise to subtle changes in 
WTI activity, which then plays a part in developmental variations in the intermediate 
mesoderm. 
7.5 Selection of alternative splice sites 
The conservation of the KTS alternative splice agrees with its importance as 
suggested by human mutation analysis. The importance of the + and - KTS isoforms 
being present at the correct ratio is underlined by the observation of two independent 
heterozygous mutations at the alternative splice site in DDS patients which completely 
inhibits the inclusion of this sequence. The perfect conservation of the zebrafish 
intron in the region adjacent to the alternative splice donor sites at the end of exon 9 
which results in the inclusion of the KTS sequence, points to the context of a 
sequence influencing splice site choice. This seems to apply even when the two sites 
are only 9 bases apart, significantly this is almost one turn of the B-DNA helix. The 
mechanism by which alternative splicing occurs is unknown but it is thought to be 
closely related to constitutive splicing, the main elements of which are the snRNPs 
(small nuclear ribonucleoprotein particles) and the SR proteins (these contain 
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alternating serine and arginine residues in the C-terminal domain). There are several 
evolutionary conserved SR proteins, although the presence of only one seems to allow 
splicing to occur. Therefore the recruitment of different SR proteins may affect the 
splice site chosen (Zahier et al., 1993). It may be that the sequence of intron 9 is 
conserved to favour the binding of particular SR proteins. The situation is 
complicated as there seem to be multiple ways by which a transcript can be 
alternatively spliced (McKeown 1992). 
The conservation of the KTS alternative splice is consistent with information 
from other genes. Alternative splicing is found in many developmentally important 
transcription factors, in PAX6 the same alternative splices have been detected in 
human as in quail (D. Englekamp personal communication) and the alternative splice 
5a which inserts l4aa in the paired domain is identical in mouse and zebrafish (Glaser 
et al., 1992). In max (a protein that dimerises with c-myc) the same alternative splice 
is seen in zebrafish and in human (Schreiber-Agus et al., 1993). 
To try to understand why exon 5 was not present in non mammalian transcripts 
the splice sites in the cDNAs were examined. Although most of the splice site 
consensus occurs in the intron there is a bias in the first two positions in the exon. 
Some of the least typical splice sites occur around exon 5. Non-consensus splice sites 
have been implicated in alternative splicing (Jackson 1991). Therefore these 
differences may be the reason why exon 5 is excluded from transcripts in chick and 
alligator. The isolation of the relevant genomic sequences will be able to resolve 
whether the sequence of exon 5 is actually conserved outside of mammals. 
RNA editing is thought to be functionally associated with splicing as in vitro 
cross species editing sometimes results in correct editing but incorrect splicing. It 
may be that the differences in the editing of exon 6 (Section 5.2.7) and the splicing of 
exon 5 i.e. the 6bp insertion in the chick and alligator at the editing position in 
mammals and the lack of a +17aa isoform in the reptilian lineage, is in some way 
connected. The editing in rat was found to occur in a developmentally regulated 
manner and was first observed after birth when kidney development is virtually 
complete. RNA obtained for chick and alligator was only obtained from embryonic 
sources so it may be interesting to look at later stages to see if any editing could be 
detected. 
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7.6 Evolution of the zinc fingers 
The data obtained here show that the rate of evolution of the zinc fingers of 
WTJ is slow, and slower than the rest of the protein (Table 5.5). This is in agreement 
with evolutionary analysis of other zinc finger genes. The comparisons of Krox 20 
and Krox 24 (EGR2&EGR1) (human to fish) (Lanfear et al., 1991, Oxtoby and 
Jowett 1993); snail (mammals to Drosophila) (Sommer et al., 1992, Hammerschmidt 
and Nusslein-Voihard 1993); ZFY family (mammals to birds) (Lanfear and Holland 
1991), Kruppel and hunchback (arthropods) (Sommer et al., 1992) show a pattern of 
substitution very similar to that obtained for WT1. The conservation between runs of 
fingers and homologous fingers has been analysed statistically (Jacobs 1992) and the 
substituted positions closely resembled the ones found in this study i.e. mostly 
between the two cysteines or the two histidines or after the second cysteine but not at 
the 'tip' of the finger. The pattern of substitution would suggest that the WTI 
orthologs retain the same DNA binding consensus sequence as human WTJ. 
Although variability is limited to regions of no known function, other positions for 
which no function is known were also found to be invariant. At these positions 
mutations have not been observed and they are not conserved in the EGR fingers. 
The lack of mutations of these sites could arise from the rarity of WT1 mutations, 
most occurring at CpG dinucleotides. Mutations at the invariant sites could be 
deleterious enough to be selected against but do not produce abnormalities that have 
been investigated. The fact that these residues are not present in the EGR zinc fingers 
but are conserved in WT1 would suggest that these residues are acting to modify the 
properties of the fingers thereby making the DNA sequence specificity of WT1 subtly 
different from that of EGR1 and 2. 
Families of similar zinc fingers are now being recognised such as the Kox and 
Fax families (Nietfield et al., 1993, Tunnacliffe et al., 1993). The latter have similar 
zinc fingers but also contain the Fax motif. They are found in clusters in the 
vertebrate genome indicating that they have probably arisen by duplication of an 
ancestral gene. WTJ belongs to the EGR family by virtue of the similarity of its 
fingers; this family includes EGR1 (Sukhatme et al., 1988), EGR2 (Joseph et al., 
1988), EGR3 (Patwardhan et al., 1991), and EGR4 (Crosby et al., 1992). These have 
three fingers, ZF1 and ZF3 having a very similar consensus sequence in the DNA 
binding region (type 1) while ZF2 is slightly different (type 2) (Figure 1.2c). WTI 
fingers 2-4 are very similar to the EGR fingers in the DNA binding region but WT1 
has an extra zinc finger (type 3) which is most similar to the first finger in the Spi 
family. The Spi family are a set of genes which also have three fingers, similar to the 
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first three fingers of WTI. This includes Spi and Sp2 (Kadonaga et al., 1987, 
Kingsley and Winoto 1992), SPR-1 and SPR-2 (Hagen et al., 1992), Drosophila 
buttonhead (Wimmer et al., 1993), and rat BTEB (Imataka et al., 1992). The EGR-
like second and third fingers are slightly different in that the first predicted backbone 
contacting residue is a lysine not an arginine, but this is a conservative substitution of 
one amino acid with a basic side chain for another. The type 1 finger is also found in 
two yeast genes, MIG1 in Saccharomyces cerevisiae (Nehlin and Barnes 1990) and 
Cre-A in Aspergillus nidulans (Dowzer and Kelly 1991). Both genes are involved in 
the regulation of catabolite metabolism and have two zinc fingers in tandem, the 
second one resembling the type 1 finger. 
The evolutionary relationship between these fingers is unknown; it is not clear 
whether it is due to homology arising from a common ancestral gene or whether the 
similarity has arisen as a result of adaptive changes producing convergent evolution 
for GC rich DNA binding sites. The most striking resemblance is not the homology of 
the individual fingers but the way in which the different fingers are in a similar order. 
Amongst these genes, for which the genomic structure is known, WTI is unique in 
having each finger in a separate exon as opposed to the others where the fingers are in 
a single exon. The intron/exon junctions occur at the same position in each finger of 
WTI and in the same phase, specifically within the glycine of the linker region. This is 
a similar genomic structure to that of TFIIIA in Xenopus (Miller et al., 1985, Tso et 
al., 1986), where all nine fingers are in separate exons with neighbouring fingers 
having similar exon junctions. From this arrangement it has been proposed that these 
fingers arose by duplications of an initial exon, as seen in other independent structural 
motifs such as kringles and growth factor domains (Patthy 1985). The process by 
which these modules of structure are duplicated and moved around is known as exon 
shuffling (Doolittle 1981). It has also been proposed that these genes have given rise 
to other genes with multiple fingers per exon (El-B aradi and Pieler 1991). This could 
have occurred by loss of introns or by reverse transcription of the mRNA transcripts 
and integration into the genome. Reverse transcription is a not an uncommon event, 
with the amount of the vertebrate genome produced by reverse transcription events 
estimated to exceed 10% (Temin 1985). 
Therefore is WTI ancestral to the EGR or Spi families? No similarities between 
WTI and the EGR or Spi families are found in addition to the homology of the zinc 
fingers. Whereas within the Spi and EGR families further homologous regions have 
been observed in the transactivation domain (Crosby et al., 1992, Wimmer et al., 
1993). Therefore if they are related to WTI by ancestry there has been a complete 
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divergence of the rest of the gene or the gene was only partially duplicated. For WTI 
to be the ancestral sequence it would have to have evolved far earlier than so far 
detected as the Spi homolog buttonhead has already been described in Drosophila. 
Intense search for, isolation and comparison of more orthologs will answer this 
question. The total genome sequencing programs that are underway in several species 
will permit the presence or absence of these genes to be definitively determined and 
provide information about the origin of these genes. 
Convergent evolution may have been a major determinant of the similarity 
between these genes (Doolittle 1994). This could be a result of the limitations 
imposed on the sequence of the fingers by the fairly rigid structure holding it together 
and their interaction with a very invariant structure i.e. DNA. Database searching for 
TFIIIA -like fingers shows that the residues in common between the WT1, EGR, and 
Spi fingers are very common in other fingers. This supports the fact that there are 
only a limited number of options allowing DNA binding. These similarities combined 
with the number of reported fingers (1340 in 1992, Jacobs 1992) means that many 
fingers may appear related but are not. Then again, it may be speculated that all 
fingers are related as they all may have arisen from a single ancesJ finger. This 
ancestral finger probably arose after the divergence of pro- and eukaryotes, as only 
eukaryotes have been found to contain the TFIIIA -like zinc fingers. 
7.7 Conservation of expression of the WTI gene in the intermediate mesoderm 
PCR and Northern blot analysis of pig, chick, alligator and Xenopus RNA from 
the intermediate mesoderm derived organs revealed expression of WTI. This 
demonstrates that in addition to the conservation of WT1 at the level of protein 
sequence there is also conservation in the pattern of gene expression. This would 
indicate that at least part of the function of WTI has been conserved in mammalian, 
reptilian and amphibian lineages. In the case of Xenopus, WTI expression in whole 
tadpole and mesonephros were compared. It was found that WTI expression was 
only detectable in the mesonephric RNA. This would suggest that expression is 
specific to the mesonephros. Unfortunately the samples compared were not from the 
same stages, so the presence of WTI could correspond to a general up-regulation of 
expression in the embryo, but it is more likely that it is due to localisation of WTI in 
the differentiating kidneys. 
In pig, chick and alligator the size of WTI transcript was found to be conserved 
when compared to human and mice. In Xenopus the size of the mRNA transcript had 
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increased to 5kb. Until a more complete Xenopus WT1 cDNA is cloned it will not be 
known whether this is due to a change in the coding or non coding regions. 
In chick an additional 2kb transcript was also seen; its identity is unknown. 
Interestingly a smaller 2.5kb testis specific transcript has been detected in mouse and 
human (Pritchard-Jones et al., 1990, Pelletier et al., 1991c), and also in the 
developing rat kidney (Sharma et al., 1992). Only the full length RNA was detected 
in pig testis of an equivalent age to when smaller transcripts are detected in mouse and 
human. In the chick in the mesonephric RNA alone no second transcript was detected 
so the small transcript may be gonad specific (Figure 6.1). The origin and functional 
importance of these smaller transcripts is not known; they may not be essential 
products in all species and could be transcriptional artefacts. These may result from a 
high level of transcription initiation with a second cryptic promoter being used or they 
maybe produced by the use of the stronger polyadenylation signal located in the 3' 
untranslated region in all species examined (Section 5.2.11). 
7.7.1 Urinary system 
In both the chick and alligator, expression of WT1 was detected by in situ 
hybridisation in the developing genitourinary ridge and localised to the developing 
nephrons. This demonstrates that there is a role for WTI in nephrogenesis outside of 
the mammals. Consistent with a role in the earliest differentiation of the nephrons, the 
expression of WTI in chick is observed with the onset of mesonephric differentiation. 
The conservation of expression suggests that Wilms'-like tumours in other species 
(such as pig, rat, chick and Japanese eel) could also result from loss of WT1 function 
disturbing nephrogenesis. This may now be investigated by looking in these tumours 
for overexpression of WD and mutations, both of which occur in human tumours. 
This will permit the proportion of WTI mutants found to be compared to the 10% 
incidence seen in human sporadic tumours. Wilms'-like tumours can be 
experimentally induced in many vertebrates, so that a greater number of tumours, as 
compared with the relatively few human cases, can be analysed. Therefore do these 
treatments affect the WT1 gene or another WT locus? Another unresolved issue is the 
relationship of WTI with novC, the IGF1 binding protein-like gene implicated in chick 
virally induced tumours (Joliot et al., 1992). Is this gene in the same pathway as 
WTJ, either upstream or downstream? 
Wilms' tumours are just one of many kidney diseases (Mierau et al., 1987). The 
involvement of WT1 in other kidney malfunctions, apart from the nephropathy seen in 
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DDS, is not known. The role of WTI in other conditions can now be investigated. 
As suggested earlier constitutional mutations of WTI in regions apart from the zinc 
fingers may produce different phenotypes. Rats are thought to be a considerably 
better model for kidney development and Wilms' tumour, as Wilms' tumours are seen 
in rats, but not in mice. Currently RWT1 is being used to investigate WTI expression 
in the postnatal rat, with the specific aim of seeing whether there are changes in WTI 
expression in pathological states known to be associated with changes in renal 
growth. Kidney infection in early life (infantile pyelonephritis) which can interfere 
with renal growth can lead to permanent kidney damage, and is the greatest cause of 
kidney failure in later life. Preliminary results suggest that WTI expression is affected 
on infection, so that modulation of WT1 activity on infection may help to avoid the 
permanent damage (E. Ostlund, Karolinska Hospital, Sweden). 
7.7.2 Gonads 
In stage 20 alligator gonads, just preceding the onset of sexual differentiation 
(stage 21-22 testis and stage 22-23 ovary), WTI expression was detected by Northern 
blotting and PCR. Expression appeared to be at approximately the same levels at 
both male and female producing temperatures. In mammals the indifferent gonad also 
expresses WTI. 
The processes that lead to gonadal sex determination in vertebrates seem to be 
highly variable: sex can be determined genetically, environmentally or a mixture of 
both. Mechanisms can vary within classes. In mammals it is the presence of the Y 
chromosome carrying the SRY gene which leads to the development of the male 
phenotype. SRY is also known as TDF (testis determining factor) because it is the 
differentiation of the testis from the indifferent gonad which is important in sex 
differentiation, and which SRY controls. Therefore is WTI functionally related to 
SRY? WTI is important for gonad development in both sexes, homozygous deletion 
of WTJ in mice (Kreidberg et al., 1993) results in an inability to form gonads, as 
opposed to the sex reversal seen when SRY is deleted. WTI is expressed from the 
earliest stages of genital ridge development i.e. in the 9 dpc mouse (Armstrong et al., 
1992) and is followed by SRY expression at 10.5 dpc (Koopman et al., 1990). 
Putative WT1 binding sites have been reported in the SRY gene promoter (Behike et 
al., 1993) suggesting that WTI could lie upstream of SRY (Bogan and Page 1994). 
The localisation of WTI expression in males to the Sertoli cells, which are important 
for sex determination, further suggests this. WTI however appears not to affect 
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primary sex determination but it can perturb secondary sex determination. In humans 
changes in dose (WAGR) or activity (DDS) of WD lead to genitourinary 
abnormalities; these are likely to be due to disturbances in the development of the 
gonad which affects hormone production on which secondary sex determination is 
dependent. 
In alligator sex determination is thought to be wholly temperature dependent. 
In males sexual differentiation of the gonad occurs during the temperature dependent 
stage, and in females just afterwards (Ferguson and Joanen 1982). Testis 
determination, similarly to mammals, is thought to be dependent on Sertoli cell 
differentiation (Ferguson and Joanen 1982, Smith and Joss 1993). In alligators many 
HMG-box containing genes including SOX genes have been identified but not an SRY 
ortholog (Coriat et al., 1993). SRY is known to be evolving at a much faster rate than 
expected when compared with other genes (Tucker and Lundrigan 1993, Whitfield et 
at., 1993) suggesting that SRY may be involved in sex determination only in mammals. 
Mammalian gonad development is known to differ from other vertebrates. In 
mammals gonadal sex reversal is very rare, but in other vertebrates this is seen to 
occur much more frequently e.g. intersexes in amphibians, temperature sensitive 
reversal of genetic sex in axolotl (Dournon et al., 1990) or by exogenous hormonal 
disturbances e.g. chicken (Elbrecht and Smith 1992) and alligator (Lance and Bogart 
1991&1992). This may suggest that in other vertebrate classes the production of 
steroid hormones in development may have a greater capacity to influence gonadal 
sex determination. It is known that steroid hormones can be produced in very early 
gonadal cells (Haffen 1970). The conservation of WTI in alligators and chick makes 
it likely that its role in early gonad development, and therefore in the hormone 
producing cells, is conserved. Therefore it is possible, in some species at least, that 
WTI plays a role in sex determination. The WD alligator ortholog is being used as a 
tool to probe early differentiation, first as a gonadal marker and maybe subsequently 
to isolate the genes involved in temperature dependent sex determination (AM Coriat, 
Guy's Hospital, London). One of the other sub-classes in which sex determination is 
being investigated is the metatheria (marsupials). This is because this sub-class shows 
most of the features of mammalian (eutherian) sex determination i.e. a testis 
determining Y chromosome, but also some effects of X chromosome dosage (Graves 
1987). Therefore metatheria probably separated from the eutheria as the Y 
chromosome/SRY system of sex determination was evolving. Again in marsupials the 
predicted protein sequence of WTI is highly conserved indicating that the mechanisms 
that control early gonad development maybe similar to those in eutherian mammals. 
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7.8 Additional sites of expression 
Similarly to mouse and human, sites of WTI expression in alligator were 
observed outside of the intermediate mesoderm, in derivatives of the lateral plate 
mesoderm and the ectoderm i.e. the limbs, body wall, heart, vitelline veins, and 
hindbrain. In the mouse expression has been observed in the lateral plate mesoderm, 
specifically the musculature of the body wall, and in defined areas of the developing 
spinal cord and brain (Armstrong et al., 1992). The expression in the heart is 
probably a result of the surrounding mesothelium expressing WTI. The viteffine veins 
contain endothelial lining cells which are a type of epithelium that differentiate from 
the angioblastic mesoderm, derived from the splanchic mesoderm. These cells also 
undergo a mesenchymal-epithelial transition which may explain why WTJ is detected 
(Balinsky 1981). These cells in mammals have not been observed to express WTI but, 
like podocytes, a major site of WTI expression, they are a subset of epithelia with 
special permeability properties. These results indicate that WD expression may not 
be limited just to the intermediate mesoderm. The importance of most of these 
expression sites of is not known. No defects have been reported in the Wri knockout 
mouse, in the limbs or body wall (Kreidberg et al., 1993). This may be because either 
that there is a species difference, or a redundancy of function in the developmental 
pathway, or that defects were too subtle to observe, or an effect of genetic 
background. In all these cases further detailed analysis of WTI expression in 
histological sections will or will not confirm the preliminary results above. If 
expression is seen, detailed localisation will be informative. 
7.9 WTI and limb development 
The expression of WTJ in the alligator limbs is of interest because of the known 
association of limb and genitourinary deformities in several species (e.g. human, 
mouse and axolotl). This implies that in these species there may be similarities 
between these systems. The WT1 expression in the limb buds has not been reported 
before. That it is a bona fide result in alligators is suggested by the subsequent 
localisation of the expression to presumptive wrist and armpit regions at the time of 
hand plate formation and its disappearance from the hind limbs. 
There is evidence for a connection between kidney and limb development. The 
limb buds develop in close proximity to the mesonephros, and the mesonephros is 
known to promote the normal differentiation of chick limb explants in culture, partly 
due to the production of IGF1 (Geduspan and Solursh 1993). The limb buds are 
212 
produced by an initial proliferation of the lateral plate mesoderm beneath the 
epidermis, cells then condense and transform into chondrocytes to produce the 
skeletal elements (Gilbert 1991). It is thought that the muscular and dermal elements 
are contributed the somitic mesoderm (Balinsky 1981). The differential 
morphogenesis of the fore and hind limbs is thought to arise as a result of the action 
of regulatory factors in the control of processes common to all four limbs, such as 
fibronectin accumulation and mesenchyme condensation, but these are differentially 
regulated in the limbs (Downie and Newman 1994). The expression of WTI in only 
the fore limb may reflect a role in this. 
Several genes have been found to be expressed in both lateral plate and 
intermediate mesoderm derived structures, specifically in the developing limbs and 
kidneys. The bone morphogenetic protein BMP-2 is expressed in the mesonephros 
and the nephric duct (C. Tickle personal communication) as well as in the limb buds, 
tooth buds, and craniofacial mesoderm (Lyons et al., 1990). The BMP family were 
originally isolated due to their inductive capabilities in bone formation and belong to 
the TGF-P superfamily. The TGF-P family is also known to be expressed in the 
developing kidneys (Hammerman et at., 1992). BMP-2 is now thought to have a 
wider role than just osteogenesis, being important in mesenchymal-epithelial 
interactions, like those required for kidney formation (Rosen and Thies 1992). The 
presence of bone in Wilms' tumours could therefore be due to the nephrogenic cells 
responding to the presence of BMP-2 when the normal developmental pathway is 
disrupted. 
Ld (limb deformity) mice were produced by the disruption of a gene due to the 
insertion of a c-myc transgene and have deformed limbs and renal aplasia (Woychik et 
at., 1990). The gene affected is the formin gene and its expression in mouse and 
chick has been studied. In the chick, the gene is expressed in the pronephros, in the 
developing tubules and the glomeruli of the mesonephros (Trumpp et al., 1992). The 
protein is detectable in the limb bud as it differentiates, and the expression becomes 
concentrated in the condensing mesenchymal cells destined to form the long bones 
and digits. In addition to those sites affected by disruption of the gene, expression is 
seen in the notochord, floor plate and ventral horns of the developing chick neural 
tube. The latter includes the small region in the spinal cord seen to express WTI in 
mouse (Armstrong et al., 1992). 
There is another mutation whose effect seems to be localised to the 
genitourinary system and the limbs. This is the short toes (s) mutation in the Mexican 
axolotl (Ambystoma mexicanum). This homozygote lethal mutation results in renal 
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aplasia which seems to affect mainly the glomeruli, which are reduced in number or 
absent. There is also an overall disorganisation of the kidney structure. At the 
molecular level there is known to be a defect in the disposition of laminin A chain 
which is randomly distributed in mutants but localised to the basement membrane in 
wild type kidneys (Washabaugh et al., 1993). Laminin A chain production is thought 
to play a role in the conversion of the mesenchyme to epithelia in the kidney because 
it is first detected at the earliest stages of nephron development (Ekblom 1989). The 
mutation also affects the development and regeneration of the limbs but not of the 
tail. Differences in laminin A chain deposition have also been observed in mutant 
limbs (Del Rio-T,nis et al., 1992). The investigation of a possible role for WTI has 
been greatly facilitated by the isolation of the axolotl WTI gene (P.A. T,nis personal 
communication). Expression patterns in the mutant and wild type are now being 
examined (K. Del Rio-Tsonis personal communication) and mutational analysis of the 
gene is also planned. 
It may be that the similar set of genes expressed in the limb, kidneys and the 
CNS reflect a similarity in the developmental decisions and morphological changes 
being made in the cells. The crocodilia, to which alligators belong, closely resemble 
the primitive archosaurs from whic1e'{les, birds, and mammals evolved. It may be 
that WT1 expression in the limbs is a feature which has been lost in subsequent 
evolution of vertebrates. The patterning of the limb bud is due to the ZPA (zone of 
polarising activity located in the posterior region of the limb bud). This can be 
mimicked by notochord which is involved in patterning of the mesoderm (Ingham 
1994) and is thought to play a role in determination of the urogenital ridge (Etheridge 
1969). Therefore WT1 expression may be elicited in both the limb and the 
intermediate mesoderm because the same spectrum of transcriptional regulators are 
present in both. 
7.10 Evolution of the vertebrate kidney and WTI 
One of the major reasons for isolating the WT1 orthologs was to compare WTI 
functionally and structurally in the context of the evolution of the vertebrate kidney. 
The two major evolutionary innovations have occurred in the vertebrate kidney. First 
came the initial evolution of the nephric system, probably pronephros-like, at about 
the same time that the vertebrates appeared. The second was the formation of the 
ureteric bud and hence the metanephros at about the same time as the appearance of 
the reptiles. The mechanisms which underlie these changes are unknown. The 
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expression of WTI in the mesonephros of amphibians demonstrates that the 
mesonephros of anamniotes and amniotes have similarities at the molecular level. The 
molecular basis for the degeneration of the mesonephros in amniotes but its retention 
in anamniotes is also unknown. WT1 missense mutations are involved in the 
degeneration of the glomeruli in DDS, therefore it may be that WTI is somehow 
involved in the normal degeneration process. The further investigation of Xenopus 
WTI will allow these questions to be answered. 
The origin of the vertebrate genitourinary system is not known. In non-
vertebrate chordates (i.e. those species with a notochord but no backbone) no 
nephrons or kidneys have been found; in fact the whole region corresponding to the 
intermediate mesoderm is not present. In the non-vertebrate chordates other methods 
of excretion are used such as nephridia (amphioxus) and storage kidneys (ascidia). It 
is thought that coelomoducts, i.e. mesodermally derived ducts which can lead from 
the coelom, could be the precursors of the nephrons as these are very similar to the 
nephrotomes seen in association with external glomeruli. These ducts are observed in 
many phyla (Barnes et al., 1993). The one coelomoduct found in amphioxus, 
Hatscheck's pit, develops in the region, at the border of the lateral plate and segmental 
(somitic) mesoderm, the location of the intermediate mesoderm in vertebrates (Grove 
and Newell 1953). Therefore how did the intermediate mesoderm evolve and how did 
the differentiation of genitourinary system come about? All these structures basically 
develop from the differentiation of tubules in this region which would suggest that this 
was an initial development. 
The specification of the vertebrate mesoderm is being unravelled. In the 
anterior-posterior direction the domains of expression of the Hox genes is thought to 
be important. These may be the factors controlling the extent of nephric 
differentiation and degeneration along the urogenital ridge, as many Hox genes are 
expressed in the kidney and its precursors (Bard and McConnell 1994). The dorsal-
ventral axis is best understood in Xenopus: there is an initial dorsal-ventral 
specification where the dorsal vegetal pole induces the notochord and muscle and the 
ventral vegetal pole induces blood, mesenchyme and mesothelium. There is then 
thought to be a dorsalising signal (Dale and Slack 1987) which induces the formation 
of the intermediate mesoderm types, including the pronephros (Lettice and Slack 
1993). In the chick, from fate maps, the lateral plate and somatic mesoderm give rise 
to the intermediate mesoderm (Lear 1994). At the molecular level the genes involved 
are just beginning to be isolated, i.e. BMP-4 (Dale et al., 1992) and Xwnt8 (Christian 
and Moon 1993) have both been shown to have ventralising activity, and goosecoid 
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has a dose dependent dorsalising activity (Niehrs et al., 1994). In contrast very little 
is known about axial-paraxial specification. During evolution it would not be hard to 
imagine that shifting the expression boundaries of one of the genes involved in these 
specifications may have taken place and so allowed an additional domain to be 
formed. 
With the increase in molecular and morphological evolutionary data, the 
question of how morphological and molecular evolution are related is able to be 
addressed. Throughout the vertebrates, the association of WTI with a typically 
vertebrate structure raises the question of whether WTJ arose around the time of 
vertebrate evolution and was a key to the initiation of kidney evolution. WTI is 
expressed during the differentiation of the coelomic epithelium into mesothelium, the 
gonads, and the nephrons; specifically during the transition from mesenchyme to 
epithelia in these tissues. The chordates belong to the deuterostomes, which are 
distinct from the protostomes. In the deuterostomes coeloms are derived as 
invaginations of the gut, in the protostomes coeloms are formed by splitting of the 
mesoderm (Gilbert 1991). Therefore WTI may be associated with coelomic 
development in all deuteromes. The amplification by PCR of a non-vertebrate 
chordate (ascidian) WTI gene was attempted but was not successful. The information 
on the vertebrate sequence may be useful in achieving this. 
The mesenchymal to epithelial cell type change was originally thought to be 
unusual (Pritchard-Jones et al., 1990) but it is found in many systems. WTI is known 
to be involved only in some of the transitions in mouse development (Armstrong et 
al., 1992). One developmental event in which the transition is being characterised is 
the differentiation of the mid gut of Drosophila (Tepass and Hartenstein 1994). The 
endodermal midgut precursors are induced to become epithelial by their interaction 
with the adjacent visceral mesoderm. This is especially interesting considering the 
relationship of the deuterostome coelom to the gut and it recently been proposed that 
there may be conserved elements in gut development of invertebrates and vertebrates 
due to the similar expression of rat HNF-4 and its Drosophila homolog (Zhong et al., 
1993). Therefore if a Drosophila WTI ortholog was sought this may be the best 
place to start looking. This of course is speculation but recent data to some extent 
has hinted that evolutionary distant systems may have a similar molecular basis. This 
in particular has been found in the resemblance in the pattern specification genes, i.e. 
the expression patterns of the hedgehog genes in vertebrate and to the 
hedgehog gene in Arthropoda (Ingham 1994). There are now reports of the 
conservation of gene expression in structures with similar functions but distinct 
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evolutionary origins e.g. the expression of PAX6 in the vertebrate eye and brain and in 
the sensory cells of the anterior region of C. elegans (Chisholm and Horovitz 1994, 
Dawkins 1994). This could be a by-product of genes being activated in similar 
regions, due to similar patterning mechanisms in these diverged species. These genes 
may have been co-opted later into specialised structures in a similar region. Therefore 
this raises the question is WT1 involved in the formation a the functional homolog of 
the kidneys; the gut derived Malpighian tubules of insects? 
7.11 The origin of WTI 
In the evolutionary comparison of species and genes the question that arises at 
the same time as "why a gene has evolved?" is "how has it evolved?". One of the 
major ways that molecular evolution is thought to occur is by gene duplication. 
Duplication leads to the release of one copy from selection pressure. In many cases 
this will lead to the loss of function of one copy, as evidenced by the presence of 
unprocessed pseudogenes, but in other cases before function is lost a separate role for 
the second gene may be acquired and subsequently selected for. The increase in 
genetic information may then favour the acquisition of new characteristics. The most 
well known example is the duplication of the homeobox gene clusters that seems to 
have occurred around the time of chordate and vertebrate evolution (Pendleton et al., 
1993). The origin of WTI is not known. Using current technology there are no 
detectable homologies to any other genes outside the zinc fingers. Knowledge of the 
tertiary structure of the transregulatory domain may allow identification of structural 
homologies when sequence homology is lost, as is now happening with the protein 
structures of enzymes (Burley 1994). Only a limited number of protein folds have 
been detected in the enzymes suggesting that it is far easier to modify an existing fold 
rather than to create a new one. The presence and position of introns between the 
zinc fingers of WTI leads to the suggestion of exon duplication having given rise to 
these. If this is the case then there may exist in more diverged species WTI orthologs 
that have 3, 2 or even a single finger. Again the sequence analysis of whole genomes 
will allow the presence or absence of WTI to be unequivocally determined. 
7.12 Future work 
This project has only just begun the evolutionary analysis of WT1. It can now 
be extended at the structural, functional and expression levels. The immediate aims 
must be to consolidate this work by isolating complete sequences for the anamniotes, 
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giving greater depth to the comparison particularly in the transactivation domain and 
also to define exactly the cell types expressing WT1 in whole-mount in situ 
hybridisation. The apparent conservation of nephrogenesis and nephroblastoma and 
the conservation of the WTI sequence and expression pattern suggest that study of 
WTI across the vertebrates will be an appropriate method for understanding WT1 
function in development and in Wilms' tumours. There are several projects that have 
been referred to above, in which the expression of WTI in various species is being 
investigated. In the future it will be particularly desirable to perform whole-mount in 
situ on the zebrafish, as these embryos are transparent and therefore particularly good 
for investigation of internal structures, especially as then it will be possible to fulfil the 
aim of looking at the pronephros and external glomeruli. The existence of a Wt] 
knockout mouse means that it is possible test whether these orthologs are functional 
in a different species by rescuing the lethal phenotype or perhaps more interestingly, 
there may be partial rescue. Also, would the introduction a WTI ortholog affect 
extent of differentiation and degeneration of the urogenital ridge. This would also test 
whether the unconserved regions are truly non-functional. One of the newest model 
organisms is the pufferfish (Fugu) which is known to have a genome one seventh of 
the size of the human genome, and genes are thought to cover correspondingly 
smaller genomic regions. Isolation of whole genomic regions of genes from pufferfish 
and introduction into other species would be a much simpler task than using 
orthologous genes from other vertebrates (Brenner et al., 1993). This is now being 
pursued with the isolation of a WTI PCR clone for zinc fingers 1-3, which is three 
times smaller than the region in human and zebrafish (S. Macrae personal 
communication). 
Finally the in vitro characterisation of WTI function may be facilitated by 
comparing the actions of the different orthologs. This may be useful in defining the 
important regions of the transregulatory domain, especially with reference to the 
homopolymer domains. 
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A Final Evolutionary Comparison 
5har: 




Sequences of WTI orthologs 
The sequences of WTI orthologs obtained in this study are shown as well as the 
published human, mouse and rat sequences. 
Where PCR clones were obtained in addition to library clones the region obtained by 
PCR is indicated. 
For the genomic sequence obtained from zebrafish the predicted exons are shown in 
bold and the predicted cDNA sequence also shown. 
In the 3' untanslated regions putative polyadenylation signals are highlighted 
A line-up of the nucleotide sequence of all the WT1 orthologs is also included 
(adapted from Clustal V output) 
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Human Will cDNA (Gessler et al., 1990) 
TCAAGGCAGCGCCCACACCCGGGGGCTCTCCGCAACCCGACCGCCTGTCCGCTCCCCCAC 
1 ------------------------------------------------------------ 60 
AGTTCCGTCGCGGGTGTGGGCCCCCGAGAGGCGTTGGGCTGGCGGACAGGCGAGGGGGTG 
SR Q R PH P GAL RN PTA C P L PH - 
TTCCCGCCCTCCCTCCCACCTACTCATTCACCCACCCACCCACCCAGAGCCGGGACGGCA 
61 ------------------------------------------------------------ 120 
AAGGGCGGGAGGGAGGGTGGATGAGTAAGTGGGTGGGTGGGTGGGTCTCGGCCCTGCCGT 
F P P S L PP T H S PT H P P RAG TA - 
GCCCAGGCGCCCGGGCCCCGCCGTCTCCTCGCCGCGATCCTGGACTTCCTCTTGCTGCAG 
121 ------------------------------------------------------------ 180 
CGGGTCCGCGGGCCCGGGGCGGCAGAGGAGCGGCGCTAGGACCTGAAGGAGAACGACGTC 
A 	Q 	A 	PG 	PR 	R 	L 	LA 	A 	IL 	D 	FL 	L 	L 	Q - 
GACCCGGCTTCCACGTGTGTCCCGGAGCCGGCGTCTCAGCACACGCTCCGCTCCGGGCCT 
181 ---------+---------+---------+---------+---------+---------+ 240 
CTGGGCCGAAGGTGCACACAGGGCCTCGGCCGCAGAGTCGTGTGCGAGGCGAGGCCCGGA 
D 	PAST 	CV 	PEP 	A 	S 	H 	T 	L 	R 	S 	G 	P - 
GGGTGCCTACAGCAGCCAGAGCAGCAGGGAGTCCGGGACCCGGGCGGCATCTGGGCCAAG 
241 ------------------------------------------------------------ 300 
CCCACGGATGTCGTCGGTCTCGTCGTCCCTCAGGCCCTGGGCCCGCCGTAGACCCGGTTC 
G 	CL 	Q 	Q 	P 	E 	Q 	G 	V 	RD 	PG 	G 	1W 	A 	K - 
TTAGGCGCCGCCGAGGCCAGCGCTGAACGTCTCCAGGGCCGGAGGAGCCGCGGGGCGTCC 
301 ---------+---------+---------+---------+ ---------+---------+ 360 
AATCCGCGGCGGCTCCGGTCGCGACTTGCAGAGGTCCCGGCCTCCTCGGCGCCCCGCAGG 
L 	GA 	A 	E 	AS 	A 	ER 	L 	Q 	G 	R 	R 	SR 	GAS - 
Translation Start-3 
GGGTCTGAGCCTCAGCAAATGGGCTCCGACGTGCGGGACCTGAACGCGCTGCTGCCCGCC 
361 ------------------------------------------------------------ 420 
CCCAGACTCGGAGTCGTTTACCCGAGGCTGCACGCCCTGGACTTGCGCGACGACGGGCGG 
G 	S 	E 	P 	Q 	Q 	MG 	SD 	V 	RD 	L 	N 	ALL 	PA - 
GTCCCCTCCCTGGGTGGCGGCGGCGGCTGTGCCCTGCCTGTGAGCGGCGCGGCGCAGTGG 
421 ---------+ ---------+---------+---------+---------+---------+ 480 
CAGGGGAGGGACCCACCGCCGCCGCCGACACGGGACGGACACTCGCCGCGCCGCGTCACC 
V 	PS 	L 	G 	G 	G 	G 	G 	CAL 	P 	VS 	GA 	A 	Q 	W - 
GCGCCGGTGCTGGACTTTGCGCCCCCGGGCGCTTCGGCTTACGGGTCGTTGGGCGGCCCC 
481 ---------+---------+---------+---------+---------+---------+ 540 
CGCGGCCACGACCTGAAACGCGGGGGCCCGCGAAGCCGAATGCCCAGCAACCCGCCGGGG 
A 	P 	V 	L 	D 	F 	A 	P 	P 	GAS 	A 	Y 	G 	S 	L 	G 	G 	P - 
GCGCCGCCACCGGCTCCGCCGCCACCCCCGCCGCCGCCGCCTCACTCCTTCATCAAACAG 
541 ---------+---------+---------+---------+---------+---------+ 600 
CGCGGCGGTGGCCGAGGCGGCGGTGGGGGCGGCGGCGGCGGAGTGAGGAAGTAGTTTGTC 
APP 	P 	APP 	P 	P 	P 	P 	P 	P 	P 	H 	SF1 	K 	Q - 
221 
GAGCCGAGCTGGGGCGGCGCGGAGCCGCACGAGGAGCAGTGCCTGAGCGCCTTCACTGTC 
601 ------------------------------------------------------------ 660 
CTCGGCTCGACCCCGCCGCGCCTCGGCGTGCTCCTCGTCACGGACTCGCGGAAGTGACAG 
E PS W G GA E PH E E 	CL S A F TV - 
CACTTTTCCGGCCAGTTCACTGGCACAGCCGGAGCCTGTCGCTACGGGCCCTTCGGTCCT 
661 ------------------------------------------------------------ 720 
GTGAAAAGGCCGGTCAAGTGACCGTGTCGGCCTCGGACAGCGATGCCCGGGAAGCCAGGA 
H F S G Q FT G TAG A CRY G P F G P - 
CCTCCGCCCAGCCAGGCGTCATCCGGCCAGGCCAGGATGTTTCCTAACGCGCCCTACCTG 
721 ---------+ ---------+---------+---------+---------+---------+ 780 
GGAGGCGGGTCGGTCCGCAGTAGGCCGGTCCGGTCCTACAAAGGATTGCGCGGGATGGAC 
PP 	P 	S 	ASS 	G 	Q 	ARM 	F 	P 	N 	A 	P 	Y 	L - 
CCCAGCTGCCTCGAGAGCCAGCCCGCTATTCGCAATCAGGGTTACAGCACGGTCACCTTC 
781 ---------+---------+---------+ ---------+---------+---------+ 840 
GGGTCGACGGAGCTCTCGGTCGGGCGATAAGCGTTAGTCCCAATGTCGTGCCAGTGGAAG 
PS 	CL 	ES 	Q 	PAIR 	N 	Q 	G 	Y 	ST 	VT 	F - 
GACGGGACGCCCAGCTACGGTCACACGCCCTCGCACCATGCGGCGCAGTTCCCCAACCAC 
841 ------------------------------------------------------------ 900 
CTGCCCTGCGGGTCGATGCCAGTGTGCGGGAGCGTGGTACGCCGCGTCAAGGGGTTGGTG 
D 	G 	T 	PS 	Y 	G 	H 	T 	PS 	H 	H 	A 	A 	Q 	F 	P 	N 	H - 
TCATTCAAGCATGAGGATCCCATGGGCCAGCAGGGCTCGCTGGGTGAGCAGCAGTACTCG 
901 ------------------------------------------------------------ 960 
AGTAAGTTCGTACTCCTAGGGTACCCGGTCGTCCCGAGCGACCCACTCGTCGTCATGAGC 
SF 	K 	H 	ED 	PM 	G 	Q 	Q 	G 	S 	L 	GE 	Q 	Q 	Y 	S - 
GTGCCGCCCCCGGTCTATGGCTGCCACACCCCCACCGACAGCTGCACCGGCAGCCAGGCT 
961 ------------------------------------------------------------ 1020 
CACGGCGGGGGCCAGATACCGACGGTGTGGGGGTGGCTGTCGACGTGGCCGTCGGTCCGA 
V 	P 	P 	P 	V 	Y 	G 	C 	H 	T 	PT 	D 	SC 	T 	G 	S 	A - 
TTGCTGCTGAGGACGCCCTACAGCAGTGACAATTTATACCAAATGACATCCCAGCTTGAA 
1021 ------------------------------------------------------------ 1080 
AACGACGACTCCTGCGGGATGTCGTCACTGTTAAATATGGTTTACTGTAGGGTCGAACTT 
L 	L 	L 	R 	T 	P 	Y 	S 	SD 	N 	L 	Y 	Q 	MT 	SQL 	E - 
TGCATGACCTGGAATCAGATGAACTTAGGAGCCACCTTAAAGGGAGTTGCTGCTGGGAGC 
1081 ---------+---------+---------+---------+---------+---------+ 1140 
ACGTACTGGACCTTAGTCTACTTGAATCCTCGGTGGAATTTCCCTCAACGACGACCCTCG 
C 	MT 	W 	N 	Q 	MN 	L 	GA 	T 	L 	KG 	V 	A 	AG 	S - 
TCCAGCTCAGTGAAATGGACAGAAGGGCAGAGCAACCACAGCACAGGGTACGAGAGCGAT 
1141 ------------------------------------------------------------ 1200 
AGGTCGAGTCACTTTACCTGTCTTCCCGTCTCGTTGGTGTCGTGTCCCATGCTCTCGCTA 
S 	S 	S 	V 	K 	W 	T 	E 	C 	Q 	S 	H 	ST 	G 	YES 	D - 
222 
AACCACACAACGCCCATCCTCTGCGGAGCCCAATACAGAATACACACGCACGGTGTCTTC 
1201 ------------------------------------------------------------ 1260 
TTGGTGTGTTGCGGGTAGGAGACGCCTCGGGTTATGTCTTATGTGTGCGTGCCACAGAAG 
N H T T P1 L C GA Q Y 	I H T HG V F - 
AGAGGCATTCAGGATGTGCGACGTGTGCCTGGAGTAGCCCCGACTCTTGTACGGTCGGCA 
1261 ------------------------------------------------------------ 1320 
TCTCCGTAAGTCCTACACGCTGCACACGGACCTCATCGGGGCTGAGAACATGCCAGCCGT 
R G I Q DV R R VP G VA PT L 	R S A - 
TCTGAGACCAGTGAGAAACGCCCCTTCATGTGTGCTTACCCAGGCTGCAATAAGAGATAT 
1321 ---------+---------+---------+ ---------+---------+---------+ 1380 
AGACTCTGGTCACTCTTTGCGGGGAAGTACACACGAATGGGTCCGACGTTATTCTCTATA 
SETS 	E 	KR 	P 	F 	MC 	A 	Y 	PG 	C 	N 	KR 	Y - 
TTTAAGCTGTCCCACTTACAGATGCACAGCAGGAAGCACACTGGTGAGAAACCATACCAG 
1381 ---------+---------+ ---------+---------+---------+---------+ 1440 
AAATTCGACAGGGTGAATGTCTACGTGTCGTCCTTCGTGTGACCACTCTTTGGTATGGTC 
F 	K 	L 	S 	H 	L 	Q 	M 	H 	SR 	K 	H 	T 	GE 	K 	P 	Y 	Q - 
TGTGACTTCAAGGACTGTGAACGAAGGTTTTCTCGTTCAGACCAGCTCAAAAGACACCAA 
1441 ---------+-------------------+---------+ ---------+---------+ 1500 
ACACTGAAGTTCCTGACACTTGCTTCCAAAAGAGCAAGTCTGGTCGAGTTTTCTGTGGTT 
CD 	F 	K 	DC 	ERR 	F 	SR 	SD 	Q 	L 	K 	R 	Q - 
AGGAGACATACAGGTGTGAAACCATTCCAGTGTAAAACTTGTCAGCGAAAGTTCTCCCGG 
1501 ------------------------------------------------------------ 1560 
TCCTCTGTATGTCCACACTTTGGTAAGGTCACATTTTGAACAGTCGCTTTCAAGAGGGCC 
R 	R 	T 	G 	V 	K 	P 	F 	Q 	C 	K 	T 	C 	Q 	R 	K 	F 	SR - 
TCCGACCACCTGAAGACCCACACCAGGACTCATACAGGTAAAACAAGTGAAAAGCCCTTC 
1561 ------------------------------------------------------------ 1620 
AGGCTGGTGGACTTCTGGGTGTGGTCCTGAGTATGTCCATTTTGTTCACTTTTCGGGAAG 
SD 	H 	L 	K 	T 	H 	T 	R 	T 	H 	T 	G 	K 	T 	SE 	K 	P 	F - 
AGCTGTCGGTGGCCAAGTTGTCAGAAAAAGTTTGCCCGGTCAGATGAATTAGTCCGCCAT 
1621 ------------------------------------------------------------ 1680 
TCGACAGCCACCGGTTCAACAGTCTTTTTCAAACGGGCCAGTCTACTTAATCAGGCGGTA 
SCR W PS C Q K K FAR SD EL V R 	- 
CACAACATGCATCAGAGAAACATGACCAAACTCCAGCTGGCGCTTTGAGGGGTCTCCCTC 
1681 ---------+---------+---------+---------+ ---------+---------+ 1740 
GTGTTGTACGTAGTCTCTTTGTACTGGTTTGAGGTCGACCGCGAAACTCCCCAGAGGGAG 
H NM H Q RN MT K L Q LA L * G V S L - 
GGGGACCGTTCAGTGTCCCAGGCAGCACAGTGTGTGAACTGCTTTCAAGTCTGACTCTCC 
1741 ---------+---------+---------+---------+---------+---------+ 1800 
CCCCTGGCAAGTCACAGGGTCCGTCGTGTCACACACTTGACGAAAGTTCAGACTGAGAGG 
G 	R S VS Q A A Q C V N C F Q V * L S - 
ACTCCTCCTCACTAAAAAGGAAACTTCAGTTGATCTTCTTCATCCAACTTCCAAGACAAG 
1801 ---------+---------+---------+---------+ ---------+---------+ 1860 
223 
TGAGGAGGAGTGATTTTTCCTTTGAAGTCAACTAGAAGAAGTAGGTTGAAGGTTCTGTTC 
T pp H * KG N F S * S S S S N F Q D K - 
ATACCGGTGCTTCTGGAAACTACCAGGTGTGCCTGGAAGAGTTGGTCTCTGCCCTGCCTA 
1861 ------------------------------------------------------------ 1920 
TATGGCCACGAAGACCTTTGATGGTCCACACGGACCTTCTCAACCAGAGACGGGACGGAT 
I P V L LET T RCA W K SW S L PC L - 
CTTTTAGTTGACTCACAGGCCCTGGAGAAGCAGCTAACAATGTCTGGTTAGTTAAAAGCC 
1921 ------------------------------------------------------------ 1980 
GAAAATCAACTGAGTGTCCGGGACCTCTTCGTCGATTGTTACAGACCAATCAATTTTCGG 
L L 	D S 	ALE K Q L TM S G * L K A - 
CATTGCCATTTGGTCTGGATTTTCTACTGTAAGAAGAGCCATAGCTGATCATGTCCCCCT 
1981 ---------+ ---------+---------+---------+---------+---------+ 2040 
GTAACGGTAAACCAGACCTAAAAGATGACATTCTTCTCGGTATCGACTAGTACAGGGGGA 
H C H L 	WI F Y C K KS H S * SC P P - 
GACCCTTCCCTTCTTTTTTTATGCTCGTTTTCGCTGGGGATGGAATTATTGTACCATTTT 
2041 ------------------------------------------------------------ 2100 
CTGGGAAGGGAAGAAAAAAATACGAGCAAAAGCGACCCCTACCTTAATAACATGGTAAAA 
D PS L L FL C S F S L GM EL L Y H F - 
CTATCATGGAATATTTATAGGCCAGGGCATGTGTATGTGTCTGCTAATGTAAACTTTGTC 
2101 ------------------------------------------------------------ 2160 
GATAGTACCTTATAAATATCCGGTCCCGTACACATACACAGACGATTACATTTGAAACAG 
L SW NI Y 	PG H V Y V S A N V N F V - 
ATGGTTTCCATTTACTAACAGCAACAGCAAGAAATAAATCAGAGAGCAAGGCATCGGGGG 
2161 ---------+ ---------+---------+---------+---------+---------+ 2220 
TACCAAAGGTAAATGATTGTCGTTGTCGTTCTTTATTTAGTCTCTCGTTCCGTAGCCCCC 
MV SlY * Q Q Q Q El N Q R A R 	R G - 
TGAATCTTGTCTAACATTCCCGAGGTCAGCCAGGCTGCTAACCTGGAAAGCAGGATGTAG 
2221 ------------------------------------------------------------ 2280 
ACTTAGAACAGATTGTAAGGGCTCCAGTCGGTCCGACGATTGGACCTTTCGTCCTACATC 
* IL SNIPE V S 	A A N L ES R M * - 
TTCTGCCAGGCAACTTTTAAAGCTCATGCATTTCAAGCAGCTGAAGAAAAGAATCAGAAC 
2281 ---------+ ---------+---------+---------+---------+---------+ 2340 
AAGACGGTCCGTTGAAAATTTCGAGTACGTAAAGTTCGTCGACTTCTTTTCTTAGTCTTG 
F C Q AT F K A H A F Q A A E E K N Q N - 
TAACCAGTACCTCTGTATAGAAATCTAAAAGAATTTTACCATTCAGTTAATTCAATGTGA 
2341 ------------------------------------------------------------ 2400 
ATTGGTCATGGAGACATATCTTTAGATTTTCTTAAAATGGTAAGTCAATTAAGTTACACT 
* P V P L Y 	N L K E F Y H S V N S 	* - 
ACACTGGCACACTGCTCTTAAGAAACTATGAAGATCTGAGATTTTTTTGTGTATGTTTTT 
2401 ------------------------------------------------------------ 2460 
TGTGACCGTGTGACGAGAATTCTTTGATACTTCTAGACTCTAAAAAAACACATACAAAAA 
224 
T LA H C S * E TM K I * D F F V Y V F - 
GACTCTTTTGAGTGGTAATCATATGTGTCTTTATAGATGTACATACCTCCTTGCACAA.AT 
2461 ------------------------------------------------------------ 2520 
CTGAGAAAACTCACCATTAGTATACACAGAAATATCTACATGTATGGAGGAACGTGTTTA 
D S FEW * S Y V S L * MY I pp C TN - 
GGAGGGGAATTCATTTTCATCACTGGGACTGTCCTTAGTGTATAAAAACCATGCTGGTAT 
2521 ------------------------------------------------------------ 2580 
CCTCCCCTTAAGTAAAAGTAGTGACCCTGACAGGAATCACATATTTTTGGTACGACCATA 
G GE F IF IT G TV L S V * K P C WY - 
ATGGCTTCAAGTTGTAAAAATGAAAGTGACTTTAAAAGAAAATAGGGGATGGTCCAGGAT 
2581 ------------------------------------------------------------ 2640 
TACCGAAGTTCAACATTTTTACTTTCACTGAAATTTTCTTTTATCCCCTACCAGGTCCTA 
MASS C K N ES D F KR K * GM V Q D - 
CTCCACTGATAAGACTGTTTTTAAGTAACTTAAGGACCTTTGGGTCTACAAGTATATGTG 
2641 ---------+---------+---------+---------+---------+---------+ 2700 
GAGGTGACTATTCTGACAAAAATTCATTGAATTCCTGGAAACCCAGATGTTCATATACAC 
L H * * DC F * VT * G P L G L Q V Y V - 
AAAAAAATGAGACTTACTGGGTGAGGAAATCCATTGTTTAAAGATGGTCGTGTGTGTGTG 
2701 ---------+---------+---------+---------+ ---------+---------+ 2760 
TTTTTTTACTCTGAATGACCCACTCCTTTAGGTAACAAATTTCTACCAGCACACACACAC 
K K MR L T G * G N P L F K D G R V C V - 
TGTGTGTGTGTGTGTGTTGTGTTGTGTTTTGTTTTTTAAGGGAGGGAATTTATTATTTAC 
2761 ------------------------------------------------------------ 2820 
ACACACACACACACACAACACAACACAAAACAAAAAATTCCCTCCCTTAAATAATAAATG 
C V CV C V V L C F V F * G R E F II Y - 
CGTTGCTTGAAATTACTGTGTAAATATATGTCTGATAATGATTTGCTCTTTGACAACTAA 
2821 ---------+---------+---------+---------+---------+---------+ 2880 
GCAACGAACTTTAATGACACATTTATATACAGACTATTACTAAACGAGAAACTGTTGATT 
R CL K L L C KY MS D N DL L F D N * - 
AATTAGGACTGTATAAGTACTAGATGCATCACTGGGTGTTGATCTTACAAGATATTGATG 
2881 ---------+---------+ ---------+---------+---------+---------+ 2940 
TTAATCCTGACATATTCATGATCTACGTAGTGACCCACAACTAGAATGTTCTATAACTAC 
N * D C I ST R C I T G C * S Y K IL M - 
ATAACACTTAAAATTGTAACCTGCATTTTTCACTTTGCTCTCAATTAAAGTCTATTCAAA 
2941 ------------------------------------------------------------ 3000 
TATTGTGAATTTTAACATTGGACGTAAAAAGTGAAACGAGAGTTAATTTCAGATAAGTTT 




R K K K K K?- 
225 
Mouse WEl cDNA (Buckler et al., 199 1) 
TGTGTGAATGGAGCGGCCGAGCATCCTGGCTCCTCCTCCTTCCCTGCTGCCGGCCCCTCT 
1 ------------------------------------------------------------ 60 
ACACACTTACCTCGCCGGCTCGTAGGACCGAGGAGGAGGAAGGGACGACGGCCGGGGAGA 
CV 	N 	GA 	A 	E 	H 	PG 	S 	S 	SF 	P 	A 	AG 	P 	S - 
TATTTGAGCTTTGGGAAGCTGGGGGCAGCCAGGCAGCTGGGGTAAGGAGTTCAAGGCAGC 
61 ------------------------------------------------------------ 120 
ATAAACTCGAAACCCTTCGACCCCCGTCGGTCCGTCGACCCCATTCCTCAAGTTCCGTCG 
Y 	L 	SF 	G 	K 	L 	GA 	AR 	Q 	L 	G 	* 	G 	V 	Q 	G 	S - 
GCCCACACCCGGGGCTCTCCGCAACCCGACCGCCTGCCTGCCTCCCCCTTTCCTTTTTTC 
121 ------------------------------------------------------------ 180 
CGGGTGTGGGCCCCGAGAGGCGTTGGGCTGGCGGACGGACGGAGGGGGAAAGGAAAAAAG 
A 	H 	T 	R 	G 	S 	P 	Q 	PD 	R 	L 	PA 	S 	P 	F 	P 	F 	F - 
CCCGCCCCTCCCTCCCACCCACTCATTCACCCACCCACCCAGAGAGAGGACGGCAGCCCA 
181 ------------------------------------------------------------ 240 
GGGCGGGGAGGGAGGGTGGGTGAGTAAGTGGGTGGGTGGGTCTCTCTCCTGCCGTCGGGT 
PAP 	PS 	H 	P 	L 	H 	PP 	T 	Q 	RED 	G 	S 	P - 
GGAACCCGGGCCCGCCGCCTCCTCGCCGCGATCCTGGACTTCCTCCTGTCGCAGGAGCCG 
241 ------------------------------------------------------------ 300 
CCTTGGGCCCGGGCGGCGGAGGAGCGGCGCTAGGACCTGAAGGAGGACAGCGTCCTCGGC 
G 	T 	R 	AR 	R 	L 	LA 	A 	IL 	D 	FL 	L 	S 	E 	P - 
GCTTCCACGTGTGTCCCGGAGCCGGCGTCTCAGCACACGCTCCGCCGGGAGCCCGGGTGC 
301 ------------------------------------------------------------ 360 
CGAAGGTGCACACAGGCCCTCGGCCGCAGAGTCGTGTGCGAGGCGGCCCTCGGGCCCACG 
A 	ST 	C 	V 	PEP 	A 	S 	H 	T 	L 	R 	REP 	G 	C - 
GTCCAGCAGCCGGAGCAACCTGGGGACCGAGGCCCCCGGAGCGCCTGGGCCAAGTCCAGC 
361 ------------------------------------------------------------ 420 
CAGGTCGTCGGCCTCGTTGGACCCCTGGCTCCGGGGGCCTCGCGGACCCGGTTCAGGTCG 
V 	Q 	Q 	P 	E 	PG 	DR 	G 	PR 	SAW 	A 	K 	85 - 
Translation Start-3 
GCCGAGAATCCGCAGGATCGCAGGAGCGGAGAACCGTCCGCATCCGAGCCGCACCTCATG 
421 --------------- * ----- ---------+---------+---------+---------+ 480 
CGGCTCTTAGGCGTCCTAGCGTCCTCGCCTCTTGGCAGGCGTAGGCTCGGCGTGGAGTAC 
A 	EN 	P 	Q 	DR 	R 	S 	GE 	PS 	A 	S 	E 	P 	H 	L 	M - 
GGTTCCGACGTGCGGGACCTGAACGCGCTGCTGCCCGCTGTGTCTTCGCTGGGCGGCGGC 
481 ------------------------------------------------------------ 540 
CCAAGGCTGCACGCCCTGGACTTGCGCGACGACGGGCGACACAGAAGCGACCCGCCGCCG 
G 	SD 	V 	RD 	L 	N 	ALL 	PA 	VS 	S 	L 	G 	G 	G - 
GGCCGCGGCTGCGGGCTCCCTGTGAGCGGCGCACGGCAGTGGGCGCCCGTGTTGGACTTC 
541 ---------+---------+---------+---------+---------+ ---------+ 600 
CCGCCGCCGACGCCCGAGGGACACTCGCCGCGTGCCGTCACCCGCGGGCACAACCTGAAG 
G 	G 	G 	C 	G 	L 	P 	VS 	GA 	R 	Q 	WA 	P 	V 	L 	D 	F - 
226 
GCGCCTCCGGGCGCCTCGGCTTACGGGTCGCTGGGCGGTCCCGCGCCTCCTCCCGCTCCG 
601 ------------------------------------------------------------ 660 
CGCGGAGGCCCGCGGAGCCGAATGCCCAGCGACCCGCCAGGGCGCGGAGGAGGGCGAGGC 
A P P GA SAY G S L G G PAP p p A P 
CCGCCGCCTCCGCCGCCACCCCACTCCTTCATCAAACAGGAGCCCAGCTGGGGCGGCGCC 
661 ---------+ ---------+---------+---------+---------+---------+ 720 
GGCGGCGGAGGCGGCGGTGGGGTGAGGAAGTAGTTTGTCCTCGGGTCGACCCCGCCGCGG 
pp 	p 	p 	p 	p 	P 	H 	S 	F 	1K 	Q 	E 	PS 	W 	G 	GA - 
GAGCCACACGAGGAGCAGTGCCTGAGCGCCTTCACCTTGCACTTCTCGGGCCAGTTCACC 
721 ------------------------------------------------------------ 780 
CTCGGTGTGCTCCTCGTCACGGACTCGCGGAAGTGGAACGTGAAGAGCCCGGTCAAGTGG 
E 	PH 	E 	E 	CL 	S 	AFT 	L 	H 	F 	S 	G 	Q 	FT - 
GGTACAGCCGGGGCCTGTCGCTACGGACCCTTCGGTCCTCCCCCGCCCAGCCAGGCGTCC 
781 ---------+---------+---------+ ---------+---------+---------+ 840 
CCATGTCGGCCCCGGACAGCGATGCCTGGGAAGCCAGGAGGGGGCGGGTCGGTCCGCAGG 
G 	TAG 	A 	CRY 	G 	P 	F 	G 	pp 	p 	p 	S 	Q 	A 	S - 
TCGGGCCAGGCCAGGATGTTCCCCAATGCGCCCTACCTGCCCAGCTGCCTGGAGAGCCAG 
841 ------------------------------------------------------------ 900 
AGCCCGGTCCGGTCCTACAAGGGGTTACGCGGGATGGACGGGTCGACGGACCTCTCGGTC 
S 	G 	Q 	ARM 	F 	P 	N 	A 	P 	Y 	L 	PS 	CL 	ES 	Q - 
CCTACCATCCGCAACCAAGGATACAGCACGGTCACTTTCGACGGGGCGCCCAGCTATGGC 
901 ------------------------------------------------------------ 960 
GGATGGTAGGCGTTGGTTCCTATGTCGTGCCAGTGAAAGCTGCCCCGCGGGTCGATACCG 
PT 	I 	RN 	Q 	G 	Y 	ST 	VT 	F 	D 	GAPS 	Y 	G - 
CACACGCCCTCGCATCACGCGGCGCAGTTCCCCAACCATTCCTTCAAACACGAGGACCCC 
961 ---------+---------+---------+ ---------+---------+---------+ 1020 
GTGTGCGGGAGCGTAGTGCGCCGCGTCAAGGGGTTGGTAAGGAAGTTTGTGCTCCTGGGG 
H 	T 	PS 	H 	H 	A 	A 	Q 	F 	P 	N 	H 	SF 	K 	H 	ED 	P - 
ATGGGCCAGCAGGGCTCGCTGGGCGAGCAGCAGTACTCCGTGCCACCTCCGGTGTATGGC 
1021 ---------+---------+---------+---------+ ---------+---------+ 1080 
TACCCGGTCGTCCCGAGCGACCCGCTCGTCGTCATGAGGCACGGTGGAGGCCACATACCG 
MG 	Q 	Q 	G 	S 	L 	GE 	Q 	Q 	Y 	S 	V 	PP 	P 	V 	Y 	G - 
TGCCACACCCCTACTGACAGTTGCACAGGCAGCCAGGCCCTGCTCCTGAGGACGCCCTAC 
1081 ------------------------------------------------------------ 1140 
ACGGTGTGGGGATGACTGTCAACGTGTCCGTCGGTCCGGGACGAGGACTCCTGCGGGATG 
C 	H 	T 	PT 	D 	SC 	T 	G 	S 	ALL 	L 	R 	T 	P 	Y - 
AGCAGTGACAATTTATACCAAATGACCTCCCAGCTTGAATGCATGACCTGGAATCAGATG 
1141 ---------+---------+---------+---------+---------+---------+ 1200 
TCGTCACTGTTAAATATGGTTTACTGGAGGGTCGAACTTACGTACTGGACCTTAGTCTAC 
S 	SD 	N 	L 	Y 	Q 	MT 	SQL 	E 	C 	MT 	W 	N 	Q 	M - 
227 
AACCTAGGAGCTACCTTAAAGGGAATGGCTGCTGGGAGCTCCAGCTCAGTGWTGGACA 
1201 ---------+---------+---------+---------+---------+---------+ 1260 
TTGGATCCTCGATGGAATTTCCCTTACCGACGACCCTCGAGGTCGAGTCACTTTACCTGT 
N L GA T L K GM A AG S S S S V K W T - 
GAAGGGCAGAGCAACCACGGTATAGGGTACGAGAGTGAGAACCACACGGCCCCCATCCTC 
1261 ---------+---------+---------+---------+ ---------+---------+ 1320 
CTTCCCGTCTCGTTGGTGCCATATCCCATGCTCTCACTCTTGGTGTGCCGGGGGTAGGAG 
E G Q S N H GIG YES EN H TAP IL - 
TGTGGTGCCCAGTACAGAATACACACCCACGGGGTCTTCCGAGGCATTCAGGATGTGCGG 
1321 ---------+---------+---------+---------+---------+----------- 1380 
ACACCACGGGTCATGTCTTATGTGTGGGTGCCCCAGAAGGCTCCGTAAGTCCTACACGCC 
C GA Q Y 	I H T HG V FR G I Q DV R - 
CGTGTATCTGGAGTGGCCCCAACTCTTGTCCGGTCAGCATCTGAAACCAGTGAGAAACGT 
1381 ---------+---------+---------+---------+---------+---------+ 1440 
GCACATAGACCTCACCGGGGTTGAGAACAGGCCAGTCGTAGACTTTGGTCACTCTTTGCA 
R 	VS 	G 	VA 	PT 	L 	R 	S 	A 	SETS 	E 	KR - 
CCTTTCATGTGTGCATACCCAGGCTGCAATAAGAGATATTTTAAGCTGTCCCACTTACAG 
1441 ---------+---------+---------+---------+---------+---------+ 1500 
GGAAAGTACACACGTATGGGTCCGACGTTATTCTCTATAAAATTCGACAGGGTGAATGTC 
P 	F 	MC 	A 	Y 	P 	GC 	N 	KR 	Y 	F 	K 	L 	S 	H 	L 	Q - 
ATGCATAGCCGGAAGCACACTGGTGAGAAACCATACCAGTGTGACTTCAAGGACTGCGAG 
1501 ---------+---------+---------+---------+ ---------+---------+ 1560 
TACGTATCGGCCTTCGTGTGACCACTCTTTGGTATGGTCACACTGAAGTTCCTGACGCTC 
M 	H 	SR 	K 	H 	T 	GE 	K 	P 	Y 	Q 	CD 	F 	K 	DC 	E - 
AGAAGGTTTTCTCGCTCAGACCAGCTCAAAAGACACCAAAGGAGACACACAGGTGTGAAA 
1561 ---------+---------+---------+---------+ ---------+---------+ 1620 
TCTTCCAAAAGAGCGAGTCTGGTCGAGTTTTCTGTGGTTTCCTCTGTGTGTCCACACTTT 
R 	R 	F 	SR 	SD 	Q 	L 	K 	R 	Q 	R 	R 	T 	G 	V 	K - 
CCATTCCAGTGTAAAACTTGTCAGCGAAAGTTTTCCCGGTCCGACCATCTGAAGACCCAC 
1621 ---------+---------+---------+---------+---------+ ---------+ 1680 
GGTAAGGTCACATTTTGAACAGTCGCTTTCAAAAGGGCCAGGCTGGTAGACTTCTGGGTG 
P 	F 	Q 	C 	K 	T 	C 	Q 	R 	K 	F 	SR 	SD 	H 	L 	K 	T 	H - 
ACCAGGACTCATACAGGTAAAACAAGTGAAAAGCCCTTCAGCTGTCGGTGGCACAGTTGT 
1681 ---------+---------+---------+---------+---------+---------+ 1740 
TGGTCCTGAGTATGTCCATTTTGTTCACTTTTCGGGAAGTCGACAGCCACCGTGTCAACA 
T 	R 	T 	H 	T 	G 	K 	T 	SE 	K 	P 	F 	SCR 	W 	H 	SC - 
CAGAAAAAGTTTGCGCGCTCAGACGAATTGGTCCGCCATCACAACATGCATCAGAGAAAC 
1741 ---------+---------+ ---------+---------+---------+---------+ 1800 
GTCTTTTTCAAACGCGCGAGTCTGCTTAACCAGGCGGTAGTGTTGTACGTAGTCTCTTTG 
Q K K FAR SD EL V R 	H NM H Q RN 
ATGACCAAACTCCACGTGGCGCTTTGAGGGGTCCGACACGGAGACAGTCCAGCATCCCAG 
1801 ---------+---------+---------+---------+---------+---------+ 1860 
228 
TACTGGTTTGAGGTGCACCGCGAAACTCCCCAGGCTGTGCCTCTGTCAGGTCGTAGGGTC 
MT K L H V AL * G V RH GD SPA SQ - 
GCAGGAAAGTGTGCAAACTGCTTCCAAATCTGATTTTGAAATTCCTCCCACTCACCTTTC 
1861 ------------------------------------------------------------ 1920 
CGTCCTTTCACACGTTTGACGAAGGTTTAGACTAAAACTTTAAGGAGGGTGAGTGGAAAG 
AG K C A N C F Q I * F * N S S H S P F - 
AAAGGACACGACTGTGGATCTACATCCGACTTCCAAGACAGCACACCTGATTGACTGCAT 
1921 ---------+---------+ ---------+---------+---------+---------+ 1980 
TTTCCTGTGCTGACACCTAGATGTAGGCTGAAGGTTCTGTCGTGTGGACTAACTGACGTA 
KG H DC G ST SD F Q D ST PD * L H - 
CCTATCAGGTTTGCCGGAAGGAGTCGGTCCTCCGCCCACTTTTGATTAACTCACAGGCCT 
1981 ---------+ ---------+---------+---------+---------+---------+ 2040 
GGATAGTCCAAACGGCCTTCCTCAGCCAGGAGGCGGGTGAAAACTAATTGAGTGTCCGGA 
P1 R FAG R SR SS A H F * L T HR P - 
GAAAAAAGTGGTTCAAGGTGTCTAGAAAGTCCAATTGTCTGAATTTTCTACTGTTAGAAG 
2041 ------------------------------------------------------------ 2100 
CTTTTTTCACCAAGTTCCACAGATCTTTCAGGTTAACAGACTTAAAAGATGACAATCTTC 
E KS G SR CL ES P1 V * IF Y C * K - 
AACCATTGTTGATAATGCCCCCCGCCCCCCCCCCCCCCGGGTTTCCTCTTCTCCTTTGTG 
2101 ------------------------------------------------------------ 2160 
TTGGTAACAACTATTACGGGGGGCGGGGGGGGGGGGGGCCCAAAGGAGAAGAGGAAACAC 
N H C * * C P P P P P P PG FL F SF V - 
ATCATTTCCCCAGGATTAGAGAGACTGTTACATTTTCTTTCATGGGATATTTATAGGCCA 
2161 ------------------------------------------------------------ 2220 
TAGTAAAGGGGTCCTAATCTCTCTGACAATGTAAAAGAAAGTACCCTATAAATATCCGGT 
uS PG L ER L L H FL SW DI Y 	P - 
GGGCATGTGTATGTGCCTGCTAATGTAAACTCTGTCATAGTTCCCATTTACTAACTGCCC 
2221 ---------+---------+---------+---------+---------+---------+ 2280 
CCCGTACACATACACGGACGATTACATTTGAGACAGTATCAAGGGTAAATGATTGACGGG 
G H V Y V P A N V N S V IV PlY * L P - 
TAGAAAGAAATAAATCAGAGAGCAAGGCACCAGGCAAGAATCGTACAGAATTTCAGAGGT 
2281 ------------------------------------------------------------ 2340 
ATCTTTCTTTATTTAGTCTCTCGTTCCGTGGTCCGTTCTTAGCATGTCTTAAAGTCTCCA 
* K El N Q R A R 	Q A RI V Q N FR G - 
CTGGCTGCAAACCTGGAAACCTGGAAGGCCAGATGTAATTCTACAGGCGATTGTTAAAGC 
2341 ---------+---------+---------+---------+---------+---------+ 2400 
GACCGACGTTTGGACCTTTGGACCTTCCGGTCTACATTAAGATGTCCGCTAACAATTTCG 
LA A N LET W K AR C N ST G 	C * 5 - 
TCATAGGTTTTGAGTAACTGCATAGTAGGTTGGTATTAACTAGAACTCTGTATAGTTAGG 
2401 ---------+---------+---------+---------+---------+---------+ 2460 
AGTATCCAAAACTCATTGACGTATCATCCAACCATAATTGATCTTGAGACATATCAATCC 
229 
S * V L S N C I V G WY * L EL C I V R - 
ACGGAGAGGAGCCTTCCTGCTCAGCTATTCACTCTGAACACTAGCACTGGGCTCTTAAGA 
2461 ---------+---------+---------+ ---------+---------+---------+ 2520 
TGCCTCTCCTCGGAAGGACGAGTCGATAAGTCAGACTTGTGATCGTGACCCGAGAATTCT 
T ER S L PA Q L FT L NT ST G L L R - 
AATCATGTTTTAAGAGCAGAGATCTTTTTTTAATGTCTTTCATTTATTTTTTAGTTGTAA 
2521 ---------+---------+---------+ ---------+---------+---------+ 2580 
TTACTACAAAATTCTCGTCTCTAGAAAAAAATTACAGAAACTAAATAAAAAATCAACATT 
N DV L RAE 1FF * CL * F IF * L * - 
TTACGTACATCCTCAGAGATGTACTTTCCTCCTCTTGTGCAGGATGTGGACGACTCGTTC 
2581 ------------------------------------------------------------ 2640 
AATCCATGTAGGAGTCTCTACATGAAAGCACGACAACACCTCCTACACCTCCTGAGCAAG 
L CT S SE MY F P P L 	Q DV ED SF - 
CATCATCTGGGGCATCTTTAGAGTGTATAGACCACACTGGTTATGTGGCTTCAAGTTGTA 
2641 ---------+---------+---------+ ---------+---------+---------+ 2700 
GTAGTAGACCCCGTAGAAATCTCACATATCTGGTGTGACCAATACACCGAAGTTCAACAT 
H H L G H L * 5 V * T T L 	MW L Q V V - 
AAAATTAAAATGACTTTAAAAGAAACTAGGGGCTGGTCCAGGATCTCACTGGTAACACTG 
2701 ---------+---------+---------+---------+ ---------+---------+ 2760 
TTTTAATTTTACTGAAATTTTCTTTGATCCCCGACCAGGTCCTAGAGTGACCATTCTGAC 
K 1KM T L K E T R G W SRI S L 	R L - 
TTCTTAAGTAACTTAAGTATCTTTCAATCTGCAAGTATGTAGGGAAAAAAAAAAAGATAT 
2761 ------------------------------------------------------------ 2820 
AAGAATTCATTGAATTCATAGAAACTTAGACGTTCATACATCCCTTTTTTTTTTTCTATA 
FL S 	L S 	F ES A S 	* G K K KR Y - 
ATTATTGTGAGGAAATCCATTGTTTAAAGGTGTGCGTGTGTTGTTGTTGTTTTTTAAAGG 
2821 ------------------------------------------------------------ 2880 
TAATAACACTCCTTTAGGTAACAAATTTCCACACGCACACAACAACAACAAAAAATTTCC 
II V R K S 	V * RCA C V V V V F * R - 
GAGGGAGTTTATTATTTACTGTAGCTTGAAATACTGTGTAAATATATATGTATATATATG 
2881 ----------------------------------------------------- L ------ 2940 
CTCCCTCAAATAATAAATGACATCGAACTTTATGACACATTTATATATACATATATATAC 
E C V Y Y L L * L El L C KY IC I Y M - 
ATGTGCTCTTTGTCAACTAAAATTACGAGGTGTATGGTATTAGCTGCATCACTGTGTGGA 
2941 ---------+---------+---------+---------+---------+---------+ 3000 
TACACGAGAAACAGTTGATTTTAATCCTCCACATACCATAATCGACGTAGTGACACACCT 
MC S L ST K I R R C M V LA AS L CC - 
TGTCAATCTTACACTGTATTGATGATAATACTAAAAATGTAACCTGCATCTTTTTCCACT 
3001 ---------+---------+---------+---------+ ---------+---------+ 3060 
ACACTTACAATGTCACATAACTACTATTATGATTTTTACATTGGACGTAGAAAAAGGTGA 
C Q S Y S V L MI ILK M * PA S F S T - 
230 
TGGCTGTCAATTAAAGTCTATTCAAAAGG 
3061 ----------------------------- 3089 
ACCGACAGTTAATTTCAGATAAGTTTTCC 
W L S 	K V Y S K? - 
231 




1 ------------------------------------------------------------ 60 
AGGCTTGGCGTGGAGTACCCAAGGCTGCACGCCCTGGACTTGCGCGACGACGGGCGGCAC 
S 	E 	P 	H 	L 	MG 	SD 	V 	RD 	L 	N 	ALL 	PA 	V 	- 
TCCTCGCTGGGCGGTGGAGGCGGCTGTGGGCTCCCTGTGAGCGGCGCGCGGCAATGGGCG 
61 ------------------------------------------------------------ 120 
AGGAGCGACCCGCCACCTCCGCCGACACCCGAGGGACACTCGCCGCGCGCCGTTACCCGC 
S 	S 	L 	G 	G 	G 	G 	G 	C 	G 	L 	P 	V 	S 	GA 	R 	Q 	WA - 
CCGGTGCTGGACTTCGCGCCTCCGGGCGCCTCGGCTTACGGGTCACTGGGCGGTCCCGCG 
121 ------------------------------------------------------------ 180 
GGCCACGACCTGAAGCGCGGAGGCCCGCGGAGCCGAATGCCCAGTGACCCGCCAGGGCGC 
P 	V 	L 	D 	F 	A 	P 	P 	GAS 	A 	Y 	G 	S 	L 	G 	G 	PA - 
CCTCCTCCCGCTCCGCCGCCACCTCCGCCGCCACCCCACTCCTTCATCAAACAGGAGCCC 
181 ---------+---------+---------+---------+---------+---------+ 240 
GGAGGAGGGCGAGGCGGCGGTGGAGGCGGCGGTGGGGTGAGGAAGTAGTTTGTCCTCGGG 
pp 	P 	A 	P 	P 	P 	P 	P 	P 	P 	P 	H 	SF1 	K 	Q 	E 	P - 
PCR clones 
AGCTGGGGCGGCGCCGAGCCGCACGAGGAGCAGTGCCTGAGCGCCTTCACCTTGCACTTC 
241 ------------------------------------------------------------ 300 
TCGACCCCGCCGCGGCTCGGCGTGCTCCTCGTCACGGACTCGCGGAAGTGGAACGTGAAG 
SW 	G 	GA 	E 	PH 	E 	E 	CL 	S 	AFT 	L 	H 	F - 
TCCGGCCAGTTCACCGGTACAGCCGGGGCCTGTCGCTACGGACCCTTCGGTCCTCCCCCG 
301 ---------+---------+---------+---------+---------+ ---------+ 360 
AGGCCGGTCAAGTGGCCATGTCGGCCCCGGACAGCGATGCCTGGGAAGCCAGGAGGGGGC 
S 	G 	Q 	FT 	G 	TAG 	A 	CRY 	G 	P 	F 	G 	pp 	p - 
CCCAGCCAGGCGTCATCCGGCCAGGCCAGGATGTTCCCCAATGCGCCCTACCTGCCCAGC 
361 ---------+---------+---------+---------+---------+ ---------+ 420 
GGGTCGGTCCGCAGTAGGCCGGTCCGGTCCTACAAGGGGTTACGCGGGATGGACGGGTCG 
P 	S 	ASS 	G 	Q 	ARM 	F 	P 	N 	A 	P 	Y 	L 	PS - 
TGCCTGGAGAGCCAGCCCTCCATCCGCAACCAAGGATACAGCACGGTCACTTTCGACGGG 
421 ---------+---------+---------+---------+ ---------+---------+ 480 
ACGGACCTCTCGGTCGGGAGGTAGGCGTTGGTTCCTATGTCGTGCCAGTGAAAGCTGCCC 
CL, 	ES 	Q 	PSI 	RN 	Q 	G 	Y 	ST 	VT 	F 	D 	G - 
GCACCCAGTTATGGCCACACGCCCTCGCACCATGCAGCGCAGTTCCCCAATCATTCCTTC 
481 ---------+---------+---------+---------+---------+---------+ 540 
CGTGGGTCAATACCGGTGTGCGGGAGCGTGGTACGTCGCGTCAAGGGGTTAGTAAGGAAG 
A 	PS 	Y 	G 	H 	T 	PS 	H 	H 	A 	A 	Q 	F 	P 	N 	H 	SF - 
AAACACGAGGACCCCATGGGCCAGCAGGGCTCGCTGGGCGAGCAGCAGTACTCGGTGCCA 
541 ---------+---------+---------+---------+---------+ ---------+ 600 
TTTGTGCTCCTGGGGTACCCGGTCGTCCCGAGCGACCCGCTCGTCGTCATGAGCCACGGT 
232 
K 	H 	ED 	PM 	C 	Q 	Q 	G 	S 	L 	GE 	Q 	Q 	Y 	S 	VP - 
CCTCCAGTGTATGGCTGCCACACCCCTACCGACAGTTGCACAGGCAGCCAGGCCCTGCTC 
601 ---------+---------+---------+ ---------+---------+---------+ 660 
GGAGGTCACATACCGACGGTGTGGGGATGGCTGTCAACGTGTCCGTCGGTCCGGGACGAG 
PP 	v 	Y 	G 	C 	H 	T 	PT 	D 	S 	CT 	G 	S 	ALL - 
CTGAGGACGCCCTACAGCAGTGACAATTTATACCACATGACCTCCCAGCTTGAGTGCATG 
661 ---------+---------+---------+---------+---------+---------+ 720 
GACTCCTGCGGGATGTCGTCACTGTTAAATATGGTCTACTGGAGGGTCGAACTCACGTAC 
L 	R 	T 	P 	Y 	S 	SD 	N 	L 	Y 	Q 	MT 	SQL 	E 	CM - 
ACCTGGAACCAGATGAACCTCGGAGCTACCTTGAAGGGAATGGCTGCTGGGAGCTCCAGC 
721 ---------+---------+---------+---------+---------+---------+ 780 
TGGACCTTGGTCTACTTGGAGCCTCGATGGAACTTCCCTTACCGACGACCCTCGAGGTCG 
T 	W 	N 	Q 	MN 	L 	GA 	T 	L 	K 	GM 	A 	AG 	S 	S 	S - 
TCAGTGAAATGGACAGAAGGGCAGAGCAACCACGGCACAGGGTACGAGAGTGAGAACCAC 
781 ---------+---------+---------+ ---------+---------+---------+ 840 
AGTCACTTTACCTGTCTTCCCGTCTCGTTGGTGCCGTGTCCCATGCTCTCACTCTTGGTG 
S 	V 	K 	W 	T 	E 	G 	Q 	S 	HG 	T 	G 	YES 	EN 	H - 
ACAACCCCCATCCTCTGTGGTGCCCAGTACAGAATACACACCCACGGTGTCTTCCGAGGC 
841 ---------+---------+---------+---------+---------+---------+ 900 
TGTTGGGGGTAGGAGACACCACGGGTCATGTCTTATGTGTGGGTGCCACAGAAGGCTCCG 
T 	T 	P1 	L 	C 	GA 	Q 	Y 	I 	H 	T 	HG 	V 	FR 	G - 
ATTCAGGATGTGCGGCGCGTATCTGGAGTGGCCCCAACTCTTGTCCGGTCAGCATCTGAA 
901 ---------+ ---------+---------+---------+---------+---------+ 960 
TAAGTCCTACACGCCGCGCATAGACCTCACCGGGGTTGAGAACAGGCCAGTCGTAGACTT 
I 	Q 	DV 	R 	R 	VS 	G 	V 	APT 	L 	R 	S 	A 	SE - 
ACCAGTGAGAAGCGTCCTTTCATGTGTGCGTACCCAGGCTGCAATAAGAGATATTTTAAG 
961 ---------+ ---------+---------+---------+---------+---------+ 1020 
TGGTCACTCTTCGCAGGAAAGTACACACGCATGGGTCCGACGTTATTCTCTATAAAATTC 
T 	SE 	KR 	P 	F 	MC 	A 	Y 	PG 	C 	N 	KR 	Y 	F 	K - 
CTGTCCCACTTACAGATGCACAGCCGGAAGCACACTGGTGAGAAACCATACCAGTGTGAC 
1021 ---------+---------+---------+ ---------+---------+---------+ 1080 
GACAGGGTGAATGTCTACGTGTCGGCCTTCGTGTGACCACTCTTTGGTATGGTCACACTG 
L 	S 	H 	L 	Q 	M 	H 	SR 	K 	H 	T 	GE 	K 	P 	Y 	Q 	CD - 
TTCAAGGACTGCGAGAGAAGGTTTTCTCGCTCAGACCAGCTCAAAAGGCACCAAAGGAGA 
1081 ---------+---------+---------+ ---------+---------+---------+ 1140 
AAGTTCCTGACGCTCTCTTCCAAAAGAGCGAGTCTGGTCGAGTTTTCCGTGGTTTCCTCT 
F 	K' D 	C 	ERR 	F 	SR 	SD 	Q 	L 	K 	R 	Q 	R 	R - 
CACACAGGTGTGAAACCATTCCAGTGTAAAACTTGTCAGCGAAAGTTTTCCCGGTCCGAC 
1141 ---------+ ---------+---------+---------+---------+---------+ 1200 
GTGTGTCCACACTTTGGTAAGGTCACATTTTGAACAGTCGCTTTCAAAAGGGCCAGGCTG 




1201 ------------------------------------------------------------ 1260 
GTGGACTTCTGGGTGTGGTCCTGAGTATGTCCATTTTGTTCACTTTTCGGGAAGTCGACA 
H L K T H PR T H T G K T SE K P F S C - 
CGGTGGTACAGTTGTCAGAAAAAGTTTGCGCGGTCAGACGAATTAGTCCGCCATCACAAG 
1261 ---------+---------+---------+ ---------+---------+---------+ 1320 
GCCACCATGTCAACAGTCTTTTTCAAACGCGCCAGTCTGCTTAATCAGGCGGTAGTGTTC 
R WY SC Q K K FAR SD EL V R 	H K - 
ATGCACCAGAGAAACATGACCAAACTCCAGCTGGCGCTTTGAGGGGTCCGACCCGGAGAC 
1321 ---------+ ---------+---------+---------+---------+---------+ 1380 
TACGTGGTCTCTTTGTACTGGTTTCAGGTCGACCGCGAAACTCCCCAGGCTGGGCCTCTG 
M H Q RN MT K L Q LA L * G V R PG D - 
AGTCCAGCGTCCCAGGCAAGAAAGTGTGTGCTTAAACTGCTTCCAAATCTGATTTTGAAA 
1381 ------------------------------------------------------------ 1440 
TCAGGTCGCAGGGTCCGTTCTTTCACACACGAATTTGACGAAGGTTTAGACTAAAACTTT 
PAS Q ARKCVLKLLL P N 	ILKK 	- 
TTCCTCCCTCTCACCTACAAAAGGACATGATGGTGGATCTTCATCCGACTTCCAAGACAG 
1441 ---------+---------+---------+---------+---------+---------+ 1500 
AAGGAGGGAGAGTGGATGTTTTCCTGTACTACCACCTAGAAGTAGGCTGAAGGTTCTGTC 
FL P L P Y KR T * W WI FIR L PR Q - 
CACACCTGTTTACTGAGTCCTATCAGGTTTGCCGGAAGGAGTCGGTCTCTGCCCACTCTT 
1501 ---------+ ---------+---------+---------+---------+---------+ 1560 
GTGTGGACAAATGACTCAGGATAGTCCAAACGGCCTTCCTCAGCCAGAGACGGGTGAGAA 




D * L PG 	- 
234 
Pig WTI cDNA 
ACTTAGGAGCCACATTAAAAGGAGTTGCTGCTGGAAGCTCCAGCTCAATGAAATGGACAG 
19 ------------------------------------------------------------ 78 
TGA1TCCTCGGTGTAATTTTCCTCAACCACGACCTTCGAGGTCGAGTTACTTTACCTGTC 




G Q S 	HG T G YES D THAT P1 L C 	- 
GTGGTGCCCAGTACAGAATACACACCCACGGTGTCTTCAGGGGCATTCAGGACGTGCGAC 
139 -+---------+-- ------- +--------- +--------- +--------- +-------- 198 
CACCACGGGTCATGTCTTATGTGTGGGTGCCACAGAAGTCCCCGTAAGTCCTGCACGCTG 
GA Q Y 	I H T HG V FR G I Q DV R R- - 
GTGTGCCTGGAGTAGCCCCGACTCTTGTGCGGTCGGCATCTGAGACCAGTGAGAAACGCC 
199 ------------------------------------------------------------ 258 
CACACGGACCTCATCGGGGCTGAGAACACGCCAGCCGTAGACTCTGGTCACTCTTTGCGG 
V PG VA PT L 	R S A SETS E KR P- 
CCTTCATGTGTGCTTACCCGGGCTGCAATAAGAGATATTTTAAGCTGTCTCACTTACAGA 
259 ------------------------------------------------------------ 318 
GGAAGTACACACGAATGGGCCCGACGTTATTCTCTATAAAATTCGACAGAGTGAATGTCT 
F 	MC 	A 	Y 	PG 	C 	N 	KR 	Y 	F 	K 	L 	S 	H 	L 	Q 	M- - 
TGCATAGCCGGAAGCACACTGGTGAGAAACCATACCAGTGTGACTTCAAGGACTGTGAGA 
319 ------------------------------------------------------------ 378 
ACGTATCGGCCTTCGTGTGACCACTCTTTGGTATGGTCACACTGAAGTTCCTGACACTCT 
- H 	SR 	K 	H 	T 	GE 	K 	P 	Y 	Q 	CD 	F 	K 	DC 	ER - 
GAAGGTTTTCTCGTTCAGACCAGCTCAAAAGACACCAAAGGAGACACACAGGTGTGAAAC 
379 ------------------------------------------------------------ 438 
CTTCCAAAAGAGCAAGTCTGGTCGAGTTTTCTGTGGTTTCCTCTGTGTGTCCACACTTTG 
R 	F 	SR 	SD 	Q 	L 	K 	R 	Q 	R 	R 	T 	G 	V 	K 	P- - 
CATTCCAGTGTAAAACTTGTCAGCGAAAGTTCTCCCGGTCCGACCACCTGAAGACCCACA 
439 ------------------------------------------------------------ 498 
GTAAGGTCACATTTTGAACAGTCGCTTTCAAGAGGGCCAGGCTGGTGGACTTCTGGGTGT 
F 	Q 	C 	K 	T 	C 	Q 	R 	K 	F 	SR 	SD 	H 	L 	K 	T 	H 	T- - 
CCAGGACTCATACA 
499 -+ ---------+-- 512 
GGTCCTGAGTATGT 
R 	T 	H 	T 	- 
235 
Marsupial mouse WTI cDNA, clone Sc41 
AGCGTGCCTCCCCCGGTCTATGGATGTCACACGCCCACCGACAGCTGCACCGGCAGCCAG 
22 ------------------------------------------------------------ 81 
TCGCACGGAGGGGGCCAGATACCTACAGTGTGCGGGTGGCTGTCGACGTGGCcGTCGGTc 
S 	V 	p 	p 	v 	Y 	G 	C 	H 	T 	PT 	D 	S 	T 	G 	S  - 
GCCCTGCTGCTCCGGACTCCCTACAACAGTGACAATCTGTACCAAATGACCTCGCAGCTA 
82 ------------------------------------------------------------ 141 
CGGGACGACGAGGCCTGAGGGATGTTGTCACTGTTAGACATGGTTTACTGGAGCGTCGAT 
ALL 	L 	R 	T 	P 	Y 	N 	SD 	N 	L 	Y 	Q 	MT 	SQL - 
GAATGCATGACCTGGAACCAGATGAACCTAGGGGCCACACTGAAGGGCCACACCACAGGA 
142 ------------------------------------------------------------ 201 
CTTACGTACTGGACCTTGGTCTACTTGGATCCCCGGTGTGACTTCCCGGTGTGGTGTCCT 
E 	CM 	T 	W 	N 	Q 	MN 	L 	GA 	T 	L 	KG 	H 	T 	T 	G - 
TATGAAAATGATAACCACACGACTCCGATCCTGTGTGGAGCCCAATATAGAATACACACT 
202 ------------------------------------------------------------ 261 
ATACTTTTACTATTGGTGTGCTGAGGCTAGGACACACCTCGGGTTATATCTTATGTGTGA 
YEN 	D 	N 	H 	T 	T 	P1 	L 	c 	GA 	Q 	Y 	I 	H 	T - 
CATGGCGTCTTTAGAGGAATACAAGATGTCCGGCGAGTGCCCGGGGTAGCCCCTACTATC 
262 ------------------------------------------------------------ 321 
GTACCGCAGAAATCTCCTTATGTTCTACAGGCCGCTCACGGGCCCCATCGGGGATGATAG 
HG 	V 	FR 	G 	I 	Q 	DV 	R 	R 	VP 	G 	VA 	P 	TI - 
GTGAGGTCAGCCACGGAGACCAATGAGAAACGCCCATTCATGTGTGCATATCCAGGCTGC 
322 ------------------------------------------------------------ 381 
CACTCCAGTCGGTGCCTCTGGTTACTCTTTGCGGGTAAGTACACACGTATAGGTCCGACG 
V 	R 	SATE 	TN 	E 	KR 	P 	F 	MC 	A 	Y 	PG 	c - 
AACAAGAGATACTTTAAGCTGTCCCACTTACAGATGCATAGCAGGAAGCATACTGGTGAG 
382 ------------------------------------------------------------ 441 
TTGTTCTCTATGAAATTCGACAGGGTGAATGTCTACGTATCGTCCTTCGTATGACCACTC 
N 	KR 	Y 	F 	K 	L 	S 	H 	L 	Q 	M 	H 	SR 	K 	H 	T 	GE - 
AAACCCTACCAGTGTGACTTCAAGGACTGTGAACGGCGATTCTCTCGATCAGACCAACTC 
442 ------------------------------------------------------------ 501 
TTTGGGATGGTCACACTGAAGTTCCTGACACTTGCCGCTAAGAGAGCTAGTCTGGTTGAG 
K 	P 	Y 	Q 	CD 	F 	K 	DC 	ERR 	F 	SR 	SD 	Q 	L - 
AAAAGACACCAAAGGAGACACACAGGTGTGAAACCATTCCAGTGTAAAACCTGTCAGAGA 
502 --------+---------+---------+---------+---------+ ---------+- 561 
TTTTCTGTGGTTTCCTCTGTGTGTCCACACTTTGGTAAGGTCACATTTTGGACAGTCTCT 
K 	R 	Q 	R 	R 	T 	G 	V 	K 	P 	F 	Q 	C 	K 	T 	C 	Q 	R - 
AAGTTCTCCCGGTCTGACCACCTGAAGACACACACCAGGACTCATACAGGTAAAACAAGT 
562 --------+---------+---------+---------+---------+ ---------+- 621 
TTCAAGAGGGCCAGACTGGTGGACTTCTGTGTGTGGTCCTGAGTATGTCCATTTTGTTCA 
K 	F 	SR 	SD 	H 	L 	K 	T 	H 	T 	R 	T 	H 	T 	G 	K 	T 	S - 
236 
GAAAAGCCCTTCAGCTGCCGGTGGCCCACTTGTCAGAAAAAATTTGCCCGCTCACATGAA 
622 ------------------------------------------------------------ 681 
CTTTTCGGGAAGTCGACGGCCACCGGGTCAACAGTCTTTTTTAAACGGGCGAGTCTACTT 
E K P F S C 	W PS C Q K K FAR SD E - 
TTAGTGCGTCACCACAACATGCACCAAACGAACATGACGAAGCTCCAGCTGACGCTTTAA 
682 ------------------------------------------------------------ 741 
AATCACCCAGTGGTGTTGTACGTGGTTTCCTTGTACTGCTTCGAGGTCGACTGCGAAATT 
L 	R 	H NM H Q RN MT K L Q L T L * - 
AAGGTCCAGGTCAAGGATCCATCTCTCTCCCAGGTAGAATGTTGTATGAACCCCGATGGA 
742 ------------------------------------------------------------ 801 
TTCCAGGTCCAGTTCCTACGTAGAGACAGGGTCCATCTTACAACATACTTGGGGCTACCT 
K V Q V K D AS L S 	V E C C MN PD G - 
AATGGGCTTTTAGCTACCTTCAACTACCTTCCCAATAAGGAAACCCCAACCGACCACGAA 
802 --------+---------+ ---------+---------+---------+---------+- 861 
TTACCCGAAAATCGATGGAAGTTGATGGAAGGGTTATTCCTTTGGGGTTGGCTGGTGCTT 
N G L LA T F NY L P N K E T PT D HE - 
GACGAGTCACCCATCGGGATGCAGC000TTCCACGTTGTCGATCATCACAGCAGTCTTCA 
862 ------------------------------------------------------------ 921 
CTGCTCAGTGGGTAGCCCTACCTCGCCCAAGGTCCAACAGCTAGTAGTGTCGTCAGAAGT 
DES P1GM ER V P CC R S S 	Q SS - 
TTTTCTCCAATCTCTTCTTCACTCCTCAAGACTCAATTTCCATTCAGT 
922 ------------------------------------------------ 969 
AAAAGAGGTTAGAGAAGAAGTGAGGAGTTCTGAGTTAAAGGTAAGTCA 
F S P I S S S L L K T Q F P F S - 
Unsequenced region -800bp 
TCTATCTGATAATGCATTGCTCATTGCCTTAACTTCAAAACAATTGCAAAGCGACTAAAT 
1 ------------------------------------------------------------ 60 
AGATAGACTATTACGTAACGAGTAACGGAATTGAAGTTTTGTTAACGTTTCGCTGATTTA 
S 	* * CIA H CL N F K TI A KR L N - 
L SD N AL L 	ALT SK Q L Q SD * I - 
Y 	I M H CS L p * L Q N N C K AT KY - 
ACTTAGATGCGTTCAGATGTTACTGATGATGATGATAANNCTTAAGAATGTAATCTGCAT 
61 ------------------------------------------------------------ 120 
TGAATCTACGCAAGTCTACAATGACTACTACTACTATTNNGAATTCTTACATTACACGTA 
T * MRS DV T D D D D ? ? * E C N L H - 
L R C V Q ML L M M M I ? L K N V IC I - 
L D A FR C Y * * * * * ? L R M * S A F- 
TTTTCACCTTCAAATTTCAATTAA.AACCCATTCAAAAAGGAAAAAAAAAAAAAAZA 
121 -------------------------------------------------------- 176 
AAAAGTGGAAGTTTAAAGTTAATTTTCGGTAAGTTTTTCCTTTTTTTTTTTTTTTT 
F S PS N F N * N P F K K E K K K K? - 
F H L Q I S I K T H SK R K K K K K? - 
FT F K F Q L K P1 Q KG K K K K K - 
237 
Chick WI cDNA, clone C2.1 
CGGCACGAGGGCGCTGAGGCGGCTGTGGGTCCACCCCCTCCCTATCCCCCCCCCCGGCAC 
1 ------------------------------------------------------------ 60 
GCCGTGCTCCCGCGACTCCGCCGACACCCAGGTGGGGGAGGGATAGGGGGGGGGGCCGTG 
R 	E 	GA 	E 	A 	A 	V 	G 	pp 	p 	p 	y 	pp 	p 	R  - 
GCGCGGACAGACACACGGCCGCACACACGGACACGCGGCCACGGACACGCGCGCACCCCA 
61 ------------------------------------------------------------ 120 
CGCGCCTGTCTGTGTGCCGGCGTGTGTGCCTGTGCGCCGGTGCCTGTGCGCGCGTGGGGT 
ART 	D 	T 	R 	PH 	T 	R 	T 	R 	G 	HG 	HART 	P - 
CCCTGCGCTGCGAGCGGGCACAGCCCCGGAGGCGATCCTGGAGAACAACCTTTCCCTGTG 
121 ------------------------------------------------------------ 180 
GGGACGCGACGCTCGCCCGTGTCGGGGCCTCCGCTAGGACCTCTTGTTGGAAAGGGACAC 
PC 	A 	A 	S 	G 	H 	S 	PG 	G 	PG 	E 	P 	F 	P 	V - 
CGCTGCTCGCCGCTCCCGCGGGCTGGACCCGGGGAGCTGCGTCGCGGAGCAAACCTCTCC 
181 ---------+---------+---------+---------+---------+---------+ 240 
GCGACGAGCGGCGAGGGCGCCCGACCTGGGCCCCTCGACGCAGCGCCTCGTTTGGAGAGG 
R 	C 	P 	L 	PR 	AG 	PG 	EL 	R 	R 	GA 	N 	L 	S - 
AAGGGCTGAGCTCTCCGGCTGGTGCCTGCAGCCGGAGCGTCCGGCTGGCGGCAGAGGCAG 
241 ---------+---------+---------+---------+---------+---------+ 300 
TTCCCGACTCGAGAGGCCGACCACGGACGTCGGCCTCGCAGGCCGACCGCCGTCTCCGTC 
KG 	* 	AL 	R 	L 	P 	A 	A 	GA 	S 	G 	W 	R 	Q 	R 	Q - 
GTGTCCTGGAATAAGTGCGGCCTGGGGGGAGACTGGCTGCCCGGCGGCAGGCAGAAGGTC 
301 ------------------------------------------------------------ 360 
CACAGGACCTTATTCACGCCGGACCCCCCTCTGACCGACGGGCCGCCGTCCGTCTTCCAG 
V 	SW 	N 	K 	C 	G 	L 	G 	G 	W 	L 	PG 	G 	R 	Q 	K 	V - 
Translation Start—* 
TGCGAGCAGATGGGGTCCGACGTCCGGGACCTGAACGCGCTGCTGCCCTCCGTGCCCTCC 
361 ---------+---------+---------+---------+---------+---------+ 420 
ACGCTCGTCTACCCCAGGCTGCAGGCCCTGGACTTGCGCGACGACGGGAGGCACGGGAGG 
C 	E 	MG 	SD 	V 	RD 	L 	N 	ALL 	PS 	V 	PS - 
CTACCGGGCAACAGCAACTGCGCCATGCCGGTGAGCAGCGCGGCGCAGTGGGCTCCCGTC 
421 ---------+---------+---------+---------+---------+---------+ 480 
GATGGCCCGTTGTCGTTGACGCGGTACGGCCACTCGTCGCGCCGCGTCACCCGAGGGCAG 
L 	PG 	N 	S 	CAMP 	V 	SS 	A 	A 	Q 	WA 	P 	V - 
CTGGACTCTCCCCCGGGGGCCTCCTACGGCTCGCTGGGGCCGCACTCCTTCATCAAGCAG 
481 ---------+---------+---------+ ---------+---------+---------+ 540 
GACCTGAGAGGGGGCCCCCGGAGGATGCCGAGCGACCCCGGCGTGAGGAAGTAGTTCGTC 
L 	D 	S 	PP 	GAS 	Y 	G 	S 	L 	G 	PH 	SF1 	K 	Q - 
GAACCCAGCTGGAACGGGTCGGACCCGCACGAGGAGCAGTACCTGAGCGCTTTCACCGTC 
541 ------------------------------------------------------------ 600 
CTTGGGTCGACCTTGCCCAGCCTGGGCGTGCTCCTCGTCATGGACTCGCGAAAGTGGCAG 
E 	P 	S 	W 	N 	G 	SD 	PH 	E 	E 	Y 	L 	S 	A 	F 	TV - 
238 
CACTTCTCCGGGCAGTTCACGGGCACGGCCGGGGCCTGCCGCTACGGGCCCTTCGGCGCC 
601 ---------+---------+-------------------+---------+---------+ 660 
GTGAAGAGGCCCGTCAAGTGCCCGTGCCGGCCCCGGACGGCGATGCCCGGGAAGCCGCGG 
H 	F 	S 	G 	Q 	F 	PG 	TAG 	A 	CRY 	G 	P 	F 	GA - 
CCGCCGCCCAGCCAGCCGCCCTCCGGCCAGGCCAGGATGTTCCCCCAACGGCCCTACCTG 
661 ------------------------------------------------------------ 720 
GGCGGCGGGTCGGTCGGCGGGAGGCCGGTCCGGTCCTACAAGGGGGTTGCCGGGATGGAC 
pp 	p 	S 	pp 	S 	G 	Q 	ARM 	F 	P 	Q 	R 	P 	Y 	L - 
CCCAACTGCCTGGAGAGCCAGCAAGCCATTCGCAACCAGGGTTACGGCACCGTGGCCTTT 
721 ---------+---------+---------+---------+ ---------+---------+ 780 
GGGTTGACGGACCTCTCGGTCGTTCGGTAAGCGTTGGTCCCAATGCCGTGGCACCGGAAA 
P 	N 	CL 	ES 	Q 	Q 	Al 	RN 	Q 	G 	Y 	G 	TV 	A 	F - 
GACGGGACTCCGAGCTACGGCCACACGCCGTCTCACCACGCCGCGCAGTTTCAGAACCAC 
781 ------------------------------------------------------------ 840 
CTGCCCTGAGGCTCGATGCCGGTGTGCGGCAGAGTGGTGCGGCGCGTCAAAGTCTTGGTG 
D 	G 	T 	PS 	Y 	G 	H 	T 	PS 	H 	H 	A 	A 	Q 	F 	Q 	N 	H - 
TCTTTCAAACACGAAGACCCCATGAGCCAGCAGCCATCTCTAGGGGACCAGCAGTACTCG 
841 ------------------------------------------------------------ 900 
AGAAAGTTTGTGCTTCTGGGGTACTCGGTCGTCGGTAGAGATCCCCTGGTCGTCATGAGC 
SF 	K 	H 	ED 	PM 	S 	Q 	PS 	L 	G 	Q 	Q 	Y 	S - 
GTGCCCCCTCCGGTGTACGGCTGTCACACCCCCACGGACACGTGCACGGGCAGCCAGGCC 
901 ---------+---------+---------+ ---------+---------+---------+ 960 
CACGGGGGAGGCCACATGCCGACAGTGTGGGGGTGCCTGTGCACGTGCCCGTCGGTCCGG 
VP 	P 	P 	V 	Y 	G 	C 	H 	T 	PT 	D 	T 	CT 	G 	S 	A - 
—PCR Clones 
CTGCTCCTGCGGACCCCCTACAACAGTGACAATTTGTACCAAATGACGTCACGACTGGAA 
961 ---------+---------+---------+---------+---------+---------+ 1020 
GACGAGGACGCCTGGGGGATGTTGTCACTGTTAAACATGGTTTACTGCAGTGCTGACCTT 
L 	L 	L 	R 	T 	P 	Y 	N 	SD 	N 	L 	Y 	Q 	MT 	SR 	L 	E - 
TGCATGACATGGAACCAAATGAACCTGGGATCCACGCTGAAGGGCCATACGACAGGATAT 
1021 ------------------------------------------------------------ 1080 
ACGTACTGTACCTTGGTTTACTTGGACCCTAGGTGCGACTTCCCGGTATGCTGTCCTATA 
C 	MT 	W 	N 	Q 	MN 	L 	G 	ST 	L 	KG 	H 	PT 	G 	Y - 
GAkTGAGAACCACAGTGCTCCCATGTTATACAGCTGTGGGGCCCAATACAGAATACAC 
1081 ------------------------------------------------------------ 1140 
CTTTTACTCTTGGTGTCACGAGGGTACAATATGTCGACACCCCGGGTTATGTCTTATGTG 
E 	N 	E 	N 	H 	S 	A 	P 	M 	L 	Y 	S 	C 	G 	A 	Y 	R 	I 	H - 
ACCCATGGAGTCTTTAGAGGCATACAAGATGTCCGACGAGTGCCAGGAGTAGCTCCGACT 
1141 ---------+---------+---------+-------------------+---------+ 1200 
TGGGTACCTCAGAAATCTCCGTATGTTCTACAGGCTGCTCACGGTCCTCATCGAGGCTGA 
T 	HG 	V 	FR 	G 	I 	Q 	DV 	R 	R 	VP 	G 	VA 	PT - 
239 
ATTGTCCGATCAGCAAGTGAGACAAATGAAAAACGCCCCTTCATGTGTGCCTACCCCGGC 
1201 ---------+---------+---------+---------+- --------+---------+ 1260 
TAACAGGCTAGTCGTTCACTCTGTTTACTTTTTGCGGGGAAGTACACACGGATGGGGCCG 
IV R S A SE TN E KR P F MC A Y PG - 
TGCAACAAGCGATACTTCAAGCTGTCCCATCTACAGATGCACAGCAGAAAGCACACTGGT 
1261 ---------+ ---------+---------+---------+---------+---------+ 1320 
ACGTTGTTCGCTATGAAGTTCGACAGGGTAGATGTCTACGTGTCGTCTTTCGTGTGACCA 
C N KR Y F K L S H L Q M H SR K H T G - 
GAAAAACCATATCAGTGTGATTTTAAGGACTGTGAACGAAGATTTTCTCGTTCAGACCAA 
1321 ---------+---------+---------+---------+---------+ ---------+ 1380 
CTTTTTGGTATAGTCACACTAAAATTCCTGACACTTGCTTCTAAAAGAGCAAGTCTGGTT 
E K P Y Q CD F K DC ERR F SR SD Q - 
CTGAAACGGCACCAAAGACGACACACAGGTGTGAAACCCTTCCAATGTAAAACCTGTCAG 
1381 ---------+---------+---------+---------+---------+---------+ 1440 
GACTTTGCCGTGGTTTCTGCTGTGTGTCCACACTTTGGGAAGGTTACATTTTGGACAGTC 
L K R 	Q R R 	T G V K P F Q C K T C Q - 
PCR clones —> 	 * 
AGAAAGTTCTCCAGATCTGATCATCTGAAGACTCATACCAGGACTCATACAGCTATAGTG 
1441 ---------+---------+---------+---------+---------+---------+ 1500 
TCTTTCAAGAGGTCTAGACTAGTAGACTTCTGAGTATGGTCCTGAGTATGTCGATATCAC 
R K F SR SD H L K T H T R T H TA IV - 
AAATGAACATCATGGCCTCAGTCCACAAATGTCAACTCCATCTACTGTGTTCACTGAAAA 
1501 ---------+---------+---------+ ---------+---------+---------+ 1560 
TTTACTTGTAGTACCGGAGTCAGGTGTTTACAGTTGAGGTAGATGACACAAGTGACTTTT 
K * T SW P Q ST N V N SlY C V H * K - 
AGGGCCTACAAGAAAGAAATTTA 
1561 ---------+ ---------+--- 1583 
TCCCGGATGTTCTTTCTTTAAAT 
RAY K K El? - 
Chick WT1 PCR sequence of ZF3&4 
* 
CAGCACTCATACAGGTAAAACAAGTGAAAAGCCTTTCAGTTGCCGATGGCCCAGCTGTCA 
1479 ------------------------------------------------------------ 1528  
GTCCTGAGTATGTCCATTTTGTTCACTTTTCGGAAAGTCAACGGCTACCGGGTCGACAGT 




K K? - 
* Position in C2.1 where homology to WTI disappears 
240 




Q 	G 	Y 	ST 	VA 	F 	D 	G 	pp 	5 	Y 	G 	H 	A 	P 	S 	H - 
CACGCCGCGCAGTTCTCCAACCACTCCTTCAAGCACGAGGACCCCATCGCCCAGCAGACT 
68 ------------------------------------------------------------ 127 
GTGCGGCGCGTCAAGAGGTTGGTGAGGAAGTTCGTGCTCCTGGGGTAGCGGGTCGTCTGA 
H 	A 	A 	Q 	F 	S 	H 	SF 	K 	H 	ED 	P1 	A 	Q 	Q 	T - 
TCCCTAGGAGACCAGCAGTACTCGGTGCCCCCGCCGGTGTACGGCTGCCACACGCCCACG 
128 ------------------------------------------------------------ 187 
AGGGATCCTCTGGTCGTCATGAGCCACGGGGGCGGCCACATGCCGACGGTGTGCGGGTGC 
S 	L 	G 	Q 	Q 	Y 	S 	VP 	P 	P 	V 	Y 	G 	C 	H 	T 	PT - 
GACAGCTGCACGGGCAGCCAGGCCCTGCTCCTGCGGACCCCCTACAACAGTGACAATTTA 
188 ------------------------------------------------------------ 247 
CTGTCGACGTGCCCGTCGGTCCGGGACGAGGACGCCTGGGGGATGTTGTCACTGTTAAAT 
D 	S 	T 	G 	S 	ALL 	L 	R 	T 	P 	Y 	N 	SD 	N 	L - 
—PCR clones 
TACCAAATGACCTCGCAGCTTGAATGCATGACATGGAATCAAATGAACTTGGGATCCACA 
248 ------------------------------------------------------------ 307 
ATGGTTTACTGGAGCGTCGAACTTACGTACTGTACCTTAGTTTACTTGAACCCTAGGTGT 
Y 	Q 	MT 	SQL 	E 	CM 	T 	W 	N 	Q 	MN 	L 	G 	ST - 
TTAAAGGGCCATGCAACAGGATATGAAAATGAGAACCACACTGCTCCTATGTTATATAGC 
308 ------------------------------------------------------------ 367 
AATTTCCCGGTACGTTGTCCTATACTTTTACTCTTGGTGTGACGAGGATACAATATATCG 
L 	KG 	HAT 	G 	YEN 	EN 	H 	TAP 	ML 	Y 	S - 
TGTGGAGCC CAATACAGAATACACAC C C ATGGAGTTTTTAGAGGAATAC AAGATGTC COG 
368 ------------------------------------------------------------ 427 
ACACCTCGGGTTATGTCTTATGTGTGGGTACCTCAAAAATCTCCTTATGTTCTACAGGCC 
b 	 C GA Q Y 	I H T HG V FR G I Q DV R - 
CGAGTGCCAGGAGTAGCTCCAACTATTGTCCGATCAGCAAGTGAGACAAATGAAAAACGT 
428 ------------------------------------------------------------ 487 
GCTCACGGTCCTCATCGAGGTTGATAACAGGCTAGTCGTTCACTCTGTTTACTTTTTGCA 
R VP G VA P TI V R S A SET NE KR - 
CCCTTCATGTGTGCATACCCTGGCTGTAATAAGCGATACTTTAAGTTATCCCATTTACAG 
488 --+---------+---------+---------+---------+---------+------- 547 
GGGAAGTACACACGTATGGGACCGACATTATTCGCTATGAAATTCAATAGGGTAAATGTC 
P F M C A Y P G C N K R Y F K L S H' L Q - 
ATGCACAGCAGAAAGCACACTGGTGAAAAACCATACCAGTGTGACTTTAAGGACTGTGAG 
548 ------------------------------------------------------------ 607 
TACGTGTCGTCTTTCGTGTGACCACTTTTTGGTATGGTCACACTGAAATTCCTGACACTC 
M H SR K H T GE K P Y Q CD F K DC E - 
241 
AGAAGATTTTCCCGTTCAGACCAACTCAAACGACACCAAAGACGACACACAGGTGTGA 
608 ------------------------------------------------------------ 667 
TCTTCTAAAAGGGCAAGTCTGGTTGAGTTTGCTGTGGTTTCTGCTGTGTGTCCACACTTT 
R R F SR SD Q L K R 	Q R R 	T G V K - 
CCCTTCCAGTGTAAAACCTGTCAGAGAAAGTTCTCTAGGTCTGATCATCTAAAGACTCAC 
668 ------------------------------------------------------------ 727 
GGGAAGGTCACATTTTGGACAGTCTCTTTCAAGAGATCCAGACTAGTAGATTTCTGAGTG 
P F Q C K T C Q R K F SR SD H L K T H - 
PCR clones —> 
ACCAGGACTCATACAGGTAAAACAAGTGAAAAACCATTCAGCTGTCGATGGCCCAGCTGT 
728 ------------------------------------------------------------ 787 
TGGTCCTGAGTATGTCCATTTTGTTCACTTTTTGGTAAGTCGACAGCTACCGGGTCGACA 
T R T H T G K T SE K P F SCR W P S C - 
CAAAAAAAATTTGCCAGATCTGATGAATTAGTTCGTCATCACAACATGCACCAGAGGAAC 
788 ------------------------------------------------------------ 847 
GTTTTTTTTAAACGGTCTAGACTACTTAATCAAGCAGTAGTGTTGTACGTGGTCTCCTTG 
Q K K FAR SD EL V R 	H NM H Q RN - 
ATGACTAACTGCAGTTGGCCCTTTAGACAGTGAAACAAACGAATAAATAAATGGGACTT 
848 ------------------------------------------------------------ 907 
TACTGATTTGACGTCAACCGGGAAATCTGTCACTTTGTTTGCTTATTTATTTACCCTGAA 
MT K L Q LA L * TV K Q TN K * MG L - 
TATTGAAACTACTGCAGACTTTTTCAATCATCCTTGATCACATCTCTAGGAAAGCTACAG 
908 ------------------------------------------------------------ 967 
ATAACTTTGATGACGTCTGAAAAAGTTAGTAGGAACTAGTGTAGAGATCCTTTCGATGTC 
* NY C R L F Q SS LIT S L G K L Q - 
CTATCTTCATTACCCATTTGAGACAGGTTAGCTAAACCGTATGGATTCTGTTCCAGTTTT 
968 ------------------------------------------------------------ 1027 
GATAGAAGTAATGGGTAAACTCTGTCCAATCGATTTGGCATACCTAAGACAAGGTCAAAA 
L S S L P1 * DR LA K P Y G F C S S F - 
CTGACCTATGGACTTTAAAAAATGCTATTCAATGTCCTATTCAATAATGTTAAGTGGTTT 
1028 ------------------------------------------------------------ 1087 
GACTGGATACCTGAAATTTTTTACGATAAGTTACAGGATAAGTTATTACAATTCACCAAA 
L T Y G L * K ML F NV L F N N V K W F - 
TAATTTGTAACTTTGTTATGGAATTACCAAAACTGTTACAGTTTAAATATTAATATAAC 
1088 --+---------+---------+---------+---------+---------+------- 1147 
ATTAAACATTGAAACAATACCTTAATGGTTTTGACAATGTCAAATTTATAATTATATTTG 
* F VT L LW NY Q N C Y S L N IN IN - 
TGTGTTGTTACTTATGTATTTTTTTTTCCTCAAkGTTCTGTTTTTATTTTTACTTGA 
1148 --+---------+---------+---------+---------+---------+------- 1207 
ACACAACAATGAATACATAAAAAAAAAGGAGTTTTTTCAAGACAAAATAAAAATGAACT 
C V VT Y V F F F P Q K SS V F IF T * - 
242 
ACATTTCAGGTGGAAAGTACTGTGCCTTTTTCAGTAATACTGTGTGTTGGGTATGTGTAC 
1208 ------------------------------------------------------------ 1267 
TGTAAAGTCCACCTTTCATGACACGGAAAAAGTCATTATGACACACAACCCATACACATG 
T F Q V E S TV P F S VI L CV G Y V Y - 
ATGTCAAAGACAAGCTTTGTGCTTGCATTCGTACTCGTGC 
1268 --+---------+---------+---------+------- 1307 
TACAGTTTCTGTTCGAAACACGAACGTAAGCATGAGCACG 
M S K T SF V LA F V LV? -  - 
243 
Xenopus WT1 cDNA 
TGCCTACCCAGGATGCAACAAGAGATACTTCAAATTGTCCCATTTGCAGATGCACAGCAG 
21 ------------------------------------------------------------ 80 
ACGGATGGGTCCTACGTTGTTCTCTATGAAGTTTAACAGGGTAAACGTCTACGTGTCGTC 
A 	Y 	PG 	C 	N 	KR 	Y 	F 	K 	L 	S 	H 	L 	Q 	M 	H 	SR - 
GAAACACACAGGGGAAAAACCGTACCAGTGTGATTTTAAAGACTGTGAGAGGCGATTTTC 
81 ------------------------------------------------------------ 140 
CTTTGTGTGTCCCCTTTTTGGCATGGTCACACTAAAATTTCTGACACTCTCCGCTAAAAG 
K 	H 	T 	GE 	K 	P 	Y 	Q 	CD 	F 	K 	DC 	ERR 	F 	S - 
TCGTTCAGATCAACTTAAAAGGCACCAAAGGAGGCACACAGGTATCAAACCTTTCCAATG 
141 ------------------------------------------------------------ 200 
AGCAAGTCTAGTTGAATTTTCCGTGGTTTCCTCCGTGTGTCCATAGTTTGGAAAGGTTAC 
R 	SD 	Q 	L 	K 	R 	Q 	R 	R 	T 	G 	1K 	P 	F 	Q 	C - 
CAAAACCTGCCAACGAAAGTTCTCCAGGTCCGACCATCTGAAGACTCACACCAGGACTCA 
201 ---------+---------+---------+---------+---------+---------+ 260 
GTTTTGGACGGTTGCTTTCAAGAGGTCCAGGCTGGTAGACTTCTGAGTGTGGTCCTGAGT 




T G - 
Axolotl WTI cDNA 
AAGTTGTCCCATTTGCAGATGCACAACCGAAAGCACACAGGTGAAAAGCCGTACCAGTGT 
1 -------------------------------------------------------------- 60 
TTCAACAGGGTAAACGTCTACGTGTTGGCTTTCGTGTGTCCACTTTTCGGCATGGTCACA 
K L S H L Q M H N R K H T GE K P Y Q C 
GATTTTAAGGATTGTGAGCGGCGATTTTCCCGTTCCGACCAACTCAAAAGACATCAAAGA 
61 ------------------------------------------------------------ 120 
CTAAAATTCCTAACACTCGCCGCTAAAAGGGCAAGGCTGGTTGAGTTTTCTGTAGTTTCT 
D F K DC ERR F SR SD Q L K R 	Q R - 
AGACACACAGGTGTGAAACCATTCCAATGTAAAACCTGTCAGAGAAAGTTCTCTCGATCT 
121 --------+---------+---------+---------+ ---------+---------+- 180 
TCTGTGTGTCCACACTTTGGTAAGGTTACATTTTGGACAGTCTCTTTCAAGAGAGCTAGA 
R 	T G V K P F Q C K T C Q R K F SR S - 
GATCATTTGAAGACCCACACCAGGACTCATACAGGT 
181 ------------------------------------ 217 
CTAGTAAACTTCTGGGTGTGGTCCTGAGTATGTCCA 
D H L K T H T R T H T G - 
244 
Zebrafish Wfl genomic DNA, clone Zia (exons in bold) 
CGGCACGAGATAACAGCTAATCTGAACATAACTGTCACCTACAAATCAAACGCTTGTGCT 
1 ---------+---------+---------+---------+---------+---------+ 60 
GCCGTGCTCTATTGTCGATTAGACTTGTATTGACAGTGGATGTTTAGTTTGCGAACACGA 
R 	El TAN L NIT VT Y K S 	A CA - 
G T R * Q L 	* T * L S PT N Q T L 	L - 
A RD N S * SE H N C H L Q 1K R L C - 
AGCCTGCAGAGCTGTGTAGCCTAGCCTGCTGTGTTATCCTTGGGTGGGTCAAGGGAGACG 
61 ---------+---------+---------+---------+ ---------+---------+ 120 
TCGGACGTCTCGACACATCGGATCGGACGACACAATAGGAACCCACCCAGTTCCCTCTGC 
S L Q SC V A * PA V L S L G G SR E T - 
AC R A V * PS L L C Y P WV G Q G R R - 
PA EL CS LA C C V I L G WV K G 	V- - 
TCTGCCACTACAGTCGTAGGAACAGTGTATTTAGTTATCAATAGCACTTAACACTCATTC 
121 ------------------------------------------------------------ 180 
AGACGGTGATGTCAGCATCCTTGTCACATAAATCAATAGTTATCGTGAATTGTGAGTAAG 
SAT TV V G TV Y L V I N ST * H SF - 
L P L Q 5 * E 	CI * L S 	AL NT H S - 
C H Y SR RN S V F S Y Q * H L T L 	H- - 
ATTACTGTGCCAGCATACAGAAATGCCATTATGCTAAGCGCTAGTTAATTAAGAGCAGAT 
181 ------------------------------------------------------------ 240 
TAATGACACGGTCGTATGTCTTTACGGTAATACGATTCGCGATCAATTAATTCTCGTCTA 
IT V P A YR N Al ML SAS * L R AD - 
L L C Q H TEMP L C * A L  N * E  M - 
Y C A S I Q K C H Y A K R * L I K S R W- - 
GGGCTTCAGCAGCGGGTAAATGAGGGAAGCGGGAGGAACGGGGGAGCGAACGTGAAATAA 
241 ---------+---------+---------+---------+---------+---------+ 300 
CCCGAAGTCGTCGCCCATTTACTCCCTTCGCCCTCCTTGCCCCCTCGCTTGCACTTTATT 
G L Q Q R V NE G S G RN G GA N V K * - 
G F SS G * MR E AG G T GE R T * N K - 
AS A AG K * G K RE ERG SE RE I R- - 
GGTCTGCCTAACGTCGTGACTAACCGTCACAGTTAGAGCTCATATCAGCAGCACGGTGAT 
301 ---------+---------+---------+---------+---------+---------+ 360 
CCAGACGGATTGCAGCACTGATTGGCAGTGTCAATCTCGAGTATAGTCGTCGTGCCACTA 
G L P NV VT N R 	5 * SS Y Q Q H G 	- 
V CL T S * L TV TV R A HIS ST VI - 
S A * R RD * PS Q L ELI S A AR * S- - 
CGCATGATCATTCACAGCTATCTCAGTATGACCATGCATGCTATGATGCTTTTTTTTTTT 
361 ---------+---------+---------+---------+---------+---------+ 420 
GCGTACTAGTAAGTGTCGATAGAGTCATACTGGTACGTACGATACTACGAAAAAAAAAAA 
R MI I H S Y L S 	TM H A MM L F F F - 
A * SF TA I S V * PC ML * C F F F F - 
H D H SQL S 	Y D H A C Y D A F F F F- - 
TTTTGCAGATGTCTTGTTTGCTGTGCAGCATTTGTCGTAGCATTAGAATTGAACACTTGT 
421 ------------------------------------------------------------ 480 
AAAACGTCTACAGAACAAACGACACGTCGTAAACAGCATCGTAATCTTAACTTGTGAACA 
245 
F C 	C L V CC A A F V V AL EL NT C - 
FAD V L F A V Q H L S * H * N * T L 	- 
L Q MS CL L C S I C R SIR I E H L L- 
TGATTTTCTCGCAGGATGTGCGGAGAGTACCGGGCATCACTCCTGCCATTGTGCGTpCA, 
481 ---------+ ---------+---------+---------+---------+---------+ 540 
ACTAAAAGAGCGTCCTACACGCCTCTCATGGCCCGTAGTGAGGACGGTAACACGCAAGTT 
* F SR R MC GE Y 	A S L L PLC V Q - 
D FLAG C A ES T G H H SC H C A F N - 
IFS Q DV R R V PG IT PA IV R S T- 
- PCR sequence 
CCGAGACCAACGAAAAAAGGCCATTCATGTGCGCCTACCCTGGCTGCA3CWAGATATT 
541 ------------------------------------------------------------ 600 
GGCTCTGGTTGCTTTTTPCCGGTAAGTACACGCGGATGGGACCGACGTTGTTTTCTATAA 
PR PT K KG H SC APT LA AT K DI - 
RD Q R K K Al H V R L P W L Q Q K IF - 
E T NE KR P F MC A Y PG C N KR Y F-
TTAAACTGTCGCACTTACAGATGCACAGCCGTAAACACACAGGTGAGAGATCCCACAGGT 
601 ------------------------------------------------------------ 660 
AATTTGACAGCGTGAATGTCTACGTGTCGGCATTTGTGTGTCCACTCTCTAGGGTGTCCA 
L NCR T Y 	C TA V NT Q V RD PT G - 
* TV A LTD A Q P * T HR * El P Q V - 
K LB H L Q M H SR K H T GE R 5 HR C- 
GCTATTGTATGTCATAAGCAAAATGCTAAGGTTGTCGTTAACATGTTTGGTTGTGTTGAA 
661 ---------+ ---------+---------+---------+---------+---------+ 720 
CGATAACATACAGTATTCGTTTTACGATTCCAACAGCAATTGTACAAACCAACACAACTT 
A IV C H K Q N A K V V V NM F G C V E - 
L L Y VI S K M L R L S L T C L V V L N - 




721 ---------+---------+---------+---------+---------+---------+ 780 
GAGTATCCCCTCTTTGGGATAGTCACACTGAGTGTCTGACACCAGCGTCCAAGAGGTCT 
L 	GE K P Y Q CD FT DC 3 R R F SR - 
5 * G RN P I S V T S 	TV V AG S PD - 
HR GET L S V * L HR LW S 	V L Q I- 
TCAGACCAGCTAAAACGACACCAGAGAAGACACACAGGTTTGCACCATTGTCCATTTTTG 
781 ---------+---------+---------+---------+-------------------+ 840 
AGTCTGGTCGATTTTGCTGTGGTCTCTTCTGTGTGTCCAAACGTGGTAACAGGTAAAAAC 
SD Q L K R 	OR R 	T G L H H C P FL - 
Q T S * ND T RED T Q V C TI V H F C - 




841 --------------------------------------------------------- 897 
ATAAAAGAACATGAAGAAATATTGACGAACGATTTCCTGTTGTTTTAGTCATATCTC 
Y F L 	L L Y N CL L K D N K ISlE - 
IF L Y F FIT A C * R T T KS V * 	- 
F SC T S L * L LA KG Q Q N Q Y 	7- 
246 
Unsequenced region -2kb 
AAAAGGTGTGATAGCGGTCTGCACTGTTGACTTGTCAACAAAGTTCACTTTCACTCGCGT 
1 ------------------------------------------------------------ 60 
TTTTCCACACTATCGCCAGACGTGACAACTGAACAGTTGTTTCAAGTGAAAGTGAGCGCA 
KR CD S G L H C * L 	N K V H F H SR - 
KG VIA V C TV DL ST K FT FT R V - 
K V * * R S A L L T C Q Q S S L S L A F- - 
TCCAAGTTTCTGAATCCTCAATCAAACACATTTAGCGTGAGTGTTTGCTGATGTATGGCT 
61 ------------------------------------------------------------ 120 
AGGTTCAAAGACTTAGGAGTTAGTTTGTGTAAATCGCACTCACAAACGACTACATACCGA 
S K FL N P Q S 	T F S VS V C * C MA - 
PS F * IL N Q T H LA * V F A DV W L - 
QV SE S S 	K HI * RE CL L MY G 	- 
GAACAGGCAGACTCTCTTGGTCTCACATACTAATTTTTTTTTTTTTTTTTTTTGTGCTGA 
121 ------------------------------------------------------------ 180 
CTTGTCCGTCTGAGAGAACCAGAGTGTATGATTAAAAAAAAAAAAAAAAAAAACACGACT 
E 	ADS L G L T y * F F F F F FL C * - 
N R Q T L L 	S H TN F F F F F F CAD - 
T G R L SW S H IL 1FF F F F F V L T- - 
CACATTTGGCTAGGCGTTTCTGACCTGTGCCTCGTTCTGTTCTTGTTGTGTGCTTGTGTG 
181 ------------------------------------------------------------ 240 
GTGTAAACCGATCCGCAAAGACTGGACACGGAGCAAGACAAGAACAACACACGAACACAC 
H 1W L G V SD L C L V L FL L C A C V - 
T F G * A FL T CA SF C S C C V L  C - 
H L A R R F * P V P R S V L V V C L C V- - 
TGTGCGACCACACTTGTGTGTTCCTGTTGTTGTGTGTGTGTAGGCGTTAAGCCATTCCAG 
241 ------------------------------------------------------------ 300 
ACACGCTGGTGTGAACACACAAGGACAACAACACACACACATCCGCAATTCGGTAAGGTC 
CAT T L 	C S C C C V C V G V K P F Q - 
V R PH L C . V P V V V C V * AL S H 55-
CD H T CV FL L L C V C 	R * Al P V- - 
PCR sequence 
TGTGAAACCTGTCAGAGAAAGTTTTCACGTTCAGACCACCTTAAGACCCACACCCGGACA 
301 ---------+ ---------+---------+---------+---------+---------+ 360 
ACACTTTGGACAGTCTCTTTCAA.AAGTGCAAGTCTGGTGGAAPTCTGGGTGTGGGCCTGT 
CE T C Q R K F SR SD H L K T H T R T - 
V K P V RE SF H V Q T T L R PT PG L - 
* N L SE K V FT FR PP * D PH Q D 5- 
CATACAGGTAAAACAAGTGCGTAAACCTTTTCATTTTTTTCATGATTCGCTCCTCTCTTT 
361 ---------+---------+---------+---------+---------+---------+ 420 
GTATGTCCATTTTGTTCACGCATTTGGAAAAGTAAAAAAAGTACTAAGCGAGGAGAGAAA 
H T G K T S A * T F S F F S * F A P L F - 
I Q V K Q V R K P F H F F H D S L L SF - 
Y  * N K C V N L F 1FF MI R S S L 5- 
CCACTCTTTGATTTAAAGTTGAATTTTTACAGGTCACTTTTTTATCTCAGCTTGTACTGG 
421 ------------------------------------------------------------ 480 
247 
GGTGAGAAACTAAATTTCAACTTAAAAATGTCCAGTGAAAAAATAGAGTCGAACATGACC 
P L F DL K L N F Y 	S L F Y L SLY W - 
H S L 	* 5 * IF T G H F F I S A CT G - 




481 ------------------------------------------------------------ 540 
CTTCAATAATTTTTTTATAAACGTCACCAAAAAAATAACTATCGGTGACCAAAATCATAA 
E VI K K IF A V V FL L 	AT G F S 	- 
K L L K KY L Q W F F Y * * P L 	L 	F - 




L 	Q L * 	- 
SF NC? - 
H S TV ?- 
Zebrafish WTI predicted cDNA sequence 
GATGTGCGGAGAGTACCGGGCATCACTCCTGCCATTGTGCGTTCAACCGAGACCAACGAA 
1 ---------+---------+---------+---------+---------+ ---------+ 60 
CTACACGCCTCTCATGGCCCGTAGTGAGGACGGTAACACGCAAGTTGGCTCTGGTTGCTT 
DV R R VP G IT PA IV R S T E TN E - 
— PCR sequence 
AAAAGGCCATTCATGTGCGCCTACCCTGGCTGCAACAAAAGATATTTTAAACTGTCGCAC 
61 ------------------------------------------------------------ 120 
TTTTCCGGTAAGTACACGCGGATGGGACCGACGTTGTTTTCTATAAAATTTGACAGCGTG 
KR P F MC A Y PG C N KR Y F K L S H - 
TTACAGATGCACAGCCGTAAACACACAGGGGAGAAACCCTATCAGTGTGACTTCACAGAC 
121 ---------+ ---------+---------+---------+---------+---------+ 180 
AATGTCTACGTGTCGGCATTTGTGTGTCCCCTCTTTGGGATAGTCACACTGAAGTGTCTG 
L Q M H SR K H T GE K P Y Q CD FT D - 
TGTGGTCGCAGGTTCTCCAGATCAGACCAGCTAAAACGACACCAGAGAAGACACACAGGC 
181 ---------+---------+---------+---------+---------+---------+ 240 
ACACCAGCGTCCAAGAGGTCTAGTCTGGTCGATTTTGCTGTGGTCTCTTCTGTGTGTCCG 
C G R R F SR SD Q L K R 	Q R R 	T G - 
PCR sequence 	—* 
GTTAAGCCATTCCAGTGTGAAACCTGTCAGAGAAAGTTTTCACGTTCAGACCACCTTAAG 
241 ---------+---------+ ---------+---------+---------+---------+ 300 
CAATTCGGTAAGGTCACACTTTGGACAGTCTCTTTCAAAAGTGCAAGTCTGGTGGAATTC 
V K P F Q C ETC Q R K F SR SD H L K - 
ACCCACACCCGGACACATACAGGTAAAACAA 
301 ---------+---------+---------+- 331 
TGGGTGTGGGCCTGTGTATGTCCATTTTGTT 
T H T R T H T G K T 	- 
248 
Alignment of the nucleotide sequence of the coding region of the WTI orthologs 
- indicates no sequence change 
• indicates a deletion/insertion 
* indicates a conserved position in all species sequenced 
Exon 1 
Human 	ATGGGCTCCGACGTGCGGGACCTGAACGCGCTGCTGCCCGCCGTCCCCTCCCTGGGTGGC 
Mouse T ----------------------------------- T--GT-T--G ----- C 
Rat T -------------------------------------- GT"G ----- C--T 
Chick 	 G -------- C ------------------------ T ---- G -------- AC. . .CG 
***** ******** ************************ * ** * ** ** 
Glycine 5 encoding region 
Human 	CC, 4 CGGCGGCTGTGCCCTGCCTGTGAGCGGCGCGGCGCAGTGGGCGCCGGTGCTGGAC 
Mouse --CGG --------- C-GG--C -------------- ACG ------------ C --- T 
Rat 	 A ---------- GGC --------------- CG --- A 
Chick -CAAA CA"G------A----------------T--C--C 
** 	** *** * 	* ** ****** **** 	*** ***** ** ** ***** 
Proline 13 
Human 	TTTGCGCCCCCGGGCGCTTCGGCTTACGGGTCGTTGGGCGGCCCCGCGCCGCCACCGGCT 
Mouse C ----- T -------- C --------------- C ------- T -------- TTC 
Rat 	 --C ----- T -------- C -------------- AC ------- T -------- TTC 
ChickC- --- -------- G--C--...0-----C---C----. ..................... 
* 	** ***** ** ** 	***** ** **** 
encoding region 
Human 	CCGCCGCCACCCCCGCCGCCGCCGCCTCACTCCTTCATCAAACAGGAGCCGAGCTGGGCC 
Mouse -------- G--T -------- A--. . .0-----------------------C 
Rat ----------- T -------- A--.. .0-----------------------C 
Chick ....................... G -------------- G ----- A--C ------ AA- 
Human 	GGCGCGGAGCCGCACGAGGAGCAGTGCCTGAGCGCCTTCACTGTCCACTTTTCCGGCCAG 
Mouse C ----- A ----------------------------- CT-G ----- C--G 
Rat C ----------------------------------- CT-G ----- C 
Chick GTC ---------------- A --------- T ----- C -------- C ----- G 




Chick 	 G-----C ----- G ----- C ----------------- CG-C--G 
***** ** ** ***** ***** ******** ******** * ** ************ 
Human 	GCGTCATCCGGCCAGGCCAGGATGTTTCCTAACGCGCCCTACCTGCCCAGC TGCCTC GAG 
Mouse CC-----------------C--C--T-----------------------G 
Rat --------------------------C - C - -T-----------------------G- -- 
Chick 	C--C-C -------------------- C--CC-ACG -------------- A ------ 
** * ** ***************** ** * 	************** ****** *** 
Human 	AGCCAGCCCGCTATTCGCAATCAGG 
Mouse -------- TA- C --C -----CA 
Rat 	 T-C--C ----- CA 
Chick AAC -------- C---- 




Mouse -A -------------- T --------- G ---------- T--C -------------- TC 
Rat 	 -A--------------T---------G-A-----T--T--C 
Chick G ---- -CCGT -------- PG -------- C -------- G--T ----- C 
Alligator 	------------- -3G-GT ------ CCG -------- C --- G-T ----------- C 
* *** **** ** * ** ****** * ** ** ** ** *** * ** ** ** ** * 
Human 	CGGCCCAGTTCCCCAACCACTCATTCAACCATCAGCATCCCATGGCCCAGCAGGGCTCCCTCG 
Mouse ------------------- T--C ----- A-- C ----- C 
Rat 	 -A--------------T--T--C-----A--C-----C 
Chick -C--------T-AG--------T-----A--C--A--C------A--------CCA--T--A- 
Alligator 	-C --------- T ---------- C -------- C ----- C ----- C-C ------- ACTCA 





MarsupialMouse 	 GC-----T--------------A--T-----G ------------- 
Chick 	-G--C ----------------- C--T ----- G--C ----- T ----------- GCG 
Alligator -A--C-----------------C--C-----C--C-----------C-----C 
* ** ********** ***** ** ** ** ** ** ** ***** ** ** **** * 
Exon 4 
Human 	CCACCCCCAGCCACCCTTTCCTCCTCACCACCCCCTACACCAGTCACAATTTATACCAAA 
Mouse ----------- CC ---- C 
Rat ---- A ----------- CC ---- C ----------------------------------- C 
MarsupialMouse ---------------- CC ------- CC ---- T ------- A ---------- C-C ------- 
Chick ----C-----------CC----C---C----C-------A------------C 
Alligator 	----C-----------CC----C---C----C-------A 
**** *********** **** ** **** ******* ********** * ***** * 
Human 	TCACATCCCAGCTTCAATGCATCACCTCCAATCACATCAACTTAGCAGCCACCTTAAACCC 
Mouse -  - - -C------------------------------------C-------T 
Rat----C-----------C--------------C---------CC-----T-----C 
Marsupial Mouse ----C--C-----A-----------------C---------C----C-----AC-C ----- 
Chick 	----C--A-CA--C-----------A-----C--A------C-C---T----CC-C ----- 
Alligator CG ----------------- A -------- A -------- CTA 




Rat 	 -A-C 
Pig ------------ A------------ A 
* * ******** ************ ************************* 
Exon 6 
Human 	CCACACCACACCCTACCACACCCATAACCACACAACCCCCATCCT ......CTCCCCACC 
Mouse ---- G-T-T ------------ T--C -------- CC-C ----------------- TT 
Rat ----C----------------T--C-----------C-----------------TT 
Marsupial Mouse -----C------A--T--A-AT-----------C--T--G-----------G--T ----- 
Chick 	--- T-CG ----- A- -T--A-AT- -C-------CTC-T-----CT-ATACAC- --T--G- - 
Alligator TCCA ----- ATAATC -------- TCTTCTATATACT----- 




Rat --- G -------------- C ------------ C ------------ 
Marsupial Mouse ------T-----------T--T--C-----T-----A--A--A 
Chick ------------------ C --T--A-----T--------A--A 
Alligator 	------------------C --T--A--T--T-----A--A--A 
*** ** *********** ** ** ** ** **** ** ** 
Exon 7 
Human 	GATGTGCGACGTGTGCCTGGAGTAGCCCCGACTCTTGTACGGTCGGCATCTGAGACCAGT 
Mouse C ----- AT ------- G ----- A -------- C ----- A -------- A 
Rat G--C--AT-------G-----A--------C-----A--------A 
Marsupial Mouse -----C--G--A-----C--G--------T---A-C--GA----A--CA-G-- -----A- 
Chick 	 C-----  A ----- A ------ T ------ ACAAAG ------ AA 
Alligator CGA ----- A -------- TAACAAAG ------ AA 
Zebrafish 	-------- GA-A--A--G--CA-CA-T--TG-CA --G--T--AA-...0 ------- AC 
***** ** * ** * ** * * ** * * ** * ** * 	** ** * 
Human 	GAGAAACGCCCCTTCATGTGTGCTTACCCAGGCTGCAATAAGAGATATTTTAAGCTGTCC 
Mouse T--T-----------A 
Rat 	 GT--T ----------- C 
Marsupial Mouse -----------A-----------AT-----------C--------C 
Chick --A -------------------- C ----- C -------- C  -- C - - - -C - C 
Alligator 	--A ----- T -------------- A ----- T ----- T ------ CC ------ TA 
Xenopus C -------- A ----- C -------- CCAT 
Zebrafish 	--A---A-G--A--------CC-----T--------C--A-----------A-----G 
** ** * ** ******** ** ** ** ** ** ** ** **** ** ** * ** 
Exon 8 
Human 	CACTTACAGATGCACAGCAGGAAGCACACTGGTGAGAAACCATACCAGTGTGACTTCAAG 
Mouse --------------T--- C  
Rat ------------------ C 
Marsupial Mouse --------------T-----------T------------ --C 
Chick --TC----------------A---- ----------A--------T--------
Alligator 	--T-----------------A--------------A -------------------- 
Xenopus TG-----------------A-----A--G--A-----G-----------T--T--A 
Zebrafish 	------------------ C-T--A ----- A--G -------- C--T ------------- CA 
** * ******** *** * ** ** ** ** ** ***** ** ******** ** * 
Human 	GACTGTGAACGAAGGTTTTCTCGTTCAGACCAGCTCAAAAGACACCAAAGGAGACATACA 
Mouse CGA ------------- C -------------------------------- C  --- 
Rat CGA ------------- C ----------------- C -------------- C --- 
Marsupial Mouse -----------CC-A--C-----A--------A-----------------------C ---
Chick --------------  A ----------------- AGCG --------- CC 
Alligator 	-------- GAA ----- C ----------- A ------ C ----------- C ---- C ---  
Xenopus -------- GA-GC-A--------------TAT-----G-----------GC 
Zebrafish 	------- GT- -C ----- C--CA-A ----------- AC ------- G--A ----- C 




Mouse -----------------------------------------T--------------T---  
Rat 	 ----------------------------------------- T 
Marsupial Mouse --------------------------C------A----------------T --------- 
Chick 	----------- C ----- A -------- C ------ A ----------- AATTT 
Alligator ----------- C -------------- C ------ A ---------- TATTTA 
Xenopus 	---A-C ----- T ----- A--C ----- CCA ------------ A ---------- T --- 
Zebrafish CTG ------------ GC ------ A ------- TATA -------- T 
** * ** ** ***** ** **** ** ** ******* ** * ** ** ** ** 




Marsupial Mouse -----A---------------------------- 
Chick 	 T--T 
Alligator T 
Xenopus 	 T 
Zebrafish ------------ 
***** ** ** **** **************** 
Exon 10 
Human 	GTGAAAAGCCCTTCAGCTGTCGGTGGCCAAGTTGTCAGAAAAAGTTTGCCCGGTCAGATG 
Mouse --------------------------- AC-------------------- G--C -----C -
Rat -------------------------- TAC -------------------- G -------- C 
MarsupialMouse -------------------C--------C--------------A--------C ------- 
Alligator 	------- A--A ----------- A ----- C--C ----- A ----- A ------ 
******* ** ******** ** *** 	** ***** **** ***** * ** ** * 
Human 	AATTAGTCCGCCATCACAACATGCATCAGAGAAACATGACCAAACTCCAGCTGGCGCTTTGA 
Mouse ----G 
Rat 	 ------------------- G-----C 
Marsupial Mouse -------G--T--C-----------C--A--G--------G--G---------A------A- 
Alligator------- T--T -------------- C ----- G -------- T ----- G --- T ---- C 
**** ** ** ** ***** ***** ** ** ******** ** ** *** ** * **** * 
252 
Appendix B 
Structure prediction plots for WTI orthologs 
Chou and Fasman prediction plots of a helix, 0 strand, and 3 turns were produced 
for WD orthologs. Hydrophobicity profile using Kyte and Doolittle algorithms also 
were generated using pepplot (GCG). The plots for human and the most diverged 








Structure Prediction Profile for Human WTI, Exon 1 
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Structure Prediction Profile for Chick WTI, Exon 1 
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Structure Prediction Profile for Human WTI, Exons 2-6 
Chou 
Fom 
150 	 200 	 250 	 300 
	
I I I 























150 	 200 	 250 
257 
Structure Prediction Profile for Alligator WT1, Exons 2-6 
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Structure Prediction Profile for Zebrafish WT1, Exons 7-9 
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